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Oral cavity cancer (OCC) is a public health problem, with approximately 355,000 new 
cases and over 177,000 deaths occurring globally per year. In comparison with many other 
cancers, 5-year survival rates for OCC are relatively poor and there has been limited 
improvement in these rates over the past few decades. Delay from first symptom to referral 
for diagnosis is a risk factor for advanced stage presentation and subsequent poorer 
survival. By contrast, the treatment of small, early-stage lesions is associated with reduced 
morbidity and mortality. The oral cavity has been described as a site which is relatively 
easy to examine, and it has therefore been proposed that improvement in outcomes should 
be possible through implementation of guidelines associated with the examination of the 
mouth and surrounding tissues for oral cancer and oral potentially malignant disorders 
(OPMDs), this process is described as a conventional oral examination (COE). 
An initial review of the literature showed that although there have been a number of 
systematic reviews and numerous clinical guidelines on the topic of the COE, there has 
been limited consistency and insufficient evidence available to support clear practice. 
Uncertainties remain around a number of factors associated with the examination process 
including: a) the method of conducting the COE, b) the target population, i.e. high risk or 
universal approach, c) the frequency of the oral cancer examination procedure, and d) the 
extent to which adjunct tools are used. Additionally, there is some ambiguity and limited 
information available on the clinical practice and views of oral health care professionals 
(OHCPs) and patients around these issues and the barriers and facilitators to implementing 
the COE in the primary dental care setting. 
This thesis describes three studies which were undertaken to try and address the identified 
gaps in the knowledge and evidence base. The first study was a systematic overview of 
systematic reviews and published clinical guidelines and aimed to identify best practice in 
relation to oral cavity cancer early detection/ screening.  The themes explored were based 
on the four factors associated with the examination process which were outlined above. 
The findings were used to develop the subsequent two studies. The second study explored 
the findings of the systematic overview among OHCPs in dental primary care in Scotland 
and the Sultanate of Oman (the home country of the author of this thesis). Qualitative in-
depth interviews were undertaken with the dental professionals to investigate current 
practice in relation to the COE process and to identify barriers and facilitators to 
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implementation. Analysis was performed using an up-to-date model of behaviour change – 
the Behaviour Change Wheel. The interviews also asked for views on the development of 
risk-based tools to facilitate the prevention and early detection of OCC. The third study 
was a qualitative survey of dental primary care patients from the two countries to explore 
their perceptions of the barriers and facilitators to a COE and to obtain their views on the 
acceptability of risk-based interventions.  
The systematic overview found that while there was a lack of evidence per se on the 
effectiveness of opportunistic screening, the conclusions of the high quality systematic 
reviews and clinical guidelines broadly advocated this approach. The high quality 
systematic reviews tended to suggest that the COE was more effective in high prevalence 
populations and also when performed in high risk individuals (defined as those who use 
tobacco and consume alcohol). However, there was insufficient evidence to support only 
conducting a COE, or doing so in a more detailed and focused way, in high risk dental 
patients. There was limited evidence, but some clinical guideline support for a risk-based 
recall interval for conducting a COE, based on assessed oral cavity cancer risks (3-6 
months for patients at high risk, and 1-2 years for those at low risk). There was no 
evidence for the effectiveness or role of adjunct technologies to support the COE in dental 
primary care for the early detection / screening of oral cavity cancer. 
The qualitative studies found that COEs were generally performed by oral health care 
professionals during dental check-ups, although patients were often not aware of this 
procedure or that it was undertaken for early detection / screening of oral cavity cancer. 
There were some variations in clinical practice with regard to how COEs were performed 
in both Oman and Scotland and also on whether a general or targeted approach was 
adopted. Most OHCPs used a universal approach, while some targeted - based on age and 
behavioural risk factors. This perhaps reflects the inconclusive results of the systematic 
overview in this area. The frequency of patient recall was generally reported to be every 
six months in both countries, and this is broadly in agreement with the evidence base, 
although some guidance supports a risk-based approach. While some OHCPs supported 
more frequent recalls for higher risk patients, there was some reluctance to increasing the 
time between visits as it was perceived that low-risk patients might not receive optimal 
care. Many of the dental professionals considered a risk-prediction tool worthy of further 
exploration, but some concerns were expressed about feasibility, particularly in relation to 
resource issues. In general, patients indicated they would consider attending more 
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frequently (3-6 months) if identified as being in a high risk group. However, they were 
somewhat more reluctant to agree to attend less often if they were identified at low risk. 
Dental patients interviewed seemed, in general, to be happy to be assessed for their oral 
cancer risk. While the OHCPs were concerned about using the term “oral cancer”, many 
patients, particularly those in Scotland, did not seem to have a problem with it. Adjunct 
methods were not used by the OHCPs. However, rather than this practice always being 
based on knowledge of the evidence base, other barriers were also cited. In Oman this was 
reported to be due in part to a lack of availability of the technologies, while some in 
Scotland mentioned time and resource constraints. Some other differences in OHCP 
responses were found between the two countries, for example – restrictions in social 
opportunities to conduct a COE in Oman and variations in the reported barriers to the COE 
(lack of guidance and training in Oman, and time and remuneration issues in Scotland). 
The commonalities and differences in identified barriers and facilitators between Oman 
and Scotland indicate opportunities to support implementation of best practice, elicited 
from the systematic overview, at both clinical and policy levels. Furthermore, research 
opportunities have been identified, for example, related to the development of a risk 
assessment tool to support the prevention and early detection of OCC in dental primary 
care. Such theory-based interventions at the clinical, policy and research levels have the 
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Chapter 1: Literature review 
1.1 Introduction  
The thesis focuses on evaluating the evidence in relation to the examination of a patient for 
oral cavity cancer and explores how best to support this practice in primary dental care.  
This chapter sets out the literature relevant to this topic area and provides a context for the 
chapters which follow.  Initially, a brief overview of non-communicable diseases and 
cancer is provided, followed by a summary of the definitions, epidemiology and clinical 
presentation of head and neck, oral cavity cancer and oral potentially malignant disorders.  
Thereafter a description of relevant risk factors and preventive approaches is described. Of 
particular relevance is secondary prevention and the importance of detecting lesions at an 
early stage. Various types of screening are described, followed by a summary of the 
literature relating to factors associated with an examination of the oral cavity for oral 
cancer. This includes the potential techniques and methodologies that can be used and the 
perceptions of oral health professionals and patients around “screening”/examination of the 
mouth for oral cavity cancer. Finally, the summary of the literature will include 
identification of uncertainties and gaps in the literature and this will provide the rationale 
for the studies undertaken and presented in this thesis. 
1.2 Non-communicable Diseases 
In 2016, around 40.5 million deaths were caused by non-communicable diseases (NCDs) 
worldwide, accounting for 71% of all global deaths  (Bennett et al., 2018). An estimated 
80% of these NCD deaths were due to a combination of cardiovascular diseases, cancers, 
diabetes and chronic respiratory diseases. Approximately two thirds of the estimated NCD 
deaths occur in low- and middle-income countries. Genetic, physiological, behavioural and 
environmental factors are the main causes of NCDs (WHO, 2011; Balbus et al., 2013). The 
NCD Countdown 2030 collaboration (Bennett et al., 2018) advocates for policies that will 
reduce risk factors and determinants and calls for equitable access to high quality and 
effective preventive, diagnostic and treatment services for NCDs. Such policies are very 
relevant for the prevention, early detection/ screening and treatment of oral cavity cancer. 
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Among the NCDs, cancer remains the second leading cause of death around the world 
(WHO, 2018). In 2018, approximately 9.6 million deaths occurred at the global level due 
to cancer, accounting for about one in six deaths. Cancer is described as a “large group of 
diseases that are characterised by abnormal growth of cells (tumour) beyond the limits of 
their usual boundaries, often accompanied by invasion into adjoining parts of the body and 
spread to other organs” (WHO, 2018). Health professionals often refer to cancers based on 
their histological type such as squamous cell carcinoma, verrucous carcinoma or 
undifferentiated carcinoma. However, they and the general public also use cancer names 
based on their primary sites, such as lung, breast, colon, prostate, uterus, skin, and head 
and neck cancer (NIH, 2019).  
1.3 Head and Neck Cancer 
Head and neck cancer (HNC) sites include the oral cavity, pharynx, larynx, paranasal 
sinuses, nasal cavity and salivary glands (NIH, 2019). Most head and neck cancers develop 
in the squamous cells in the upper aerodigestive epithelium (Argiris et al., 2003; Rivera, 
2015) and are known as squamous cell carcinomas.  In 2018, head and neck cancer was 
described as the seventh most common cancer across the world, with just under 900,000 
new cases and 450,000 deaths (Bray et al., 2018). Estimated HNC incidence rates vary 
widely around the world, from 26.3 per 100,000 persons in Melanesia to 2.2 per 100,000 
persons in Western Africa (Hashim et al, 2019). This is likely due to differing rates of 
exposure to the main risk factors. Hashim and co-authors (2019) also report that the 
average age of HNC diagnosis is between 50 and 70 years and that the incidence rate is 
higher in males than females, with the ratio ranging from 2:1 to 4:1.  
Very many cases of HNC are diagnosed at an advanced stage with consequent impact on 
survival rates and morbidity due to less effective treatment and more radical surgery to 
organs required for functions such as speech and swallowing (Hashim et al, 2019). In 
addition to surgery, radiotherapy and chemotherapy can impact outcome (Pauloski et al., 
1998; Jehn et al., 2019), including quality of life (QoL) (Van der Waal et al., 2011; Wong 
and Wiesenfeld, 2018).There is, however, a high level of heterogeneity among head and 
neck sites in terms of epidemiology, natural history, treatment and prognosis (Chow, 
2020). Consequently, it is important to focus on specific sites of interest when undertaking 
work aimed at gaining a better understanding of the disease from the perspective of 
burden, risk factors, diagnosis, treatment and preventive services. The term “oral cancer” 
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has often been used in the literature to describe a subgroup of HNCs, but this can be further 
divided into oral cavity and oropharyngeal groups, and the former grouping is the focus of 
this thesis.  
1.4 Oral Cancer Definition 
Within both the peer-reviewed literature and cancer registry reports, oral cancer has many 
definitions, with different terms used and variations in subsite inclusion (Conway et al., 
2018). Attribution of specific subsites to either the oral cavity or the oropharynx can vary, 
and some subsites have been included in both. Consensus is important to allow study of 
factors such as epidemiological trends, aetiology and tumour behaviour.  
The standard classification disease codes relevant to cancer sites are the World Health 
Organization’s International Statistical Classification of Diseases and Related Health 
Problems 10th revision (ICD-10) and the International Classification of Diseases for 
Oncology (ICD-O). Recently, Conway and co-authors (2018) have reviewed the ICD-10 
codes and recent major epidemiological studies and have suggested a “compromise” 
method for defining oral cavity and oropharyngeal cancers. This is based on anatomy and 
association with human papillomavirus (HPV). Using this method, the oral cavity has been 
defined as the sites: the inner lip (C00.3-C00.9), other and unspecified regions of the 
tongue (C02) (excluding lingual tonsil [C2.4]), gum (C03), floor of mouth (C04), palate 
(C05), and other unspecified parts of the mouth (C06). The oropharyngeal cancer sites 
have been defined as: the base of the tongue (C01), lingual tonsil (C2.4), tonsil (C09), 
oropharynx (C10), and pharynx unspecified including Waldeyer’s ring / overlapping sites 
of oral cavity and pharynx (C14). 
1.5 Oral Cavity Cancer  
The US National Cancer Institute has used a slightly different definition of the oral cavity 
to that outlined above, namely, it has described it as including “the lips, the lining inside 
the cheeks and lips, the front two thirds of the tongue, the upper and lower gums, the floor 
of the mouth under the tongue, the bony roof of the mouth, and the small area behind the 
wisdom teeth”  (NCI, 2020). 
The oral cavity is lined by oral mucosa, which is mainly stratified squamous epithelium 
and a lamina propria of dense connective tissue (Syrjänen, 2003). The epithelium tends to 
4 
 
be keratinized in areas which are subject to continuous friction such as the hard palate 
(Bruch, 2017). In highly mobile areas, such as the soft palate and the floor of the mouth, 
the lamina propria is connected to the underlying structures via loose submucosal 
supporting tissue, whereas in the bony areas, such as the hard palate, the lamina propria is 
bound to the periosteum by a dense fibrous submucosa (Kumar, 2015).  
Oral cavity cancer develops when cells undergo changes known as “mutations” (Rivera, 
2015). It most commonly starts in epithelium cells, with almost 90% being oral squamous 
cell carcinoma in origin (El-Naggar et al, 2017). What causes cell mutation is still unclear, 
but there are number of risk factors that have been identified and may increase the risk of 
mouth cancer (West et al., 2006; Antunes et al., 2013; Winn et al., 2015). These will be 
explored further in Section 1.8. 
1.5.1 Global Patterns of Oral Cavity Cancer 
Oral cavity cancer (OCC) has been described as a public health problem which carries 
significant morbidity and mortality (McGurk, 2010).  In 2018 it was estimated that cancers 
of the lip and oral cavity combined represented the 16th most common cancer globally, 
with approximately 355,000 new cases and over 177,000 deaths during that year (Bray et 
al., 2018). The site definition was based on the WHO Classification of head and neck 
tumours (El-Naggar et al, 2017) and extended from the lip to buccal mucosa, with 
inclusion of the tongue, mouth, floor of mouth and palate. It is recognised that incidence 
rates and deaths vary greatly across the world and it therefore important that there is an 
understanding of these regional patterns to enable the development of relevant preventive 
and treatment strategies. 
An update of global patterns and trends of cancers of the lip, tongue and mouth has 
recently been published (Miranda-Filho and Bray, 2020). The information relating to 
incidence and death rates were extracted from IARC’s GLOBOCAN database of national 
estimates, available at the Global Cancer Observatory. Overall, incidence and mortality 
rates were higher in males than females, with age-standardised incidence rates per 100,000 
ranging by region from 0.5 to 21.2 in males and from 0.5 to 12.0 in females. In relation to 
both incidence and mortality, the countries with the highest rates included Papua New 
Guinea, Pakistan, India, Bangladesh and Afghanistan. The authors stated that cancers of 
the lip, tongue and mouth combined were the most common form of cancer in males in 
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both India and Pakistan, and the second most common in Papua New Guinea. They also 
examined temporal trends in the incidence of mouth cancer and reported most national 
registries, including some European countries, are showing a decreasing trend in males. In 
contrast, for females, a different pattern is being observed, with increasing rates seen in 
most populations, particularly in many European countries. 
1.5.2 Patterns of Oral Cavity Cancer in Oman and Scotland  
As this thesis relates to work conducted in the Sultanate of Oman (referred to as Oman) 
and in Scotland, it is relevant to describe the patterns of OCC in these two countries. 
1.5.3 Patterns of Oral Cavity Cancer in Oman  
A hospital-based registry, known as The Oman Cancer Registry, was established in 1985 
and since 1996 this has functioned as a population-based cancer registry. A comprehensive 
report on ‘Cancer Incidence in Oman’ is published annually by the Department of Non-
Communicable Disease, and the report for 2016 was published in 2019 (MOH, 2019).  
The report provides data on incidence rates, based on the estimated mid-year population. 
The age standardised rates, adjusted to the world standard population, for all cancers 
among Omanis in 2016 were 67.4 per 100,000 for males and 79.3 per 100,000 for females. 
The annual report does not refer to oral cavity cancer (OCC) as an entity but does, 
however, provide data for head and neck cancer. Additionally, age-adjusted incidence rates 
are presented for the ICD-10 codes relating to the individual sites of lip (C00), tongue 
(C01-02) and mouth (C03-06).  
In the report for 2015 (MOH, 2018), HNC was listed as the 9th most common cancer in 
Oman. In the following year, it was not within the list of the 10 most common cancers. For 
this latter year, the age standardised incidence rate for head and neck cancer was 3.0 per 
100,000 for males and 1.9 per 100,000 for females. The trends in head and neck cancer 
over the past 20 years show a fall from approximately 5.0 to 3.0 per 100,000 for males, 
while the age standardised incidence rate for females has remained stable at around 2.0 per 
100,000.  
The annual report also compares the age-standardized incidence rate (per 100,000) of HNC 
in Oman with selected other countries in the region, for the years 2008-2012. The 
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estimated value for females in Oman was similar to Bahrain and lower than other Gulf 
Cooperation Council (GCC) countries (e.g. Kuwait and Qatar), while the rate for Omani 
males was the lowest rate among other GCC countries (MOH, 2018). 
The age standardised incidence rates presented in the 2016 annual report (MOH, 2019) for 
cancers of the lip, tongue and mouth have been combined for the purposes of this thesis to 
produce a rate for ‘oral cavity cancer’.  These rates (per 100,000) were 1.4 for males and 
1.3 for females. The trends in incidence rate of oral cavity cancer in Oman for males and 
females from 1996 to 2016 are shown in Figure 1.1. 
 
Figure 1.1 The trends in the age-standardised incidence rates per 100,000 of oral 
cavity cancer in Oman, 1996-2016 
 
Source: Data from Ministry of Health - Oman 
1.5.4 Patterns of Oral Cavity Cancer in Scotland 
A recent article by Conway and co-authors (Conway et al., 2018) described the 
epidemiology of oral cavity cancer across the UK.  Data from individual cancer registries 
in Scotland, England, Wales and Northern Ireland were re-analysed using the site 
definitions described in Section 1.3 to allow a standardised inclusion of codes and 
meaningful comparison of rates among countries. For Scotland, the age-standardised 
incidence rates (per 100,000 person-years) for OCC in 2016 were 10.0 for males and 5.6 
for females. These rates were higher than in the other UK nations for both genders. For 
7 
 
males in 2016, the incidence rate for OCC in Scotland was similar to that for 
oropharyngeal cancer (10.0 and 9.7 per 100,000, respectively), while for females the rate 
for oropharyngeal cancer was lower at 2.7 per 100,000. The burden of both oral cavity 
cancer and oropharyngeal cancer is higher for those from socio-economically 
disadvantaged areas. 
According to Conway, Purkayastha and Chestnutt, (2018) trends in the incidence rates for 
oral cavity cancer in Scotland (males and females combined) remained relatively stable 
between 2000 and 2016. They were consistently higher than those observed in the other 
UK countries over the time period, although a steady rise in rates was seen in both England 
and Wales. The trends for oral cavity cancer in Scotland differ to those seen for 
oropharyngeal cancer.  Over the same period a rapid rise in the incidence of oropharyngeal 
cancer has been seen both in Scotland and the other UK nations.  Analysis of data from 
Scotland and England has projected that the incidence rates of oropharyngeal cancer will 
overtake those of oral cavity cancer over the next decade.  
Ingarfield and co-workers (Ingarfield et al., 2019) have investigated the survival of head 
and neck cancer patients in Scotland from an inequalities perspective. Based on a cohort of 
head and neck cancer patients, unadjusted models showed a clear gradient in survival 
across deprivation groups at 1-, 5- and 12-years. Following adjustment for patient, tumour 
and treatment factors (for example: age, sex, smoking and alcohol behaviour, site and stage 
of the tumour) the inequality was no longer present, suggesting that many factors play a 
role in the inequality of survival of patients with head and neck cancer. 
1.5.5 Clinical Presentation of Oral Cavity Cancer 
Oral cavity (or mouth) cancer can present in a number of different ways (Lewis, 2018) and 
a major problem is that many cases present at an advanced stage with consequential 
impacts on survival rates and quality of life. Lewis (2018) has pointed out that tumours 
within the oral cavity grow at different rates and that the size of the lesion and presence or 
absence of regional metastatic spread at the time of diagnosis is more important than how 
long it has been present. However, it is acknowledged that an advanced stage of the tumour 
is very often associated with late diagnostic detection of the disease (Hashim et al, 2019).  
A classical presentation is described as a single deep ulcer with rolled margins on the 
lateral border of the tongue. However, it can also present as a swelling, as erythema or as 
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speckled red and white patches. The site, size, and clinical and histological appearance of 
OCC all influence survival rates (Lewis, 2018). 
Oral cavity cancer does not, however, have mutually exclusive signs and symptoms 
(McGurk and Scott, 2010). Thus, many lesions of the oral cavity, for example some white 
patches such as frictional keratosis, will not have any malignant potential, while others 
may have mucosal abnormality and be potentially malignant.  This has important 
implications for the examination of the mouth for oral cavity cancers in primary dental care 
and for the appropriate referral of patients with “suspicious lesions” to secondary care 
(McGurk and Scott, 2010). This will be discussed in greater depth later in the thesis.  
1.6 Staging of Oral Cavity Cancer    
Cancer Research UK (NCI, 2015) indicates that mouth cancer can be staged using the 
number staging system or the TNM classification.  As indicated in Table 1.1 below, the 
numbering system usually divides mouth cancer into four main stages, with stage 1 
representing an early cancer and stage 4 an advanced cancer. Additionally, stage 0 is 
sometimes used to describe cancer at a very early stage, described variably as carcinoma in 
situ or pre-cancer.  
Table 1.1 Mouth cancer staging  
 
Stages Descriptions 
Stage 0 Carcinoma in situ or pre-cancer. There are abnormal cells but they are contained within 
the lining of the mouth with no spread. 
Stage 1 The earliest stage of invasive cancer. The cancer is 2 cm or smaller and no more than 5 
mm deep. There is no spread to nearby tissues, lymph nodes or other organs. In the 
TNM staging system this is T1, N0, M0. 
Stage 2 The cancer is larger than in stage 1 (can be up to 4 cm in size and 10 mm in depth) but 
has not spread to nearby lymph nodes or other organs. In the TNM staging system this 
is T2, N0, M0. 
Stage 3 The cancer is larger than 4 cm or 10 mm deep with no spread to lymph nodes or other 
parts of the body: T3, N0, M0; or the cancer is any size but one lymph node on the 
same side has cancer cells, with the lymph node being no more than 3 cm across: T1, 2 
or 3, N1, M0. 
Stage 4 The cancer is advanced. This is further divided into three stages: 4a, 4b and 4c.  In 
stage 4c, the cancer has spread to other parts of the body such as the lungs or bones: 
any T, any N, M1. 
The stage of the cancer influences both treatment options and outcomes. Detection of oral 
cavity cancer in the early stage, when the lesion is less than 2 cm with no local spread or 
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metastasis (stage 1) is associated with a high 5-year survival rate of around 85%, whereas 
for a stage 4 tumour, the 5-year survival rate is only around 10% (Lewis, 2018).  
It is now understood that oral cavity cancers arise from non-invasive lesions of the 
stratified squamous epithelium and that histologically these lesions can range from normal 
mucosa to high grade dysplasia / carcinoma in situ, representing a model of neoplastic 
progression (Ray, 2017). These conditions are known as Oral Potentially Malignant 
Disorders (OPMD) (Lewis, 2018), with the advanced end of the spectrum corresponding to 
Stage 0 described above. 
1.7 Oral Potentially Malignant Disorders (OPMD) 
Oral potentially malignant disorders (OPMDs) consist of a diverse group of conditions that 
may precede the development of oral squamous cell carcinoma. In 2020, a comprehensive 
review of the clinical and management aspects of OPMDs was published 
(Warnakulasuriya, 2020). This described the changing terminologies used over the past 
decades, conditions and definitions within this group, prevalence and risk factors 
associated with the disorders, as well as clinical appearance, malignant transformation 
rates and management options.  
Ray (2017) has also reported on the historical evolution of terminologies associated with 
oral disorders and related cancers. Until 2007, the terms commonly used to describe oral 
potentially malignant disorders were “precancer” or “premalignant” lesions or conditions. 
However, following an expert group meeting of the WHO Collaborating Centre for Oral 
Cancer, these terms were replaced with the OPMD terminology. This combined the terms 
“lesion” and “condition” into that of “disorder” and used the term “potentially malignant” 
in recognition of the fact that not all disorders would progress to malignancy over time 
(Warnakulasuriya, 2020).   
Many conditions are recognised as OPMDs, meaning that a patient with any of these 
disorders has an increased risk of developing mouth cancer compared to those with a 
healthy oral mucosa. The most common and / or important OPMDs include: leukoplakia; 
erythroplakia; erythroleukoplakia; proliferative verrucous leukoplakia; oral submucous 
fibrosis and oral lichen planus. Definitions exist for each of these disorders and it is 
important that these are used both in clinical practice and for epidemiological purposes 
(Warnakulasuriya, 2020).  For example, misclassification of oral leukoplakia, to include 
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white patches which carry no increased risk of oral cancer, can lead to a diverse range of 
prevalence figures being reported for this condition.  
Ray (2017) has noted that it is difficult to get accurate data on the global prevalence of 
OPMDs as information is sparse. However, according to a recent systematic review (Mello 
et al., 2018),  epidemiological surveys have estimated a global prevalence of OPMDs of 
around 4.5%, with variation among different populations.  The prevalence is generally 
higher among Asians and males and the average age of patients with OPMDs is said to be 
between 50 and 69 years.  
Warnakulasuriya (2020) reports that there is no consistent pattern regarding the natural 
history of OPMDs and that it is difficult to predict which lesions will progress onto cancer. 
A systematic review of observational studies related to oral leukoplakia showed a very 
wide range of malignant transformation rates (0.1% to 34.0%) (Warnakulasuriya and 
Ariyawardana, 2016). The OPMDs at high risk of malignant transformation include 
erythroplakia, eyrthroleukoplakia, proliferative verrucous leukoplakia and oral submucous 
fibrosis, while Warnakulasuriya (2020) has stated that the risks are lower in homogeneous 
leukoplakia and in oral lichen planus. 
The major risk factors for the most common OPMDs are tobacco (both smoked and 
smokeless), high alcohol consumption and chewing betel quid containing areca nut 
(Warnakulasuriya, 2020).  
Following diagnosis of an OPMD, patient management involves assessing risk, providing 
advice on risk factors, selecting an appropriate intervention and providing follow-up. 
Assessing risk is based both on individual risk factors and on clinico-pathological findings. 
These factors include age, ability to moderate lifestyle risk factors, presence of red areas in 
white and red patches and the grade of dysplasia identified pathologically 
(Warnakulasuriya, 2020).  
As a result of evidence from a systematic review (Mehanna et al., 2009) suggesting that 
excision of lesions may reduce the risk of transformation, it is recommended that high risk 
lesions should be excised.  However, due to the potential presence of field change within 
the oral mucosa, excision of a lesion may have limited effectiveness (Thomson, 2015; 
Lingen et al., 2017).  
In summary, OPMDs are important risk factors for the development of oral cancer. 
Important points to note include: the use of agreed terminology; accurate diagnosis; 
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primary and secondary prevention relating to the main modifiable risk factors; excision of 
lesions where appropriate; and regular follow-up of patients at intervals determined by an 
individual risk assessment. 
1.8 Risk Factors of Oral Cavity Cancer  
Due to the relatively low incidence of OCC and the lag time between exposure to risk 
factors and cancer diagnosis, investigations of risk factors for OCC are usually undertaken 
via case-control studies (Conway et al., 2018).   
The International Head and Neck Cancer Epidemiology (INHANCE) consortium is a 
collaboration of international researchers and research groups with large case-control 
studies which investigates the risk factors for head and neck cancer overall, and for the 
specific subsites including oral cavity and oropharyngeal cancer. The consortium 
undertakes pooled analysis of individual-level data from different studies on a large scale, 
thus enabling research questions relating to aetiology to be addressed in a way that would 
not be possible within individual studies (Winn et al., 2015). For example, the large 
volume of data allows precise estimates of risk to be calculated and the influence of 
confounding factors to be studied. The focus is on behavioural, social, environmental and 
genetic risk factors and the interactions among them (Winn et al., 2015). In 2018, it was 
reported that the consortium had pooled data from 35 studies across the world (including 
USA, Europe, Latin America, Brazil and Asia), with data on over 25,000 patients with 
head and neck cancer and over 37,000 controls (Conway et al., 2018).  
A comprehensive review of the findings of the consortium was published by Winn and co-
authors (2015).  This aimed to provide a better understanding of the causes and 
mechanisms associated with HNC.  The review acknowledged the lack of study data from 
areas of the world with very high rates of head and neck cancer, i.e. South-East Asia, and 
while INHANCE data are analysed at the subsite level, including oral cavity cancer, most 
of the findings presented within the review of the consortium’s work were at the higher 
level of head and neck cancer. A review of risk factors specifically for oral cavity cancer 
(Radoï and Luce, 2013) has highlighted the problems of comparing findings from different 
studies due to the lack of uniformity in defining oral cavity cancer in terms of case 
definitions and sites included.  
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Detailed below is a brief review of the literature relating to the risk factors for head and 
neck and oral cavity cancer. 
1.8.1 Smoked and Smokeless Tobacco 
Findings from case-control studies have shown that tobacco smoking is a major risk factor 
for head and neck cancer (Radoï and Luce, 2013; Winn et al., 2015). Hashibe and co-
workers (2007) estimated the effects of cigarette smoking among those who had never 
drunk alcohol and found the former behaviour to be associated with an over two-fold 
increased risk of head and neck cancer. Furthermore, the risks increased with frequency, 
duration and pack-years of cigarette smoking. The INHANCE consortium further studied 
the effect of total exposure to smoking (Lubin et al., 2009) and found that above 15 
cigarettes per day, smoking fewer cigarettes per day, over a longer period of time was 
worse than smoking a higher number of cigarettes over a shorter period. An INHANCE 
study has also shown that within one to four years of quitting smoking, benefits can be 
seen in relation to reducing the risks of head and neck cancer (Marron et al., 2010).  
Interestingly, the review by Radoi and Luce (2013) reports that several case-control studies 
have shown that the oral cavity seems to be the anatomical site within the upper 
aerodigestive tract which is least sensitive to the effects of smoked tobacco, with the most 
affected site being the larynx. They further report that this finding has been confirmed in 
large pooled analysis from INHANCE. In such analysis, they report the risk of OCC was 
1.4-1.7 times higher in smokers than in non-smokers among never drinkers. As shown for 
head and neck cancer, their review also reported an increasing risk of OCC with increased 
frequency, duration and lifetime cumulative smoking history (Radoi and Luce, 2013). 
Smokeless tobacco, used as powdered snuff or as tobacco chewing, has also been shown to 
have an increased risk association for oral cancer (Wyss et al., 2016), with an almost two-
fold risk, even among those who have never smoked.  
1.8.2 Alcohol Drinking 
Hashibe and co-authors (2007), from an analysis of INHANCE data, estimated that alcohol 
drinking among those who had never used tobacco was linked to a two-fold increased risk 
of head and neck cancer, but only among heavier drinkers (three or more drinks per day). 
In a study of the pattern of alcohol consumption, INHANCE investigators found that there 
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was greater head and neck cancer risk from a higher intake over a shorter period of time 
compared with a lower intake over a longer period (Lubin et al., 2009). 
The review of risk factors for oral cavity cancer (Radoi and Luce, 2013) reported that the 
risk seemed to increase with daily quantity, duration of consumption and lifetime 
accumulation. However, they pointed out that the pooled analysis of INHANCE data by 
Hashibe et al (2007), referred to above, found that the increase in risk of OCC in non-
smokers by frequency and duration of alcohol consumption was low and statistically non-
significant. This pooled analysis also showed that the risk seemed to be lower among 
heavy drinkers (five or more drinks per day) for the oral cavity (OR 1.2, 95% CI 0.6-2.6) 
than for the pharynx (OR 5.5, 95% CI 2.3-13.4). 
1.8.3 Joint Effect of Tobacco and Alcohol Consumption 
A number of studies have investigated the combined role of tobacco and alcohol 
consumption in oral cavity cancers and found the joint effect to be multiplicative or greater 
than multiplicative in most cases (Radoï and Luce, 2013). A pooled analysis of INHANCE 
data (Hashibe et al., 2009) found that compared to non-smokers and non-drinkers, those 
who smoke and drink have their risk of OCC multiplied by 4.8 (95% CI 2.6-8.8). 
1.8.4 Betel Quid 
Betel quid is used commonly in South Asia, Southeast Asia and the Pacific Islands and 
also by those of South Asian origin around the world, with a reported prevalence of betel 
quid chewing in the Solomon Islands of over 75% (Tovosia et al., 2007). In the regions 
mentioned above, a high proportion of oral cavity cancers can be attributed to this habit 
(Hashim et al., 2019). Betel quid consists of the areca nut and often slaked lime wrapped in 
the leaf or other part of the Piper betle plant.  Other ingredients can include tobacco, spices 
and herbs. 
A systematic review has reported that betel quid without tobacco had an almost three-fold 
increased risk association with oral cancer (Gupta and Johnson, 2014). Additionally, Radoï 
and Luce (2013) reported that a review of 11 case-control studies suggested that the odds 
ratios for betel chewing were 1.5-3 times higher than those for tobacco smoking and 2-11 
times higher than for alcohol consumption. They also reported that chewing betel-tobacco 
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seemed to have around a two-fold higher odds ratio for oral cavity cancer than chewing 
betel alone. 
1.8.5 Diet 
A number of INHANCE studies have investigated the effect of diet on the risk of head and 
neck cancer. The analyses were based on dietary habit data collected via food frequency 
questionnaires. A pooled analysis (Bosetti et al., 2013) of studies showed that a dietary 
pattern based on foods high in antioxidant vitamins and fibre, such as fruits and vegetables, 
was associated with reducing by half the risk of head and neck cancer. A later study by 
Edefonti and co-authors (2015) showed a similar odds ratio for oral cavity/pharynx cancer 
when comparing the highest and lowest quintile of vitamin C intake. Winn et al (2015) 
have stated that these findings are similar to those of other large case-control studies which 
have also shown a protective effect of fruit and vegetables.   
A recent paper from the INHANCE consortium (Bravi et al., 2020) has presented an 
update on finding from the group. In addition to confirming the above findings, they have 
also found an inverse association between drinking caffeinated coffee and head and neck 
cancer risk, and this was also found for the anatomical sub-site of the oral cavity. 
Lubin and co-authors (2011) have investigated body mass index (BMI) and the risk of head 
and neck cancer. They found that compared to those of normal BMI, those with a low BMI 
had higher odds ratios for the disease, and furthermore that lower BMI levels also 
increased smoking and drinking-related risks of both oral cavity and pharyngeal cancers.  
1.8.6 Oral Health 
Conway and co-authors (2018) have reported that analysis of the INHANCE dataset has 
shown that, after adjusting for smoking and alcohol consumption, the positive oral health 
behaviours of daily toothbrushing and regular dental attendance may modestly reduce the 
risk of oral cavity cancer.  Fewer missing teeth showed a similar finding.  The review by 
Radoi and Luce (2013) indicated that case-control studies have found that decayed, broken 
and filled teeth were not associated with increased risk. While no increased risk is 
associated with the wearing of a removal denture per se, some studies have shown an 
increased risk, particularly on the tongue, from denture-associated sores associated with ill-
fitting appliances (Radoï and Luce, 2013).  
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The risk associated with the use of mouthwashes, many of which contain alcohol, is 
uncertain. A pooled analysis by Boffetta and co-authors (2016) found a slightly elevated 
risk of oral cavity and oropharyngeal cancer after prolonged use (greater than 35 years) and 
use more than once per day.  However, there were difficulties associated with recall bias 
and the ability to completely disentangle the confounding factors of smoking and alcohol 
consumption from this analysis. The authors therefore suggested that further research was 
required in this area. 
1.8.7 Socioeconomic Status  
The large number of case-control studies within the INHANCE consortium has enabled 
more precise measurement of the effects of education and income on head and neck cancer 
when adjusting for or ruling out the effects of tobacco smoking and consumption of 
alcohol.  An analysis (Conway et al., 2015), involving 31 case-control studies, observed an 
over two-fold increased risk for both low education and income status that could not be 
accounted for by smoking, alcohol and dietary habits.  Furthermore, the odds ratios were 
approximately 1.6 among those who neither smoked nor consumed alcohol.  The authors 
therefore suggest that low education and income are risk factors for head and neck cancer, 
independent of the major risk factors of tobacco smoking and alcohol  (Conway et al., 
2015). 
1.8.8 Marijuana 
Marijuana smoke contains carcinogens at levels that can be higher than in tobacco smoke. 
This has raised concerns that marijuana smoke might be a risk factor for cancer (Hashibe et 
al., 2005). However, evidence for an association between marijuana and oral cancer is 
limited and difficult, partly due to the fact that many users of marijuana are also tobacco 
smokers and consumers of alcohol, leading to the likelihood of some residual confounding 
in analysis.  A pooled analysis of INHANCE data did not find an increased risk of oral 
cavity cancer associated with marijuana use, and this included frequency per day and 
cumulative consumption over time (Berthiller et al., 2009). 
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1.8.9 Human Papilloma Virus (HPV) 
HPV is the most common sexually transmitted virus and infection is associated with 
oropharyngeal cancer rather than oral cavity cancer risk (Smith et al., 2004). HPV 16 and 
HPV 18 subtypes are the main high-risk oncogenic types (Gillson et al., 2015). This review 
by Gillson and co-workers found that oral HPV is more prevalent amongst men than 
women. They also identified factors associated with carriage of oral HPV which included 
tobacco and alcohol use, oral sex, multiple sexual partners, same sex partners and earlier 
sexual debut. In theory, HPV associated oropharyngeal cancers can be prevented by 
behaviour modifications, safer sex practice and vaccinations (Gillison et al., 2012). An 
international, multi-centre case-control study reported that the proportion of HPV positive 
oropharyngeal cases were 60% in the USA and 31% in Europe (Anantharaman et al., 
2017). It is assumed that the HPV attributional proportion in Europe is likely to be rising to 
closer to that of the USA with the rapid increasing number of cases of oropharyngeal 
cancer seen in recent years in Europe (Conway et al., 2018). The aetiological fraction for 
oral cavity cancer has been estimated to much lower, perhaps as low as 3% (Gillison et al., 
2015).  
1.8.10 Genetics 
Genetics have been implicated as a risk factor for oral cancer (Winn et al., 2015). Certain 
genetic loci, including several related to nicotine and alcohol metabolism and DNA repair 
pathways have been found to be associated with head and neck cancer risks. This, 
therefore, demonstrates the potential for “genetic-environmental risk interactions” (Winn et 
al., 2015). INHANCE studies have also identified a moderately strong hereditary risk, with 
a suggested increased risk associated with having a first degree relative with head and neck 
cancer (Negri et al., 2009).  
1.8.11 Summary of Risk Factors  
In summary, pooled analysis of large case-control studies has enabled investigation of risk 
factors for HNC and OCC, with calculation of precise estimates of risk and appropriate 
adjustments for confounding factors. Identification of risk factors are essential for the 
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development of appropriate preventive strategies at both individual and population levels 
and to enable the assessment of individual risk within a primary health care setting. 
1.9 Prevention of Oral Cavity Cancer  
The practices of maintaining health and well-being are not new and, since ancient times, 
wisdom has decreed that “prevention is better than cure.” As indicated in earlier sections, 
non-communicable diseases, including cancer, are a major burden both to individuals and 
to health care systems (Levine et al., 2019).  
The WHO (2020) has stated that, in the long-term, prevention offers the most cost-
effective strategy for the control of cancer. It calls for national policies to be developed and 
implemented to reduce exposure to cancer risk factors, raise awareness of the disease and 
provide information to support the adoption of healthy lifestyles. The organisation 
estimates that between 30-50% of all cancer cases are preventable and that, at the global 
level, tobacco is the single greatest avoidable risk factor for cancer deaths.  
Implementing appropriate preventive health care strategies can have a profound effect on 
the quality of life of individual people and populations and can also have a major impact 
on health care provision and spending (Levine et al., 2019). Such preventive strategies can 
be described as primary, secondary or tertiary in nature (Reichart, 2001).   
Primary prevention refers to activities or measures that are directed towards reducing the 
risk of exposure to a risk factor (for example smoking and alcohol consumption) or a 
health determinant at either the individual or population level (Reichart, 2001). It is 
described as intervening before health effects occur (Wallace and Chen, 2006). Secondary 
prevention involves detecting and treating disease at an early stage. Examples include 
screening processes to identify unrecognised disease in an apparently healthy, 
asymptomatic population (WHO, 2020a) through measures such as regular blood pressure 
checks and mammography. Secondary preventive measures are said to focus on the sub-
clinical and the early clinical stages of a disease (D’souza and Addepalli, 2018). These 
measures “enable early detection and prompt effective intervention to correct departures 
from a state of health” (D’souza and Addepalli, 2018).  Tertiary prevention is managing 
diseases post-diagnosis to slow disease progression. The main purpose of the third level of 
prevention is to reduce or eliminate long-term impairments and disabilities, minimize 
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suffering, optimise function, assist in adjusting to limitations in health and function 
resulting from the event, and sometimes extend survival (Hoey et al., 2019).  
Low OCC survival rates are associated with late diagnosis and risk-associated behaviours 
therefore both primary prevention, to reduce incidence, and secondary prevention, to 
improve early detection, are key approaches for reducing the burden associated with this 
disease. The work of this thesis focusses primarily on the examination of the oral cavity for 
signs of potentially malignant or early malignant disease. This is an example of secondary 
prevention and will be discussed further. A brief review of factors pertinent to the primary 
prevention of OCC will also be provided, but tertiary prevention is out with the scope of 
this work. 
1.9.1 Primary Prevention of Oral Cavity Cancer 
1.9.1.1 Structural, Intermediate and Proximal Approaches 
As indicated in earlier sections, smoking and excessive alcohol consumption are two of the 
major risk factors for OCC.  These behaviours can be described as proximal factors or 
“causes” of the disease.  However, it is now recognised that such behaviours are influenced 
by the environments and circumstances in which people live. These are described as 
intermediate determinants and include material circumstances; levels of social interaction 
and community cohesion; access to amenities and services; and psychosocial factors such 
as stress.  These circumstances are, in turn, affected by structural determinants such as 
economic, social and welfare policies at national level (Peres et al., 2019). These structural 
and environmental factors are therefore described as the “causes of the causes” (Figure 
1.2). The structural, intermediate and proximal levels can also be described as upstream, 
midstream and downstream determinants, respectively. To add to the complexity, large, 
multi-national corporations, such as the tobacco and alcohol industries, also have a major 
influence on behaviours and they too operate at these three levels. For example, through 
lobbying of policymakers, marketing at the community-based intermediate level, and by 
influencing the social norms of individuals. These concepts have recently been described 





Figure 1.2 Social and commercial determinants for oral disease 
 
 
Source: Peres et al (2019)  
For the reasons outlined above, it is now accepted that solely providing risk factor-related 
information and advice to individuals will have limited impact on changing behaviour and 
thus preventing diseases such as OCC. In addition to individual-level (proximal) 
behavioural approaches (for example primary care-based one-to-one counselling, health 
education and pharmacological treatments associated with smoking and / or alcohol 
consumption), for optimal effects, public health interventions for disease prevention should 
also include intermediate and structural approaches. The different policy levels advocated 
to prevent disease, promote health and reduce health inequalities from the Dahlgren and 
Whitehead (1991) model are: 
1. Strengthening individuals (downstream) 
2. Strengthening communities  
3. Improving infrastructure and access to services 
4. Making structural changes to economic, cultural and environmental conditions 
(upstream) 
A successful use of this approach has been seen in relation to the tobacco control agenda.  
The WHO Framework Convention on Tobacco Control (FCTC) (WHO, 2004)  has 
facilitated a global, coordinated action to reduce tobacco consumption, lower smoking 
rates among children, and counteract the tobacco industry’s lobbying, promotional and 
advertising activity. By 2019, 181 countries had ratified or acceded to the treaty (Hoffman 
20 
 
et al., 2019).  Provision within the treaty requires that parties implement measures such as: 
limiting the interaction between lawmakers and the tobacco industry; taxation and other 
measures to reduce demand; protecting people from the effects of passive smoking; health 
warnings on packaging; banning tobacco advertising; raising public awareness of the 
harmful effects of smoking; offering help to people to end their addictions to tobacco; and 
banning the sale of tobacco products to minors. The former WHO Director-General 
Margaret Chan has said that “without question, the WHO Framework Convention on 
Tobacco Control is the most powerful tool we have, as an international community, to 
reduce the global disease burden” (Chan, 2008). 
1.9.1.2 Common Risk Factor Approach   
OCC and other oral diseases share many of the same modifiable risk factors as other NCDs 
(Glick et al., 2012). These include tobacco use, high alcohol consumption, unhealthy diets 
and socio-economic determinants. Therefore, adopting a shared and common risk factor 
approach to prevention is considered rational (Sheiham and Watt, 2000), and the 
integration of oral health into NCD prevention and control strategies is advocated. The 
adoption of the common risk factor approach by health professionals can contribute to 
health improvement across many systems, including oral health, and oral health 
professionals can contribute not only to oral health but also to general health. 
In 2011, the United Nations (UN) convened the first high-level meeting on the prevention 
and control of NCDs. The outcome of the meeting was a UN political declaration which 
included for the first time reference to oral diseases within the context of NCDs (Nation, 
2011). Article 19 of the Declaration stated that “UN member states recognize that renal, 
oral and eye diseases pose a major health burden for many countries and that these diseases 
share common risk factors and can benefit from common responses to non-communicable 
diseases” (Mensah and Mayosi, 2013). More recently, the WHO produced a global action 
plan for the prevention and control of NCDs (WHO, 2015).  This plan, for the period 2013-
2020, provided a road map and policy options for nations and organisations to adopt to 
help address the burden of NCDs. It emphasised the need for multisectoral action at all 
levels, and the four shared behavioural risk factors highlighted were tobacco use, unhealthy 
diet, physical inactivity and the harmful use of alcohol. The action plan mentioned oral 
diseases, including oral cancer, and in addition to commenting on the shared health 
benefits from preventive approaches relevant to oral cancer, it also included as an objective 
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“oral cancer screening among high risk groups (e.g. tobacco users, betel nut chewers) 
linked with timely treatment” (WHO, 2015).   
1.9.2 Secondary Prevention of Oral Cavity Cancer 
The oral cancer-related objective mentioned above is an example of secondary prevention 
and is reminder that while concerted approaches and efforts are being made to prevent 
NCDs, including OCC, the diseases remain within populations, with associated high 
burdens on individuals and society. Recent advances in the treatment of head and neck 
cancer have resulted in some improvements in outcomes, however, cancer in this 
anatomical region is still associated with high morbidity including pain, disfigurement, 
dysfunction, psychosocial distress, as well as death (Van der Waal et al., 2011; Wong and 
Wiesenfeld, 2018; Chow, 2020). These outcomes are related to the often-late presentation 
of the disease and, as described earlier, the poorer survival rates associated with more 
advanced stages of the cancer. It is therefore important that lesions are detected and treated 
at an early stage to improve patient outcomes and reduce service costs. 
1.10 Early Detection/ Screening 
Brocklehurst and Speight (2018) have stated that the oral cavity is easy to examine and 
oral lesions relatively easy to detect. There has therefore been interest and debate for many 
years on screening for mouth cancer. 
Screening aims to detect disease early and has a number of definitions. Some, such as that 
of the World Health Organisation (WHO, 2020b), relate to screening programmes: 
“screening is defined as the presumptive identification of unrecognized disease in an 
apparently healthy, asymptomatic population by means of tests, examinations or other 
procedures that can be applied rapidly and easily to the target population.” Furthermore, 
the UK National Screening Committee (Public Health England, 2019) defines screening as 
“the process of identifying healthy people who may have an increased chance of a disease 
or condition. The screening provider then offers information, further tests and treatment. 
This is to reduce associated problems or complications. Screening should always be a 
personal choice.”   
The recent Report of the Independent Review of Adult Screening Programmes in England 
states that the term ‘screening’ is widely used in the health care setting and can take many 
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different forms (NHS England, 2019).  These range from national population screening 
programmes (such as breast and bowel cancer screening) to screening that occurs as part of 
routine health care (such as general medical practice screening for high blood pressure 
during an appointment for another problem). This report (NHS England, 2019) describes a 
hierarchy of screening, with the main types being as follows: 
• National population programmes which target large groups of the population to screen 
for early signs of cancer or disease. For example, cervical, breast and bowel cancer 
screening. 
• Targeted or risk stratified screening which seeks to target screening at people who are 
at higher risk of a cancer or disease. For example, women with a family history of 
breast cancer. 
• Opportunistic screening - recommended for certain groups but which does not involve 
them being actively invited for screening. For example, the National Chlamydia 
Screening Programme which aims to regularly test young sexually active individuals 
for chlamydia. 
• Screening delivered as part of routine health care. This is described as a type of 
screening which is not part of a national screening programme and occurs during the 
provision of health care. The report includes “a dentist screening for oral cancer during 
a routine check-up” as an example of such an activity.   
1.10.1 Screening Approaches for Oral Cavity Cancer 
Several approaches have been considered for oral cavity cancer screening programmes and 
these include targeting high risk individuals and opportunistic screening within primary 
health care.  The main test is a visual inspection, but genetic-based tests and HPV testing 
have also been considered (Hashim et al., 2019). However, these authors have identified 
three major barriers to the implementation of large-scale screening for OCC.  These are: 1] 
the lack of evidence that such an approach is effective in substantially reducing mortality; 
2] a lack of consensus on who within the population should be screened; and 3] a lack of a 
risk-based screening protocol for OCC that can be easily applied. 
A Cochrane systematic review of oral cancer screening programmes identified only one 
study worldwide which had been properly conducted and which evaluated the clinical 
efficacy of mouth cancer screening (Brocklehurst et al., 2013). This large cluster-
randomised controlled trial was carried out in Kerala, South India over a 15 year period 
and involved four rounds of screening using a conventional oral examination 
(Sankaranarayanan et al., 2013). Although no significant difference was found in oral 
cancer mortality between the intervention and control groups, at the end of the trial a 
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significant (24%) reduction in mortality was seen for high risk groups (those who smoked 
and/or consumed alcohol) in the screened compared to the control group. While the 
Cochrane review acknowledged the significant findings of the trial, they identified a high 
risk of bias associated with the study and concluded that further studies were needed to 
recommend population screening programmes.  
Many countries set specific criteria for determining whether national screening 
programmes are appropriate, and these usually cover the following areas: the condition, the 
test, the intervention, the screening programme and the implementation criteria. The UK 
National Screening Committee (NSC, 2003) assesses potential new screening programmes 
against 20 criteria within these five topic areas.  Brocklehurst and Speight (2018) have 
explored the potential strengths and limitations of a national screening programme for oral 
cancer in the UK and have shown that many of the screening criteria outlined above have 
either not been met or not been evaluated in relation to this disease. A computer modelling 
simulation of the costs of screening for oral cancer in different health care settings was 
carried out by Speight and co-worker (2006). Their results suggested that in the UK, oral 
cancer screening could be cost-effective if it were targeted to high risk individuals and 
carried out opportunistically by general medical practitioners and / or general dental 
practitioners. Thus, Brocklehurst and Speight (2018) state that although there is some 
evidence to suggest that the screening of high risk groups may be effective and cost-
effective, they conclude that there is insufficient evidence for the setting up of national 
programmes. Additionally, they make the point that similar conclusions have been reached 
by Government bodies around the world and therefore none have recommended oral 
cancer screening as part of a national programme. 
Issues with a screening programme relate to the prevalence of the disease and to the fact 
that studies investigating “screening” for oral cancer have included OPMDs within the 
criteria of a positive test, although it is known that the overall malignant transformation 
rate is low. Brocklehurst and Speight (2018) also question whether an opportunistic 
screening programme for oral cancer would be effective in a dental practice setting, as 
many of those at highest risk of oral cancer are unlikely to be regular dental attenders. 
Interestingly, the American Cancer Society has recommended that oral cancer screening is 
carried out as part of a general cancer check-up by physicians. Furthermore, a strategy 
document associated with the US Department of Health and Human Services has set goals 
for 2020 to increase the number of adults receiving an annual examination for mouth 
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cancer and the proportion of oral cancers diagnosed at an early stage (Hashim et al., 2019). 
However, these authors state that less than 20% of adults in the US, over the age of 40 
years, report having had an examination for oral cancer during their lifetime.  
Thus, in countries with relatively low incident rates and primary dental care systems in 
place, current evidence supports the examination of the mouth for cancer as fitting into the 
category of “screening delivered as part of routine health care” (Public Health England, 
2019) rather than a national screening programme, and efforts are being made to increase 
compliance and implementation via regulations, recommendations and guidelines (Hashim 
et al., 2019). However, these authors caution that the evidence on which such 
recommendations have been made are reported to be low. 
Although the hierarchy mentioned above divides “opportunistic screening” and “screening 
delivered as part of routine health care” into two separate entities, within the oral cancer 
literature, the two terms are often used interchangeably when referring to an examination 
of the mouth for OCC when attending a routine dental appointment. 
1.11 Examination of the Mouth for Oral Cavity Cancer as Part of a 
Routine Dental Appointment 
Dental professionals working in primary dental care have the opportunity to carry out an 
examination for oral cavity cancer and OPMDs when patients attend as part of routine 
health care. 
Many guidance documents and online sites (NIH, 2013; CRUK, 2015) provide advice on 
how to conduct an intra- and extra-oral examination of the mouth for signs of mouth 
cancer or potentially malignant lesions. There is some variation in the content and extent of 
the methodology recommended but, overall, this tends to consist of a visual examination of 
the sites within the oral cavity and facial region, and palpation of the regional neck nodes. 
This is known as a ‘conventional oral examination’ (COE). This two-step method of 
screening has been described by the US National Institute of Health (NIH, 2013) guide for 
oral health care professionals (2013) as follows: “The examination is conducted with the 
patient seated upright. All prostheses are removed. The extraoral and perioral tissues are 
checked first, starting with an inspection of the face, head and neck region. Any changes in 
facial symmetry or on the skin such as colour, fissuring or growth need to be documented. 
The regional lymph nodes are then palpated bilaterally for any kind of enlargements. A 
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recommended sequence should be followed including: preauricular, submandibular, 
anterior cervical, posterior auricular and posterior cervical regions. In step two, the oral 
health care professionals should follow a seven-step systematic assessment of the lips, 
labial mucosa and sulcus, commissures, buccal mucosa, gingiva, tongue, floor of the 
mouth and the palate”. 
Recommendations relating to a COE are often communicated through clinical guidelines 
for dental health care professionals working in primary care and have been developed by a 
wide range of different health and professional organisations and agencies in many parts of 
the world (e.g. American Cancer Society ACS, 2003; SIGN, 2006; US Preventive Service 
Task Force USPSTF, 2014). Additionally, some regulatory bodies have made it a 
requirement that a COE is carried out, for example the General Dental Council in the UK 
(GDC, 2012). Furthermore, the GDC recommends that dental health professionals should 
keep their skill up to date by undertaking continuing professional development in the area 
of “oral cancer – early detection” (GDC, 2019). However, in other parts of the world, 
including Oman, no national guidance or advice from regulatory bodies exist. 
A review by Walsh and co-authors (2013) has reported that a COE is better at classifying 
the absence of OCC or OPMDs in disease-free individuals than in classifying the presence 
of these conditions in those affected by the diseases. This is due to the fact that carrying 
out a COE may not be sufficient to distinguish an innocuous lesion from one which is 
malignant or potentially malignant (Lingen et al., 2017). For this reason, McGurk and 
Scott (2010) have argued that while an examination for oral cancer on all patients attending 
primary dental care may seem laudable, clinical guidelines can be poor at helping 
practitioners to discriminate between OPMDs and other diseases of the soft tissue. Thus, 
detecting and referring patients with all such lesions to secondary care has the potential to 
swamp the health care system. They further argue that the policy of carrying out a COE on 
all patients attending dental primary care has had limited effectiveness to-date, with limited 
change in the proportion of patients diagnosed with stage 1 and stage 4 tumours over many 
decades. They also point out that asymptomatic oral cavity cancers may be missed, 
particularly if the clinician is carrying out an inspection to the same degree on all patients, 
rather than focussing more on high-risk individuals.   
McGurk and Scott (2010) have therefore called for improved data collection to enable a 
mathematical risk model to be produced in the long-term, based on the risk factors outlined 
in Section 1.9. In the absence of such a model, they suggest that a risk factor checklist 
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should be completed by patients, with the information enabling the oral health professional 
to apply their clinical diagnostic skills in a more selective and effective manner. Hashim 
and co-authors (2019) also mention this risk assessment approach and acknowledge that its 
effectiveness requires further research. As mentioned earlier, the WHO recommends oral 
cancer screening among high risk groups (WHO, 2015), while the Report of the 
Independent Review of Adult Screening Programmes in England (NHS England, 2019) 
includes screening for oral cancer as part of a dental check-up as an example of screening 
delivered as part of routine health care. 
The effect of the frequency of the COE on the stage of OCC at diagnosis is also an area 
requiring further research. There is some evidence that repeat examinations may be 
effective for patients who have considerable previous contact with primary health care 
(Hashim et al., 2019) and a dose-response association between continuous primary care 
contact and earlier stage diagnosis of oral cavity cancers has been reported (Prout et al., 
1990). Warnakulasuriya (2020) recommends the frequency of follow-up of patients with 
OPMDs should be based on the individual’s risk assessment, with consideration of patient 
compliance.  
As indicated earlier, it can be difficult, at the clinical level, to differentiate between a 
malignant or potentially malignant oral lesion and one which is innocuous. In other sites of 
the body where distinguishing the nature of lesions can be problematic, adjunctive tests 
and technologies can assist in disease detection and discrimination. Consequently, a 
number of adjuncts, which have been purported to aid the evaluation of oral mucosal 
lesions, have been developed and are commercially available for use in dental primary 
care. These Adjunct Tools include vital staining, light-based detection, biomarkers and 
brush biopsy (Patton et al., 2008; Devji, 2018). However, their potential to aid the 
detection of OPMDs and early OCCs in the dental primary care setting has yet to be 
proven (Rashid and Warnakulasuriya, 2015; Warnakulasuriya, 2017).  
In summary, although there are many systematic reviews, clinical guidelines and guidance 
toolkits available on the topic of the examination for oral cavity cancer in dental primary 
care (Yamada et al., 2015), an initial search of the literature has indicated insufficient 
evidence and consensus concerning the provision of clear advice in relation to the early 
OCC detection process. Factors include: the description and extent of the conventional oral 
examination; whether the approach should be targeted (i.e. for high-risk patients stratified / 
determined by sociodemographic / behavioural risk factors) or for all patients attending; 
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the frequency of the assessment / recall period; and the potential use of Adjunct Tools. In 
addition, the extent to which the guidelines have included the highest quality evidence and 
quality appraisal is uncertain. The literature associated with these issues will be explored in 
depth in Chapter 3. 
1.12 Current Practice and Perceptions of Primary Care Dental 
Professionals in Relation to an Oral Cancer Examination 
An oral health care professional’s knowledge, awareness and perceptions of oral cancer 
screening in the primary care setting is a crucial element in the effectiveness of the 
examination process (Aldossri et al., 2020).  
A recent study of dental hygienists, conducted in Nova Scotia by Tax and co-workers 
(2017), found that although respondents believed themselves to be knowledgeable about 
oral cancer screening, only 13% performed an extra-oral examination and 7% an intra-oral 
examination for the detection of oral cancer. The study participants identified patient 
compliance, lack of time and the dentist performing the examinations, as the main barriers 
in preventing them from undertaking the examinations. They also indicated they would not 
have the power within the practice to overcome many of the obstacles which prevent them 
from conducting oral cancer screening (Tax et al., 2017). 
Mariño et al (2017) conducted a survey to assess oral cancer screening practices among a 
wide range of oral health professionals in Victoria, Australia. This included dental 
specialists, primary care dentists, oral health therapists, dental therapists, and dental 
hygienists. The study had a very low response rate of under 10% (9% for dentists and 23% 
for other oral health professionals). Only around half (51%) of the respondents reported 
conducting oral cancer examinations routinely, but over 90% accepted that opportunistic 
screening should be carried out on a routine basis. For those not conducting an 
examination on every patient, the factors influencing whether one was carried out were 
reported to include the age and medical history of the patient, whether the patient had 
complained of an oral health problem, and the presence of behavioural risk factors such as 
smoking and alcohol consumption. Lower levels of oral cancer-related knowledge and 
confidence in conducting an oral cancer examination were associated with a decreased 
likelihood of conducting opportunistic screening for this disease (Mariño et al., 2017). 
Similar findings have been reported by Haresaku et al (2018), where around half (51.4%) 
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of Japanese dentists and dental hygienists were found to perform oral cancer screening 
routinely on their patients. Again, there was an association between levels of knowledge 
and confidence and the likelihood of the Japanese oral health professionals conducting an 
oral cancer screening.  Both studies (Mariño et al., 2017; Haresaku et al., 2018) have 
recommended the need for additional training programmes related to oral cancer practices 
for oral health professionals to increase levels of participation in these activities.  
A recent survey of dentists in Ontario, Canada (Aldossri et al., 2020) used a 25-item self-
administered oral cancer questionnaire. It also had a response rate of around 10%. A high 
proportion of responding dentists (over 80%) reported always or very frequently carrying 
out an examination of the mouth for oral cancer in all adult patients, and the percentage 
rose for those over 45 years of age. Well over 90% of the practitioners indicated they could 
recognise the common signs of oral cancer and were confident in carrying out a COE, 
however, confidence levels were much lower (around 20%) with regard to the use of 
adjunct screening tools.  The major barriers to carrying out an oral cancer examination 
included the lack of a separate fee code for this activity and the lack of clinical guidelines 
from professional associations (Aldossri et al., 2020). A small proportion of participants 
mentioned that they were not comfortable palpating a patient’s lymph nodes or that they 
felt that an oral cancer examination would cause patient concern (both 13%).  
In the Middle East, a number of studies have assessed oral cancer screening awareness, 
opinions and practices of primary care dentists. This included one in Kuwait (Nazar et al., 
2019) and one in UAE (Hashim et al., 2018). Cross-sectional study designs were used in 
both studies, with response rates of 71% and 80% respectively. The main shared finding 
was that all dentists had knowledge of the major risk factors associated with oral cancer. 
Furthermore, in Kuwait (Nazar et al., 2019), many of the dentists reported that they were 
aware of the most common sites, shapes and occurrence of oral cancer. By contrast, in the 
UAE, only 30% of the participants reported awareness of the most common sites (Hashim 
et al., 2018). In terms of screening practice, Nazar et al (2019) reported more than half of 
the dentists in primary health care reported conducting examination for their patients; and 
81% of the dentist routinely referred their patients to a specialist. However, a lack of 
confidence in conducting a visual screening was reported by dentists in UAE (Hashim et 
al., 2019). The majority of dentists in both countries (92.4% in Kuwait and 84.9% in UAE) 
expressed an interest in attending continuing education related to oral cancer. One of the 
major limitations in both studies was the involvement of dentists alone, without inclusion 
29 
 
of other oral health professionals such as oral therapists and dental hygienists who can also 
contribute to the early detection of oral cancer. In Oman, no studies have been conducted 
to assess oral health professionals’ awareness, opinions, attitudes and practices in relation 
to oral cancer detection. A very recent study has, however, reported on the effect of a head 
and neck awareness campaign among patients (Al-Dhahli et al., 2020). 
In summary, most of the studies on this topic area have used self-administered 
questionnaires and have had relatively low response rates.  Some have included different 
members of the primary dental health care team, while others have focussed on dentists.  
Many of the investigations have lacked a behavioural theoretical approach in the design 
and analysis of the questions. The levels of knowledge, confidence and practice related to 
carrying out an examination for the early detection of oral cancer varied in different parts 
of the world, and in some countries, including Oman, there has been a lack of research in 
this area. 
1.13 Perceptions of Patients in Relation to an Oral Cancer 
Examination When Attending Dental Primary Care 
Incorporating patients’ views when developing clinical guidelines is important because 
patients’ needs and preferences are potential barriers to implementation (Gagliardi et al., 
2011; Kastner et al., 2015; Armstrong et al., 2018).  Previous studies have looked at dental 
patients’ views on oral cancer (Warnakulasuriya et al., 1999; West et al., 2006). Some have 
focused on patient awareness of oral cancer, with variable findings, while Awojobi and co-
authors (2012) have also explored views on screening services.  They have reported that 
many participants had a positive opinion about screening and showed willingness to accept 
help from dental practitioners to reduce their risk of oral cancer.  
These findings are in contrast to a qualitative study on patients’ views on oral cancer 
screening in dental settings carried out in the UK (Zohoori et al., 2012). They conducted a 
focus group among patients who smoked cigarettes and / or drank alcohol to identify their 
knowledge of oral cancer and factors contributing to the uptake of oral cancer screening. 
They found that the participants had a low level of knowledge related to oral cancer, 
including its signs and symptoms. Furthermore, participants reported that if they observed 
signs and symptoms of oral cancer, they would seek help from a health professional - but 
preferring to attend a medical practitioner rather than a general dental practitioner. This 
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was due to a) the expense of dental visits and b) a perception of this being outside the 
scope of the professional role of the dentist: “they are tooth specialists, not mouth 
specialists”.  
There were further barriers related to geographical access, and perceptions around a 
dentist’s ability to refer to specialists and prescribe medicine. The participants also did not 
utilize the offer that was provided to them to have a free oral examination (Zohoori et al., 
2012). This study shows that patients’ views can be at odds with recommendations. 
However, the study had some limitations: all participants were either smokers or drinkers 
(or both) which excludes others at possible increased risk of getting oral cancer such as 
individuals with low intake of vegetables and fruits and weakened immune systems (Ram 
et al, 2011; American Cancer society, 2018; Cancer Research UK, 2018; Canadian Cancer 
society, 2020). In addition, the study was not informed by analysis based on psychological 
models or theories of behaviour. There is evidence from the literature (Rawahi, 
Asimakopoulou & Newton, 2017) that the use of such psychological models for deriving 
findings from qualitative work helps in a rigorous extraction of factors important for 
uptake of evidence-based recommendations.  
The lack of consensus on acceptability of oral cancer screening in the dental setting 
(Awojobi et al., 2012; Zohoori et al., 2012) may be due in part to a) the setting, b) the 
patient groups or c) the methods (quantitative vs qualitative), but nevertheless validates 
further exploration.  
Overall, there are variable interpretations of the acceptability of comprehensive screening 
for oral cancer in dentistry, little or no work looking at different cultures / countries, and a 
variable and limited picture with respect to the application of psychological / behavioural 
theory in designing research questions and extracting themes, which is now viewed as 
essential. 
1.14 Summary  
Oral cavity cancer is a public health problem, representing the 16th most common cancer 
globally, with approximately 355,000 new cases and over 177,000 deaths per year (Ferlay 
et al., 2015; Bray et al., 2018). Incidence and mortality rates vary greatly across the world, 
and in some countries, such as those in South East Asia and the Pacific Islands, it is one of 
the most common cancers. There has been limited improvement in 5-year survival from 
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oral cavity cancer in the past few decades (Pulte and Brenner, 2010) and a meta-analysis 
has confirmed that delay from first symptom to referral for diagnosis is risk factor for 
advanced stage presentation and subsequent poorer survival (Seoane et al., 2016). The 
INHANCE consortium has facilitated investigation and identification of the major risk 
factors for oral cavity cancer (Winn et al., 2015). It has therefore been surmised that 
improvement in incidence and death rates should be possible through a combination of 
preventive interventions and examination of the mouth for oral cancer and OPMDs.  
As the oral cavity is one of the most accessible parts of the human body, there has been 
much interest in screening for oral cancer. However, no country has set up a national 
screening programme for the disease. Reasons for this include the relatively low incidence 
of OCC in most countries, lack of evidence that such a programme would reduce mortality 
rates, uncertainty about the natural history of OPMDs and lower dental primary care 
attendance rates among those at higher risk of OCC.  Instead, in many countries it is 
recommended that an examination of the oral cavity for malignant or potentially malignant 
lesions should form part of a routine check-up in dental primary care.  Although there have 
been a number of systematic reviews and numerous clinical guidelines on the topic of the 
COE, there are still uncertainties around a number of factors associated with the 
examination process. These include: a) the method of conducting the conventional oral 
examination, b) the target population, i.e. high risk or universal approach, c) the frequency 
of the oral cancer screening procedure, and d) the extent to which Adjunct Tools are used. 
The literature review found that the practice of carrying out an oral examination in dental 
primary care varied among oral health professionals.  Many of the findings were based on 
surveys with low response rates. While some practitioners felt knowledgeable about the 
examination process, others called for evidence-based clinical guidelines and clarity on 
issues such as the use of adjuncts. The issue of the perceptions of patients was also raised 
in some studies. However, there is limited literature and variable interpretation of the 
views of patients with regard to the acceptability of a COE in dental primary care.  In the 
research involving both the dental professionals and the patients, there is limited work 
exploring the effect of different cultures and / or countries on potential barriers and 
facilitators to the COE, and the inclusion and use of behavioural theory in designing 
research questions and analysing findings is variable.   
This thesis aims to explore further the gaps identified in the literature review, and the aims, 
research questions and objectives are set out in the following chapter. 
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Chapter 2: Aims and Objectives 
This thesis evaluates the evidence-base in relation to early detection and screening of oral 
cavity cancer; and assesses factors associated with implementation in primary care dental 
settings. Three main studies were conducted in order to achieve these aims and are 
reported in chapters 3, 4, and 5.  
2.1 Study 1: Systematic Overview of Clinical Guidelines and 
Systematic Reviews in Relation to Oral Cavity Cancer Early 
Detection / Screening  (Chapter 3) 
2.1.1 Aim 
To assess pre-existing evidence and identify best practice for the early detection  / 
screening for oral cavity cancer, undertaken by oral health care professionals in primary 
dental care.    
2.1.2 Research Questions 
What methods  / approach for early detection / screening of OCC are considered best 
practice for oral health care professionals when assessing patients attending primary care 
dental health care settings, including:  
1. What is the effectiveness of the conventional oral examination? 
2. Should the approach be population, opportunistic, or targeted based on risk 
factors? 
3. With what frequency should the assessment be undertaken? 
4. Should Adjunct Tools be used in addition to the conventional oral examination?  
2.1.3 Objectives 
1. To systematically search for evidence including systematic reviews and 
clinical guidelines in relation to the early detection / screening for OCC in 
primary care dental settings. 
2. To appraise the quality of the evidence using recognised and validated 
critical appraisal tools.  
3. To describe and rate the evidence in relation to the effectiveness of the 
clinical examination / assessment process including; the applicability to 
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dental settings; the approach (e.g. opportunistic, universal, targeted); the 
frequency of assessment; and the use of Adjunct Tools. 
4. To synthesize the evidence of extracted data from systematic reviews and 
clinical guidelines in order to identify best practice for the early detection  / 
screening of OCC in primary care dental settings. 
 
The synthesised results from the systematic overview conducted in this first study will 
guide the conduct of the qualitative studies (Studies 2 and 3), with the oral health care 
professionals and patients respectively.  
2.2 Study 2: Qualitative exploration of the perceptions of oral health 
care professionals on early detection/ screening for OCC in 
primary care dental settings in Scotland and Oman (Chapter 4) 
2.2.1 Aim 
To explore which components of best practice evidence, synthesized in the first study, 
were being implemented by oral health care professionals (OHCPs). A supplementary aim 
was to make a cross-country / inter-cultural comparison between Oman and Scotland. 
2.2.2 Research Questions 
1. What is the current practice of OHCPs in relation to early detection / screening of 
OCC? 
2. What are the barriers and the facilitators of implementation of best practice 
evidence in relation to OCC early detection / screening in primary care dental 
settings? 
3. How do these OHCP experiences and views compare between those from Oman 
and Scotland? 
2.2.3 Objectives 
1. Gain ethical approval to access and recruit patients in the primary health 
care settings in Oman and Scotland.  
2. Design a semi-structured interview guide incorporating open-ended and 
fixed response questions based on the best evidence identified in the 
systematic overview.  
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3. Collect and collate data from representative groups of OHCP working in 
primary health care dental settings in both countries.  
4. Analyse data using Behaviour Change Wheel (COM-B) psychological 
theory.  
5. Report findings and discuss in relation to evidence-based practice in the four 
dimensions of screening / early detection for oral cavity cancer, namely: 
conventional oral examinations, role of targeting, frequency of assessment, 
and use of adjuncts. 
6. Compare findings between Oman and Scotland.  
2.3 Study 3: Patient views on early detection / screening for OCC in 
dental settings in the Sultanate of Oman and Scotland (Chapter 5)  
2.3.1 Aim 
To explore the views of adult patients attending primary care dental settings in relation to 
oral cancer early detection / screening. A supplementary aim was to make a cross-country / 
inter-cultural comparison between Oman and Scotland.  
2.3.2 Research questions 
1. What are patients’ experiences of previous and current practices in relation 
to early detection / screening for oral cavity cancer within primary care 
dental settings?  
2. What are the barriers / facilitators from the patient perspective to 
implementing OCC early detection  / screening in primary dental care 
settings?  
3. How do these patient views and experiences compare between Oman and 
Scotland? 
2.3.3 Objectives  
1. Gain ethical agreement and consent from research institutions in relation to 
this study: Ministry of Health (Oman)  
2. Design a semi-structured interview guide incorporating open-ended and 
fixed response questions on implementation of the best evidence identified 
in the systematic overview 
3. Collect and collate interview data from a representative group of patients 




4. Analyse data using psychological theory such as COM-B and Theoritical 
Domains Framework (TDF).  
5. Report findings and discuss in relation to evidence-based practice in the four 
dimensions of screening / early detection for oral cavity cancer, namely: 
conventional oral examinations, role of targeting, frequency of assessment, 
and use of adjuncts. 
6. Compare findings between Oman and Scotland. 
The thesis Discussion (Chapter 6) summarises and synthesises the findings across the three 
studies, and discusses the strengths and limitations of the thesis. Finally, recommendations 
for intervention development, practice, policy, and research will be proposed. An overview 
of the aims and objectives for each project is presented below in Figure 2.1.  





Chapter 3: Systematic Overview of Clinical Guidelines and 
Systematic Reviews in Relation to Oral Cavity Cancer 
Early Detection / Screening  
3.1 Introduction  
The initial search and review of the peer-reviewed literature and clinical guidelines 
(Chapter 1) indicated there were many clinical guidelines from across the world which had 
collated evidence and made recommendations in relation to early detection / screening for 
oral cavity cancer. Initial scoping indicated there were some differences and 
inconsistencies in the guidelines. To navigate and provide clarity for oral health care 
professionals working in primary care settings, a systematic overview approach appraising 
this collated evidence-base within clinical guidelines was proposed. This would involve 
systematically searching, appraising the quality, and synthesising the findings to identify 
the evidence and best practice in relation to the early detection / screening process. The 
following aspects or dimensions of the early detection / screening process were identified 
by the author in the scoping review process – a taxonomy that will be used throughout the 
thesis: i) the nature / description of the assessment (conventional oral examination; COE); 
ii) whether the approach should be a targeted (i.e. to high-risk patients stratified / 
determined by sociodemographic / behavioural risk factors) versus a population (i.e. 
universal to all patients) approach; iii) the frequency of the assessment (recall / review 
interval); and iv) the use of the Adjunct Tools (e.g. vital staining, light-based detection, 
biomarkers, and brush biopsy), In addition, the extent to which the clinical guidelines have 
included the highest quality evidence, and indeed have adopted a robust literature search, 
and quality appraisal is uncertain. Moreover, during the scoping process, many systematic 
reviews were identified which had reviewed aspects of the early detection / screening 
process. 
Therefore, there is a need to assess the relevant clinical guidelines and systematic reviews 
in this field using a systematic approach to provide clarity for primary care oral health care 




Clinical guidelines also known as clinical practice guidelines or clinical guidance are 
defined as “systematically developed statements to assist practitioner and patient decisions 
about appropriate health care for specific clinical circumstances.” (Lohr and Field, 1992). 
They are intended to provide recommendations on how to provide health care services – 
with the twin aims of improving quality of care and patient outcomes. Increasingly, 
clinicians and care providers are having to deal with numerous and sometimes differing or 
contradictory guidelines (Graham and Harrison, 2005). The quality of clinical guidelines is 
variable and can have a questionable evidence base - with poor guidelines having the 
potential to lead to the use of interventions which are neither effective nor cost-effective 
and could harm patients (Feder et al., 1999).   
Systematic reviews are defined as reviews of the literature or evidence-base which are 
undertaken in a methodical way to avoid potential selective biases of traditional narrative 
literature reviews (Petticrew and Roberts, 2006). Systematic reviews are usually focused 
on a specific topic or question and methods were first developed for reviewing and 
collating evidence of effectiveness from randomised controlled trials of clinical 
interventions although methods are being adapted to other settings and study types 
(Campbell Collaboration, 2020; Cochrane Collaboration, 2020). There are three core 
aspects of systematic reviews - systematic and comprehensive search of international 
literature; quality appraisal of identified included studies; and synthesis of findings of 
included studies (Petticrew and Roberts, 2006; Popay et al., 2006).   
Systematic overviews, sometimes also known as “umbrella reviews” (Aromataris et al., 
2015), are systematic reviews of systematic reviews or systematic reviews of clinical 
guidelines. These overviews are particularly helpful for policymakers to inform decision 
making – resolving uncertainties or debates in guidance or evidence; and when the quantity 
of evidence or materials is vast and there already has been several attempts to synthesis 
and distil from perhaps different perspectives (e.g. different settings or countries (Silva et 
al., 2012; Aromataris et al., 2015).These overviews have a similar structure to systematic 
reviews of intervention or observational studies, but include “systematic reviews” as the 
studies rather than including the primary studies; and are conducted where a number of 
intervention systematic reviews already exist (Silva et al., 2012).This approach has also 
been applied to clinical guidelines to utilise these sources of evidence, where randomised 
controlled trials or systematic reviews perhaps do not exist, or to cover areas of practice 
not suited to randomised trial methodology. Examples of overviews include an overview of 
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clinical guidelines in relation to osteoarthritis (Brosseau et al., 2014) and an overview of 
Cochrane reviews in relation to endometriosis management (Brown and Farquhar, 2014).   
Thus far, to the author’s knowledge, this systematic overview approach has not been 
applied to the topic of early detection  / screening of oral cancer; nor have both systematic 
reviews and clinical guidelines been systematically reviewed together within the one 
overview. 
3.2 Aims and Objectives 
3.2.1 Aim 
To assess pre-existing evidence and identify best practice for the early detection  / 
screening for oral cavity cancer, undertaken by oral health care professionals in primary 
dental care.       
3.2.2 Research Questions:  
What methods  / approach for early detection / screening of OCC are considered best 
practice for oral health care professionals when assessing patients attending primary care 
dental health care settings, including:  
• what is the effectiveness of the conventional oral examination? 
• should the approach be population, opportunistic, or targeted based on risk factors? 
• with what frequency should the assessment be undertaken? 
• should Adjunct Tools be used in addition to the conventional oral examination? 
3.2.3 Objectives:  
• To systematically search for evidence including systematic reviews and clinical 
guidelines in relation to the early detection / screening for OCC in primary care 
dental settings. 
• To appraise the quality of the evidence using recognised and validated critical 
appraisal tools.  
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• To describe and rate the evidence in relation to the effectiveness of the clinical 
examination / assessment process including; the applicability to dental settings; the 
approach (e.g. opportunistic, universal, targeted); the frequency of assessment; and 
the use of Adjunct Tools. 
• To synthesize the evidence of extracted data from systematic reviews and clinical 
guidelines in order to identify best practice for the early detection  / screening of 
OCC in primary care dental settings. 
3.3 Methods 
Methods for the development of this overview were developed and adapted from generic 
guidance on systematic overviews / umbrella reviews (Silva et al., 2012; Aromataris et al., 
2015), and on guidance on undertaking individual systematic reviews (Cochrane 
Collaboration, 2020), as well as from reporting checklists – including the Preferred 
Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) 2015 
checklist (Shamseer et al., 2015), and the Meta-analysis of Observational Studies in 
Epidemiology (MOOSE) checklist (Stroup et al., 2000).  Other systematic overviews of 
systematic reviews (Haran et al., 2014; Asamoah et al., 2017; Leigh-Hunt et al., 2017), or 
overviews of clinical guidelines (Huang et al., 2013; Haran et al., 2014) were also 
consulted for approaches. To the author’s knowledge, this overview was the first overview 
to combine a systematic overview of both clinical guidelines and systematic reviews. It 
was undertaken in parallel with a similar overview on primary prevention of oral cancer 
undertaken by a colleague PhD student (Mathur et al., 2015).   
The protocol for this overview study was published in the journal Translational Research 
in Oral Oncology (Al Bulushi et al., 2016), and was reported against the PRISMA-P 
checklist.  
No ethics approval was required for this study. 
3.3.1 Eligibility Criteria  
3.3.1.1 Types of Studies  
This study includes evidence from systematic reviews and clinical guidelines in relation to 
early detection / screening for OCC in primary care dental settings. Both clinical guidelines 
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and systematic reviews are likely to include specific recommendations and evidence on 
OCC early detection / screening for dental health care professionals in primary care 
settings. Our search included peer-reviewed and grey literature and it was not restricted to 
any language. The systematic reviews were searched from 1946 to current date and the 
clinical guidelines sought from 2000. Case studies / reports, published abstract only and 
systematic review protocols were excluded. 
3.3.1.2 Types of Participants  
The population group for this study is the adult population (including high-risk individuals) 
who attend primary health care dental settings.  
3.3.1.3 Types of Interventions  
This includes early detection / screening interventions for detecting OCC by dental health 
care professionals / teams in primary care dental settings. These interventions include 
conventional clinical oral examinations along with other adjunct methods (such as vital 
rinsing / staining, light-based detection, blood and saliva biomarker analysis and brush 
biopsy). 
3.3.1.4 Types of Settings  
This study focused on applicability to primary care (also known as community) dental 
settings. 
3.3.1.5 Study Outcomes  
1. Evidence for effectiveness of interventions (e.g. does early detection / screening 
decrease the incidence rates of OCC; does early detection / screening improve the 
stage of diagnosis and / or improve mortality rates; what could be the harms of the 
screening; and is it cost effective?). 
 
2. Description of an evidence-based intervention (i.e. the clinical oral examination; 
frequency of the assessment; use of adjunct methods and whether the approach 
should be population, opportunistic or targeted based on risk factors).  
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3.3.2 Information Sources  
3.3.2.1 Databases 
A systematic overview for clinical guidelines and systematic reviews in the worldwide 
literature was performed in December 2017 with the support of a medical subject librarian 
(HW-A) in the following databases:  
1. Cochrane Library from 1966 to present,  
2. Medical Literature Analysis and Retrieval System Online (MEDLINE) from 1946 
to present,  
3. Excerpta Medical dataBASE (EMBASE) from 1947 to present,  
4. Web of Science Core Collection: Citation Indexes from 1900 to present, 
5. PubMed (a free search engine accessing primarily the MEDLINE database of 
references and abstracts on life sciences and biomedical topics) from 1946 to 
present,  
6. SCOPUS (a bibliographic database containing abstracts and citations for academic 
journal articles) from 1966 to present, 
7. Turning Research into Practice (TRIP) from 2000 to present. 
3.3.2.2 Other Sources  
Professional organizations’ / associations’ websites from around the world were searched 
for additional global clinical guidelines in relation to OCC early detection. A List of 
professional organizations / associations is included in Appendix 3.1. Despite the 
limitations in searching on Google in relation to language, geographical biases and lack of 
replicability, a list of target phrases was used to run in Google searches to discover grey 
literature in the form of web-published guidelines from official bodies. A list of phrases 
used for Google / Google Scholar search are included in Appendix 3.2. The reference lists 
of the selected papers were hand searched for additional studies. In addition, citation 
searches were conducted in Google Scholar and Web of Science of the selected papers to 
identify further systematic reviews and clinical guidelines. 
3.3.3 Search Strategy 
A search strategy was developed with the medical librarian and a clinical expert in the area 
of OCC (JG). Multiple databases were searched with the following and related terms: 
“cancer”, “neoplasm”, “oral potentially malignant disorders”, “oral”, “mouth” “head and 
neck”, “buccal”, “lips”, “tongue”, “assess”, “screen”, “inspect” and “exam”. The terms 
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were followed by appropriate truncation symbols (for example * or $). For further 
refinement Boolean operators such as (AND/OR proximity) were used. The search was 
limited to titles/abstracts rather than full bibliographic records. The search results in 
MEDLINE and EMBASE were limited to systematic reviews, using the SIGN search filter, 
or clinical guidelines, using the Texas School of Public Health search filter. These search 
filters are pretested strategies that identify the higher quality evidence which are indexed in 
the major medical databases. The sample search strategy in MEDLINE is appended 
(Appendix 3.3).  
3.3.4 Data Management  
All the search results including bibliographies, citation and references were managed 
through a reference manager ‘Mendeley’. The collected records (systematic reviews and 
clinical guidelines) were evaluated independently by two investigators from the research 
team (NMB for all and one from LMDM, JG, AR, or DIC). The evaluation included 
reviewing titles, abstracts, and full text of articles. Duplicate records were removed. A 
PRISMA four-phase flow diagram was designed to indicate the search process. The 
diagram mapped out information about the number of records identified in the literature 
searches based on inclusion criteria, number of studies included and excluded and the 
reasons for exclusion. The final selected systematic reviews and clinical guidelines were 
assessed for quality and risk of bias. If discrepancies were identified at any stage, these 
were resolved by discussion amongst all members of the review team. This methodological 
stage was adapted from the Cochrane Collaboration (Higgins and Green, 2011). 
3.3.5 Data Extraction  
The Cochrane Collaboration data collection form was adopted, modified and pilot tested to 
meet study specified requirements (Higgins and Green, 2011). The piloted data extraction 
form was used independently by two investigators (NMB for all and one from LMDM, JG, 
AR, or DIC). The following information were extracted from the included systematic 
reviews and clinical guidelines: authors/organization (e.g. Cochrane, ADA), date of 
publication, number / type of studies included, interventions, outcomes, main results and 
conclusions – including recommendations which included the level of evidence used 
within the systematic review and clinical guidelines. A data extraction form for the 
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systematic review was developed (Appendix 3.4). A similar form was used to extract the 
data from the clinical guidelines (Appendix 3.5). Any missing information from the reports 
were recorded as ‘not described’ in the data extraction forms. Discrepancies were resolved 
through discussion by the review team. 
3.3.6 Quality Assessment and Risk of Bias  
3.3.6.1 Systematic Reviews  
The methodological quality and the risk of bias of the included systematic reviews were 
assessed by three reviewers (NMB for all plus supervisors in pairs LMDM and JG or AR 
and DIC). Reviews were performed in triplicate because most reviewers were new to the 
process and recently developed appraisal tools were being used. All systematic reviews 
were assessed using two different tools: AMSTAR – A measurement tool to assess the 
methodological quality of systematic reviews (Shea et al., 2007) and the ROBIS – risk of 
bias in systematic reviews (Whiting et al., 2016).  
The AMSTAR tool is a valid and reliable tool (Shea et al., 2007). It consists of 11 items 
each with the options “Yes”, “No”, “Can't Answer” or “Not Applicable” to complete. It 
assesses the quality of the key steps of systematic reviews including comprehensive 
unbiased search approach, duplicate study selection and data extraction, quality 
assessment, synthesis, as well as a priori design (Shea et al., 2009). The maximum score 
on AMSTAR for a systematic review is 11; scores of 0-4 are considered low quality; 
scores of 5-8 moderate quality; and scores of 9-11 are high quality systematic reviews.  
In addition, the more recently developed ROBIS tool (Whiting et al., 2016) was used – this 
tool is complementary to AMSTAR and specifically assesses risk of bias in systematic 
reviews. This tool is completed in three phases: (1) assess relevance (optional), (2) identify 
concerns with the review process, and (3) judge risk of bias. Phase 1 - is optional – it 
concerns study data. As this was collected via the data extraction forms, this phase of the 
ROBIS assessment was not undertaken. Phase 2 - covers four domains through which bias 
may be introduced into a systematic review: study eligibility criteria; identification and 
selection of studies; data collection and study appraisal; and synthesis and findings. Phase 
3 - assesses the overall risk of bias in the interpretation of review findings and whether this 
considered limitations identified in any of the phase 2 domains. Signalling questions are 
included to help judge concerns with the review process (Phase 2) and the overall risk of 
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bias in the review (Phase 3); these questions flag aspects of review design related to the 
potential for bias and aim to help assessors judge risk of bias in the review process, results, 
and conclusions (Whiting et al., 2016)  
The outputs of the AMSTAR and ROBIS tools were compared, and the items/domain 
which focused on quality appraisal was prioritized in defining overall quality of systematic 
reviews and in the data synthesis. 
3.3.6.2 Clinical Guidelines  
The quality of the clinical guidelines was assessed by three reviewers (NMB for all plus 
supervisors in pairs LMDM and JG or AR and DIC) using the AGREE II instrument 
(Brouwers et al., 2010). This tool consists of 23 key items organized within six domains 
followed by two global rating items (“Overall Assessment”). Each domain captures a 
unique dimension of guideline quality. Domain 1 - Scope and Purpose is concerned with 
the overall aim of the guideline, the specific health questions, and the target population 
(items 1-3). Domain 2 - Stakeholder Involvement focuses on the extent to which the 
guideline was developed by the appropriate stakeholders and represents the views of its 
intended users (items 4-6). Domain 3 - Rigour of Development relates to the process used 
to gather and synthesize the evidence, the methods to formulate the recommendations, and 
to update them (items 7-14). Domain 4 - Clarity of Presentation deals with the language, 
structure, and format of the guideline (items 15-17). Domain 5 - Applicability pertains to 
the likely barriers and facilitators to implementation, strategies to improve uptake, and 
resource implications of applying the guideline (items 18-21). Domain 6 - Editorial 
Independence is concerned with the formulation of recommendations not being unduly 
biased with competing interests (items 22-23). For this study, the overall score of each 
guideline and overall score for Domain 3 were used to compare between guidelines. The 
maximum score on AGREE II is 7, and scores of 1-2 indicate that the clinical guideline is 
considered of low quality, scores 3-5 is of moderate quality; and scores 6-7 that the clinical 
guideline is of high quality. 
The scores for each domain for each of the three reviewers were compared and consensus 
score for that domain was agreed. These individual domain scores were used to calculate 
an overall AGREE II score for the clinical guideline as per AGREE II methods (Brouwers 




3.4.1 Search Results – Systematic Reviews 
The systematic review search strategy initially yielded 1424 papers (Figure 3.1). After 
removal of duplicate studies and title screening the number reduced to 71 systematic 
reviews. Abstract screening further reduced this by excluding 35 papers, and so 36 
systematic reviews were identified as requiring full text review. Of these, 14 systematic 
reviews met the inclusion criteria for this overview (Appendix 3.6). The reference list of 






















Figure 3.1 PRISMA Flow Diagram for Systematic Reviews  
 
 
3.4.2 Search Results – Clinical Guidelines  
The search strategy identified 2621 clinical guidelines (Figure 3.2). Additionally, 48 
potentially relevant clinical guidelines had been previously identified from initial scoping 
search and from supervisors obtained from other sources (these were all largely identified 
by the search and duplicates were removed accordingly). After removal of duplicates and 
title screening, the number reduced to 82 clinical guidelines. After abstract screening, 28 
clinical guidelines were retrieved for full text review from which 20 met the inclusion 
criteria (Appendix 3.8). An additional clinical guideline document was included which was 
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an update of a previous guideline so the final included number did not change. The 
reference list of excluded records (n=8 with reasons) is included in Appendix 3.9.  
   
Figure 3.2 PRISMA Flow Diagram for Clinical Guidelines  
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3.4.3 Characteristic of Included Systematic Reviews 
The characteristics of the included systematic reviews are presented in Table 3.1. There 
were 14 systematic reviews which met the inclusion criteria, half (n=7) of which had been 
published between 2012 and 2017. Of these recent reviews, there were three published as 
part of the Cochrane Collaboration and one under the auspices of the American Dental 
Association (as part of their updated clinical guidelines in 2017). The studies consistently 
drew on the same single randomized controlled trial in the literature (Sankaranarayanan et 
al., 2005).   
Ten of the systematic reviews assessed the effectiveness of the clinical oral examination, 
while nine reviews investigated the additional role of Adjunct Tools. Two of the reviews 
were focused on recall intervals and one was on a variety of screening models and 
community-based intervals. Most reviews (n=7), where specified, included studies in the 
dental primary care  / community settings. Outcomes considered were both oral cavity 
cancer and oral potentially malignant disorders (13). Reducing mortality was another 
















Table 3.1 The characteristics of included systematic reviews 
 









West Midlands & 
Evaluation Services 
15 studies – each 
study was a case 
series, 1 prospective 
cohort study 
Narrative synthesis  
(economic analysis) 
COE/Adjunct Secondary care  and 






Force on Community 
Preventive Services 
19 studies (reported 
in 24 articles) 
Narrative synthesis Population/ 
Universal 
n/s OCC + OPC (+ 
stage) 
Mortality  
 Patton. (2003) Department of 
Dental Ecology, 
School of Dentistry, 
University of North 
Carolina. 
21 related to COE, 
10 related to 
adjunctive technique 
(adj tech),  
2 related to COE 
augmented by Adj 
tech.  
Narrative synthesis COE/Adjunct Community  OPMD 




NHS R&D HTA 
Programme 
Caries = 25 studies 
Periodontal disease = 
9 studies  
Oral cancer = 2 
studies  
Grouping studies by 
statistical 
significance and 
direction of effect 
 
Recall/frequency n/s OCC 
OPMD  





7 papers describing 8 
studies included 
Meta-analysis COE/Adjunct Community/population 
screening 
OPMD 
OCC    
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Downer et al. 
(2006) 
Eastman Dental 




28 articles  Narrative synthesis COE/Adjunct Primary care  OCC (+stage) 
OPMD 
morbidity, mortality, 
survival,   
Patton et al. 
(2008) 
University of North 
Carolina,  
23 articles  Narrative synthesis COE/Adjunct Primary care OPMD, OCC 
Epstein et al. 
(2012) 
Cedars Sinai Medical 
Center, LA.  
24 (observational 
Studies)  
Meta-analysis  COE/Adjunct Various study settings   OPMD (dysplasia)  
OCC. 












13 studies Narrative synthesis  
 
COE/Adjunct Different settings used 
the interventions  




Collaboration   
1 RCT Meta-analysis was 
not applicable (less 
than 3 trials) 
COE/Adjunct  Clinical settings (under 
type participants)  
OCC (mortality)  
OCC, OPMD 

































School of Dentistry, 
University of 
Barcelona (Spain) 











COE/Adjunct n/s Early diagnosis, 
OPMD, 
OCC (stage) 




38 articles  Narrative synthesis  COE/Adjunct Primary care  OPMD 
COE=Clinical Oral Examination; OCC= Oral Cavity Cancer; OPC= Oral and Pharyngeal Cancer; OPMD = Oral Potential Malignant Disorders; RCT=Randomized Control 











3.4.4 Characteristic of Included Clinical Guidelines  
There were 20 clinical guidelines that met the inclusion criteria (Tabel 3.2). They were 
from the following countries: 10 from UK, six from US, one from New Zealand, two from 
Canada and one from South Australia. Around half (n=9) of the clinical guidelines were 
published after 2010. 
The guidelines covered different areas such as, recall, prevention, assessment, diagnosis 
and management, early detection, oral health assessment and review, and screening.  
The majority of the clinical guidelines covered one or more areas of the four themes 
(clinical oral examination, use of adjuncts tools, frequency of screening and target 
population).  For example, 12 of the 20 clinical guidelines covered the clinical oral 
examination, eight discussed the use of  Adjunct Tools for early detection / screening of 
OCC, 10 gave recommendations in relation to recall / frequency of screening, and 12 
discussed which target population should be examined in relation to OCC.  
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Title of Clinical Guideline Country 4 themes 
COE Adjuncts Frequency Target 
pop. 
ACS (2003) American Cancer Society American Cancer Society 
Guidelines for the early detection of 
cancer. 
USA Y N Y Y 
GU-GDS (2003) University of Glasgow- 
Glasgow Dental School 




Y Y N N 
NICE (2004a) National Institute for Clinical 
Excellence 
Dental Recall – Recall interval 
between routine dental examination 
UK N N Y Y 
NICE (2004b) National Institute for Clinical 
Excellence 
Guidance on Cancer Services- 
Improving outcomes in head and 
neck cancers (The manual) 
UK Y N N N 
CRUK (2005) Cancer Research UK Mouth cancer referral guidelines for 
dentists 
UK N N Y Y 
SIGN (2006) Scottish Intercollegiate 
Guidelines Network 
Diagnosis and management of head 
and neck cancer 
Scotland - 
UK 
Y Y Y Y 
AHRQ (2007) Agency for Healthcare 
Research and Quality 
HealthPartners Dental Group and 
Clinics oral cancer guideline 
US Y Y Y Y 
CCO (2007) 
 
Cancer Care Ontario Organizational Standards for 
diagnostic Assessment Programs 
Ontario - 
Canada 
N N N N 
CDSBC (2008) College of Dental Surgeons of 
British Columbia 
Guideline for the early detection of 









Title of Clinical Guideline Country 4 themes 
COE Adjuncts Frequency Target 
pop. 
MOH-NZ  (2009) Ministry of Health New 
Zealand 
Suspected cancer in Primary Care- 
Guidelines for investigation, 




N N N N 
BDA (2010) British Dental Association Early detection and prevention of 
oral cancer: management strategy 
for dental practice. 
UK Y Y Y Y 
BAO (2011) British Association of 
Otorhinolaryngology 
Head and neck cancer – 
multidisciplinary management 
guidelines. 
UK N N N N 
SDCEP (2012) Scottish Dental Clinical 
Effectiveness Programme  




Y N Y Y 
SCCN (2013) State Cancer Clinical 
Network. Head and Neck 
Cancer Working Group 




N N Y Y 
NIH (2013) National Institute of Dental 
and Craniofacial Research. 
Detecting Oral Cancer A guide for 
Professionals 
UK Y N N Y 
USPSTF (2014) US Preventive Services Task 
Force.  
Screening for oral cancer: US 
Preventive Services Task Force 
Recommendation Statement. 
US Y N N Y 
MSKCC (2014) Memorial Sloan Kettering 
Cancer Center 
Head and neck cancer  US Y N Y Y 
SPH (2015) Solutions for Public Health Appraisal of Screening for oral 
cancer 
 





Title of Clinical Guideline Country 4 themes 
COE Adjuncts Frequency Target 
pop. 
MSCCC (2016) Maryland State Council on 
Cancer Control 
Maryland comprehensive Cancer 
control plan - Oral cancer (chapter 
12) 
Maryland Y Y Y N 
ADA (2017) American Dental Association Adjunct for the evaluation of 
potentially malignant disorders in 
the oral cavity 
US Y Y N Y 




3.4.5 Methodological Quality of the Sytematic Reviews using AMSTAR Tool 
Of the 14 systematic reviews, five were considered low quality (AMSTAR scores 0-4), 
four were scored as moderate quality (AMSTAR 5-8), and five were judged as having high 
quality (AMSTAR 9-11). Table 3.3 shows the scores for the individual items and overall 
AMSTAR scores for each of the included reviews.   
Table 3.3 AMSTAR scores for the included systematic reviews (n=14) 
Y = Yes, N = No, CA=Can’t Answer, NA = Not Applicable  




1 2 3 4 5 6 7 8 9 10 11 Total Y 
Gray et al. (2000) Y Y Y CA Y Y Y Y N N N 7 
Truman et al. (2002) N Y N N Y N Y N CA N N 3 
Patton. (2003) N N Y Y N Y N N N N Y 4 
Davenport et al. (2003) Y Y Y N Y Y Y CA Y CA N 7 
Downer et al. (2004) N Y Y N N Y CA N N N Y 5 
Downer et al. (2004) CA Y Y N N Y N N Y N N 4 
Patton et al. (2008) N Y Y Y Y Y Y N N N Y 7 
Brocklehurst et al. 
(2010) 
Y Y Y Y Y Y Y Y Y Y N 10 
Epstein et al. (2012) Y Y Y Y Y Y Y Y Y Y N 10 
Riley et al, (2013) Y Y Y Y Y Y Y CA NA Y Y 9 
Walsh et al. (2013) Y Y Y N Y Y Y Y Y N Y 9 
Warnakulasuriya et al. 
(2014) 
N Y Y N N Y N N N N N 3 
Torras et al. (2015) N Y Y N N Y N N N N N 3 
Lingen et al. (2017) Y Y Y CA Y Y Y Y Y Y CA 9 
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3.4.6 Description of the Quality Assessment for the Included Systematic Reviews 
using AMSTAR Tool 
As shown in Table 3.3, 12 included reviews used two independent data extractors, 
performed a comprehensive literature search and provided the characteristics of their 
included studies (items 2, 3, 6). Eight reviews assessed the scientific quality of the 
included studies (item 7), and only four reviews used the results of the methodological 
rigor and scientific quality in their conclusion (item 8). In terms of combining the findings 
of studies (item 9) only five reviews used a method to combine the findings properly. The 
likelihood of publication bias was only assessed in three reviews (item 10). The source of 
funding was acknowledged in only five reviews (item 11). Around half of the reviews 
published / provided their protocol (item 1), whereas less than half stated that they 
searched for reports regardless of their publication type (i.e. grey literature or unpublished 
literature) (item 4). Eight included reviews provided a list of included and excluded studies 
(item 5).  
3.4.7 Risk of Bias in the Systematic Reviews using the ROBIS Tool 
Of the 14 systematic reviews, six were scored as low risk of bias, five were of high risk of 
bias, and three were considered unclear. Table 3.4 shows the overall scores of the ROBIS 





Table 3.4 ROBIS scores for the included systematic reviews (n=14) 
 
D= Domains (i.e. D1=Domain 1, D2= Domain 2, D3=Domain 3, D4=Domain4). (A.B.C=risk of bias sub 
sections. Y = Yes, PY = Probably Yes, PN = Probably No, N = No, NI = No Information 
 
3.4.8 Comparison of AMSTAR and ROBIS Scores for each Systematic Review 
A comparison of AMSTAR and ROBIS scores for each systematic review (n=14) is shown 
in Figure 3.3. These comparisons were used to provide an overall quality assessment for 
each systematic review. There were five systematic reviews considered high quality (with 
high AMSTAR and low ROBIS), four systematic reviews were considered moderate 
quality (with moderate AMSTAR scores and unclear ROBIS), and five systematic reviews 





Judging Risk of Bias Risk of Bias in 
the Review* 
Risk of Bias 
Overall 
D1 D2 D3 D4 A B C 
Gray et al. (2000) L L UC H PN PY PY Unclear 
Truman et al. (2002) H H H H PN PN PN High 
Patton (2003) H H L H Y PY PY High 
Davenport et al. (2003) L L L H PY PY PY Unclear 
Downer et al. (2004) L L UC UC PY Y PN Unclear 
Downer et al. (2006) L H H H N PN PY High 
Patton et al. (2008) L L L UC PN PY PN Unclear 
Brocklehurst et al. (2010) L L L L Y Y PY Low 
Epstein et al. (2012) H L UC H PN PN N Low 
Riley et al. (2013) L L L L PY PY PY Low 
Walsh et al. (2013) L L L L Y Y Y Low 
Warnakulasuriya et al. (2014)  L L UC H PN PY N High 
Torras et al. (2015) H L H H PY PY N High 
Lingen et al. (2017) L L L L Y Y PY Low 
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Lines are AMSTAR scores. Boxes are ROBIS scores – H = High Risk of Bias, L = Low Risk of Bias, UC = 
Unclear. 
3.4.9 Methodological Quality of the Clinical Guidelines 
Of the 20 clinical guidelines using the AGREE II tool, six were rated overall as high 
quality, nine were rated moderate quality, and five rated as low quality. For this review, the 
overall quality scores of the clinical guidelines ranged from six being the highest score and 
two the lowest, with the mean score being four. There was general agreement between 
overall score and percentages of domain. There was good alignment between overall score 
and the scores % of domain #3 – showing that the rigour of methods was driving overall 
quality.  
3.4.9.1 Description of the domains for the clinical guidelines  
The AGREE II scores for each clinical guideline in all six domains are shown in Table 3.5. 
In the scope and purpose domain (Domain 1), the US Preventive Services Taskforce’s 
clinical guideline in screening for oral cancer scored the highest (around 93%) as they 
clearly defined their overall objectives, the health question and target populations. For the 
stakeholder involvement domain (Domain 2), both the UK NICE clinical guideline for 
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recall intervals between routine dental examination, and the US preventive services task 
force’s clinical guideline in screening for oral cancer scored around 85%. Both of these 
clinical guidelines included patients, their representatives, and other stakeholders in the 
development of the clinical guidelines. The biggest differences in clinical guidelines were 
seen in the rigor of development domain (Domain 3), as the highest domain score was 85% 
for the SIGN guideline, and the lowest was 3% for a private head and neck centre based 
guideline in USA (Memorial Sloan Kettering Cancer Center). The SIGN guideline in 
diagnosis and management of head and neck cancer clearly stated the systematic method 
they used to search for evidence, the selecting criteria of the evidence, the strength and the 
limitation of the body of evidence, the method they used to formulate the evidence, the 
health benefits, side effects and risk in formulating the recommendations, the link between 
the recommendations and the supporting evidence, the experts reviews of their guidelines 
prior to publication, and they also provide their procedure in updating their guideline.  The 
US Preventive Services Task Force’s clinical guideline in screening for oral cancer scored 
the highest in the clarity of presentation domain (Domain 4). The format of the guideline, 
the language and the structure were very clear and they scored around (87%) for this 
domain. Lack of information in relation to potential organisational barriers, cost 
implications, and tools for application, led to low scores across all clinical guidelines for 
the applicability domain (Domain 5). The highest score for this domain was 80% and the 
lowest score was (1%). In general, the score was also low for the clinical guideline’s 
editorial independence domain (Domain 6); which was concerned with the formulation of 
recommendations not being unduly biased with competing interests. The highest score was 
78% for a published review in JADA, and the lowest was 0% for the Memorial Sloan 
Kettering Cancer Center. 
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Overall Quality Score 
D1 D2 D3 D4 D5 D6 
Total % Total % Total % Total % Total % Total %  
NICE (2004a) 55 85% 55 85% 143 83% 44 65% 59 65% 26 56% 6 
High Quality 
NICE (2004b) 47 70% 45 67% 114 63% 52 80% 55 60% 22 44% 6 
SIGN (2006) 47 70% 46 69% 147 85% 53 81% 58 64% 34 78% 6 
MOH-NZ (2009) 53 81% 51 78% 122 68% 52 80% 37 35% 32 72% 6 
USPSTF (2014) 59 93% 55 85% 140 81% 56 87% 43 43% 33 75% 6 
ADA (2017) 54 83% 41 59% 118 65% 53 81% 37 35% 32 72% 6 
SDCEP (2012) 49 74% 50 76% 98 51% 45 67% 59 65% 25 53% 5 
Moderate 
Quality 
SCCN (2013) 49 74% 35 48% 122 68% 44 65% 43 43% 28 61% 5 
AHRQ (2007) 41 59% 35 48% 121 67% 23 26% 28 22% 27 58% 4 
BAO (2011) 41 59% 38 54% 79 38% 54 83% 25 18% 8 6% 4 
SPH (2015) 48 72% 32 43% 120 67% 47 70% 18 8% 9 8% 4 
CCO (2007) 52 80% 27 33% 91 47% 35 48% 43 43% 9 8% 3 
CDSBC (2008) 50 76% 42 61% 42 13% 44 65% 25 80% 14 22% 3 
BDA (2010) 46 69% 31 41% 69 31% 48 72% 54 58% 14 22% 3 
MSCCC (2016) 22 24% 23 26% 51 19% 33 44% 37 35% 11 14% 3 





Overall Quality Score 
D1 D2 D3 D4 D5 D6 
Total % Total % Total % Total % Total % Total %  
GU-GDS (2003) 34 46% 13 7% 26 1% 26 31% 21 13% 17 31% 2  
Low Quality 
cont. 
CRUK (2005) 37 52% 28 35% 33 6% 51 78% 18 8% 14 22% 2 
NIH (2013) 25 30% 17 15% 42 13% 44 65% 18 8% 11 14% 2 











3.5 Data Synthesis  
3.5.1 Domain Identification  
Data from the included systematic reviews and clinical guidelines were extracted for the 
four themes. Table 3.6 shows the themes covered in each of the systematic reviews 
grouped by study quality; and Table 3.7 indicates the themes included in each of the 
clinical guidelines grouped by guideline quality.  
Table 3.6 Summary of themes covered in systematic review and overall quality 



















Epstein et al. (2012) Y Y Y N 
Brocklehurst et 
al.(2013) 
Y Y N N 
Riley et al. (2013) N N N Y 
Walsh et al. (2013) Y Y Y N 







Gray et all. (2000) N Y N N 
Davenport et al. (2003) N N N Y 
Downer et al. (2004) Y Y N N 






Truman et al. (2002) N N N N 
Patton. (2003) Y Y Y N 
Downer et al. (2006) N N Y N 
Warnakulasuriya et al. 
(2015) 
Y N Y N 
Carreras-Torras & Gay-
Escoda. (2015) 
Y Y Y Y 




Table 3.7 Summary of themes covered in Clinical Guidelines with overall quality 





CG ID Organisation/association Country 4 themes 
COE Use of 
Adjunct 








National Institute for Clinical 
Excellence 
UK N N Y Y 
NICE 
(2004b) 
National Institute for Clinical 
Excellence 















N N N N 
USPSTF 
(2014) 
US Preventive Services Task 
Force.  
US Y N N Y 
ADA 
(2017) 
American Dental Association 
 









Agency for Healthcare 
Research and Quality 
US Y Y Y N 
CCO 
(2007) 
Cancer Care Ontario Ontario - 
Canada 
N N N N 
CDSBC 
(2008) 





N Y Y Y 
BDA 
(2010) 
British Dental Association UK Y Y Y Y 
MSCCC 
(2011) 
Maryland State Council on 
Cancer Control 
Maryland Y Y Y N 
BAO 
(2011) 
British Association of 
Otorhinolaryngology 
UK N N N N 
SDSEP 
(2012) 
Scottish Dental Clinical 
Effectiveness Programme  
Scotland - 
UK 
Y N Y Y 
SCCN 
(2013) 
State Cancer Clinical Network. 




N N Y N 
SPH 
(2015) 
Solutions for Public Health 
 






3.5.2 Theme One – Conventional Oral Examination (COE)  
This theme focuses on the clinician’s role in the primary health care dental setting in 
performing conventional clinical visual and tactile intra- and extra-oral examinations on 
their dental patients. This theme assesses the evidence in relation to conducting such 
examinations as part of their routine care in terms of its effectiveness in detecting oral 
potentially malignant disorders (lesions) or in detecting oral cavity cancer at an early stage. 
The effectiveness of screening tests is assessed by the measures: sensitivity and specificity 
(IARC, 1999). Sensitivity measures the ability of a screening test to correctly identify 
those with a disease (or true positive rate). Specificity measures the ability of a screening 
test to correctly identify those without the disease (true negative rate). Thus sensitivity 
measures true positive tests, while specificity measures false negatives.  
3.5.2.1 Systematic review  
High quality systematic reviews 
Three of the five systematic reviews rated as high quality considered the conventional oral 
examination (COE), with two focusing on sensitivity and specificity (Table 3.8). Walsh et 
al (2013) in their high quality Cochrane systematic review undertook an analysis of 
Quality 
Level 















University of Glasgow- 
Glasgow Dental School 
UK - 
Scotland 
Y Y N N 
CRUK 
(2005) 
Cancer Research UK 
 
UK N N Y Y 
NIDCR  
(2013) 
National Institute of Dental and 
Craniofacial Research. 
UK Y N N N 
MSKCC  
(2014) 
Memorial Sloan Kettering 
Cancer Center 




sensitivity and specificity of 10 studies (with 25,568 participants) which evaluated the 
COE against a gold standard expert specialist clinical examination. There was a wide range 
of types of screening studies evaluated in the review, including: opportunistic screening 
(e.g. as part of a routine check-up appointment by a dentist) or as part of an organised 
population-based screening programme. While there was limited difference by these study 
types, the review found that the sensitivity estimates were highly variable and dependent 
on the prevalence of oral cavity cancer (OCC) or OPMD (which itself varied from 1 to 
51% in the studies analysed). In the eight studies with prevalence of 10% or lower, the 
sensitivity estimates were highly variable - ranging from 50% to 99%, while specificity 
was consistently high around 98%. Where the prevalence, in one study, was higher (22%), 
sensitivity was 95% and specificity was 81%; and in another where prevalence was higher 
still (51%), the sensitivity was 97% and specificity was 75%. 
Thus, in low prevalence populations (typically between 1 and 5%), the COE was 
consistently better at classifying the absence of OPMD or OCC in disease free individuals 
than the more variable performance in classifying the presence of disease in individuals 
with OPMD or oral cavity cancer.  
The Walsh et al (2013) Cochrane review complements another recent robust high-quality 
Cochrane review by Brocklehurst and colleagues (2013), which assessed the overall 
effectiveness of screening programmes for the early detection and prevention of oral 
cancer. It identified only one randomised control trial of a conventional oral examination 
which was followed up for a sufficiently long enough period to assess mortality outcomes. 
The RCT was undertaken in Kerala, India with COEs performed by trained health workers 
and they followed participants up for 15 years. The study reported a relatively lower 
sensitivity (than Walsh et al 2013) of 64% but did not report specificity, and Brocklehurst 
et al (2013) in their review undertook a post-hoc analysis of positive predictive test 
performance of 74% (calculated based on the number of screen‐selected oral cancers as a 
proportion of total screen positive biopsy confirmed subjects).  While the evidence in the 
systematic review was limited to one trial (which was also assessed as having some risk of 
bias), the review authors concluded that opportunistic screening via COE – particularly in 
high risk individuals (identified as those who used tobacco or alcohol or both) – may 
potentially improve outcomes through detecting cancer at an earlier stage. 
Epstein et al (2012) assessed the effectiveness of COE in predicting histologic diagnosis of 
dysplasia or OCC. They found poor correlation between the diagnosis made on the basis of 
67 
 
COEs and the diagnosis made on the basis of biopsy results. The review reported 93% 
sensitivity for COE, but specificity was only 31%. They concluded that COE alone was not 
enough to detect OPMD and OCC.  
Overall, the high quality systematic reviews identified some, albeit limited, evidence of the 
effectiveness of COE in the detection of OPMD and OCC – with a tendency for increasing 
sensitivity with increasing prevalence populations, and a suggestion via a single RCT of 
increased COE effectiveness (in terms of improved survival outcomes) among higher risk 
individuals. 
 
Table 3.8 High Quality Systematic Review- COE  
 
Study ID Results and / or Conclusions 
Walsh et al (2013) 
  
Prevalence OCC or OPMD <10%  
Sensitivity = 0.50 (95%CI 0.07, 0.93) to 0.75 (95% CI 0.92, 0.97) 
Specificity = 0.98 (95%CI 0.97, 1.00) 
Prevalence OCC or OPMD = 22% 
Sensitivity = 0.95 (95%CI 0.92, 0.97) 
Specificity = 0.81 (95%CI 0.79, 0.83) 
Prevalence OCC or OPMD = 51%  
Sensitivity = 0.97 (95%CI 0.96, 0.98)   
Specificity = 0.75 (95%CI 0.73, 0.77) 
“Index tests at a prevalence reported in the population (between 1% and 5%) 
were better at correctly classifying the absence of OPMD or oral cavity cancer 
in disease-free individuals than classifying the presence in diseased 
individuals”.  
“General dental practitioners and dental care professionals should remain 
vigilant for signs of OPMD and oral cancer whilst performing routine oral 
examinations in practice”. 
Brocklehurst et al 
(2013)   
Only one RCT included (assessed as having a high risk of bias).  
Sensitivity of 64% but did not report specificity. 
Post-hoc analysis of positive predictive test performance of 74%. 
Comparing screened group and control group 
Overall mortality RR = 0.88 (95%CI 0.69, 1.12)  
High-risk individuals (tobacco and/or alcohol) RR = 0.76 (95%CI 0.60, 0.97)  
No differences in incidence rates 
Reduction in Stage III or worse RR = 0.81 (95%CI 0.70, 0.93)   
“…opportunistic visual screening by appropriately trained dentists and oral 
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Study ID Results and / or Conclusions 
health practitioners is recommended for all patients and particularly for those 
who use tobacco, alcohol or both. Systematic examination of the oral cavity by 
front-line health workers should remain an integral part of their routine for 
routine recall appointments”. 
Epstein et al (2012)  Diagnostic OR = 6.1 (95%CI 2.1, 17.6)  
Sensitivity = 0.93 (95%CI 0.91, 0.94) 
Specificity = 0.31 (95%CI 0.28, 0.34) 
“COE was considered to have poor overall performance as a diagnostic method 
for predicting dysplasia and OSCC”. 
“COE of mucosal lesions generally is not predictive of their histologic 
diagnosis”. 
Moderate quality systematic reviews 
Only one review rated as having moderate quality and moderate risk of bias assessed COE 
(Appendix 3.10). The earlier systematic review (Downer et al., 2004), included a meta-
analysis of eight studies (prospective cohorts with gold standard verification) with wide 
variation in prevalence of OPMD / OCC lesions (from 2% to 51%). They reported a 
weighted pooled estimate of sensitivity (85%) and estimate of specificity (96%) for COE. 
These relatively high levels led to the authors more assertively positive conclusion for 
COE: “A generally high level of discriminatory ability and consistency in test performance 
was apparent among the studies included, irrespective of their clinical heterogeneity”.  
The addition of this moderate quality systematic review would provide more 
(confirmatory) support for the role of COE. 
Low quality systematic reviews  
Of the five lower quality systematic reviews, four considered the effectiveness of COE 
(Appendix 3.11). The most recent review by Warnakulasuriya and colleagues (2015) 
identified a larger number (n=16) of studies (all from Europe) and wider range of study 
types (not limited to RCTs) than the other reviews. They examined the effectiveness of 
COE and reported that there were no consistent results in the studies reviewed and that 
only a small number of studies (n=6) analysed against histological confirmed outcomes. 
No meta-analysis of these studies was undertaken, only ranges of sensitivity (0.68 – 0.98) 
and specificity (0.71 – 0.96) for COE were reported. The review authors strongly 
concluded that the feasibility of screening for OPMDs by COE was demonstrated, 
however, they recognised the need for more testing and research of implementation 
strategies in European countries.    
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Carreras-Torras and Gay-Escoda (2015) included a brief description of current protocols 
for detecting OPMD via a COE – this involved visual inspection of the oral cavity and 
tactile examination of the head and neck lymph nodes. Their (lower quality) review 
concluded that COE alone cannot reliably differentiate between benign and dysplastic 
lesions due to its low specificity and high sensitivity (quoting Epstein et al 2012 data), and 
that this was mainly because many of the benign lesions look like oral malignancies.  
Evidence was also lacking in the earlier and quite limited systematic review that was 
conducted by Patton (2003) in relation to the effectiveness of visual screening in 
community settings. The author stated that with low population prevalence, the actual 
value of screening in detecting new cases of OCC is more effective in high risk individuals 
than mass population screening.  
3.5.2.2 Clinical Guidelines  
High quality clinical guidelines  
Of the six clinical guidelines rated as high quality, four reported evidence-based 
recommendations in relation to the clinical oral examination. These guidelines were: NICE 
(2004b), SIGN (2006), USPSTF (2014), and ADA (2017). 
The scope of review of the USPSTF (2014) included the role of oral cancer screening by 
means of clinical visual inspection and palpation performed by the primary care providers 
on asymptomatic adults as a means of reducing associated morbidity and mortality. The 
terms “asymptomatic” is not clearly defined in the document, however, it is implied that it 
is the general routine adult population attending primary care providers. They conclude: 
“… the USPSTF is unable to make a recommendation in favour of or against screening.” 
(rated as “I” (insufficient) evidence statement). This guideline concludes that there is: “… 
inadequate evidence that the oral screening examination accurately detects oral cancer.”; 
that there is “….  inadequate evidence on the diagnostic accuracy [of COE]”; and that there 
is “… inadequate evidence… [COE] … improves morbidity or mortality” (rated as “I” 
(insufficient) evidence. (Table 3.9). USPSTF (2014) described the COE “screening test” as 
involving visual inspection (with the aid of a mouth mirror) of the face, neck, lips, labial 
mucosa, and buccal mucosa, and gingiva, floor of the mouth, tongue, and palate; as well as 
tactile palpation of the regional lymph nodes of the neck, tongue, and floor of the mouth. 
The guideline also assessed the evidence in relation to the accuracy of screening in 
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identifying oral cancer or OPMD. This high quality clinical guideline reported that there 
was insufficient evidence on whether screening reduces morbidity or mortality in general 
or in high risk US populations. It also stated that there was a lack of evidence on harms 
from the screening test or from false positive or false negative results. The USPSTF (2014) 
referenced the NIDCR (2013) guideline in making the recommendations, which is a simple 
guide for health care professionals on how to perform COE for oral cancer or OPMD. 
The ADA (2017) guidelines updated the ADA (2010) clinical guideline and made 
evidence-based recommendations for primary care practitioners in relation to the 
assessment and detection of oral cancer. The ADA (2017) guideline has a particular focus 
on the role of adjuncts for the evaluation of OPMDs (and undertakes its own systematic 
review as part of the process (Lingen et al, 2017).  This high-quality evidence-based 
document recommended: “The panel suggests that clinicians [dentists] should obtain an 
updated medical, social, and dental history and perform an intraoral and extraoral 
conventional visual and tactile examination [refers to initial, routine, or emergency visits] 
in all adult patients” (rated as Good Practice Statement – based on no quality of evidence 
rating, and no strength of recommendation assigned). This review does not reference or 
cite the Kerala RCT (Sankaranarayanan et al, 2005) as reviewed in ADA (2010), where 
they concluded that community-based screening by means of visual and tactile 
examination in the general population intended to detect early and advanced oral cancer 
may not alter disease specific mortality, but may reduce oral cancer mortality among the 
high risk group (defined as smokers and alcohol drinkers). ADA (2010) also rated the 
evidence in this area as a “Good Practice Statement” – which they define as based on an 
“overwhelming amount of indirect evidence” (Table 3.9). The indirect evidence includes 
drawing heavily on the Kerala RCT (Sankaranarayanan et al, 2005) and an earlier 
Cochrane systematic review by Kujan et al. (2006).  
Similarly, the SIGN (2006) guideline on diagnosis and management of head and neck 
cancer stated that: “Dental practitioners should include a full examination of the oral 
mucosa as part of routine dental check-ups” (rated as a “Good Practice Point” – i.e. based 
on clinical guideline development group expert opinion, which was below the four grades 
of recommendation used in this guideline; Table 3.9). Moreover, SIGN (2006) did not 
specify or detail the steps involved in the clinical oral examination process.  
NICE (2004b) is guidance for cancer services to improve outcomes in head and neck 
cancer. While this guidance document focused on developing urgent referral guidance and 
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referral pathways for patients with suspected head and neck cancer, it does, however, make 
the point that “… systematic examination of the oral mucosa by dentists could be carried 
out as part of routine dental inspection” (rated as “Grade B” – i.e. mid-level evidence in 
their guideline; Table 3.9).  
 
Table 3.9 High Quality Clinical Guidelines – COE 
 
All of these high quality clinical guidelines suggest that any abnormality detected should 
be re-evaluated in two weeks and if still present biopsied or referred for biopsy. The 
(higher quality) clinical guidelines acknowledge that there is limited evidence on the 
effectiveness of a clinical visual and tactile examination in detecting both oral cancer 
(including at an earlier stage) and OPMD in asymptomatic adults in primary dental care. 
However, largely on the basis of expert opinion, these guidelines recommend that a full 
mouth examination should be an integral part of routine dental examinations (check-ups) 
CG -ID Year  Recommendations Evidence Rating 
NICE (2004b) 2004 
 
 
“… systematic examination of the oral 
mucosa by dentists could be carried out 
as part of routine dental inspection.” 
Grade B – Base on evidence 
from non-randomised control 




“Dental practitioners should include a 
full examination of the oral mucosa as 
part of routine dental check-up [sic].” 
Good Practice Point – Based 
on the clinical experience of 









“… inadequate evidence that the oral 
screening examination accurately 
detects oral cancer.” 
“…  inadequate evidence on the 
diagnostic accuracy [of COE]”. 
“… inadequate evidence … [COE] … 
improves morbidity or mortality.” 
I  statement – Based on 
conclusion that the current 
evidence is insufficient to 
assess the balance of benefits 
and harms of the service. 
Evidence is lacking, of poor 
quality, or conflicting, and 
the balance of benefits and 






“The panel suggests that clinicians 
[dentists] should obtain an updated 
medical, social, and dental history and 
perform an intraoral and extraoral 
conventional visual and tactile 
examination [refers to initial, routine, 
or emergency visits] in all adult 
patients.” 
Good Practice Statement – 
Based on no quality of 
evidence rating, with no 




and that clinicians should stay alert for signs and symptoms and use their clinical judgment 
and experience. Moreover, these high quality clinical guidelines did not detail or specify 
the processes involved in the clinical visual and tactile examination – which is perhaps not 
surprising given a limited evidence base on these specific aspects to draw from. 
Furthermore, the grading schemes, which were used in these clinical guidelines, concluded 
that the evidence was not at a sufficiently high level, i.e. the grades were based on: 
insufficient evidence; evidence from one RCT only; evidence from non-experimental 
descriptive studies; or from the expert clinical experience of the guidelines development 
team.  
Moderate quality clinical guidelines 
The nine moderate (and indeed the low) quality clinical guidelines, in contrast to the high 
quality ones, provided more in-depth recommendations and descriptions in relation to how 
to perform the clinical oral examination. These recommendations were based on expert 
opinion rather than cited evidence (Appendix 3.12).   
The MSCCC (2016) cited the ADA (2010) and “recommends that dentists look for signs of 
cancer while performing routine exams in all patients, particularly those who use tobacco 
or consume alcohol heavily” and the ACS (2003) “recommends oral exams as part of 
routine cancer-related check-ups”. The MSCCC (2016) was an update of MSCCC (2011) 
which performed a review of existing US clinical guidance at the time, which came to 
same conclusions. 
The South Australian SCCN (2013) guidelines recommended “…dental and medical 
examinations with appropriate health questionnaires (such as skin, voice, oral symptoms, 
swallowing and behavioural assessments for risk factors)”. There was no evidence base 
cited, nor was the strength of recommendation given.  
The older US AHRQ (2007) guideline described as a “major recommendation” that “visual 
examination of the oral soft tissues, extraoral head and neck tissues and palpation of the 
head and neck lymph nodes is considered the standard of care as part of a complete dental 
examination”. It did not describe the strength of the recommendation or evidence base. 
The SDCEP (2012) clinical guidelines provided details for the dental team on conducting a 
comprehensive oral health assessment. It provided action points (recommendations) for the 
dental team at a summary level within their Guidance in Brief document and more detailed 
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level guidance in the full document. The action points were not given a strength of 
recommendation nor was the evidence base cited.   
The BDA (2010) clinical guidelines “occasional paper” on early detection and prevention 
of oral cancer similarly did not cite the evidence base or assign a strength of 
recommendation. It recommended a “head and neck and oral soft tissue examination 
should be carried out…” – they provided a detailed guide on visual and tactile examination 
(data not shown).   
The UKSPH (2015), made reference to the Walsh et al (2013) systematic review, and 
reported that there was insufficient evidence to determine the accuracy of a COE. This 
guideline also found one study (Ibrahim et al, 2014) published since Walsh et al (2013) 
which claimed 100% sensitivity for COE, however, the study design was weak with no 
follow-up and it could not reliably ascertain cases of oral cancer that were missed by 
screening.  
Low quality clinical guidelines  
Of the five clinical guidelines rated as low quality, three made recommendations in relation 
to COE (Appendix 3.13). One low quality clinical guideline from the US National Institute 
of Dental and Craniofacial Research (NIDCR, 2013) provided a detailed procedure for 
health care professionals on how to conduct the intra-oral and extra-oral examination. This 
was produced in the form of a leaflet / poster to act as an accessible guide for health care 
professionals. Although there was no evidence that any specific screening / examination 
method could have improved outcomes for those diagnosed with head and neck cancer. 
The other lower quality clinical guideline by the Memorial Sloan Kettering Cancer Center 
in US (MSKCC, 2014) recommended a head and neck examination including the oral 
cavity and oropharynx by a primary care physician. However, it did not provide any details 
on how these examinations should be performed. The University of Glasgow – Glasgow 
Dental School (GU-GDS) clinical guidelines recommended a thorough and methodological 
examination of the mouth. A detailed step-by-step guide for undertaking extra-oral and 
intra-oral examination for suspicious lesions was provided. The GU-GDS clinical 
guideline also did not make reference to the evidence base.  
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3.5.3 Theme Two: Target Population 
This theme aims to assess the evidence in relation to the “target population” for receiving 
early detection / screening of oral cavity cancer or OPMD interventions. It will address 
questions including: should they be delivered via a mass or invitational screening approach 
for the general population, or an opportunistic approach for those attending primary health 
care settings?; and should they be delivered to all patients attending these settings, or 
further targeted to high risk individuals (i.e. tobacco / alcohol users)? 
3.5.3.1 Systematic Reviews  
High quality systematic reviews 
The Cochrane review by Walsh et al., (2013) covered the issue of the target population for 
COE for early detection / screening of oral cavity cancer or OPMD; however, it was not a 
primary focus of their review. Out of the thirteen studies appraised in their review, five 
included “high risk” groups which were defined as either having a previous history of head 
and neck cancer or were older tobacco smokers. These studies were generally undertaken 
in high prevalence countries and reported higher sensitivity and specificity of the COE to 
detect OPMD (as in Table 3.10). The authors reported that although the evidence of the 
accuracy of the COE for early detection of OPMD was not consistently strong, there was 
some evidence that COE as a component of a population screening programme could 
reduce mortality and produce stage-shift in high risk populations (Kerala study). However, 
they concluded that “General dental practitioners and dental care professionals should 
remain vigilant for signs of OPMD and oral cancer whilst performing routine oral 
examinations in practice.”  
The Cochrane systematic review by Brocklehurst et al., (2013) found evidence for  a 
population-based screening programme reducing the mortality rate in high risk individuals 
(defined as tobacco smokers and alcohol drinkers) rather than in a high risk population per 
se (Table 3.10). This finding was from the community-based randomised controlled trial of 
oral cancer screening from Kerala in India (Sankaranarayanan et al., 2005). The review 
points out that while the study was conducted in a relatively high prevalence population 
base, the effectiveness in terms of stage shift of earlier detection and reduced mortality was 
observed in high risk individuals (those who smoked tobacco and drank alcohol). 
However, they do report concerns about the fact it was only one trial and that the trial had 
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a high risk of bias. The review also examined the health economic literature (including 
economic evaluation of the Kerala study), reporting that COE could be cost-effective 
among high risk individuals – with improved survival and reduced treatment burden 
associated with earlier stage shift of detection. However, this was a post-hoc extrapolation 
from data from a population-wide community screening programme. They reported that 
COE was effective, and also cost effective when focused on high risk individuals – with 
improved survival, and reduced treatment burden associated with stage-shift.The 
Brocklehurst et al. (2013) review, as per the Walsh et al. (2013) review, concluded that 
“opportunistic visual screening by appropriately trained dentists and oral health 
practitioners is recommended for all patients and particularly for those who use tobacco, 
alcohol or both.” 
 
Table 3.10 High Quality Systematic Review (Target Population) 
 
Study ID Results and / or Conclusions 
Walsh et al (2013)  “... even though the evidence of accuracy is not consistently strong, there 
is some evidence ... that implementing COE as a component of a 
population screening programme can reduce mortality and produce stage-
shift in a high-risk population.”  
“General dental practitioners and dental care professionals should remain 
vigilant for signs of OPMD and oral cancer whilst performing routine oral 
examinations in practice.” 
Brocklehurst et al 
(2013)   
“There is evidence that a visual examination as part of a population-based 
screening programme reduces the mortality rate of oral cancer in high-risk 
individuals.” 
“However, the evidence is limited to one study, which has a high risk of 
bias and did not account for the effect of cluster randomisation in the 
analysis.” 
“... good evidence that opportunistic screening of high-risk groups is cost-
effective” ... “However, these results also need to be read in context of the 
relative prevalence of the condition.” 
“The results suggest that there is insufficient evidence to recommend a 
whole population screening programme for oral cancer. However, the 
results from the Kerala study suggest that a targeted population approach 
could reduce the mortality rate and produce a stage shift, but the risk of 
bias in the included study means that further well-designed randomised 
controlled trials are necessary to establish the validity of this relationship.” 
“In the meantime, opportunistic visual screening by appropriately trained 
dentists and oral health practitioners is recommended for all patients and 
particularly for those who use tobacco, alcohol or both. Systematic 
examination of the oral cavity by front-line health workers should remain 
an integral part of their routine for routine recall appointments.” 
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These two high quality systematic reviews drawing on largely the same original studies 
agreed: i) that a conventional oral examination should be performed opportunistically as 
part of routine dental care – although this statement lacked an evidence-base itself and was 
more precautionary; ii)  that there was insufficient evidence for population  / invitational 
screening approaches; and iii) despite some evidence in support of greater effectiveness in 
high risk individuals, they both considered it insufficient to recommend an approach which 
focused on or stratified to high risk individuals, favouring an opportunistic approach on all 
patients attending dental practice.   
 
Moderate quality systematic reviews 
The moderate quality systematic reviews did not specify any details about the target 
population in relation to early detection  / screening for oral cavity cancer or OPMD.  
Low quality systematic reviews 
The Warnakulasuriya et al. (2015) systematic review included 16 European studies (no 
randomised controlled trials) assessing COE to detect OCC or OPMD. While they did not 
synthesise the study findings, they found no evidence to support either a population-based 
or targeted screening approach, with some mixed evidence on invitational approaches 
(which seemed to be more successful in workplace settings). They concluded by proposing 
that the two possible best approaches, which would need further research on effectiveness, 
would be opportunistic screening in dental practices or screening of selected high-risk 
populations (Appendix 3.14). Warnakulasuriya et al (2015) also noted the concerns that a 
dental practice approach would not include sufficient high-risk individuals (as they are less 
likely to attend dental settings) – which has previously been described as the “inverse 
screening law” (Netuveli et al., 2006).  
The earlier systematic review by Patton  (2003) reported insufficient evidence to draw 
conclusions regarding the effectiveness of COE for oral cancer screening in community 
settings in low risk populations, but reported (without particular reference to evidence) that 
targeted COE of high-risk individuals may be more effective than mass screening. Patton 
also recommended that: i) adults above the age of 40 should undergo regular routine COE 
as part of medical and dental primary health care check-ups; ii) high risk groups (tobacco 
and alcohol users) should be motivated to regularly attend primary care settings for COE; 
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and iii) tobacco cessation interventions could be included as part of the early detection  / 
screening COE intervention (Appendix 3.14).  
A systematic review by Downer et al., (2006), also produced no evidence on potential 
benefits associated with an oral cancer screening programme. Upon review completion 
they reported in their discussion that evidence had emerged from the report of the Kerala 
study, which stated that screening for OCC “may be effective; at least in developing 
countries with a high incidence of the disease”.  
These lower quality-rated systematic reviews similarly supported opportunistic early 
detection / screening approaches, but more clearly identified that high risk individuals were 
less likely to attend routine dental appointments for this opportunity and therefore some 
form of targeted encouragement to reach these groups was needed.   
3.5.3.2 Clinical Guidelines  
High quality clinical guidelines  
Three of the six high quality-rated clinical guidelines included details of the target 
population for early detection / screening (National Institute for Clinical Excellence, 2004; 
USPSTF, 2014; ADA, 2017) 
The NICE (2004a) dental recall clinical guideline recommended that: a “thorough dental, 
head and neck examination” should be carried for “all new NHS dental patients” and for 
all returning patients attending for “check-up” appointments; and a social history for 
excessive alcohol and tobacco use should be undertaken each time. The outcome of the 
social history did not influence whether the patient should have a COE or not or the nature 
/ content of the COE (Table 3.11). These recommendations were evidence-graded as “GPP 
– A good practice point is a recommendation for best practice based on the clinical 
experience of the Guideline Development Group”. 
The USPSTF (2014) guidelines did not recommend population based screening – this was 
given a “Grade I statement”, as mentioned above in the first theme (COE). The 
supplementary evidence synthesis found that there was no evidence on oral cancer 
screening either for the general population or for selected high-risk groups which would be 
applicable to the US. However, they noted that high-risk group targeted screening 
strategies may be applicable in high prevalence populations (this was based on the one 
“Kerala RCT” which they rated as having “good quality”). This guideline also reviewed 
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the health economic literature. Here they reported that a targeted (high-risk) approach in 
primary care dental (and perhaps medical) settings was potentially cost-effective (this was 
based on one RCT, and two decision-analysis models). 
The ADA (2017) clinical guidelines recommended that dental clinicians undertake COE in 
all adult patients after updating their medical, social, and dental history (no quality of 
evidence rating, nor strength of recommendation was assigned). This high quality-rated 
clinical guideline supports opportunistic COE for all patients attending dental 
appointments.  
 












“New NHS dental patient: Full 
patient histories recorded; Thorough 
dental, head and neck examinations 
for new NHS dental patient”  
“Oral Health Reviews: Update patient 
histories, Update exam.” 
GPP – A good practice point is a 
recommendation for best practice 
based on the clinical experience of 







“... concludes that the current 
evidence 
is insufficient to assess the balance of 
benefits and harms of 
screening for oral cancer in 
asymptomatic adults.” 
I statement – Based on conclusion 
that the current evidence is 
insufficient to assess the balance of 
benefits and harms of the service. 
Evidence is lacking, of poor quality, 
or conflicting, and the balance of 







“The panel suggests that clinicians 
[dentists] should obtain an updated 
medical, social, and dental history 
and perform an intraoral and extraoral 
conventional visual and tactile 
examination [refers to initial, routine, 
or emergency visits] in all adult 
patients.” 
Good Practice Statement – Based on 
no quality of evidence rating, with no 
strength of recommendation assigned 
79 
 
Moderate quality clinical guidelines  
The target population for early detection / screening was covered in five of the nine clinical 
guidelines rated as moderate quality: (CDSBC, 2008; BDA, 2010; SDCEP, 2012; UKSPH, 
2015; MCCCP, 2016) (Appendix 3.15).  
The UKSPH (2015) considered the UK National Screening Committee criteria (UKNSC) 
in relation to the effectiveness of a COE in either a population or targeted basis were not 
met. This assessment was based largely on the Walsh et al (2013) Cochrane review.  
The Maryland Comprehensive Cancer Control Plan - MCCCP (2016) guidelines reviewed 
four other earlier North American clinical guidelines, which had been published between 
1996 and 2003, only one of which (ACS 2003) was included in this overview. They 
identified a lack of consensus in relation to target population and opportunistic vs. 
population approaches. They concluded that there was insufficient evidence to recommend 
general population screening. However, for high risk or indeed for opportunistic screening 
of all patients they noted that “this does not mean that such examinations are not 
effective”. They also pointed out that those at highest risk may be less likely to attend for 
regular dental appointments and that screening efforts should also focus on encouraging 
medical physicians to routinely inspect the oral cavity in high risk patients; and they went 
on to recommend extending opportunities for opportunistic screening (Appendix 3.15). 
The SDCEP (2012) clinical guidance on oral health assessment recommended that a COE 
was performed on all patients (irrespective of risk) attending primary care dental practice. 
This was based solely on the “expert opinion of the guideline development group”.   
The British Dental Association (BDA, 2010) recommended that a head and neck and oral 
soft tissue examination be carried out on all patients as part of their routine dental “check-
up” appointments. They proposed that this examination should occur at the start of each 
new course of treatment, and further / more frequent check-ups need to be undertaken for 
high risk groups (smokers and alcohol users). There was no reference to the evidence base 
for these recommendations. They also did not find evidence to support population-based 
screening, but recommended opportunistic screening (COE) in dental settings for all 
patients. However, the recommendations were based on a UK report on screening for 
cancer and precancer which was published in 1993 (Appendix 3.15). 
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The College of Dental Surgeons of British Columbia (CDSBC- 2008) recommended COE 
on “all patients at the time of the new patient examination and at the general dental recall 
[appointment]”. It was not clear what evidence this was based on. 
Taken together, the moderate quality-rated clinical guidelines did not differ from the 
higher quality clinical guidelines – generally recommending COE opportunistically for all 
patients attending primary dental care appointments, based on expert opinion rather than an 
evidence-base.   
Low quality clinical guidelines  
The four low quality clinical guidelines which considered the target population for early 
detection / screening of oral cancer were: (ACS, 2003; CRUK, 2005; NIH, 2013; MSKCC, 
2014; Appendix 3.16).  
MSKCC (2014) advised that all individuals visit a primary care physician for a COE and 
visit a dentist for “dental evaluation”, although they acknowledge that “no screening 
method has been proven to improve survival for people with head and neck cancer”. No 
evidence sources were quoted.  
NIDCR (2013) stated that the COE should be undertaken during the dental check-up visit. 
It went on to say “clinicians should be particularly vigilant in checking those who use 
tobacco or excessive amounts of alcohol”. There were no details provided on how to be 
particularly vigilant or whether that would involve doing anything differently. There was 
no evidence source provided for this statement.   
CRUK (2005) and ACS (2003) were similar in proposing some targeting based on age-
group and risk factors. While CRUK recommended COE in every dental examination, they 
suggested this should be undertaken with a “higher level of suspicion” and “if the patient is 
a smoker or heavy alcohol drinker, chews betel nut (areca nut) or tobacco, or is over 40 
years”, although there were no details of what undertaking a COE with a “higher level of 
suspicion” would involve. ACS (2003) recommended COE on the occasion of a periodic 
health examination, rather than a stand-alone examination for those aged 20 years and 
over.   
These low quality-rated clinical guidelines also generally recommended opportunistic COE 
as part of regular dental and health check-ups. 
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3.5.4 Theme Three: Frequency of Conventional Oral Examination  
The frequency of people having a Conventional Oral Examination in primary care dental 
practice is intertwined with the frequency of dental “check-ups” (which should include 
both a dental and oral health assessment). How the recall interval between such visits is 
determined is increasingly subject to review in many countries. Traditionally this recall 
interval has been fixed at six-monthly for all (Riley et al., 2013). However, the justification 
and lack of evidence base for this has been questioned (Davenport et al., 2003). Integral to 
determining the frequency of a COE is the risk associated with oral cancer or OPMD.   
3.5.4.1 Systematic Reviews 
Very few systematic reviews have specifically considered the issue of the frequency of 
COE for early detection / screening for OCC or OPMD. 
High quality systematic reviews  
One high quality-rated systematic review by Riley et al. (2013) aimed to determine the 
beneficial and harmful effects of different fixed recall intervals (e.g. 6 months versus 12 
months) for dental check-ups. This Cochrane review took oral cancer into its consideration, 
but identified only one small RCT with 188 participants, which the reviewers assessed as 
having a high risk of bias (Table 3.12). Therefore, no conclusions were made regarding the 
beneficial and harmful effect of varying recall intervals between dental checks.  
 
Table 3.12 High Quality Systematic Review - Frequency  
 
Study ID Results and / or Conclusions 
Riley et al (2013) 
 
“There is a very low-quality body of evidence from one RCT which is 
insufficient to draw any conclusions regarding the potential beneficial 
and harmful effects of altering the recall interval between dental check-
ups.” 
Moderate quality systematic reviews  
The clinical effectiveness and cost effectiveness of routine dental checks was assessed by 
(Davenport et al., 2003). This moderate quality review also assessed the cost effectiveness 
of routine dental checks of different recall frequencies in improving quality of life, 
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reducing the morbidity associated with dental caries, periodontal disease, and oral cancer, 
as well as reducing the mortality associated with oral cancer in adults. In the review, two 
studies (one cross-sectional and one retrospective case-series) were included that 
investigated the relationship between frequency of dental check-ups and oral cancer 
outcomes. These two studies both from the 1990s had conflicting results. The cross-
sectional study based in primary and secondary care settings in London, UK (involving n= 
2027 participants) found that recall intervals of less than 12 months do not impact on 
tumour size at diagnosis (“no association between dental check frequencies ≥ 12/12 and < 
12/12 and a diagnosis of oral cancer and precancer”) (Jullien et al., 1995). The 
retrospective case-series study, based in tertiary care hospital clinics in Iowa City, US 
(involving n=53 participants) concluded that increasing the interval to more than 12 
months may significantly increase the size of tumours at diagnosis (“decreasing dental 
check-ups frequencies (>12/12 only and for intervals decreasing  by ≥ 12/12) may results 
in a significantly increased tumor size and more advanced stage at diagnosis”) (Rubright et 
al., 1996; Appendix 3.17). 
However, overall, the systematic reviews concluded that there was limited evidence to 
support or refute the practice of six monthly dental check-ups, although this final 
conclusion was based mainly on dental caries data. 
Low quality systematic reviews  
None of the systematic reviews rated as lower quality considered the frequency of 
undertaking COE for early detection or screening of oral cancer.  
3.5.4.2 Clinical Guidelines – Frequency of Conventional Oral Examination 
High quality clinical guidelines 
Only one of the six high quality-rated clinical guidelines included details of the frequency 
of COE for early detection and screening (National Institute for Clinical Excellence, 2004).  
The NICE (2004a) clinical guideline on dental recall intervals recommended that the 
interval between oral health reviews should be based on the patient’s needs, on the basis of 
disease levels and risk from the disease. For oral cancer risk assessment the guideline 
recommends that this should include tobacco and excessive alcohol history as well as the 
presence of OPMD identified via a COE; and that following a risk assessment dentists 
should then use their clinical judgement to weight these factors (along with other dental 
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risks) to determine the recall interval. They suggested that patients identified at high risk of 
oral cancer should have a COE and history at between 3 and 6 months intervals, and those 
at low risk could have intervals increased to between 12 and 24 months. These 
recommendations were rated “grade D” and considered a “Good Practice Point” (Table 
3.13). This was based on expert consensus, which was collated via a robust methodological 
approach, however, there were no specific research studies associated with oral cancer 
cited in the document (because there were no high-quality studies available). 
The high quality-rated clinical guideline from NICE (2004a) was the only guideline which 
provide a detailed description on recall intervals considering COE for early detection of 
oral cancer – proposing a risk based recall interval.  
 
Table 3.13 High Quality Clinical Guidelines – Frequency  
 






















“The recommended interval between oral health 
Reviews should be determined specifically 
foreach patient and tailored to meet his/her 
needs, on the basis of an assessment of disease 
levels and risk of or from dental disease” [Grade 
D] 
“During an oral health review, the dental team 
(led by the dentist) should ensure that 
comprehensive histories are taken, examinations 
are conducted and initial preventive advice is 
given. This will allow the dental team and the 
patient (and/or his or her parent, guardian or 
career) to discuss, where appropriate: the 
patient’s ability or desire to visit the dentist at 
the recommended intervals” [Grade GPP]  
“The shortest interval between oral health 
reviews for all patients should be 3 months” 
[Grade GPP] 
“The longest interval between oral health 
reviews for patients younger than 18 years 
should be 12 months” [Grade GPP] 
“The longest interval between oral health 
reviews for patients aged 18 years and older 
should be 24 months” [Grade GPP] 
“Dentists use clinical judgement to weigh the 
risk factors and protective factor when deciding 
on a patient’s recall intervals.” [Grade GPP] 
 
Grade D “Evidence Level 3 or 
4 Or Extrapolated evidence 
from studies rated as [Level] 
2+ or Formal consensus”  
Level 3= Non-analytic studies 
(e.g. case reports, case series) 
Level 4 = Expert opinion, 
formal consensus. 
Level 2+ = Well-conducted 
case-control or cohort studies 
with a low risk of 
confounding, bias or chance, 
and a moderate probability 
that the relationship is causal.  




Moderate quality clinical guidelines 
Five of the nine moderate quality-rated clinical guidelines provided information in relation 
to frequency of early detection / screening for OCC or OPMD (AHRQ, 2007; CDSBC, 
2008; BDA, 2010; SDCEP, 2012; SCCN, 2013).   
The South Australian Head and Neck Cancer Pathway (2013) recommend improving 
community awareness by promoting 6 to 12 month dental and medical examinations with 
appropriate health questionnaires. However, what this examination included was not 
clarified in this guideline, and this recommendation was not based on any evidence.  
SDCEP (2012) recommended a comprehensive oral health assessment, which included 
assessment of head and neck and oral mucosal tissue, every 24 months for adults (>18 
years), and 12 months for children. This recommendation was based on the experience and 
knowledge of the guideline development group. However, these clinical guidelines did 
recommend “Focused Oral Health Reviews (FOHRs)” to be carried out within the 24 
months interval, and that “both the number of FOHRs and the intervals between them will 
vary depending on the patient’s risk of future oral disease.” The guideline refers to the 
National Institute for Clinical Excellence, (2004) intervals, however, it does explicitly set 
out how oral cancer risk and COE assessment is included.    
The BDA occasional paper guideline on early detection and prevention of oral cancer 
(2010), recommended opportunistic screening should be at the beginning of each new 
course of treatment, although they noted in relation to oral cancer that “since the objective 
is opportunistic case finding rather than invitational screening, there is no precise answer to 
a question about the desirable intervals between mouth examinations”. They suggest that 
the interval should vary based on risk – without clearly indicating how this relates to oral 
cancer, and they cite the Health Development Agency’s consensus statement on the 
Scientific Basis of Dental Health Education as evidence (Levine, 1996), and they also 
recommended that dental teams should follow the NICE (2004a) clinical guidance on 
dental recall intervals (Appendix 3.18).  
The British Columbia (2008) clinical guideline on early detection for oral cancer, 
recommended that on the basis of present evidence and potential benefit, systematic oral 
cancer screening should be offered annually to all individuals from the age of 40. 
However, the details of the evidence were not provided. 
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The Agency for Healthcare Research and Quality (2007) recommended that inspection of 
the mouth, oropharyngeal soft tissues and head and neck lymph nodes should be conducted 
at each dental hygiene visit and that individuals with risk for oral cancer would require 
more frequent recall intervals. No additional detail was provided and the recommendations 
were not based on any cited evidence. 
Collectively, the moderate clinical guidelines gave a very mixed picture of recall interval 
in relation to performing the COE – with the more recently published guidelines proposing 
a risk based recall interval. 
 
Low quality clinical guidelines  
One low quality rated clinical guideline recommended a frequency for oral cancer early 
detection / screening activities (MSCC, 2014).  
The MSCC (2014) clinical guideline recommended that a yearly physical examination of 
the head and neck and oropharynx should be undertaken by a primary care physician and 
similarly a yearly clinical oral examination should be carried out by a primary care dentist. 
This low quality-rated clinical guideline recommended building oral cancer COEs into 
routine dental check-ups (Appendix 3.19). 
3.5.5 Theme Four: Adjunct Tools    
In addition to the conventional visual and tactile oral examination (COE), a number of 
adjunctive techniques or methods have been proposed and evaluated to try to improve the 
early detection of OCC and OPMD in primary care dental settings. These techniques 
include: vital rinsing or staining, light-based detection, exfoliative cytology, and blood and 
saliva analysis.  
Vital staining techniques use a number of dyes which aim to stain areas of the oral mucosa 
with cells that have a high reproductive rate, such as dysplastic or neoplastic cells. Their 
main uses seem to be to indicate the area of the oral mucosa that needs to be examined and 
biopsied. Examples of dyes include toluidine blue, methylene blue, and Lugol’s Iodine 
staining (Carreras-Torras and Gay-Escoda, 2015).  
Light-based detection methods use devices which are based on the principle of differential 
tissue reflectance and tissue auto-fluorescence in normal and dysplastic areas of the oral 
86 
 
mucosa, and thus aim to improve the examination procedure. Examples include Velscope 
(tissue fluorescence imaging), ViziLite plus (chemiluminiscence), and tissue fluorescence 
spectroscopy (Rethman et al., 2010).  
Both the vial staining and light-based detection system adjunct methods basically work 
under the assumption that abnormal mucosal tissue which is undergoing some metabolic or 
structural changes have different levels of absorbance and reflectance when they are 
exposed to different types of light or energy (Lingen et al, 2008).  
Exfoliative cytology, via a brush biopsy, is a minimally invasive adjunct method to collect 
cells from the oral mucosa (Lingen et al, 2008).  
Furthermore, there are blood and saliva analyses Adjunct Tools that require laboratory 
analysis to identify biomarkers (such as transcriptomic and proteomic markers) which are 
proposed to be discriminatory for detecting (squamous cell) oral cavity cancer 
(Markopoulos et al., 2010). 
3.5.5.1  Systematic Reviews 
High quality systematic reviews 
Walsh et al (2013) in their high quality Cochrane review of assessment methods for the 
detection of oral cavity cancer and potentially malignant disorders found only one RCT 
among the 13 test accuracy trials they included, which assessed an adjunct method (Table 
3.14). This community-based trial by Su et al (2010) in Taiwan, directly evaluated COE 
and vital rinsing, and there were no eligible diagnostic test accuracy studies evaluating 
light-based detection or blood or salivary sample analysis. The community-based trial 
included 7,975 participants and directly compared COE with COE plus vital rinsing. It 
reported a slightly higher detection rate for oral cavity cancer in the COE plus vital rinsing 
adjunct trial arm. However, overall, the systematic review authors concluded, based on this 
single trial (which was rated as having “unclear” risk of bias due to patient selection) with 
its marginal effects, that there was insufficient evidence in relation to the use of vital 
rinsing as part of a screening programme or early detection in primary care.  
The effectiveness of current screening methods, including visual examination, toluidine 
blue, fluorescence imaging or brush biopsy, in decreasing oral cancer mortality were also 
assessed by Brocklehurst et al (2013). This high quality Cochrane review did not find any 
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RCTs which investigated the role of adjunct methods in screening for the early detection of 
oral cancer.  
Similarly, Epstein and colleagues (2012) conducted a high quality systematic review 
focusing on the effectiveness of the COE and included the use of adjuncts in predicting 
oral cancer or OPMD. Unlike Cochrane, they did not limit their inclusion criteria to RCTs 
and included 24 studies (with 7,079 patients) assessing COE and the use of adjunctive 
techniques. However, they concluded, that while adjunct tests are potentially needed (due 
to OCCs often being detected or diagnosed at a late stage) to increase the ability 
("diagnostic yield") of COE to identify early lesions, such techniques or indeed research 
and the evidence on such techniques are not yet available. 
As part of the process of the American Dental Association clinical guidelines update 
(ADA, 2017), the guideline development team collaborated with the Cochrane Oral Health 
Group to update earlier Cochrane reviews (Walsh et al., 2013; and Macey et al., 2015) to 
assess the effectiveness of adjuncts for the evaluation of potentially malignant disorders in 
the oral cavity. This systematic review was separately published (Lingen et al., 2017). It 
should be noted here that the Macey et al. (2015) Cochrane review was excluded from this 
current overview on the grounds that it was focused in secondary rather than primary care, 
and on diagnosis rather than early detection, assessing the role of adjuncts in relation to 
biopsy / histopathological assessment, and was out of scope for this overview. In any case, 
however, the Macey et al. (2015) Cochrane review found that the quality of studies 
investigating adjunct tests was poor, and that no adjunct test would replace the standard 
clinical oral examination in guiding traditional scalpel biopsy and histological assessment. 
Lingen et al. (2017) found that adjuncts had limited diagnostic test accuracy when it is 
used as an alternative in the primary care settings. Lingen et al. (2017) also reported low 
quality evidence (including serious risks of bias among studies) suggesting cytology 
testing of suspicious lesions appeared to have the highest accuracy among adjuncts 
(sensitivity 0.92;  and specificity 0.94); however they concluded that OHCPs should 
“remain skeptical about the potential benefits of any adjunct in clinical practice” 
particularly in primary care dental settings for early detection  / screening of oral cavity 
cancer.  
Overall, the summary of high-quality systematic reviews points to insufficient available 
evidence to draw conclusions of effectiveness or to recommend the use of Adjunct Tools 
alongside or instead of COE to improve the early detection of OCC and OPMD.  
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 Table 3.14 High quality Systematic Reviews - adjuncts tools 
 
Study ID Results and/or Conclusions 
Walsh et al (2013)  “One study (7975 participants) directly compared COE with COE plus vital 
rinsing in a randomised controlled trial. This study found a higher detection rate 
for oral cavity cancer in the conventional oral examination plus vital rinsing 
adjunct trial arm.” 
“… overall, risk of bias for this study (Sue 2010) which directly compared two 
index tests in a randomised controlled trial to be at unclear risk of bias for 
patient and index test, Concern regarding the over all applicability of the study 
was high.”  
“… other tests include the use of a blue ’dye’, illumination with a special light 
and self examination by the individual. The review found a lot of variety in the 
ability of the 
different tests to differentiate between healthy mouths and non-referable lesions 
and more serious lesions or oral cancer. Overall, visual examination by a front-
line health worker proved to be the best method. Between 59% and 99% of 
mouth cancers were detected, although sometimes normal tissue was mistaken 
for oral cancer. The remaining techniques examined were not as good at 
detecting mouth cancer and identified less than a third of cases.” 
Brocklehurst et al 
(2013)   
“ … there was no evidence to support the use of adjunctive technologies like 
toluidine blue, brush biopsy or fluorescence imaging as a screening tool to 
reduce oral cancer mortality.”  
Epstein et al (2012)  “… a COE of mucosal lesions generally is not predictive of their histologic 
diagnosis. The fact that OSCCs often are diagnosed at an advanced stage 
emphasizes the need for improving the COE and the need to develop adjuncts to 
assist in oral mucosal lesion detection and diagnosis”.  
Lingen et al (2017) “Overall, adjuncts showed limited DTA when contextualized to be used in 
primary care settings. The main concerns are the high rate of false-positive 
results and serious issues of risk of bias and indirectness of the evidence. Low-
quality evidence suggests that cytologic testing seems to be the most accurate 
adjunct among those included in this review.” 
“Pooled sensitivity and specificity of adjuncts: 
for the evaluation of innocuous lesions ranged from 0.39 to 0.96,  
for the evaluation of suspicious lesions ranged from 0.31 to 0.95.”  
“Cytologic testing used in suspicious lesions appears to have the highest 
accuracy among adjuncts … 
Sensitivity = 0.92 (95%CI 0.86 to 0.98); 
Specificity = 0.94 (95%CI 0.88 to 0.99);   
…low-quality evidence.” 






Moderate quality systematic reviews 
There were three systematic reviews rated as moderate quality which assessed the role of 
Adjunct Tools in the early detection of OCC (Patton et al., 2008; Downer et al., 2004; Gray 
et al., 2000).  
The Patton et al. (2008) review assessed the effectiveness of a number of Adjunct Tools to 
the standard visual and tactile oral examination. They found 23 studies (with a range of 
study designs) in total, with most (n=15) focusing on toluidine blue. While concluding 
there was limited evidence for adjuncts overall, they did find that toluidine blue had a 
potential role in improving early detection among high risk populations. However, on 
further examination of their data, high risk was defined as those attending “oral mucosal 
disease clinics” where there was higher underlying prevalence of OPMD. Therefore, this 
evidence is more applicable to its use as a diagnostic aid in a secondary care setting, rather 
than early detection in primary care (Appendix 3.20) 
On the other hand, Downer and colleagues (2004) conducted their systematic review on 
test performance in screening in apparently healthy individuals for oral cancer and 
precancer in primary care. The review focused on the COE examination and they found no 
evidence of the effectiveness of toluidine blue dye as an adjunct technique to COE, and 
they concluded that the use of the toluidine blue would not be beneficial in primary care 
settings (Appendix 3.20). 
Gray et al. (2000) also focused only on vital staining / toluidine blue for oral cancer 
screening in primary care. In addition to effectiveness, they assessed the cost-effectiveness 
of toluidine blue. They identified 14 studies in secondary care and one in primary care (not 
dental primary care). All secondary care studies were in high risk populations of clinical 
cohorts with oral mucosal lesions – and there was a wide range of sensitivity and 
specificity reported (no meta-analyses was performed). The one primary care study was 
underpowered to create an effect. In addition, in their economic analysis, the costs per case 
detected and per person cured were extremely high (Appendix 3.20).This systematic 
review concluded that toluidine blue as an adjunct to COE in primary dental care was 
neither effective nor cost-effective.  
Overall, these moderate quality systematic reviews have a greater focus on toluidine blue 
(than on other adjuncts). Taken together, the evidence does not support the use of Adjunct 
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Tools (including toluidine blue) in primary dental care settings for the early detection of 
OCC and OPMD.  
Low quality systematic reviews  
The systematic review conducted by Patton (2003), which was rated as low quality, 
focused on community-based (primary care) screening programmes. Patton assessed the 
evidence as “fair” on the use of toluidine blue as a diagnostic tool for oral precancerous 
lesions; and concluded that there was evidence that toluidine blue was effective as a 
diagnostic tool in high risk individual and suspicious mucosa lesions. This conclusion was 
based on high sensitivity and specificity ranges from included studies (Appendix 3.21). 
However, on closer inspection, these studies were set in specialist/referral practices, i.e. 
settings with an aim of toluidine blue guiding “diagnosis”. The Patton (2003) review does 
conclude that there is insufficient evidence for adjunctive techniques in relation to 
improving detection of oral malignancies in community screening programmes. 
In relation to cytological techniques and molecular analysis, Carreras-Torras and Gay-
Escoda (2015) undertook a more recent, but lower quality rated systematic review. They 
provided a detailed description of potential adjunct methods for early detection of OCC 
and OPMD, which including more recent developments in cytological techniques, 
molecular analyses, imaging and genetic studies techniques. They concluded there was 
insufficient scientific evidence on the use Adjunct Tools for the early detection of OCC or 
OPMD. They also concluded that toluidine blue, due to its high sensitivity and low 
specificity, was not suitable as part of screening in primary care, but they did consider it as 
having a potential role in supporting biopsy procedures in secondary care / specialist 
settings (Appendix 3.21). 
Overall, it appeared that the historic lower quality systematic reviews highlighted evidence 
for the potential role of toluidine blue for early detection of oral cancer particularly in high 
risk populations. A deeper inspection of the data and studies used in these systematic 
reviews show that these high risk populations were patients already in specialist / referral 
clinics or secondary care with a suspicious OPMD and were not attending for routine 
primary dental care nor invited as part of a screening programme. Therefore, the lower 




3.5.5.2 Clinical Guidelines  
High quality clinical guidelines  
Out of six high quality rated clinical guidelines, only three considered the use of adjunctive 
screening aids to assist the clinician with the detection of early cancerous changes (SIGN, 
2006; USPSTF, 2014; ADA, 2017). 
The US Preventive Services Task Force (USPSTF, 2014) produced a high quality clinical 
guideline in relation to screening for oral cancer in primary care. The recommendations 
focused on screening of the oral cavity of asymptomatic adults aged 18 years or older by 
primary care providers. They concluded that all the adjunct methods, including toluidine 
blue, chemiluminescent, auto-fluorescent lightening, and brush cytopathology, had not 
been adequately tested, and therefore they did not make any recommendations for their use 
(Table 3.15). Specifically, in relation to toluidine blue, they reported it was not found to 
significantly improve screening for OPMD or OCC and did not improve outcomes. No 
acceptable evidence for other adjunctive devices was found in the literature reviewed. 
The ADA (2017) clinical guideline was a high quality update of ADA (2010). Part of the 
guideline development process involved undertaking a robust (high quality) systematic 
review of the role of adjuncts and this was published separately and has been included 
above (Lingen et al., 2017). The recommendations largely reflect the findings of their 
systematic review. The clinical guideline provided a number of recommendations 
addressing a range of clinical questions in relation to the role of adjuncts (Table 3.15). The 
guideline did not recommend the use of any vital staining, auto-fluorescence, tissue 
reflectance, salivary, or other adjuncts to identify or as they describe it “to triage” in 
primary care for OPMD or OCC in either healthy adults with symptoms or oral mucosal 
lesions (whether these were suspicious or not). The only potential proposed use of adjuncts 
related to the role of cytological adjuncts in the evaluation of OPMD among adult patients 
with “clinically evident seemingly innocuous or suspicious lesions” and only when a 
patient declined the clinical recommendation of referral to a specialist / biopsy of lesion. In 
this scenario, the guideline recommended that a primary care clinician could use a 
cytological adjunct (e.g. “brush biopsy”) to provide additional lesion assessment, with a 
positive or atypical cytological test reinforcing the need for a referral / biopsy. A negative 
test would indicate the need for periodic follow-up of the patient. The strength of this 
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cytological adjunct recommendation was described as “conditional” and based on low 
quality evidence “with serious issues of risk of bias” (Table 3.15). 
The SIGN clinical guideline on diagnosis and management of head and neck cancer (2006) 
acknowledged the lack of evidence to support the use of toluidine blue in primary care 
dental settings. The guideline based this recommendation on the clinical experience of the 
guideline development group.  
In summary, the high quality clinical guidelines did not support the use of different adjunct 
methods in primary care dental settings, and this was due to an absence of evidence of 
effectiveness.  
Table 3.15 High Quality Clinical Guidelines – Adjunct Tools  
CG –ID Recommendations Evidence Rating 
ADA (2017) Recommendation 3: The panel does not 
recommend cytologic adjuncts for the 
evaluation of potentially malignant disorders 
among adult patients with clinically evident, 
seemingly innocuous, or suspicious lesions. 
Should a patient decline the clinician’s 
recommendation for performing a biopsy of the 
lesion or referral to a specialist, the clinician can 
use a cytologic adjunct to provide additional 
lesion assessment. A positive or atypical 
cytologic test result reinforces the need for a 
biopsy or referral. A negative cytologic test 
result indicates the need for periodic follow-up 
of the patient. If the clinician detects persistence 
or progression of the lesion, immediately 
performing a biopsy of the lesion or referral to a 
specialist is indicated. 
“Recommendation 4: The panel does not 
recommend autofluorescence, tissue reflectance, 
or vital staining adjuncts for the evaluation of 
potentially malignant disorders among adult 
patients with clinically evident, seemingly 
innocuous, or suspicious lesions.” 
  
“Quality of evidence: Low” 
“Strength of recommendation: 
Conditional” 
“Low: Our confidence in the effect 
estimate is limited; the true effect may 
be substantially different from the 
estimate of the effect.” 
“Conditional: Recognize that different 
choices will be appropriate for 
individual patients and that you must 
help each patient arrive at a management 
decision consistent with his or her 
values and preferences. Decision aids 
may be useful helping patients make 
decisions consistent with their values 
and preferences.” 
“Quality of evidence: Low to Very low”  
“Strength of recommendation: 
Conditional”  
“Very low: We have very little 
confidence in the effect estimate; the 
true effect is likely to be substantially 
different from the estimate of the 
effect.” 
USPSTF (2014) “… additional tests proposed as adjuncts to the 
oral cancer screening examination include 
toluidine blue dye staining, chemiluminescent 
and autofluorescent lightening device and brush 
cytopathology. These screening and adjunct 
tests have not been adequately tested in primary 
care…”  
 
I statement – Based on conclusion that 
the current evidence is insufficient to 
assess the balance of benefits and harms 
of the service. Evidence is lacking, of 
poor quality, or conflicting, and the 
balance of benefits and harms cannot be 
determined.   
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Moderate quality clinical guidelines  
There were four moderate quality clinical guidelines which provided some statements in 
relation to the use of adjunctive methods for the early detection of oral cancer and OPMD.  
The Agency for Health care Research and Quality (AHRQ, 2007) clinical guideline did not 
recommended the use of toluidine blue as part of a screening examination, stating that it 
did not improve detection of lesions. It could not identify any studies of other adjuncts that 
met the inclusion criteria (Appendix 3.22). 
The College of Dental Surgeons of British Columbia (CDSBC, 2008) clinical guideline 
recommended (based on expert opinion) the use of adjunctive tools (toluidine blue and 
direct fluorescence visualisation) to complement the COE for helping to identify OPMD 
and OCC lesions. This recommendation was aimed at both primary care dentists 
undertaking the annual oral cancer screening examination or at the time of identification of 
any suspicious lesion (Appendix 3.22). 
The British Dental Association (BDA, 2010) stated that there was not sufficient evidence 
of effectiveness of adjuncts in primary care, and that while sensitivity for adjuncts was 
high the specificity remained low. They recommended a thorough visual and digital 
examination for early detection of OPMD / OCC. However, they did state that while “a 
soft tissue examination without the use of adjunct will be completely adequate” they 
indicated that the use of adjuncts had a potential role in increasing the accuracy of an 
examination among “high risk patients without obvious lesions” and that “there is also a 
possible benefit in the way the use of an adjunct raises patient awareness” (Appendix 
3.22). The evidence in support of these statements was limited and selective with only the 
Patton et al. (2008) systematic review being cited, and another narrative review by Lingen 
et al. (2008). 
The Solutions for Public Health (2015) reviewed screening for oral cancer against the UK 
National Screening Committee (NSC) criteria for appraising the viability, effectiveness, 
and appropriateness of a screening Programme (NSC, 2003). They could not identify 
sufficient scientific evidence to support adjuncts to COE including vital rinsing, light-
SIGN (2006) “There is no evidence for an effective screening 
programme for head and neck cancers, in 
particular, toluidine blue dye does not appear to 
be a cost – effective method of screening for 
oral cancer in primary care (dental) setting”  
Good Practice Point – Based on the 
clinical experience of the guideline 
development group.  
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based detection, and biomarkers, used singly or in combination to detect oral cavity cancer 
and OPMD. They did not recommend the use of adjunctive tools for early detection of 
OCC and OPMD. 
Overall, the moderate quality-rated and more recently published clinical guidelines did not 
recommend the use of the adjunctive tools to COE in early detection of oral cavity cancer 
or OPMDs in primary care settings. Earlier clinical guidelines were perhaps getting ahead 
of the evidence-base in proposing the role of vital staining adjuncts, which were not borne 
out either by the evidence or continued in subsequent years. 
Low quality clinical guidelines  
The Glasgow University Dental School (2003) guideline was only the lower quality 
clinical guideline that indicated a role for the use of an adjunct in early detection of OCC. 
The guideline recommended that the technique had some limited use in specialist centres. 
It was not entirely clear, but likely, that this use was in relation to guiding diagnostic 
biopsy in specialist centres. However, the guideline was clear for primary health care 
settings, where it recommended that screening should be done via visual examination to 
detect any abnormalities (Appendix 3.23).   
3.6 Synthesis of Theme Findings  
This section brings together the syntheses of the four key themes covering both systematic 
reviews and clinical guidelines and compares and contrasts their findings.  
3.6.1 Evidence of the Effectiveness of Conventional Oral Examination in Early 
Detection / Screening of Oral Cavity Cancer 
The high quality systematic reviews consistently showed broadly similar findings. They 
were in agreement that there was limited evidence of the effectiveness of the conventional 
oral examination (COE) in identifying oral potentially malignant disorders and oral cavity 
cancer. What evidence that was available, showed a tendency for this to be more effective 
in both high prevalence populations and also when performed in high risk individuals 
(defined as those who use tobacco and consume alcohol). However, this evidence of the 
effectiveness was largely drawn from a single large randomized controlled trial 
(Sankaranarayanan et al., 2005) undertaken by community health care workers in a high 
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OPMD prevalence / high OCC incidence country (India), albeit the effectiveness in terms 
of reduced mortality was observed in high risk individuals. The application of this 
evidence to primary care dental settings in lower incidence countries is a pragmatic one 
based on expert opinion of this and other more limited studies. 
The high quality clinical guidelines reflected the systematic review, with their clinical 
recommendations not extending beyond the systematic review findings. There was a 
tendency for the lower quality guidance documents, which took an expert opinion 
approach, to better describe or detail the COE process, for which the evidence base is even 
more limited and which warranted a more practical approach.  
There were no systematic reviews or references within them to trials on the method or 
content of the COE – covering for example: i) how to examine and / or palpate all relevant 
sites of the head and neck, and all sites of the oral cavity, ii) the type of light to use, 
whether to use gauze or dental mirrors, iii) symptom and sign checklists and how to record 
/ capture examination findings on clinical records, and iv) consideration of which dental 
professionals should perform COE and how they should be trained. However, the lower 
quality clinical guidelines did set out aspects of how to perform the COE, but none did so 
comprehensively, covering all of the different examination aspects. 
3.6.2 Evidence of Whether Conventional Oral Examination Should be Delivered 
Targeted, Universally or Opportunistically  
In summary, the high quality systematic reviews reported there was a lack of evidence in 
relation to whether there should be any form of targeting of early detection / screening for 
oral cancer. There was a particular absence of randomised control trials (RCTs) in this 
area, but the difficulty in conducting such trials was acknowledged. The systematic 
reviews noted that a targeted approach could potentially be attractive from effectiveness 
and especially cost-effectiveness perspectives, however, the lack of high quality evidence 
meant that a need for a more precautionary approach to undertaking a COE in all patients 
attending primary (dental) care was generally concluded (albeit there was not specific 
evidence to support opportunistic screening). It was recognized that there remain 
challenges in increasing the attendance levels for these opportunistic examinations, 
particularly among high risk groups.  
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The clinical guidelines seemed to have universal agreement that COE ought to be 
performed opportunistically on all patients attending for dental check-up appointments, 
and that while the higher quality-rated clinical guidelines suggested that oral cancer risk 
assessment should be undertaken at the same time, they did not go so far as to recommend 
a different COE approach or focus dependent on the outcome of the risk assessment. The 
lower quality guidelines seemed to indicate greater vigilance or higher degree of suspicion 
should be brought to performing the COE on higher risk individuals, but details of what 
this would involve were absent as was the evidence to support these statements. 
Overall, the high-quality rated clinical guidelines included recommendations which 
reflected the (albeit limited) systematic review evidence base fairly well. Both the clinical 
guidelines and systematic reviews reported a lack of evidence base and did not make 
recommendations for a population screening programme (even a targeted or stratified one). 
There was insufficient evidence available for such a programme to meet the screening 
programme criteria (WHO Wilson, Jungner, 1968; NSC, 2003). The clinical guidelines did 
not make recommendations which over-reached the evidence available, and they did tend 
to suggest the opportunistic approach in primary care dental settings for both “all” patients 
and high-risk patients should be similar. However, they did suggest that patients’ oral 
cancer risk status should be ascertained - through the use of a smoking and alcohol 
consumption history. 
3.6.3 Evidence of the Frequency of Recall Interval for Undertaking a Conventional 
Oral Examination   
Overall, in terms of the frequency of conducting an oral cancer examination, the practice 
has been traditionally to examine a patient every six months. The limited body of 
systematic reviews identified concluded that there was a very limited evidence base 
regarding recall intervals and more high-quality systematic reviews and clinical trials were 
required to determine the frequency of the recall interval, including in relation to oral 
cancer early detection / screening.  
There was a very limited evidence base on the frequency of undertaking oral cancer early 
detection / screening COEs, which seemed to be put down to the complexity of testing this 
via a RCT.  
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The clinical guidelines developed their recommendations for best practice from expert 
opinion when the evidence was more limited. The one high-quality clinical guideline 
(National Institute for Clinical Excellence, 2004) pointed towards supporting the 
determination of the frequency of COEs on a risk basis. For example, where the patient 
smokes and / or consumes alcohol the recall interval should be shorter (3-6 months) than 
for patients at lower risk (between 1 and 2 years). There was less consensus from the lower 
quality clinical guidelines, which tended to suggest a yearly COE. Clinical guidelines also 
tended to recommend that oral cancer early detection / screening should be an 
opportunistic and integral part of routine dental check-ups.  
3.6.4 Evidence for the Role of Adjunct Methods to the Conventional Oral 
Examination   
Overall, there was a lack of evidence for the role of adjuncts (to the conventional oral 
examination) in primary care. The systematic reviews overall, but especially the high 
quality-rated systematic reviews did not provide convincing evidence to support their use. 
It was interesting to note that reviews with increasing risk of bias (moderate quality) and 
from earlier times, reported more support for the role of toluidine blue in early detection of 
oral cavity cancer and OPMD. The high quality clinical guidelines were in agreement with 
the evidence-base in the high quality systematic reviews and did not recommend the use of 
Adjunct Tools to COE for early detection of OCC or OPMD. These guidelines reported 
that only low grade evidence was available to support the use of adjuncts in general dental 
practice. Both the most historic (NCCDPHP, 1996) and most recent (ADA, 2017) clinical 
guidelines were recommending adjuncts – toluidine (vital staining) and cytology (brush 
biopsy), respectively. They both referenced the evidence-base, but the more recent, higher 
quality ADA (2017) clinical guidelines acknowledged the significant limitations of the 
evidence.   
While outwith the scope of this overview, there was a clearer role and consistency in the 
clinical guidelines, if not necessarily supported by a direct evidence base in the systematic 
reviews, for the role of adjuncts to support and guide the clinical biopsy / histopathological 
assessment of oral mucosal OPMD or OCC lesions.  
Conversely, there were no (positive) findings / recommendations reported in the systematic 
reviews, which were absent from the clinical guidelines.  
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3.7 Strengths of this Overview 
This overview chapter took a robust systematic approach in an attempt to identify the best 
practice for early detection / screening of oral cavity cancer in primary dental care. While 
there are many reviews and editorials written on this topic (Kujan et al., 2005; Cicciù et al., 
2019; Psoter et al., 2019), to the thesis author’s knowledge, this is the first attempt to apply 
a systematic overview approach. The methods have been peer-reviewed as the protocol has 
been published and include the novel approach of systematically reviewing systematic 
reviews and clinical guidelines simultaneously (Al Bulushi et al. 2016).  
A taxonomy of how to consider the evidence was developed to guide the overview, this 
included key aspects, domains, or themes of the practice of early detection / screening, 
namely: the clinical oral examination assessment, whether it should be targeted or different 
in higher risk groups, the frequency of assessment, and the evidence for the role of adjunct 
methods to the clinical oral examination.    
A thorough systematic search developed in collaboration with a subject specialist librarian 
using multiple databases was used to identify systematic reviews on oral cancer early 
detection / screening. In addition, databases were searched for clinical guidelines as well as 
searching the internet for clinical guidelines from a long list of clinical, health, and 
professional organisations. Screening of titles, abstracts, and full text papers / document 
was undertaken by two assessors.  
Comprehensive quality appraisal of the included systematic reviews was performed (by 
three assessors) using two instruments (AMSTAR and ROBIS). While there was not much 
difference between the systematic reviews which scored high on AMSTAR and low risk of 
bias on ROBIS, this dual quality assessment process provided greater clarity on the quality 
of the systematic reviews – particularly those of highest quality. Quality appraisal of the 
clinical guidelines was also undertaken by three assessors using the AGREE II tool. This is 
a recently rigorously developed instrument (Brouwers et al., 2010), which has a detailed 
training manual to guide and standardise assessment of the quality of clinical guideline 
documents.  
As there were no quantitative data to perform a meta-analysis, a narrative data synthesis of 
the findings of the systematic reviews and the recommendations of the clinical guidelines 
was performed. This narrative synthesis gave primacy to the quality of systematic review 
and clinical guidelines and the recency of their publication. It was undertaken within the 
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early detection / screening domains developed, and systematic reviews and clinical 
guidelines were cross-compared and contrasted.  
This overview approach of combining the systematic reviews and the clinical guidelines 
was novel, but was done out of necessity on several counts: the multiple systematic 
reviews (but the dearth of original research studies available for these systematic reviews), 
and the large quantity of clinical guidelines from around the world available on this topic. 
It is worth pointing out that these systematic overview approaches are going to be 
increasingly required and further developed as science and literature expands. There are 
often multiple systematic reviews in the published literature some of which are updated 
sequentially, but some are overlapping in time-frames of original studies included or in the 
focus or angle of the review. Therefore combining, synthesising, and distilling the 
evidence is going to be an ever increasing challenge. 
3.8 Limitations of this Overview 
There were a number of limitations to the overview and they will be discussed here. Such 
limitations are well described in the literature on methods for systematic reviews (e.g. as 
highlighted in early versions of the Cochrane Handbook - Higgins and Green, 2006). The 
primary issue is the same as for all systematic reviews, namely they are dependent on the 
quality or level of evidence of the original studies included in them. This is a similar, if not 
greater issue, for systematic overviews, which are once again removed from the original 
studies or trials. However, it is anticipated that a good quality systematic review (in its 
synthesis, findings, and conclusions) takes into account the quality of the original studies. 
Thus, it aims to mitigate for over or under emphasising the quality or strength of the 
evidence base. During the synthesis process in this thesis overview, this tension, between 
the systematic review and the original source studies, manifested in the thesis author being 
drawn into looking closely at and sometimes reviewing the original studies within the 
systematic reviews. An alternative overview approach could have been to have taken out 
the middle-man – i.e. the systematic reviews themselves and gone straight to the source 
studies from the outset. However, this would seem somewhat a duplication of effort of 
many of the identified systematic reviews that have gone before in this area, including 
several Cochrane reviews, and would probably have been out with the scope or feasibility 
of a PhD thesis - requiring a large team approach, as per the Cochrane review approach.  
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Another related issue that had to be borne in mind was data duplication, there were several 
original studies that appeared in several of the systematic reviews. Care had to be taken not 
to over emphasis their findings. In some ways the lack of original underpinning source 
studies limited this issue. 
In late 2018 a special edition of BMC Systematic Reviews outlined many of the 
methodological issues with systematic overviews (McKenzie, 2018).These included 
overlap reviews, outdated reviews, quality assessment of the included reviews, publication 
bias, GRADE schemes (Pollock et al., 2017). 
Problems with narrative synthesis are well recognised in systematic reviews as described in 
the Cochrane Handbook “Non-statistical syntheses … are challenging, however, because it 
is difficult to set out or describe results without being selective or emphasizing some 
findings over others.” (Higgins and Green, 2011). The Cochrane Handbook goes on to 
suggest that one way around this is to set out in the review protocol the plan of narrative 
synthesis and reporting. This was done as part of the published protocol (Al-Bulushi et al., 
2016), but this is not in itself sufficient to address the complexity of narrative synthesis 
methods. More recent reporting and methods have very recently been developed – 
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline by 
colleagues at the University of Glasgow (Campbell et al., 2020). Some of the items of the 
SWiM guidance had been followed in this overview (i.e. item 1 – grouping the study types, 
item 3 and 4 describing the synthesis methods in a protocol and identifying priority 
criteria, and item 8 presenting the evidence - as in the narrative data extraction tables in 
Appendices 3.4 and 3.5). However, some of the items (items 2, 6 and 7 related to defining 
outcome criteria and heterogeneity) would not necessarily apply in this overview, which 
had broader dimensions than a simple outcome metric. The SWiM method could have 
improved the narrative synthesis analysis using its focus on the certainty of evidence. 
However, there is an expectation in SWiM that this certainty of evidence is itself assessed 
by a stakeholder jury voting on the certainty of the evidence base.  
Finally, there was a surprising lack of studies that went into detail about the clinical 
process for undertaking (and recording) a COE. However, the clinical guidelines were also 
not as specific on these detailed examination methods. On reflection, the source clinical 
guidelines documents were perhaps not the best suited to this level of detail, and training 




The main findings of the systematic overview were a re-emphasis of the importance of a 
clinical oral examination for early detection / screening of oral cancer opportunistically at 
the time of the routine dental care appointment in primary care. Oral cancer screening does 
not meet the criteria for a population, invitational, or targeted formal screening 
programme. There was no evidence for the need or added benefit of adjunct methods (e.g. 
vital staining, light-based detection, biomarkers and brush biopsy). There was no evidence 
that a different or enhanced COE should be performed on patient who are at higher risk of 
oral cancer (i.e. those who smoke / use tobacco and / or drink alcohol), however, there is 
one high quality clinical guideline recommendation that higher risk patients should have 
their COE at a greater frequency (at least yearly). To identify those patients at risk, a 
tobacco and alcohol history risk assessment should be performed at the time of the clinical 
oral examination. 
The next steps in the thesis research plan were to investigate the feasibility of 
implementing these findings with practitioners and patients in primary care dental practice 











Chapter 4: Qualitative exploration of the perceptions of oral 
health care professionals on early detection/ screening for 
OCC in primary care dental settings in Scotland and Oman 
4.1 Introduction 
As a follow-up to the systematic overview, this qualitative study was conducted with the 
aim of: a) exploring which components of the synthesized best practice evidence and 
clinical guidelines are reportedly implemented in current practice by oral health care 
professionals (OHCPs); b) assessing barriers to implementation towards recommendations 
for intervention to support evidence-based screening and early detection of oral cancer in 
general dental practice. 
A seminal report by the US Institute of Medicine (Wolfe, 2001) underpins repeated efforts 
to understand the barriers that influence the translation of high quality evidence to adopted 
practice, which has now seen concerted effort under the umbrella term of ‘implementation 
science’. Such barriers, covering individual dental practitioner attitudes and characteristics, 
organisational aspects such as time and resource, and social influences from patients, peers 
and stakeholders, have been observed in relation to a wide range of recommended dental 
practice including: standard precautions for exposure (Hedayati et al., 2014), antibiotic 
prescribing (Newlands et al., 2015), preventive management of caries (Templeton et al., 
2015) and the provision of care for dependent older people (Göstemeyer et al., 2019).   
The best-known model for ensuring rigorous exploration of barriers (and facilitators - those 
factors which support rather than inhibit good practice) is a framework from health 
psychology known as the Behaviour Change Wheel (Michie, Atkins and West, 2014; 
Figure 4.1). It is in use across many different fields of health and medicine. For example, 
in paediatric health programmes (Alexander et al., 2014) and mobilization of vulnerable 
elders (Moore et al., 2014), in identifying barriers and facilitators to learning in the 
workplace in qualitative study (Lloyd et al., 2014), and vaccination and other antiviral 
medicine (Rubinstein et al., 2015). Moreover, it has been used to develop interventions and 
guidelines to modify health behaviours (Jackson et al., 2014; Lister, 2014; Atkins and 
Michie, 2015; Bérubé et al., 2015) and in systematic reviews to identify the mechanism of 








The core of the BCW is the ‘COM-B’ psychological model (Figure 4.2) used to understand 
behaviours and help in providing a “behavioural diagnosis” (Michie et al., 2014). 
According to COM-B, an individual’s behaviour is the result of an interaction between 
three main elements:  the capability (C) in carrying out the behaviour, opportunity (O) to 
carry it out, and motivation (M) towards  the behaviour (Michie et al., 2014).The general 
utility of the BCW comes from this diagnosis of what underlies behaviour and using that to 
drive appropriately targeted interventions (see Chapter 6).  
 






The model derives from initial work which resulted in the Theoretical Domains 
Framework (TDF). This consists of 14 behavioural domains (constructs) which are 
subsumed within the three arms of the COM-B model (Atkins and Michie, 2015).  The 
TDF itself was produced from combining 128 constructs from behaviour change theories 
(Cane et al., 2012). 
The arrows in Figure 4.2 represent the relationship between the three primary system 
constructs and the behaviour. The COM-B model elements are not discrete but often 
interconnected (i.e. if we change one element it will automatically change the other). For 
example, if we decrease the opportunity this may over time affect the motivation of the 
individual towards the behaviour (Michie et al., 2014). This framework has also been 
applied across many health care settings such as: to identify barriers in managing type 2 
diabetes in primary care (Rushforth et al., 2016); in understanding clinicians’ behaviour 
towards blood transfusion (Francis et al, 2014); in understanding  surgeons’ perceptions on 
routine pre-operative testing (Patey et al 2012); for physician Hand Hygiene Compliance  
(Squires et al, 2014); and in the development of an intervention to modify blunt chest 
injury management (Curtis et al, 2017).  
In this study we have employed a pragmatic coding based on the more parsimonious / 
abstracted COM-B model within the BCW. In the following study in Chapter 5 with dental 
patients the same model is employed but there is also coding of the factors using the 
original TDF categories. Table 4.1 shows the TDF domains and the relation with the 
COM-B model coding. 
Table 4.1 COM-B model constructs (from TDF Domains) adapted from Cane, 
O’Connor and Michie (2012) 
 
TDF Domain Original Definition COM-B for this thesis 
Knowledge  (An awareness of the existence of something) Psychological Capability  
(C. Psy.)  
Knowledge, confidence, 
awareness, ability to 
understand  




(The ability to retain information, focus selectively 
on aspects of the environment and choose between 
two or more alternatives) 
Behavioural 
Regulation 
(Anything aimed at managing or changing 
objectively observed or measured actions) 
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TDF Domain Original Definition COM-B for this thesis 
Skills  (An ability or proficiency acquired through practice) Physical Capability  
(C. Phys.) 
Technical / clinical skills 
Social influences  (Those interpersonal processes that can cause 




Views of others such as 





(Any circumstance of a person's situation or 
environment that discourages or encourages the 
development of skills and abilities, independence, 
social competence, and adaptive behaviour) 
Physical Opportunity 
(Op. Phys.) 
Resources, time, money, 
training, guidance etc. 
Social/Professional 
Role and Identity  
(A coherent set of behaviours and displayed 




Reasoned behaviour such as 
learned from experience or 




(Acceptance of the truth, reality, or validity about an 
ability, talent, or facility that a person can put to 
constructive use) 
Optimism  (The confidence that things will happen for the best 
or that desired goals will be attained) 
Beliefs about 
Consequences  
(Acceptance of the truth, reality, or validity about 
outcomes of a behaviour in a given situation) 
Intentions  (A conscious decision to perform a behaviour or a 
resolve to act in a certain way) 
Social/Professional 
Role and Identity  
(A coherent set of behaviours and displayed 




Basic views such as those 
driven by social/ professional  
identity; dispositional factors 
 
Optimism  (The confidence that things will happen for the best 
or that desired goals will be attained) 
Reinforcement  (Increasing the probability of a response by 
arranging a dependent relationship, or contingency, 
between the response and a given stimulus) 
Emotion  (A complex reaction pattern, involving experiential, 
behavioural, and physiological elements, by which 
the individual attempts to deal with a personally 




Table 4.1 shows the six categories (right hand column) adapted from the models and used 
to guide the present interviews and interpretation in Chapters 4 and 5. This study and the 
following study with patients explored this range of influences in relation to the 
recommended practices for the early detection / screening for OCC by OHCPs identified in 
Chapter 3. The use of the framework ensured that interviews covered a range of potential 
influences on behaviour. Capability included, for example, the OHCPs capacity to engage 
in essential thought processes, (e.g., comprehension of the need for early detection / 
screening of OCC) as well as essential physical / technical processes (e.g., the capability to 
conduct a conventional oral examination). Opportunity included environmental factors that 
were enablers / facilitators of, or barriers to, the prescribed desirable behaviour, including 
physical factors (e.g., time, access to resources, cost, and training) as well as social factors 
(e.g., religious / cultural beliefs, norms of the professionals’ roles). Finally, Motivation 
included reflective or emotional reasoning that encouraged or inhibited the OHCPs 
desirable behaviour. This can include, for example, beliefs and impulses arising from 
associated learning from previous cases / events, or more fundamental dispositions or 
orientations, such as a general drive towards preventive care, or otherwise.  
The COM-B model was deemed an appropriate theoretical framework to underpin the data 
analysis, because it facilitated: a) structured explanation of why the adherence to best 
practice evidence and guidelines in relation to early detection for OCC was not necessarily 
implemented by all the OHCPs who participated in this research; and b) what steps might 
be taken towards improving uptake (Chapter 6).  
4.2 Methodology 
The research methodology for this chapter is broadly defined as phenomenological, 
because it is rooted in the fundamental idea that people’s own experiences of a 
phenomenon of interest are important aspects to its reality (Denzin & Lincoln, 2008).  
Phenomenology-inspired work when engaging professionals is relatively common, 
especially in nursing (Beck 1994), though there are debates as to whether the tradition is 
truly phenomenological (Zahavi and Martiny, 2019). This study explored and interpreted 
the self-reported lived experiences and perceptions of a purposive sample of OHCPs, 
focusing on issues of intentionality, emotionality, and conscious behaviour around the 
topic, using a first-person perspective. This attendance to personal views of practitioners is 
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important in implementation research where people are being asked to follow certain 
principles or guidelines. The research extracted the “essence” of the interview responses in 
the tradition of a phenomenological research design (Merriam, 2014).   
4.2.1 Research Design 
The aims were achieved by means of a qualitative methodology, adopting a naturalistic 
approach, in which the researcher explored the phenomenon of the early detection / 
screening of oral cavity cancer (OCC) in clinical settings, attempting to make sense of and 
interpret this phenomenon in terms of the lived experiences and perceptions of OHCPs 
(BDJ, 2010). The data were collected by conducting semi-structured interviews with a 
purposive sample of OHCPs working in primary dental services in two countries (Scotland 
and Oman).  
All interviews for this thesis in Chapters 4 (professionals) and 5 (patients) were designed 
by the author, who also designed and carried out all analysis. Interviews in Scotland were 
carried out by another student who was examining behavioural risk factors and 
intervention (Mathur, 2019). The author of this thesis explored those issues in Omani 
interviews in a reciprocal arrangement. The ‘whole’ integrated interview (OCC screening 
plus behavioural assessment and advice) was piloted by the two researchers together.  
Examination of care in different countries was important (Rosen et al, 2004), because all 
health care is practiced in a social and cultural context. It is also known inequality exists 
with intra- and extra-oral examinations being less likely for low educated / low income 
groups, and minority ethnic versus white groups (Gupta et al., 2019).  
Variance in care, inequalities and / or disparities in health care may be associated with 
sociocultural differences that influence the providers' attitudes, expectations, and behaviour 
including clinical decision-making processes (Smedley, Smith, & Nelson, 2003; Park, 
2013).  
The reason for conducting a qualitative study, focused on the responses of OHCPs to open-
ended interview questions, was that it provided an opportunity for an in-depth exploration 
of the topic, which could not be so easily addressed through a questionnaire / survey based 
on ‘fixed response’ formats, such as Likert scales (Green & Thorogood, 2009; Stewart et 
al. 2008).  
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The qualitative study enabled the researcher: a) to elicit how and why OHCPs made certain 
personal decisions regarding screening / early detection of OCC; and b) to gain sufficient 
detail to understand the facilitators or barriers of implementation of best practice evidence 
and guidelines. The role of the researcher in the interview procedure was to develop a 
rapport with the participants, to clarify the questions, to prompt and encourage detailed 
answers, and to gain a meaningful insight into the attitudes, beliefs, preferences, and ‘lived 
experiences’ of the participants (Merriam, 2014).  
4.2.2 Population and Participants 
In countries with universal or population coverage of primary care dental services, OHCPs 
have an important role to provide visual screening / early detection services as part of 
routine dental services (SIGN, 2006 and ADA, 2010).  Consequently, OHCPs represented 
the most appropriate population of professionals to interview in order to achieve the aims 
of this study. 
Semi-structured interviews were conducted with a total of 31 OHCPs providing primary 
dental services of which 13 were in Scotland and 18 were in the Sultanate of Oman. 
Female OHCPs (17) represented 54.8 % of the sample.  Recruitment aimed to cover a wide 
range of experience; the average reported length of professional practice experience of the 
OHCPs was 15 years, with a wide range of 1 month to 36 years.  
The rationale for choosing this non-probabilistic purposive sample is that participants can 
then inform a defined topic of which they have experience, providing empirical data. An 
important consideration of such samples is how large they should be. Data saturation 
(Walker, 2012; Fusch and Ness, 2015) occurs in qualitative research because the analysis 
of interview transcripts follows a ‘law of diminishing returns’. That is, after a certain 
number of participants have been interviewed, little or no new information emerges.  
The sample size used in this study (31 OHCPs) was considered sufficient to achieve 
saturation, following Green and Thorogood (2009; p120) who suggested that, in the 
context of health care research, "the experience of most qualitative researchers is that, in 
interview studies, little that is new comes out of transcripts after you have interviewed 20 
or so people" The topic was also relatively focused - thus all the participants were drawn 
from a group receiving similar training, and were asked the same or similar questions, 
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based on the application of an a priori template. The number of statements obtained from 
the OHCPS in Scotland and Oman were approximately equal.  
This approach ensured that the assumption of saturation was satisfied through the 
homogeneity of the participants, the content and structure of the interviews (Guest et al., 
2006) and the specified cultural contexts (Romney et al., 1986).  
4.2.3 Ethics 
Because this researched involved human subjects, specific ethical approval was obtained in 
advance from the Medical, Veterinary and Life Sciences (MVLS) ethics committee of the 
University of Glasgow (Appendix 4.1). For the participants in Oman, ethical approval from 
the Research and Ethical Review & Approval Committee (RERAC) for the Ministry of 
Health Oman was deemed to not be required for this small set of pilot interviews 
(Appendix 4.2). Ethical approval was also obtained from the West of Scotland Research 
Ethics Service (Appendix 4.3). After reading an information sheet (Appendix 4.4), all of 
the participants in this study provided their informed written consent (Appendix 4.5). The 
participants’ rights to anonymity and confidentiality were respected. Data were secured 
stored and processed in accordance with the data security protocol of the Community Oral 
Health Unit (available on request). The OHCPs are referred to only by code names and the 
identity of their practices is not revealed.  The researcher reports no conflicts of interest. 
4.3 Data Analysis 
One important consideration in this type of research is whether to use computer assisted 
qualitative data analysis software (CAQDAS) such as QSR Nvivo (Richards.L, 1999).  
This is relatively widely used, and allows for researchers to manage large amounts of 
qualitative data such as transcripts, notes or videos, and create codes for analysis (Bringer 
et al., 2004). However, there are strong criticisms of its use for the analysis of interview 
transcripts in health care research. 
CAQDAS can involve too many mechanistic and rigid processes, and puts pressure on the 
researcher to focus on volume and breadth, rather than on depth of meaning (St. John and 
Johnson, 2000). The use of CAQDAS also reportedly results in the researcher exceeding 
the limits of the valid conclusions that can be drawn from qualitative data, for example, 
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through the coding of an excessive number of themes that may have limited meaning 
(Shönfelder, 2011). CAQDAS is also said to encourage researchers to collect and analyse 
very large cumbersome data sets, in excess of the amount of data required to achieve 
thematic saturation (Pope et al., 2000).  Further, Zamawe points out that CAQDAS does 
not add to the scientific value of qualitative research, rather just makes data handling 
easier: “The main function of CAQDAS is not necessarily to analyse data, but rather to aid 
the analysis process, which the researcher must always remain in control of…no software 
can analyse qualitative data. NVivo and all other CAQDAS are basically only data 
management packages” (Zamawe, 2015).   
In the context of qualitative research in dentistry, Burnard et al. (2008) and Stewart et al. 
(2008) also highlighted that CAQDAS does not replace the researcher’s need to become 
fully immersed in the data. Thus, on balance it was decided not to employ dedicated 
software, but rather to manage the organisation and coding of data using Microsoft Word 
and Excel files drawn from interview transcripts.  
In order to extract in-depth meanings from the interview transcripts the researcher made 
sense of the data by personally exploring, manually extracting, and interpreting significant 
statements to identify the themes. The first stage of the data analysis involved identifying 
clusters of statements among the interview transcripts that could be classified using a 
primary template based on a core of a priori themes extracted from the initial review of the 
literature and guidelines concerned with the early detection / screening for OCC (Al 
Bulushi et al., 2016).  
4.3.1 Template Analysis 
Template analysis, which is a widely used method for interpreting qualitative data in health 
care, business, and management research (Brooks et al., 2015; King, 2004; Waring & 
Wainright, 2008; King & Brookes, 2017) was applied to interpret the interview transcripts.  
The use of template analysis was in line with the aim of examining recommendations for 
the implementation of best practice by OHCPs, and / or to recommend future pilot study(s) 
into supporting preventive care.  Whilst similar, thematic analysis (Braun and Clarke, 
2006; Fereday and Muir-Cochrane, 2006; Clarke et al., 2015) tends to be more inductive 
(exploratory) and template analysis more deductive (confirming a template or thematic 
structure). The template analysis was underpinned by a) a core set of a priori themes (Table 
111 
 
1.5), and sub-themes extracted from the overview of systematic reviews and clinical 
guidelines; and b) the construction of theoretical connections between the a priori thematic 
areas, and behavioural and organisational themes in Capability, Opportunity, and 
Motivation derived from the COM-B model for identifying behavioural targets for possible 
intervention.   
The priori themes were:  
Theme 1: Conventional oral examination (COE) 
Theme 2: Target population  
Theme 3: Frequency of screening 
Theme 4: Adjunct tools  
The three stages of the data analysis involved: a) refining the initial template into a revised 
template, in response to the information provided and issues raised by the interviewed 
participants; b) identifying further clusters of statements that could be classified into 
emergent sub-themes by inductive interpretation; and c) making theoretical connections 
underpinned by the Capability, Opportunity, and Motivation (COM-B) model of 
behaviour, as defined in Table 4.1. Each of the themes were sub-divided into Enablers (i.e., 
capabilities, opportunities, or motivations that facilitated the early detection / screening of 
OCC) or Barriers (i.e., capabilities, opportunities, or motivations that hindered the early 
detection / screening of OCC).  
Questions focus on the themes and probed for barriers / facilitators. A number of 
supplementary questions (Appendix 4.6) were asked about the specific issue of using a risk 
prediction tool (Conway et al., 2018) (INHANCE, 2018) and the feasibility of 
implementing such a tool in primary health care dental settings. Questions were designed 
to explore the views of the oral health care professionals on: benefits of having a tool for 
oral cancer that profiled / quantified risk using some patients information; the best way to 
utilize the tool in the practice; whether it might be used as a decision tool; if using the tool 
would help in introducing the term “oral cancer risk”; and how the professionals felt their 
colleagues would react to this tool and if they would be willing to use it. 
The data analysis process was rigorous and required repeated contemplation and reflection 
for a period of over four months. This process was essential to make sense of the dataset, 
following Burnard et al. (2008) who, in the context of qualitative research in dentistry, 
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emphasized that "Analyzing and presenting qualitative data is one of the most confusing 
aspects of qualitative research" and "The process of qualitative data analysis is labor 
intensive and time consuming". All of the significant statements provided by OHCPs that 
could be classified into themes were transcribed line by line into the rows of an MS Excel 
spreadsheet.  Each individual statement was manually coded with the ID code and status of 
the participant, and the statement number (e.g., S1 D1 referred to the first statement of 
dentist number 1 in Scotland). Each statement was initially classified within one of the a 
priori themes before refinement.  All the themes in the secondary template were then 
connected according to how they reflected the facilitators / enablers and barriers associated 
with the Capability, Opportunity, and Motivation components within the COM-B model.  
All the coded statements were aggregated into each constituent theme using the sort 
function of MS Excel, as described by Meyer and Avery (2009).  
4.3.2 Authenticating the Qualitative Analysis  
This type of interpretive research requires that the data analysis and subsequent results 
conform to the need for credibility, dependability, authenticity, and transferability (Denzin 
& Lincoln, 2008).  Credibility was achieved through: a) the provision of evidence, in the 
form of a selection of significant statements, that were used to identify the themes; and (b) 
application of reflexive thinking to ensure that the results are believable and trustworthy. 
The researcher was aware of the need for reflexivity, meaning that in order to “negotiate 
the swamp” of qualitative data analysis (Finlay, 2002) she reflected personally upon what 
role she played in constructing knowledge, and tried to understand how and why she 
interpreted the data in such a way as to extract certain themes in preference to others 
(Johns, 2004; Johnson & Duberley, 2003; Day, 2012).  
Because this research had a cross-cultural context, the researcher was also driven 
reflexively by cultural respect and awareness during analysis. As recommended by 
McCullough-Zander (2000) she did not work in conflict, but worked in conjunction with, 
the diverse belief systems related to the provision of health care that are inherent in 
different cultures. The researcher did not intentionally give preference to the statements of 
respondents whose opinions agreed with her own opinions, nor for example where answers 
matched consensus information provided in the literature or guidelines, as identified in the 
systematic overview.   
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Dependability was assured because the researcher provided sufficient methodological 
information for another researcher to repeat the data collection and analysis procedures and 
thereby obtain similar if not the same results.  Authenticity was established by using an 
open process involving consented participation by the participants, promoting the 
participants’ willingness to discuss their lived experiences and perceptions. Authenticity 
was also assured by the researcher seeking advice from the project team; there was close 
examination of assigning of statements during the analysis, and disagreements were 
discussed at length until consensus was achieved. Transferability of conclusions, i.e. how 
this study may inform and be applicable to other OHCPs working outside Scotland and 
Oman, is discussed in Chapter 6.  
4.4 Results 
The results are presented according to the four themes: conventional oral examination, 
target population, frequency of screening, and use of Adjunct Tools. Then, the structure of 
each theme is subdivided into: the prevalence of best practice behaviour(s) specified from 
Chapter 3; tabulated barriers and / or facilitators for optimal behaviour(s); and a short 
summary.  
4.4.1 Participant Characteristics 
In total there were 31 participants in this qualitative study (Oman n=18 and Scotland 
n=13). The characteristics of the participants are presented in Table 4.4. The majority of 
the participants from Oman were dentists (n=14), three of the participants were dental 
hygienists and there was one dental therapist. The most experienced participant had 24 
years of experience and the least participant had three years. Five of the participants 
worked in Muscat city (Capital) and the remaining 13 worked outside the capital in the 
regional areas of Oman.  
Similarly, in Scotland the majority of the participants were dentists (n=10, 3 males and 7 
females). There were two dental hygienist / therapists and one dental hygienist. The 





Table 4.2 Oral Health Care Professionals Characteristics (Oman and Scotland) 
Oman 
 




O1 Female  Dentist  11 Capital  
O2 Male Dentist  3 Regional  
O3 Male Dentist  6 Regional  
O4 Female  Dentist  3 Regional  
O5 Female  Dentist  16 Capital  
O6 Female  Dentist  3 Regional  
O7 Male Dentist  10 Regional  
O8 Male Dentist  24 Regional  




O9 Male Dentist  7 Regional  
O10 Male Dental Hygienist 20 Regional  
O11 Female  Dental Therapist  5 Capital  
O12 Male Dental Hygienist 7 Regional  
O13 Male  Dental Hygienist 21 Regional  
O14 Male Dentist 5 Regional  
O15 Female  Dentist 4 Regional  
O16 Female  Dentist 18 Regional  
O17 Male Dentist 13 Capital  




ID Gender Role 
Years of 
Experience 
All Greater Glasgow and 
Clyde Health Board;  
Scottish Index of Multiple 
Deprivation (2016) Quintile 
(1= most deprived, 5 = least 
deprived) 
S1 Female  Dentist  36 1 
S2 Female  Dentist 17 5 
S3 Male Dentist 31 5 
S4 Male Dentist 18 1 




4.4.2 Theme One: Conventional Oral Examination (COE) 
Findings from the systematic overview (Chapter 3) recommended that the conventional 
oral examination should be performed for every dental patient on a routine basis, i.e. 
delivered opportunistically as an expected service in the primary care dental setting:  
The COE should be delivered opportunistically, as part of routine primary care dental 
appointments. 
4.4.2.1 Prevalence of Recommended Behaviour(s)  
There was some variation in the description of examinations and it could be difficult to 
interpret how comprehensive they were, e.g. with respect to specific areas of the oral 
cavity, or to extra-oral aspects, but broadly the majority of participants in both countries 
described conducting conventional oral examination as recommended:  
“You can look all over the oral cavity…the measure suspect areas, lips, tongue, sides of the 
tongue also, floor of the mouth, cheeks [...]” (O3) 
“If somebody’s open mouth immediately you will see the tongue and the borders and then, 
when you, check even the teeth you need to pull a little bit aside you need to pull the 
tongue.  So, I check the teeth and I see the tongue, at the same time I see floor of the 
mouth. So, everything is done altogether.” (S1) 
“Extraoral just systematic - you just looking at the patient up above for symmetry then 
TMJ then extra facial tissues, bones, mouth opening, then you go intraoral soft and hard- 
buccal then mucosa palate tongue lateral ventral aspect, dorsal aspect of the tongue.” (O10) 
 
Although OHCP interview responses from both countries indicated the examination was 
broadly being done, there were some selective targeting (see next theme). Some (Oman) 
said they performed an extra-oral examination only according to need rather than routinely:  
S6 Female  Dentist 23 1 
S7 Female  Dentist (VT) 1 month 2 
S8 Female  Dentist 33 2 
S9 Female  Dentist 16 2 
S10 Female  Dental Hygienist 32 3 
S11 Female  Hygienist/Therapist (VT) 2 months 5 
S12 Female  Hygienist/Therapist (VT) 2 months 2 
S13 Female  Dentist 14 1 
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“Intra-oral examination, yes, or extra-oral whenever we feel that there is a need, but not 
routinely. Mirror, probe.  We look at the gum, the teeth……the surrounding tissue, just a 
quick over…overview and…three in one tongue” (O6) 
[So do you conduct…oral soft tissue examinations for all of those…patients?] “Not…not 
always” (O7). 
4.4.3 Barriers and Facilitators  
Table 4.4 shows the behavioural diagnostic coding for COE, i.e. barriers or otherwise to 
evidence-based practice. 
 
 Table 4.3 Behaviour model coding for COE with illustrative quotations  
 
Coding Description  Illustrations  
C. Psy. Generally good 




“It is just standard and it is very easily to detect any oral cancer in 
every standard examination.  We are prepared to do examination.  
We are detecting cancer and precancer…lesion and any suspicious 
lesions” (S1). 
“We are searching for any abnormalities…ulcers, resistance ulcer 
also…and after that we are going to… palpate… suspected. 
Everything you suspect you should check a lot” (O3). 
C. Phys. Some technical 
variation e.g. order of 
intra/extra oral 
examination 
“Labial, buccal, retromolar, um, floor of mouth, base of tongue, 
anterior two thirds of tongue… Oropharynx, tonsillar, gingivae. 
And then, um, lymph nodes, posterior lymph nodes, internal 
jugular, sort of, high, medium and low…and then some 
mandibular submental […]” (S5) 
“[…] I sort of start from the… the chin below and… feel round 
their jawline […] so, do extraoral and then sort of look at their 
face to…to ensure that both sides are symmetrical, um, and then 
look for anything suspicious, um, and then do intraoral 
examination” (S11) 
Technical omission 
such as visual only, or 
internal only  
“We do…we check but it’s mainly a lymph node check and then a 
soft tissue examination. Just a visual examination” […] (S8). 
“General examination, like teeth, gums and buccal mucosa and 
tongue” (O2) 
Op. Soc. COE carried out but 
perception of patient 
worry might be an 
inhibiting factor – 
more so in Oman 
 
“Um, I don’t say I’m looking for oral cancer… because I think the 
word cancer scares people a lot. know some people say that you 
should use that term, but I just say that I’m checking all the tissues 
and making sure there’s…that everything is looking healthy” 
(S7). 
[So basically, […] you will be doing the work, and without… 
panicking the patient?] “Yes, of course; that will make them freak 
out.” (06). 
Mixed reports from 
Oman on social 
barriers with respect to 
gender of OHCP/ 
“Yes…some of the [female] patients they want a female dentist to 
examine them.” (O2).  
“[You are a male dentist and you have a female patient, do you 
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Coding Description  Illustrations  
patient  think there is any barriers?] “Well I don’t face any trouble in this 
because, you know, in our religion, it’s fine to be seen by a 
doctor, because it’s for treatment.” (O1) 
Op. Phys. Some reports in 
Scotland about time 
constraints inhibiting 
COE  
“If you know, how long does it take you to do a full charting?  
[…]  To look at the soft tissues, to look round the head and neck?  
All these things and then to ask about…some patients it takes you 
ten minutes just to get through the [medical history] before you 
even look at these things.” (S5). 
“The thing about it's an NHS practice and it's busy…and I know 
it's not an excuse but time restraints.” (S10). 
M. Ref. Some motivation from 
previous detection  
“Just check for lumps and bumps all over the skin […] I’ve 
certain seen, I’ve seen a couple of squamous cell carcinomas” 
(S5) 
M. Auto.  Reports in Oman of 
COE not being within 
scope of professional 
practice/ role  
“No, we don’t do patient screening. This is usually done by the 
dentists and it is his work” 
(O11).   
 
4.4.4 Theme Summary- COE  
COE is reportedly being implemented in practice in both countries, with some qualifiers: 
• Participants broadly reported screening patients, but some barriers were outlined  
• However, in Scotland time and resources issues were the strong barriers 
• In Oman, lack of training (and a perception from hygienists that only the dentist 
should perform COE) emerged as barriers 
• Most were happy to relate the screening to cancer. One exception in Scotland felt 
this was ‘scary’ (a social opportunity barrier) but this ‘cancer taboo’ barrier was 
stronger in Oman (see next chapter for the patient perspective) 
• Reports of other cultural barriers in Oman were by no means homogenous, but as 
might be expected there were some sensitivities, for example for a male dentist 
examining a female patient 
4.5 Theme Two: Target Population  
Chapter 3 shows some equivocal evidence in terms of targeting, but concludes in 
summarizing the systematic overview that:  
• COE should be conducted opportunistically for all (i.e. the general public)  
• Risk status should be ascertained through smoking and alcohol history 
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4.5.1 Prevalence of Recommended Behaviour(s)  
Seven of the OHCPs in Scotland (S1, S2, S4, S5, S7, S9 and S10) clearly reported early 
detection / screening detection of OCC through universal conventional oral examination 
among the general patient population (emphasis in bold / underline added), for example: 
“Everybody has to be… checked because we know… that… risk of a cancer could… affect 
everybody so we need to treat everybody in the same way.” (S1).  
“Generally look at as much as we possibly can, for everybody.” (S4).  
“Yes, every single patient, yes, soft tissue exam…either nothing or anything that I'm 
aware of I will write it down and I will bring it to the attention of the dentist straightaway.” 
(S10) 
 
However, four of the OHCPs in Scotland (S1, S6, S8, S11) reported targeting - that is that 
they mainly employed early detection via conventional oral examination and soft-tissue 
charting among the high-risk population, for example:  
“Especially elderly people it doesn’t matter what is the gender who have diabetes, high 
blood pressure, problem with circulation and. arterial sclerosis, heart disease…also taking 
some sort of medications, which affect circulation in the small blood vessels, can be in the 
higher risk of the cancer” (S1).  
“Especially with maybe older people and denture patients.” (S6). 
“It’s for all the patients over 30.” (S8). 
“I particularly check smokers…So right at the back normally here is where sort of 
smokers’ keratosis and the ridges, and things.” (S11) 
 
The picture in Oman was similar in that seven of the OHCPs in Oman (O1, O2, O3, Q4,07, 
O9 and O10) reported early detection / screening of OCC through conventional oral 
examination for the general patient population, for  example: 
“Mostly we do a detailed examination for each patient.” (O2 D). 
“General examination for all appointed patients.” (O10). 
 
However again there were reports of targeting to the higher risk population, for example: 
“[So, if your patient, for example, has a risk factor, he’s a smoker, he’s an alcohol drinker, 
then you tend to do the, the screening only in those patients]? Exactly.” (08) 
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4.5.2 Barriers and Facilitators  
Table 4.5 shows the behavioural diagnostic coding for targeting based on risk, i.e. barriers 
or otherwise to evidence-based practice. 
Table 4.4 Behaviour model coding for target population with illustrative 
quotations   
 
Coding Description  Illustrations  
No coding for capability or social opportunity  
Op. 
Phys. 
Training / guidance / 
protocol facilitates good 
practice  
“Well, the…the guideline when we were training was to do it for 
everybody at examination […] (S9). 
“[Is it a protocol you have to do this for every patient]?  Yes- it’s a 
protocol. Even intraoral or extraoral.” (O3). 
Lack of local written 
guideline is a potential 
barrier  
“I’m just following, like… the basic guidelines, which is, like… 
routinely checking up. [Okay, but you don’t have anything written 
in the clinic?] No.” (O8). 
Resources issues favour 
targeting (i.e. are a barrier 
to universal examination) 
“Under the current…system of remuneration I think… that’s 
difficult… the amount of things that we’re being asked to look at as 
well as…so there’s oral cancer.  Then there’s tooth wear.  There’s 
tooth erosion… bruxing…clicking jaws…temporomandibular 
joints, dah, dah, dah, dah.  So the…amount of stuff we’re meant to 
record at an examination… is quite large and I think …it would be 
difficult to get you to carry that on every patient, at every exam.“ 
(S3). 
“Em, it comes down to time and money…Eh, and constantly every 
time something else comes out you’re adding onto it, but funding 
doesn’t increase in any way, shape or form… and you can set all 
the guidelines in the world, but people won’t do it if...em, if there’s 
no way of funding it…” (S4). 
M. Ref.  Targeted screening was 
reasoned on smoking risk 
(can be interpreted s a 
barrier to universal 
checks)  
“I particularly check smokers…So right at the back normally here 
is where sort of smokers’ keratosis and the ridges, and things.” 
(S11) 
 
M. Auto. General point about the 
position/ professional role 
of dentists with regards to 
early detection  
“A huge advantage about dentists is we get the healthy people, so 





4.5.3 Theme Summary- Target Population 
The varying reports among OHCPs on targeting perhaps reflect the results of Chapter 3, 
where evidence was unclear and guidance was varied as to whether targeting those at risk 
is recommended (i.e. some guidelines recommend screening of high risk patients and some 
recommend patients above 40+, though the majority suggest universal screening as part of 
a routine dental check-up): 
• Responses across countries were very similar - mostly general public screening 
with some targeting, mainly on age and smoking  
• Guidance / protocols did emerge as a facilitator for carrying out COE for all 
• Universal detection / screening efforts bring a resource consideration which was 
mentioned in Scotland 
4.6 Theme Three: Frequency of Screening 
There was a limited evidence base for a differential in the frequency of oral cancer 
screening /early detection based on risk in the systematic review. In practice, convention is 
to carry out checks every six months for all. One high quality guideline (NICE, 2004a) 
recommended that frequency of recall should be based on patient risk (i.e. smoker or 
alcohol drinker) with a suggested recall interval of 3-6 months for high risk and 12-24 
months for lower risk: 
• There is no strong evidence but some guidance recommends risk-based recall 
intervals (shorter for high risk patients)  
4.6.1 Prevalence of Recommended Behaviours 
Recall intervals for routine checks were reportedly almost always universal i.e. the same 
for all patients. There was some reluctance to reducing checks (increasing time between 
screens) in that ‘low’ risk patients might not receive optimal care (see Table 4.6):  
“But given that we look at everybody I don’t know are we going to look different because 





Most recall discussions in Scotland focused on what we might term ‘follow up’ – i.e. 
reactive to something like a lesion or abnormality being observed (rather than proactive 
checks based on risk per se):   
“If I identify a thing that I don’t know what it I’ll get them back in …two weeks’ time to 
see if it’s resolving.” (S2). 
“If it looks atypical… then I would book them back in and I would… want to see them 
in… two or three weeks.” (S5). 
Similarly in Oman, checks were not more frequent based on risk factors, but if lesions 
were picked up. Here they are referred straight away (rather than patients being brought 
back to the OHCP for follow-up): 
“What we normally do is, we refer and they are being followed up at the tertiary centre.  
We don’t follow them up. Er, well, they, they may come for other [things], you know, 
[such as] for filling or scaling, but they…for the white lesion, they are being followed up in 
the…for the lesion particularly, and they may follow it up in the tertiary.” (O6). 
4.6.2 Barriers and Facilitators  
Table 4.6 shows the behavioural diagnostic coding for recall frequency based on risk, i.e. 
barriers or otherwise to evidence-based practice. 
Table 4.5 Behaviour model coding for frequency of screening with illustrative 
quotations  
 
Coding Description  Illustrations  
No coding for capability 
Op.Soc. Patients risk 
perception may be a 
barrier to shorter recall 
intervals  
“The trouble is the patient doesn’t always come back so… that’s a…a 





Structure of practice is 
based on regular 
checks for all 
“Statement of Dental Remuneration and the … Practitioner Services 
and Scottish Dental Practice Board, they make all the rules and we 
have to follow them and obviously show that we’re doing care for 
patients.” (S7). 




“Well, in my opinion, let us [bring] in those kinds of people who are 
with high risk… Yeah.  Because of time, saving time, and for so 
many…” (O13).  
“ …I think the main thing with dentistry is…it needs to be kind of easy 
to access…because you don’t have a lot of time with each patient in 





Coding Description  Illustrations  
 Lack of guidance 
emerged in Oman  
“I don’t have any protocol here. [No guidelines?] We didn’t [You 
don’t follow any?] No.” (O2). 
“We don’t have, here, something like…something will guide us.” 
(O4). 
 Risk tools (see below) 
could be a resource to 
facilitate risk-based 
examinations  
“Okay.  And…and I think this…the [risk assessment] tool could be 
used as a decision tool for clinical examination […]” (S3). 
 
M. Ref. In Scotland, some 
reflection on the 
unintended effect of 
missed detection for 
‘low risk’ patients  
“…I just…my worry would be…we’d miss…yeah.  Uh-huh…And, 
um, you know, I’m…I’m sure oral cancer must develop in some low 
patients as well as the high risks, you know.” (S2). 
 
 
No coding for automatic motivation  
4.6.3 Theme Summary- Recall Frequency  
Recall was reportedly universal at twice yearly. This is broadly what the evidence review 
currently supports, though guidance suggests a risk-targeted approach: 
• Responses across countries were very similar - but in Scotland patients were 
recalled for further observation when abnormality observed, and in Oman referred 
in the first instance  
• Frequent recall for high risk patients was supported, but a barrier emerged in terms 
of resources, and in terms of patients not attending check ups  
• Less frequent recall for low risk patients was less well received – the barrier being 
the view that they might be at risk from later detection 
• Lack of clinical guidelines in Oman was a barrier as it was reported OHCPs had no 
guideline to follow  
4.7 Theme Four: Use of Adjunct Tools  
The systematic overview shows a lack of supporting evidence for the use of Adjunct Tools 
alongside the conventional oral examination for detecting OCC and OPMD in the primary 
care dental setting: 
• Adjunct tools not recommended in Primary Care  
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4.7.1 Prevalence of Recommended Behaviour(s) 
Only two of the OHCPs in Scotland and none of the OHCPs in Oman reported that they 
used Adjunct Tools (e.g., stains, fluorescents), though most were aware of them:   
“Do you use any agent tools to identify a lesion?] No [So do you think…is it feasible to 
use in your practice] Yeah.  Oh yeah, definitely. I’m aware that we could do it in the 
practice.” (S2). 
“I’ve heard of them but no, no, I don’t do anything like that.  I don’t know that we have the 
equipment. I’ve never been provided with them in any practice.” (S9) 
“No, they’re not using it.” (O8). 
As their use is not currently recommended in the Primary Care dental setting, this might be 
said to be ‘evidence-based practice’. However, it is still interesting to explore the reasons 
given for use / not use.  
4.7.2 Barriers and Facilitators  
Table 4.6 shows the behavioural diagnostic coding for Adjunct Tools for screening. 
Table 4.6 Behaviour model coding for Adjunct Tools with illustrative quotations  
Coding Description  Illustrations  




“I would very much rather refer to somebody who was... more specialised 
than me rather than, you know, doing... that kind of slightly more 
advanced testing […]” (S4).  
 





training would be a 
facilitator in terms 
of resource 
opportunity  
“…I’ve heard of them but [...] I would obviously want to…to think about 
maybe having some training before I was to…to do anything like that...” 
(S9). 
“Using things like visual tools for the patient would be really good as well 
on top […] because we don’t use that in current practice […]” (S11).  
Resource/ time 
barriers  
“I try to introduce in another practice but you have to pay for better 
tool…you have to pay for the test NHS… doesn’t cover additional 
examination. The test altogether takes around twenty minutes to do it 
properly and… also we use the white light to highlight the toluidine 
blue…this test takes between twenty to thirty minutes.” (S1). 
In Oman, non-use 
attributed mainly to 
lack of provision of 
tools  
“No, we don’t use it. [because] It’s not provided.”(O1).  
“No, we have lack of these tools.” (O3) 
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Coding Description  Illustrations  
 Some reflection in 
the other direction – 
a facilitator for 
usage  
“[Do you use any tools?] I feel like it would be probably really beneficial 
because like oral cancer can be quite aggressive as well and, um, like if 
you're finding that sort of middle like stage like patients’ chances of 
surviving is dramatically reduced.  Um, I feel anything, because it's the 
patient’s life at the end of the day, anything that can help prevent the loss 
of life would be massively beneficial in practice.” (S11).  
 
“[What might improve things?] So yeah, erm, something a little bit more 
specific, and maybe even the staining, erm, whether that might be, you 
know, to use different dyes for staining, erm, again might be a good idea 
in, in detecting and maybe moving forward….I'll certainly have a look at 
these and I will speak to the dentist regarding these dyes.” (S10). 
No coding for automatic motivation 
 
4.7.3 Theme Four Summary  
Whilst Adjunct Tools are not well supported by evidence (Chapter 3) and not observed in 
practice here, there are still what we might call ‘barriers’ to implementation. In Oman lack 
of provision of tools was cited for non-use, and time and resources (including training 
needs) were cited in Scotland. This might tentatively be inferred as “doing the right thing 
for the wrong reason’(this might actually be ‘coded’ in terms of lack of knowledge- 
capability issues re evidence-based dentistry in relation to the use of Adjunct Tools): 
• Rather than reflecting on evidence, the OHCPs in Oman overwhelmingly attributed 
physical opportunity barriers such as unavailability of resources for not using such 
Adjunct Tools in screening patients for oral cancer 
• In Scotland time and resource issues for carrying out such screening were 
mentioned (although some had researched the evidence)  
 
4.8 Risk Prediction / Assessment tools  
Themes two and three cover targeting and recall based on risk. OHCPs were specifically 
asked about risk assessment in practice and the acceptability / feasibility of using a risk 
prediction tool for identifying those at high risk of oral cancer; a prototype tool developed 
by the INHANCE network (INHANCE, 2018) was used to facilitate discussions. 
The majority of professionals broadly welcomed the idea of using such a risk tool: 
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“If it is approved risk factor assessment then yes. As this will be like a guideline for us to 
use it.” (O1). 
“I think generally positive, I would imagine…Erm, yes, it’s hard to say.  Everybody has 
very different opinions [laugh] but…I think, you know, most dentists want to make sure 
that they’re helping patients, that they’re detecting things early.” (S9). 
 
Barriers were mainly resource (physical opportunity) based and are again tabulated.   
Table 4.7 Behaviour model coding for risk assessment tools with illustrative 
quotations  
 
Coding Description  Illustrations  
No psychological capability coded  
C.Phys. Technical question 
about reliability of 
administering tools  
“[It] can cause confusion because if a nurse does it in a different 
way with each dentist on different days, that’s how mistakes 
happen.” (S5).  
“Um, in…at the end of the day, the only thing you’ve actually got 
is…is the quality of, er, the person doing the assessment. (S5). 
Op.Soc. Social barrier for 
patients answering risk 
questions (use of 
waiting room as a 
facilitator)  
“I prefer they do it in the waiting area….[why]… I think on their 
own they may be true to themselves… They might be more honest.  
Whereas, when you’re faced with questions, you may not want to 
answer, or give the entire truth, to someone else as an answer.  
You don’t want them to look down on you.” (O17). 
“Well unless I try it on a few patients and see their results I cannot 
judge.” (O18). 
Social barrier in 
explicitly raising cancer 
risk  
“.  I don’t know if it could alarm patients.  I don’t know how that 
would…maybe that brings about change.  I’m not…I’m not sure.  
Um, but I think that if you were using a tool like this, 
it…definitely highlights in the patient, why are they talking about 
this?  You know, this is obviously important.” (S2). 
“because the minute you say…cancer, patients get really nervous, 
um, and they do get nervous if you say you’ve seen something in 
their mouth, so you have to just be very diplomatic, you don’t 
want to nu…worry them, but you obviously want to tell them what 
you’ve seen…So yeah, I think that’s probably quite a good idea.” 
(S7). 
Op. Phys. Time to assess risk is a 
barrier 
“Time as I mentioned we have only 30 minutes for each patient 
and the majority of the patients come in for treatment not for 
consultations.  So, if I ask them to conduct this that will take at 
least how many minutes?  Twenty minutes, fifteen minutes to 
finish it”.” (O18) 
“Em, there’s only so much time you can allot to it.  So, eh, if 
you’ve got an admin process and a clinical process. Em, you 
know…How...how do you allot the time, eh…that you’re 
compressing more and more things into the...same time, eh.” (S4). 
“...That is the sort of thing that you probably need to increase your 
appointment time for, isn’t it?...Because it already takes them five 
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Coding Description  Illustrations  
or six minutes to fill up the medical questionnaire.” (S8). 
“Em...It’s, em, it’s...it’s very nice in theory. In practice, eh, not so 
simple.  Em, you know, you’re...you’re talking about, eh, hundreds 
if not thousands of patients in a week...eh, that are trying to...to fill 
all these things out. Em, if somebody is willing to fund us to have, 
you know, a couple of hundred tablets so that...if you happen to 
have lots of people there and...they walk out with one and, you 
know, everything else that’s...that’s good.  Em, but I think that 
the...the feasibility of that is...is quite low.” (S4). 
Building routine would 
be a facilitator, as 
would technical 
delivery  
“Um, I think again it would just…as long as it’s not going to eat 
into too much time…I think you can still do a very thorough 
examination and not spend too much time on it, um, if you’re 
doing it properly, so if you just make it part of your routine.” (S7). 
“It could be app, er, like, er…er, of, er, are you risk of cancer, 
check yourself…Yeah, er, yeah, set of questions could be, er, but, 
er, yeah, maybe it will be good.  Maybe it will be good. And then 
he can do self, er, for example, people on…on their mobile phones 
are looking for apps.” (S1). 
 Most professionals in 
Scotland saw resource 
barriers with regards to 
software as this would 
require an electronic 
link to the patient 
management system: 
“It would need to be paper I think…because we don’t have a 
computer sitting.” (S8). 
“If it was incorporated in to R4 would be really helpful.” (S2). 
“I mean and…and certainly something electronic but I mean most 
practices are computerised now, not everybody…but…and, er, 
quite a number of practices, and we’re looking to do this as well, I 
know the doctors do this, have, erm, you fill in your medical 
history on a tablet.” (S3). 
M. Ref. Reasoning that accuracy 
improved by direct 
administration 
“I think face to face is much better. At least I would have the 
correct and real information from the patient directly.  If I talk to 
him face to face and then fill it directly, step by step, that will help 
more.” (O18). 
No automatic motivation coded 
 
4.8.1 Risk Tool Summary  
Overall, the risk prediction tool could be said to be broadly considered worth exploring, 
but with feasibility concerns regarding resource (physical opportunity) barriers. There was 
an additional social barrier with the issue of whether patients would be rendered upset by 
introducing cancer risk explicitly: 
• Broadly welcomed but some social barriers with patients, in both countries.  
• Time, money, training etc. would need to be taken into consideration by the tool 
developers in order ensure that product might be implemented with few or no 
obstacles to enhance care.  
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• Waiting room completion by patients (i.e. questions not administered directly) 
might overcome time barriers, but dentists would worry about accuracy of data.  
4.9 Discussion  
Four themes defined by the primary template in Table 4.1 (i.e., conventional oral 
examination, target population, frequency of screening, Adjunct Tools) were explored in 
this qualitative study from the practitioners’ perspective, together with their views on risk 
assessment tools.   
The results were broadly consistent with the findings of the systematic review and the 
presence or absent of evidence across the themed areas. However, the reported results, 
based on these themes, indicate that not all the best practice evidence and guidelines are 
currently implemented by OHCPs in either Scotland or Oman. This backs up previous 
work showing variation in practice (LeHew et al., 2010) and issues following and 
implementing guidelines (Ayres and Paas, 2007).  
Comprehensive examinations were partially in evidence, but some descriptions of activity 
were vague and there were some gaps. Under COE, the structured examination including 
intra- and extra-oral aspects and, e.g. pulling the tongue, is well addressed in dental health 
care education in various levels (Uti et al., 2006, Seoane et al., 2012) but descriptions in 
this study were varied and could be difficult to decipher.  
There were wide variations among the OHCPs in both Scotland and Oman regarding the 
specific criteria that they applied to focus their early detection / screening for OCC on high 
risk patients. We know there are knowledge gaps in GDPs’ awareness which probably 
drive different opinions on screening per se, and how effective it can be for reducing 
mortality and morbidity (Kujan et al., 2006).  
Criteria for targeting included elderly patients, patients over 40, patients with high blood 
pressure, problems with circulation, arterial sclerosis, and heart disease, as well as denture 
patients, smokers, and alcohol drinkers. The need to identify more specific criteria in order 
to identify high risk patient needs further evaluation. Cognitive capabilities were different 
between Scotland and Oman, because in Oman the OHCPs appeared to have little or no 
knowledge or understanding of written guidelines such as those provided to the OHCPs in 




Recall was interesting in that practitioners mainly described follow-up (e.g. after observing 
a lesion). However, broadly, they had comparable intervals for all patients whether high or 
low risk. This is in line with current Cochrane evidence although guidance suggests this 
worthy of continuing exploration. OHCPs on balance were more wary of longer intervals 
for low risk patients (as might be expected) but there were resources issues raised for more 
frequent checks / shorter time intervals for high risk patients (National Institute for Clinical 
Excellence, 2004) 
Use of Adjunct Tools was limited in OHCPs in both Scotland and Oman. Omani reasons 
were more simply about opportunity / availability, whereas there was some more reflection 
and reasoning in Scotland. However, in Scotland time and resource issues, including 
training, were raised. It is known from Chapter 3 that visual-based techniques lack strong 
evidence (Messadi, 2013) despite some small studies indicating promise (Richards, 2010), 
and there might still be utility in raising knowledge / awareness in this regard. 
This research was partly driven by the researcher’s personal perspective of being 
influenced by more than one culture, which reflects a large population of clinical oral 
health professionals with experience of working and /or studying in both Western and Arab 
cultures (Aboul-Enein and Ahoul-Enein, 2010). Differences in practice were not perhaps 
as large as one might expect given the socio-political and cultural setting in each part of 
this study. But this may in part be due to the high proportion of Omani practitioners who 
studied or obtained qualifications abroad.  
Broadly, efforts in Oman are needed to help relieve the restrictions on social opportunities 
for OHCPs to conduct early detection / screening of OCC associated with (a) religious / 
cultural beliefs regarding the treatment of female patients by male dentists, and (b) the 
psycho-social barrier of talking about oral cancer. Future work could explore further the 
wider cultural landscape affecting all health and social care interactions. For example, this 
research was not concerned directly with identifying cultural stereotypes, reflecting unique 
patterns of behaviour and belief, that characterize specified groups of people in different 
nations.  
In Scotland, time, cost, and lack of resources were the main limiting factors for routine 
screening / early detection efforts overall. Such barriers related to spending time explaining 
the risk to individuals has been previously indicated in a study carried out in general 
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practice by (Steenkiste et al., 2004). This was the main sphere for barriers to use of risk 
assessment / prediction tools which were broadly seen as worthy of further exploration.  
4.9.1 Strengths and Limitations  
The significance of this study lies in the attempt to relate practice (work as done) to 
evidence / guidance (work as dictated or planned; Clay-Williams and Braithwaite, 2016).  
The use of a flexible theory-based framework ensured coverage of the potential barriers 
and facilitators affecting behaviours under each theme which together make up the 
behavioural domain of the early detection / screening of OCC. 
The theoretical frame was useful and important to show coverage of barriers. The 
components of the COM-B model (Mitchie et al., 2011) are applicable to this area of 
practice;  physical / psychological capabilities (skills and knowledge) and physical 
opportunities (time and resources) in particular interact to enable the early detection / 
screening of OCC.  The descriptions of the physical capabilities of the OCHPs in Scotland 
and Oman when conducting conventional oral examination and soft tissue charting, and 
capabilities in taking biopsies, appeared to be similar.  
Results indicated that social opportunities for OHCPs to conduct early detection / 
screening of OCC in Oman may be more restricted than in Scotland, due to: (a) religious / 
cultural beliefs regarding the treatment of female patients by male dentists, and (b) the 
psycho-social barrier of talking about cancer (Bertakis, 2009, Henderson and Weisman, 
2001), however within the scope of the study, it was not possible to delve deeply into the 
wider social / cultural issues.  
The generalisations that can be drawn from the analysis of qualitative research data 
obtained from a purposive sample are limited by the thematic results being a reconstruction 
of the subjective experiences and perceptions of a small number of participants, working in 
specific situations and locations (Mayring, 2007). Other OHCPs in different situations and 
locations could have provided different information to that provided by the OHCPs who 
participated in this study. Whilst some attempt was made during sampling to ensure a 
spread of responses and through numbers to achieve some data saturation, the findings of 
this study are not necessarily generalizable to the OHCP population as a whole.  
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The researcher did not intentionally eliminate any statements that were directly opposed to 
her own personal opinions, or information provided in the systematic reviews or clinical 
guidelines.  Nevertheless, despite attempting to maintain a neutral stance, the researcher 
recognised that, like all observers, she has subjective prejudices. Her subjective judgments 
and personal ideas relating to the need for OHCPs to implement improved methods of 
detecting, screening and preventing OCC might possibly bias some of the results and 
conclusions. 
4.9.2 Conclusions and Recommendations  
The knowledge gaps indicate that guidance could be targeted for intervention (see Chapter 
6). Future research is required, based on the findings of the current study, to establish 
which written guidelines could be built into a future pilot intervention to support the early 
detection of oral cancer in general dental practice. This issue is particularly important for 
the OHCPs in Oman, where such guidelines appear to be absent (there is patient 
management software (Al-Shifa: Health care Information System) (MOH, 2019 and Al 
Ghabri et al., 2014) which provides for documenting COE results but this is underutilised.   
In Oman, guidance is lacking and facilitation through this means is likely to have an effect. 
These new guidelines should include: a) descriptions of best practice to conduct COE and 
soft tissue charting, including discussion around the use of Adjunct Tools; b) the specific 
criteria applied to focus attention on the early detection  /screening for OCC among high 
risk patients; c) the optimum time interval to recall patients with suspected OCC; d) the 
best pathways for the referral of patients to specialists, and for the receipt of feedback. 
Future implementation could potentially employ Quality Improvement (QI) principles such 
as the Plan-Do-Study-Act (PDSA) cycle, thus incorporating a built-in evaluation process. 
The PDSA cycle is widely applied to evaluate the effectiveness of health promotion and QI 
programmes (Healey & Zimmerman, 2010). A PDSA approach here might be fruitful in: 
reviewing related procedural standards / up-to-date evidence for clarity in the practices 
discussed here; co-designing improvement with OHCPs; taking into account the restraints 
of cost, time, and other resources; designing workshops and / or training programmes; etc. 
Routine methods such as the collection of audit or self-report data might allow for 
summative assessment on improved evidence-based practice (Dimitrov & Rumrill, 2003).  
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The next chapter now builds on these results by exploring patient experience and views in 
relation to oral cancer early detection / screening in a further exploration designed to 
overcomes the barriers related to implementation of the synthesised evidence base 




Chapter 5: Patient views on early detection / screening for 
OCC in dental settings in the Sultanate of Oman and 
Scotland 
5.1 Introduction 
This chapter builds upon the overview of evidence-based practice (Chapter 3) and the 
theory-based exploration of the professional perspective in Chapter 4 to incorporate patient 
views in relation to oral cavity cancer early detection / screening, by describing a 
qualitative study which was conducted with a sample of adult patients attending primary 
care dental settings in both Oman and Scotland. The main aim was to provide data for a 
final synthesis of the evidence base with perspectives of professionals and patients alike in 
this area; a further aim was to make a comparison between the two countries.   
It has been reported previous that patients may lack general knowledge of oral cancer and 
be unable to recognise symptoms  (Ford and Farah, 2013).  
Involving patients’ views in the development of clinical guidelines and their decision-
making in treatment plans have potential for improving the quality of health care and 
treatment outcome; this is through meeting patients’ needs and preferences (Loh et al., 
2007; Gagliardi et al., 2011; Kastner et al., 2015; Armstrong et al., 2018).  Although 
existing recommendations (e.g. NICE) support the patient’s involvement in their treatment 
plan of care, there is limited evidence to conclude that patient involvement in health care 
system decision-making helps to improve health outcomes and service utilization (Joosten 
et al., 2008; Shay and Lafata, 2014; Boss et al., 2015; Friedrichs et al., 2016; Kashaf, 
McGill, and Berger, 2017). Nonetheless, patient involvement has been shown to help them 
to improve their knowledge and decision-making related to their treatment (Joosten et al., 
2008; Shay and Lafata, 2014; Boss et al.,  2015; Friedrichs et al., 2016; Kashaf, McGill, 
and Berger, 2017).    
 
In relation to oral cancer screening, previous studies (chapter 1) have looked at patient 
views on oral cancer screening in dental settings (Warnakulasuriya et al., 1999; West et al., 
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2006; Zohoori et al., 2012). However, little or no work has looked at different cultures / 
countries, and there is a patchy picture with respect to the application of psychological / 
behavioural theory in designing research questions. 
5.2 Aims and Objectives 
This study accordingly aimed to explore the following research questions:   
a) What are patients’ experiences of previous and current OCC prevention within 
primary care dental settings?  
b) What are patients’ levels of awareness and understanding in relation to OCC?  
c) How do patient views provide barriers / facilitators to practitioners implementing 
OCC early detection / screening? 
d) What are the patients’ suggestions in relation to the development of interventions 
for improving OCC early detection / screening, including use of risk prediction 
tools for targeted prevention? 
In order to answer these questions this study had the following objectives:  
1. To gain ethical approval from research institutions in relation to this study from 
both countries 
2. To recruit patients in both settings. This study involved targeted recruitment of 
patients attending practice 
3. To collect data via a semi-structured interview guide incorporating open-ended and 
fixed response questions  
4. To analyse the data using psychological theory  
5. To report the findings and discuss them in relation to the evidence-base and 
dentists’ views  
5.3 Method 
The theoretical frame is described in Chapter 4. Patient responses were coded in terms of 
the TDF and COM-B frameworks (Cane et al., 2012) and assessed for whether they 
presented barriers or helped to facilitate the desired screening behaviour of professionals. 
The design chosen for this study was a ‘mixed-method’ questionnaire incorporating both 
open (free response) and closed (fixed answer) questions (Boynton and Greenhalgh, 2004). 
The selected questionnaire type was incorporated primarily for practical reasons – 
interviews were necessarily short, being conducted during dental visits. Qualitative / open-
ended questioning was thus supplemented with some time-saving fixed-response questions 




Participants were adult patients attending dental primary care settings in both countries. 
Participants were English-speaking adults in Scotland, and Arabic and English speakers in  
Oman. A total of 48 patients were interviewed, n=24 in each country. Recruitment was 
facilitated via contacting primary care clinics who gave access to facilities for interviews 
and permission to approach patients arriving on the fieldwork days who were then 
consented by the researcher according to the ethical protocol.  
5.3.2 Designing the Topic Guide  
For the semi-structured interview, a topic guide was developed with the research team of 
psychologists and dental and public health professionals. Topic guides are a key tool in 
facilitating data collection as they ensure the interviewer covers pre-set questions but 
allows for this to be done in a flexible way. In this study, the research followed the 
Interview Protocol Refinement (IPR) framework (Castillo-Montoya, 2016). This 
framework consists of four stages: 1) Align interview question with research questions, 2) 
Construct an inquiry-based conversation, 3) Receive feedback on interview protocols, 4) 
Pilot the interview protocol. 
Stage 1: Interview question align with research question  
This stage involved alignment of research questions on oral cancer screening with 
questions to ask patients. As there was no pre-existing interview question-set available 
from the literature, questions were developed based on study aims, the narrative synthesis 
of evidence (Chapter 3), and from findings from professional interviews (Chapter 4).  
Stage 2: Construct an inquiry-based conversation  
It is important under IPR that questions do not treat participants as solely being vehicles 
for extracting answers to research questions – but are also designed to allow them to 
express their lived experience - in this case of attending dental clinics. This inquiry-based 
conversation is achieved through: a) tailoring language of questions to interview ones 
rather than formal research ones; b) following social rules of ordinary conversation so that 
questions are fairly naturalistic; c) having a variety of questions / ways to probe; d) having 
a hierarchy with general topic questions and follow-up / prompt questions to be used where 
appropriate or necessary (Appendix 5.1). In this study, there was also the consideration of 
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language - for example ensuring that the Arabic translation of the clinical guidelines was in 
everyday language that could be understood by the patients. 
Stage 3: Receiving feedback on interview protocols  
The researcher received feedback on the topic guide structure, length and the writing style 
from the advisory group of experts in behavioural science, dental public health and oral 
medicine who contributed to the development of the survey instrument. This stage was 
very important to enhance the validity and robustness of the study guide.  
Stage 4: Piloting the interview protocol   
In stage 4, practice interviews (and training) were conducted with patient volunteers in 
Scotland in the presence of two supervisors (AJR and DIC) in order to further develop / 
fine-tune the topic guide in response to any difficulties or omissions and to give the 
researcher practice in interview technique. One of the pilot ‘patients’ was a ‘smoker and 
regular alcohol drinker’, while the other was a ‘non-smoker and occasional alcohol 
drinker’; one of the participants was 50-60 years old, and the second between 20-30 years. 
Subsequent reflections and feedback from the pilot participants and supervisors prompted 
some changes to the survey instrument. For example, the sequencing of the interview 
questions was changed (for example, having a risk score first, and then categorisation 
option of traffic light or percentage). Generally, however, it was felt that the questions 
were acceptable and relevant to patients attending dental practices in Scotland. No major 
changes were required following the pilot. In Oman, the questions were used in both 
languages (Arabic and English), the questions were checked with a few relatives (medical 
professionals) and no major changes were required.  
5.3.3 Recruiting the Sample  
As in the study reported in Chapter 4, purposive sampling (Ritchie, 2014) was employed in 
order to capture a range of views from people that could inform the research aims – i.e. 
adult patients attending a dental clinic. Smaller sample sizes are typically used for 
qualitative studies as the aim is not to make statistical inferences to the wider population 
(Ritchie et al., 2003) but to provide a rich detail to inform development of more definitive 
studies. Practically, data saturation (no new themes or experiences emerging) is achievable 
without large samples - which would be prohibitively time consuming to collect and 
analyse - and which would lead to high levels of repetition (Guest et al., 2006; Ritchie, 
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2014). For qualitative studies, sample sizes of between 12-60 are recommended (Creswell, 
1998; Ritchie, Lewis and Elam, 2003) but saturation can be achieved earlier in some cases.  
In the present study, the author aimed to recruit 24 dental patients attending primary care 
dental settings in each country, subject to reaching saturation. 
5.3.4 Analysis  
The data for this study were analysed thematically (Braun and Clarke, 2006) guided by the 
linked theoretical frameworks of the TDF and COM-B models described in the previous 
chapter for patient barriers (Atkins and Michie, 2015).  
Analysis first set out current practice from the patient perspective – i.e. answers to 
questions on previous experiences with oral cavity examination (e.g. did / does the dentist 
retract your cheek, did / does dentist pull your lower lip to check the inner side of your lip, 
did / does dentist use gauze to grasp the lip of your tongue and look at the back and the 
side of the tongue?). Responses were thematically coded according to the TDF domains 
and COM-B components and assessed as barriers or facilitators to recommended practice.  
5.3.5 Ethical Considerations 
For the purpose of fulfilling ethical requirements for this qualitative study, formal 
approvals were obtained from the two countries. In Oman, the approval was granted from 
the ethics committee of the School of Medicine, Dentistry and Nursing at the University of 
Glasgow (Appendix 5.2), and the Research and Ethical Review & Approve Committee 
(RERAC) for the Ministry of Health in the Sultanate of Oman (Appendix 5.3). In Scotland, 
the ethical approval was obtained from the National Health Service (NHS) Research Ethics 
Committee (REC) (Appendix 5.4), and the NHS Greater Glasgow & Clyde Research & 
Development (R&D) department (Appendix 5.5). Moreover, “a letter of access for 
Research” was obtained because the patient interviews were conducted in NHS premises 
(Appendix 5.6). Process was followed by ensuring coverage of: obtaining informed 
consent from study participants; ensuring privacy of procedure; maintaining confidentiality 
and secure storage of data; and aggregation of results. The main difference was the number 
of Health Board approvals required in Scotland compared to Oman where research related 
requirements are standardized at a national level under the Ministry of Health.  
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5.3.6 Procedures for Consent 
In Oman, primary health care facilities in urban (city) and rural areas were contacted by the 
primary researcher by telephone for the purpose of obtaining approval to interview a group 
of scheduled dental patients with specified criteria to ensure a range of responses (age 18-
60, both genders, use or non-use of tobacco and alcohol, geographical region). A total of 
five primary care centres gave approval to having their patients interviewed and were 
provided with a copy of the study ethical approval as needed. Each of the dental patients 
was first approached by the assigned dentist and verbal consent was obtained.  Patients 
were then approached by the researcher individually for formal written consent (Appendix 
5.7) after receiving an information sheet (Appendix 5.8) which gave clear explanation 
about the study and its purpose. Patients were also informed that participation was 
completely voluntary and there was no harm or disadvantage in refusing to participate and 
they were free to discontinue at any point of interview process. The written consent was in 
both Arabic and English language to ensure clarity and transparency for Oman 
participants.   
In Scotland, patient selection criteria were provided to dental clinic, and they were 
requested to screen the list of patients who had an appointment on a selected date. Upon 
patient approval to participate, the staff member introduced the patient to the researcher in 
the waiting area.  
5.3.7 Privacy and Confidentiality  
Each dental patient in Oman and Scotland was interviewed in a private room or quiet 
corner of a waiting room. Where possible, the room door was closed with an ‘interview in 
progress’ sign placed on the door. The interview was recorded and saved to computer file 
for transcription and analysis. The participating dental patients were informed that their 
recorded responses would not be shared or used except for research purposes. This issue 
was particularly sensitive in Oman, for example, where for cultural reasons, experiences 
with smoking and alcohol are not socially acceptable to disclose (though smoking and 
drinking exist in private). Confidentiality was assured by using unique ID numbers for 
Omani patients (OP1,OP2…, OP24) and for patients in Scotland (SP1,SP2…., SP24). 
After completion of each recorded interview, the selected dental patients were reassured 
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that the data obtained would be securely stored in accordance with University data security 
protocols, with access limited to the research team alone.  
5.4 Results 
A total of 48 dental patients were interviewed from the Sultanate of Oman and Scotland 
(n= 24 in each setting). The interviews were conducted in 2017 between February and 
March. Interviews were responsive to patient need and willingness to answer questions to 
various degrees and depths and therefore ranged in duration from 12 to 24 minutes each. 
5.4.1 Characteristics of Participants from the Sultanate of Oman and Scotland 
There were 24 patient participants from Oman (11 female [46%] and 13 male). There was 
some diversity in backgrounds: 20 Omani, two Egyptians, one Pilipino and one Moroccan. 
The eldest participant was 50 years old while the youngest was 22 years of age. The 
majority of the participants in Oman were non-drinkers and non smokers; only one 
Philipino was a drinker - there was one ex-smoker and one current smoker. Professionally, 
those participants were from various backgrounds: administrator, chief executive officer, 
students, policeman, private business owner, practicing nurse, and they represented both 
rural and city inhabitants (Table 5.1). 
In Scotland, there were again 24 patient participants (15 female [63%] and 9 male). A third 
reported ‘non-Scottish’ country of origin. The age range was between 56 years to 24 years 
old. Among these, five were current smokers, eight were ex-smokers, and 11 were non-
smokers. Out of the 24, 14 were alcohol drinker and 10 were non-drinker. The participants 
came from different back grounds, 12 were not working, six had manual and six non-









Table 5.1 Demographic data for participants from the Sultanate of Oman 
 









































































































































































Table 5.2 Demographic data for participants from Scotland 
ID Gender Age Country of 
Origin 
Ethnicity Occupation Tobacco use Alcohol use 





SP2 F 36 Syria Asian Arab Not Working non-smoker non-drinker 
SP3 M 41 Syria Asian Arab Not Working non-smoker non-drinker 
SP4 M 37 India Asian Indian Non Manual ex-smoker non-drinker 
SP5 M 57 Scotland White 
Scottish 
Manual ex-smoker drinker 
SP6 F 56 Czechia White Czech Manual current 
smoker 
non-drinker 
SP7 F 72 Scotland White 
Scottish 
Not Working ex-smoker non-drinker 
SP8 F 27 Scotland White 
Scottish 
Manual non-smoker drinker 
SP9 M 46 Scotland White 
Scottish 
Manual ex-smoker drinker 
SP10 F 40 Italia Black Italian Not Working ex-smoker drinker 
SP11 F 28 Scotland White 
Scottish 
Not Working current 
smoker 
drinker 
SP12 M 54 Scotland White 
Scottish 
Manual ex-smoker drinker 
SP13 F 67 Scotland White 
Scottish 
Not Working current 
smoker 
non-drinker 
SP14 M 67 Scotland White 
Scottish 
Not Working ex-smoker drinker 
SP15 F 65 Ireland White Irish Not Working non-smoker drinker 
SP16 M 69 Scotland White 
Scottish 
Not Working non-smoker non-drinker 
SP17 F 44 Scotland White 
Scottish 
Not Working non-smoker drinker 
SP18 F 44 Deutschland White Dutch Non Manual non-smoker drinker 
SP19 M 34 Scotland White 
Scottish 
Non Manual non-smoker drinker 
SP20 F 32 England African 
British 
Non Manual non-smoker non-drinker 
SP21 F 72 Scotland White 
Scottish 
Not Working non-smoker non-drinker 
SP 22 F 32 Scotland White 
Scottish 
Non Manual non-smoker non-drinker 
SP 23 F 49 Scotland White 
British 
Non Manual ex-smoker drinker 
SP24 F 65 Scotland White 
Scottish 





5.4.2 Frequency of Dental Clinic Visits and Reasons for Attending 
Participants were asked about the frequency of their dental clinic visits in the last five 
years and the reasons for their visits. In Oman, the majority had visited the clinic between 
2-4 times over five years. Those visits were reported to be mainly for general check-ups 
and / or follow up, as well as scaling and polishing (oral hygiene). One dental patient 
reported that the purpose for their dental clinical visit was for an implant. In contrast, the 
majority of the participants from Scotland visited the dental practice twice a year for each 
of the last five years. Similar reasons were reported for their visits, mainly being check-up 
/ routine dental appointments.  
In general, this reporting of attendance for routine check-ups is a facilitator to opportunistic 
COE, that is patients presenting for pain / treatment needs only would negate some 
opportunity for routine checks or checks targeted based on risk factors.   
5.4.3 Knowledge of Oral Cancer Causes   
On a scale from “no knowledge” to “very good knowledge”, 9/24 ( 37.7% ) of dental 
patients (one Egyptian, one Philipino, and seven Omanis) reported  “no knowledge” about 
the causes of mouth cancer, while 11/24 (45.8%) of patients (one Egyptian, 10 Omanis ) 
reported “slight/little knowledge” about mouth cancer causes. Three patients (12.5%; one 
Moroccan and two Omani) had “some knowledge” and just one Omani patient reported 
“good knowledge” (nobody reported “very good knowledge”). In contrast to the Oman 
participants, Scottish patients reported slightly better knowledge in relation to the causes of 
mouth cancer, and related that this came mainly from media sources. Two patients 2/24 
(8%) said they had good knowledge, 20/24 (83%) reported having “slight/little knowledge” 
and only two female patients 2/24 (8%) reported having “no knowledge”. As reported, 
dental visits were more frequent in Scotland which may be seen to be in accordance with 
this higher self-reported knowledge. 
5.4.4 Experience of COE 
Patients were asked if anyone from the dental team checked them for mouth cancer inside 
the mouth (by retracting the cheeks, pulling the lower lip, grasping the tip of the tongue 
and looking at the posterior lateral aspect of your tongue). In Oman, the dental patients 
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reported little recall of experiencing a conventional oral examination of the tongue / mouth 
when they received dental care:  
“No, pulling the tongue they are not doing”. (OP12) 
“No, they are not doing like this, they’re seeing for the, I don't know what they call...?” 
(OP12) 
“Never, all my life they didn’t do like this” (OP 15)   
“Frankly, no.  They were just focusing on my teeth only” (OP 18) 
 
There was a broadly similar picture in Scotland. Intra-oral checks for mouth cancer were 
reportedly rare. Just two patients said they had received this type of check-up by their 
dentist:  
“[…] He always asks me to stick my tongue out to the left and to the right. Is that 
associated with it?  Yeah” (SP4). 
“I’ve heard about it.  The first time I’d ever heard about it was in this dentist. I’d heard 
about mouth cancer before but the first time I’d ever heard of a dentist giving my mouth a 
check-up was when she lifted up my tongue and she had looked inside my mouth [...] ” 
(SP5). 
 
Findings were similar when patients responded to questions about experiencing or being 
aware of receiving extra-oral examination: 
• Participants from Oman: 
“He did not check outside my mouth” (OP 1). 
“no these things did not happen, she checked my teeth, did the x-rays, she told your tooth 
is broken, and scratches, you need some sets to clean and treat it. but using that gauze and 
checking up and down, not happened”.(OP 5) 
“No, just a general look.”  (OP 13).  
• Participants from Scotland: 
“No, I don't think I've had that, no.” (SP1) 
“I’ve not noticed.  They might have done it, but I’ve just not been aware of it. Or I might 
have just thought they were trying to position my head, so…”(SP3) 
 
Just one patient in Scotland felt they had been checked extra-orally, saying:  
“Aye, I remember her doing all sorts of different things because I was enquiring” (SP5).  
This is in contrast with findings from the previous chapter, whereby this type of check was 
reportedly common. Of course, patients not being aware of experiencing this type of check 
is not in itself a barrier. But it does suggest that raising awareness might prove fruitful, in 
that patient expectation might be a potential driver to professional duty / responsibility.  
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5.4.5 Patient Knowledge  
Having relayed their experiences, patients were asked whether they were aware that they 
could be checked for mouth cancer by dental teams.  
Tables 5.3 and 5.4 show responses from each country for this item, coded by COM-B / 
TDF and then collated in terms of whether they enable (facilitators) or inhibit (barriers) 
opportunistic checks by dental teams. 
 
Table 5.3 Barriers/ facilitators presented by patient knowledge of mouth cancer 
checks in Scotland (B= barrier; F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient knowledge/awareness  
Social opportunity/influence for practitioners (also may affect motivation) 
Some resource (physical opportunity) implication as time would be required to increase knowledge/ 
raise awareness 
CODING SUMMARY 
Lack of patient knowledge indicates a potential barrier for dental professionals, as patients will not 
expect, or request mouth cancer checks and may need more explanation/ information before checks are 
carried out  
 
Question: Do you know you could be checked for mouth cancer by dental team? 
ID Responses  B F E 
SP1 No I didn't know that. x   
SP2 Yeah, I think happy, yeah.  When I know about cancer, 
mouth cancer risk, yeah, in the future, maybe, yeah. 
 x  
SP3 No, just a general check, not for cancer. x   
SP4 No. x   
SP5 [Patient not asked the question]   x 
SP6 Yes, she describes everything.  x  
SP7 No, do you need to ask for that? x   
SP8 [Patient not asked the question]   x 
SP9 [Patient not asked the question]   x 
SP10 [Patient not asked the question]   x 
SP11 I know that, aye, I think so, aye.  x  
SP12 I never knew that, no.  I never knew that, honestly. x   
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SP13 No, I didn’t know that but, as I say, when you’re getting 
your check-up, she does give you a good check-up, but I 
didn’t know that they could do all that... 
x   
SP14 No, I didn’t know that. x   
SP15 No.              x   
SP16 No. x   
SP17 [Patient not asked the question]   x 
SP18 Well I haven’t really been thinking about it, but then my 
mother-in-law was sent for a biopsy [inaudible 15:08], yes 
of course, it makes sense.  Of course they check.  But then I 
hadn’t realised that by sticking my tongue out that’s how 
they do it.   
  x 
SP19 No. x   
SP20 Well, I assumed they would probably know, they would 
notice it because they’re dentists, yes. 
 x  
SP21 Oh, no, no, no, I do believe they do, yeah.   x 
SP22 [Patient not asked the question]   x 
SP23 Yeah, because they ask…when they check you, they ask 
you to move your tongue around and to check all the 
different parts of your mouth, and I assume they’re 
checking for abnormalities, and things like that. 
 x  
SP24 I didn’t, no. x   







Table 5.4 Barriers/ facilitators presented by patient knowledge of mouth cancer 
checks in Oman (B= barrier; F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient knowledge/awareness  
Social opportunity/influence for practitioners (also may affect motivation) 
Some resource (physical opportunity) implication as time would be required to increase knowledge/ 
raise awareness 
CODING SUMMARY 
Lack of patient knowledge indicates a potential barrier for dental professionals, as patients will not 
expect, or request mouth cancer checks and may need more explanation/ information before checks are 
carried out  
Question: Do you know you could be checked for mouth cancer by dental team? 
ID Responses B F E 
OP1 Honestly I don’t know, if I knew I would ask him if he 
could check me for mouth cancer. But thanks to Allah that 
they did clean my teeth and I feel better now. 
x   
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OP2 No I don’t know. I only know the dentist for teeth only not 
for cancer screening.  
x   
OP3 No I don’t know about that, because when we went to him 
just we thought about teeth pain and we don't have 
background about what he does. 
x   
OP4 Of course the doctor know more than the patient, he know 
everything. 
  x 
OP5 Nobody did it unfortunately, …. no they are not doing it x   
OP6 No I dont know, I can't evaluate.. x   
OP7 I don’t know actually, this is my first time hearing this. 
[…] But I don’t know about their ability in doing this 
screening; It’s my first time I hear that they can do that.  
x   
OP8 It depends on the dentist, if he has the experience.    x 
OP9 This is my first time I am hearing this from you. x   
OP10 I don’t know that, this is my first time I am aware about 
this screening.   
x   
OP11 I know he can do it, but at the same time I cannot blame 
him, because of the number of patients waiting outside. 
But if it is part of his role then he should fulfil this role 
completely, and he should not be wary about being behind 
the schedule or late. And we need to be patient. 
 x  
OP12 I don't know. x   
OP13 No, I don’t know. I think just if I ask them. x   
OP14 [Participant not asked the question]   x 
OP15 They can but if they have this information they should do 
it for the patient. 
  x 
OP16 No, no I didn't know, I didn't know.  x   
OP17 I know this […] they put the stick inside and he can open 
your mouth then put a light, the laser and they check only 
like this […]  
 x  
OP18 No, nothing happened. No, this is my first time. x   
OP19 No, I didn’t know that.  Nobody informed me about it. x   
OP20 No. x   
OP21 Yes, I know because the other dentists they know how to 
check but they didn't do for me. 
 x  
OP22 No, I don’t know.  But I think if they could do that it 
would be better. 
x   
OP23 No. x   
OP24 No.  I don’t know. x   







Tables 5.3 and 5.4 show that on balance patient (lack of) knowledge can present a barrier 
to uptake of checks, especially in Oman. This may be important in that the evidence and 
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guidance reviewed in this thesis shows considerable recognition by global associations that 
the scope of practice in primary care has certainly expanded from simple treatment of oral 
disorders to include a demonstrable commitment to standards of disease prevention, health 
promotion, and health maintenance. Patients being unaware of this is a potential barrier to 
address.  
5.4.6 Patient views on acceptability  
Having relayed their experiences and knowledge, patients were asked whether they were 
happy to be examined in this way. Tables 5.5 and 5.6 show responses from both countries 
for this item, again coded by COM-B / TDF and then collated in terms of whether they 
enable (facilitators) or inhibit (barriers) opportunistic checks by dental teams.  
 
Table 5.5 Barriers/ facilitators presented by patient happiness to accept mouth 
cancer checks in Scotland (B= barrier; F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient happiness/ acceptability (could be down to a number of things including previous experience but 
is motivational) 
Social opportunity / influence for practitioners (also may affect motivation and capability – skills in 
dealing with patients who are less accepting) 
Some resource (physical opportunity) implication as time would be required to address reasons for 
patients’ lack of willingness 
CODING SUMMARY 
Patients happiness to accept indicates a potential barrier for dental professionals, as patients may refuse, 
or could require more time, effort and skill before checks are carried out  
Question: Would you be happy to be examined during your appointment? If no, 
why not? 
ID Responses  B F E 
SP1 No I wouldn’t mind aye.  x  
SP2 Yeah, yeah, yeah.  x  
SP3 Yes, no problem, okay.  x  
SP4 Yeah, that’s fine.  x  
SP5 Yes.  Aye.  Yeah.  x  
SP6 Aye, because the earlier it’s diagnosed there is a higher 
chance to recover from it. 
 x  
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SP7 I would feel okay about it, because they're only…you 
know what I mean, they're not giving you jags and all that.  
No, I would be quite happy. 
 x  
SP8 Yeah, because if you were coming for a check-up and it 
was a part of it, yeah, I wouldn’t mind. 
 x  
SP9 Aye, any visit, I don’t mind, aye.  x  
SP10 Yes, it's okay, it's for my own good, it's for my own 
health. 
 x  
SP11 I would feel okay, aye, happy.  x  
SP12 Oh no, I wouldn’t bother.  They may have done it, I’ve 
been unaware.  But I don’t think they’ve done it, but they 
may have done it. 
 x  
SP13 No problem, because, as I say, I’ve not got hardly any 
teeth left.  I don’t mind that because, as I say, the earlier 
you can have something like that, the better. 
 x  
SP14 Aye, of course I would, aye.  x  
SP15 Yes, but I’d rather say myself than you say it to them.     x 
SP16 Yeah, of course, hmm; As long as he doesn’t hurt me!  
I’m a wimp when it comes to pain. 
  x 
SP17 No, I felt reassured because it was the first time it had ever 
happened.  I  didn’t feel as if I had it, I felt as if I was with 
a dentist who was really good at her job, so that was good. 
 x  
SP18 Yeah, totally.  I don’t know whether it would make 
much… 
 x  
SP19 Yeah, I think that’s important, because you can’t skirt 
around these issues, you know.  Ignorance is bliss, but it’s 
not bliss when it’s too late.  So it’s important.  Very 
important. Very happy. 
 x  
SP20 I’d be happy.  x  
SP21 I wouldn't object to that, no.  x  
SP22 To be honest I would trust them to know what they were 
doing.  They’re the professionals. 
 x  
SP23 I wouldn’t mind.  x  
SP24 Hmm.  I’d be very interested, yeah.  x  













Table 5.6 Barriers/ facilitators presented by patient happiness to accept mouth 
cancer checks in Oman (B= barrier; F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient happiness/ acceptability (could be down to a number of things including previous experience but 
is motivational) 
Social opportunity / influence for practitioners (also may affect motivation and capability – skills in 
dealing with patients who are less accepting) 
Some resource (physical opportunity) implication as time would be required to address reasons for 
patients’ lack of willingness 
SUMMARY 
Patients happiness to accept indicates a potential barrier for dental professionals, as patients may refuse, 
or could require more time, effort and skill before checks are carried out  
Question: Would you be happy to be examined during your appointment? If no, 
why not? 
ID Responses B F E 
OP1 Yes nobody know so better for protection.   x  
OP2 It will be good, it will motivate me to take more care.  x  
OP3 No I don’t have any objection, if the checkup makes me in 
healthy situation. 
 x  
OP4 I don’t mind, this is for my benefit and I learn from him.   x  
OP5 Not at all, he is welcome to do the test  x  
OP6 If he did this would indicate that the doctor really understands 
his/her job perfectly and capable and this will gain him/her a 
good reputation when I praise him/her in front of my friends 
and people. 
 x  
OP7 As long as this is a new thing it’s good thing.   x  
OP8 You know, prevention is better than cure, and I don’t mind to 
be checked. 
 x  
OP9 Of course, I don’t mind Because it’s for my health benefit. As 
you know prevention is better than cure. If the dentist explained 
to me what he want to do and why he want to do it for example, 
I will be happy to help them in participating in reducing the 
incidence of this disease. 
 x  
OP10 For sure I will be comfortable for my health benefit.  x  
OP11 I don’t mind, because of my health  x  
OP12 If they are expert in this no problem for me, he is a doctor he 
can do for me what to be done. 
 x  
OP13 For me, better if you check without telling. If he found 
something wrong, better if he tell me, but if first check nothing 
wrong, only check, I wish if they didn’t tell me because of this 
reason. 
  x 
OP14 Yes, of course I would be happy.  x  
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OP15 Yes. I’ll be more happy if I don’t have cancer.  I mean, they 
will tell me if I have or not I have or don’t I have, I mean.  They 
tell me immediately that means I’ll be happy, yes, if I have or 
not. 
 x  
OP16 Yes, I would be happy. If I know this is because of the to know 
if I have something like cancer or anything bad, it is good for 
everyone to do it.   
 x  
OP17 Yes, I'm very happy to receive this and to learn something and 
for the future and for maybe our friend, our family.  […]    
 x  
OP18 I would love to be. I think we should have this kind of check-up 
once a year at least. Well, I think I have to make sure that 
everything is okay with me, so I would love to be checked. 
 x  
OP19 Sure. Just to have the comfort that I don’t have any such 
problems with my mouth and teeth. 
 x  
OP20 Yes, of course. Because it’s a sort of protection now if you are 
telling me that if the doctor checks my mouth cavity for the 
cancer’s appearance; so I assume it could be an early detection 
of any problem, so I would be happy really. 
 x  
OP21 Yeah. Because I know if I have cancer or not. Yeah, to prevent.   x  
OP22 Yes, of course.  Because first of all this will save my life.  If for 
example there is a certain level for having this kind of cancer, 
so I think, yeah, I would be happy and I would appreciate their 
concern about it. 
 x  
OP23 Yes, yes. Yes, because to be in the safe side, as you say in 
Arabic [speaks Arabic]. In English, is that prevention better 
than cure. 
 x  
OP24 Yes, of course. To make sure about my health, and to check if I 
have anything, it will be...it will give me some information. 
 x  







Table 5.5 and 5.6 show an encouraging picture in terms of patient happiness / motivation 
to be checked. There were only one or two slightly equivocal responses with regards to 
being told results or feeling pain. This willingness is an enabler for dental professionals 
carrying out checks and should be fed back to the profession as part of intervention  / 
recommendation (see Chapter 6). 
The next question of interest was to gather patient preferences with regards to OHCPs 
explicitly speaking of the checks in terms of oral cancer.  Professionals in the previous 
chapter reported some worries about introducing and using cancer terminology with 
patients in relation to opportunistic screening - assuming this may not be acceptable to 
patients. Interestingly, this broadly appeared more of a motivational barrier in Omani 
patients. Scottish patients were split on whether they would broadly welcome such 
discussion. Patients were asked to rate their feelings in response to the question “how do 
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you feel about the dental team using the term cancer?” using a 5-point Likert scale from 
not happy at all to very happy.  More than half of the patients from Scotland reported being 
“happy” or “very happy”; no patients from Oman were “very happy” and some were “not 
happy at all”. This is an emotional barrier in Oman, with the psychological impact of the 
term cancer coming through in open-ended responses which are tabulated in Tables 5.7 and 
5.8.   
Table 5.7 Patient views from Scotland on professionals using the term mouth 
cancer (B= barrier; F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient motivation 
Social opportunity / influence for practitioners (also may affect motivation) 
Some resource (physical opportunity) implication as time would be required to facilitate 
communication using different terms if necessary  
CODING SUMMARY 
Lack of patient preference for using the term indicates a potential barrier for dental professionals, 
as patients will be resistant to checks if associated with the fear of the term and may need more 
careful communication or explanation of what is happening before/ during checks.  
Question: How would you feel about dental team using the term “mouth 
cancer check” while examining you?  Why, why not? 
ID Responses  B F E 
SP1 Well, very happy, to me, means, you know, it would 
happen absolutely every time. 
 x  
SP2 It would. It would a wee bit. I’d probably go, oh my 
God, I hope they don’t see anything. It would terrify me 
a wee bit, but I wouldn’t say, oh no, don’t check. Yes, 
I’d be fine. 
 x  
SP3 Because you can’t skirt around these issues, you know.  
Ignorance is bliss, but it’s not bliss when it’s too late.  
So it’s important.  Very important. 
 x  
SP4 I don’t think I’ve got any, so it wouldn’t terrify me, 
‘cause I wouldn’t expect them to find anything. 
 x  
SP5 Very happy   x  
SP6 No, no.  If you’ve got cancer, you’ve got cancer, so 
better to know about it than not. So I’d be fine. 
 x  
SP7 [Not asked the question]   x 
SP8 Well, I think, as you say, the earlier…if they find out 
earlier, there’s a chance of sorting it out.  That’s why, 
yeah. 
 x  
SP9 No, no, cancer doesn’t frighten me anymore, because  x  
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I’ve already had it.  It used to be a big scary thing, but 
some cancers can get cured. […] I had the bowel 
cancer, and when I found out there was a bowel cancer 
they discovered the lung cancer, and they thought it was 
different.  So that’s how I got the lobe took away.  But 
when the pathology came back, they were the same, so I 
was lucky […]  
SP10 No, no.  It’s just a check-up, so I wouldn’t mind.  x  
SP11 Just in case there's something there and I've not noticed 
it, maybe they can, so...aye. 
 x  
SP12 It would scare me, no, no, no, I don't like going for the 
scan or those things, no, no, no. 
x   
SP13 No, it would maybe scare me if I haven’t spoken to you 
but because I know that it's a good idea, yeah. 
 x  
SP14 It wouldn’t bother me because they're trying to look out 
for you and check any early signs. 
 x  
SP15 I would feel okay about it, because they're only…you 
know what I mean, they're not giving you jags and all 
that.  No, I would be quite happy. 
 x  
SP16 Very happy   x  
SP17 Aye, probably a good idea actually.  Obviously to 
detect it at an early stage.  They would know better.  
‘Cause you wouldn’t know you had it, you know, 
myself obviously, if I had something like that. 
 x  
SP18 Happy   x  
SP19 Happy   x  
SP20 [Not asked the question]   x 
SP21 I don’t know.  I suppose it just, sort of, puts the idea in 
your head that there might be…you know, you go to the 
dentist thinking, oh, I hope I don’t have to have dental 
treatment; but then it might make you think of another 
problem that you haven’t thought about. 
x   
SP22 No.  No, it wouldn’t terrify me.  I’d feel more content if 
they did do it, yeah. 
 x  
SP23 Happy   x  
SP24 I don’t know.  I guess just that…  I think I would be 
very happy if it was already something that was on my 
radar.  I think it’s just that it’s something else that I’ve 
not been thinking of that perhaps I ought to, and if they 
started checking for it and telling me, that would be 
absolutely fine […]  
 x  











Table 5.8 Patient views from Oman on professionals using the term mouth cancer 
(B= barrier; F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient motivation 
Social opportunity / influence for practitioners (also may affect motivation) 
Some resource (physical opportunity) implication as time would be required to facilitate 
communication using different terms if necessary  
CODING SUMMARY 
Lack of patient preference for using the term indicates a potential barrier for dental professionals, 
as patients will be resistant to checks if associated with the fear of the term and may need more 
careful communication or explanation of what is happening before/ during checks  
Question: How would you feel about dental team using the term “mouth 
cancer check” while examining you?  Why, why not? 
ID Responses  B F E 
OP1 Yes I encourage to tell the patients, who knows I 
might don’t know about it, and the disease is 
progressing increasing. So better to inform. 
 x  
OP2 I see it difficult, I prefer he do the treatment and the 
check-up without using the word cancer. If he use it I 
might not come back. I will be in doubt about. 
x   
OP3 In the fact the cancer word is create panic inside me 
and our society and it is means for us dangerous 
disease so when the dentist ask us to do this checkup 
and we may feel surprised, because I’m scared it 
might be in me. 
x   
OP4 He should tell, that I am doing this and this, to have 
benefit from doctor. 
 x  
OP5 The word cancer first is a strong word and people 
interact with it and get scared and will guess that 
doctor might saw something, will have periodical 
check , will see the way, the gum, the tongue, without 
using the word! […] Even there is nothing , 
frightening will be there 
x   
OP6 I would prefer if he/she does not mention it, Cause it 
makes me over think when I heard "cancer". 
x   
OP7 I would like him to tell me, it is also ok with me, so I 
can learn from him. At the same time you know we 
have a lot of new diseases which developed recently 
that we never hear about it. So when he tell me it is 
for my own education.  
 x  
OP8 […] I prefer he don’t tell me first. This is the human 
nature- [to] have some phobia. 
x   
OP9 I prefer he use the word “cancer”. Because we are in 
the era that a person should know everything about 
himself. So, he can take care and follow all the 
 x  
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preventive steps with the dentist, this is my point of 
view. There is nothing to be hidden. 
OP10 I prefer he do the check up without telling me what he 
is doing. When he discover something not normal 
then he should explain to me because you know, when 
we hear about these type of disease we get scared and 
feel to faint.  
x   
OP11 It is better if he tell me. It is right that the word cancer 
is big, but it will create awareness specially for young 
generation. You come for something but you will 
discover more things. 
 x  
OP12 Because I am health care worker no problem for me. 
It is normal word because we are screening for 
[inaudible] females for HIV like this for my safety, 
for my health. 
 x  
OP13 Because this disease is not easier, and this word is not 
easier to my ear, I don’t want to know. Because if I 
know, if it’s there or not, directly I’m thinking why, 
why, why. Even if I haven’t. But, you know, this is 
dangerous. So we didn’t accept it ourselves. Not 
happy. 
x   
OP14 I prefer, because I prefer to tell that.   x  
OP15 Well, yes, why not?  They said sometime…they 
should…I think so depending on the patient.  Some 
patient they don’t like they hear about their cancer.   
 x  
OP16 Not nice, not nice. Because I think if they can use 
another word like we will check if there is any cysts 
or anything […] because many of the patients they 
don't have idea of this, they thought maybe he saw 
something so because of that he said.  So they will 
start to think and psychiatrically they will think I have 
this thing. 
x   
OP17 […] word cancer it should be. Yes, yes.   x  
OP18 You can say happy. Well, at least I’m going to feel 
like they’re taking enough care of me. 
 x  
OP19 Maybe I would be like worried at the beginning, but 
afterwards…  I mean to do it, it would be fine. I mean 
it will just comfort me, because in case if I have it I 
might have to…I might need to be treated.  […] So I 
don’t mind.  It might be scary but it’s better to know 
than…earlier than to know later, you know. 
 x  
OP20 Yeah, I think it…it is quite heavy to digest when 
someone says it’s a cancer check up, or just cancer 
check up. Yeah. But I believe it has to be maybe in a 
different way where maybe the patient shouldn’t 
know much about it and it comes as a routine check 
up while doing a routine filling or whatsoever, rather 
than saying a cancer; because I don’t know other 
countries how they feel it, but maybe as Middle East, 
we are in Middle East, they feel it quite heavy to just 
tell them that it’s a cancer check up or something like 
that […]  
x   
OP21 Not sure. Because I’m not sure because it’s just tricky   x 
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and then I’m not sure also if I have cancer.   
OP22 […] I think I would say happy, I would be happy, 
yeah. Although it would scare me I would be happy 
because I know that the doctor’s doing his job and 
taking care of his or her patients.  So this would also 
make me feel comfortable that they are taking care of 
me and that’s why. 
 x  
OP23 Not sure.  Maybe first I will scare about the word 
cancer, but I want to check because this is better for 
me. 
  x 
OP24 I’m not sure really, but I think the word cancer is a 
difficult word to accept, so it’s...I feel I will not be 
happy. 
Because cancer is fearing, you know, when 
you...it’s...I don’t know how to say, but it’s...it’s not 
easy word to accept or to feel you are fine, it makes 
you worry about your health, so that why, or maybe 
we prefer not to hear this word. 
x   







Tables 5.7 and 5.8 show that most patients in Scotland are willing to be informed by the 
dentist that oral screening for cancer is taking place. This is an enabler that can motivate 
the dentist to carry out checks and speak openly to the patient about it. In contrast, over 
two fifths of Oman responses indicate a preference not to be informed about cancer 
screening directly based broadly on fear of the disease and negative connotations of the 
term.  
So, while patients in Oman and Scotland were happy to be examined systematically, there 
are mixed responses in terms of having explicit cancer discussions. Especially in Oman 
there is a general preference that OHCPs do the examination but not use the word “cancer” 
in front of the patient. This is a potential barrier – as professionals have a duty to a) explain 
what they are doing and b) ask patients if it is acceptable. This is an implementation barrier 
in the social influence / opportunity sphere that can potentially be addressed (see Chapter 
6). 
Finally, patients were asked about the acceptability of professionals using a risk prediction 
tool for targeting those at high risk of oral cancer for preventive care and interventions. A 
number of such tools have been developed to be used in the clinical settings for predicting 
cancer risks in individuals (Kim et al., 2004; Weber et al., 2017). Patients were presented 
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with the example of a prototype tool developed by the INHANCE network (INHANCE, 
2018). 
Overall, dental patients participating in this study responded positively to areas probed by 
the researcher using the INHANCE tool as an example. Having said that, dental patients 
from Oman once more had cultural concerns (social influences) for some types of 
questions (in reference to smoking and drinking). Scottish patients generally saw such 
tools as acceptable, with one patient being concerned about the insurance implications of 
disclosing health behaviours (these are motivational barriers or facilitators).  
Both patient groups felt they might on balance prefer to go through a risk prediction tool 
with the dentist (i.e. through direct communication) rather than fill it in themselves e.g. 
electronically in the waiting room. They felt this would essentially serve their overall 
treatment plan better in the long run, avoid unexpected technical issues using applications, 
and ensure they could obtain clarification directly from the dentist for unclear questions if 
the need would arise. Whilst understandable, this is a potential barrier in terms of the time / 
resources available to the dental team, who would generally prefer some way of expediting 
less demand on the consultation time itself, although accuracy could be an issue of self-
completed by patients.  
Patients were asked how they would prefer the risk level to be presented, with some 
indications for a ‘traffic light’ system (red, amber, green):  
“It’s more clear. It explains exactly where I am. Percentage might tell you exactly where 
are you, but here might be some mistake. But if I belong to low category there must be a 
range that I belong to that” (OP7) 
“The traffic light: I’m quite attracted to the traffic light system. When I was working, I 
introduced a scheme to monitor repairs, and it was a traffic light system we used, so traffic 
light system is quite a good idea” (SP6) 
Others preferred a basic number / percentages as more acceptable due to ease of 
interpretation, clearer measurement, and the ability to see changes over time (e.g. a 
worsening):  
“..So if we talk about colours -  how much in red? How much in yellow, how much in 
green. So, percentage is more clear” (OP5). 
“Maybe because the percentage is different than other category. May be with category I 
feel I am at risk, but with percentage I can measure myself were I am out of one hundred 
and I will take better care of myself” (OP3) 
“Traffic lights or a high/low risk factor is quite ambiguous.  Doesn’t really tell us too much 
but a risk factor…a percentage, you could really…you know, if it was under a certain 
157 
 
percentage, you would say, well…it gives you something to work to, to the next time you 
were to score it.  Whereas a traffic light system might not reflect that. Whereas a 
percentage, you could go up from 25 per cent to 33 per cent the next visit and you’re like, 
I’ll need to make further changes.  It, kind of, creates a pattern.  It tells us, you know, take 
it down” (SP3) 
“It would just be easier to gauge” (SP13). 
Coded answers on whether patients were happy to be risk graded based on their social 
history are shown in Tables 5.9 and 5.10.   
 
Table 5.9 Perceptions on having a risk score from Scottish patients (B= barrier; 
F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient preference/motivation  
Social opportunity / influence for practitioners  
CODING SUMMARY 
Lack of patient acceptance indicates a potential barrier for dental professionals, as patients may be 
more collaborative re. their care if they know their risk level   
Question: How would you feel about dentist telling you a risk score as high, 
medium, or low for mouth cancer based on your personal information – e.g. 
smoking, alcohol, age, years of education, family history? 
ID Responses  B F E 
SP1 Oh I'd be fine if they were doing that.  x  
SP2 Hmm…high, medium and low.  High, medium is good.  
High, medium. 
 x  
SP3 Yes, no problem.  x  
SP4 Yes, I think it would be helpful.  x  
SP5 Aye, it’s alright receiving it, but it’s…you might not have 
it.  You could be a smoker or a drinker and never get 
mouth cancer.  And the other way about.  You could have 
smoked and drink all your life and still not get it.  So…I’d 
be okay to receive it, aye.  Yeah. 
 x  
SP6 She doesn’t want to know so she’s not happy about it. x   
SP7 If I needed it? If I was at risk, yes, I would take…Happy.  x  
SP8 Yeah, I probably would be happy if they did some sort of 
risk score to make you maybe a wee bit more aware of 
your chances of getting it. 
 x  
SP9 I'd be happy.  x  
SP10 Oh no- if I'm not included it's okay, but if they say I may, x   
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then I don't want any bad news. Not happy somehow. 
SP11 Aye, okay, no bother.  x  
SP12 Aye, I’m happy with that as well.  x  
SP13 I think that would be a good thing. You know, if I go out 
one day a week, this is an extra day for me, so no, I 
would...I think it would be a good thing. I would be happy 
for them to do that. 
 x  
SP14 It wouldn’t bother me, aye.  x  
SP15 Fine, yes.  x  
SP16 No problem, no.  That would be fine.  x  
SP17 I don’t think that would even effect my…I think it would 
be really positive.  I think that the more people that are 
smoking…we live in the west of Scotland and it’s a real 
drink culture and alcohol as you know…so I think it would 
be really positive, especially if you’re saying it to children, 
you know, teenagers, you know, and it starts to maybe 
make them think when they come to the dentist about their 
teeth and stuff. 
 x  
SP18 Well, yeah, risk scores, I would want to know but I 
wouldn’t want the insurance companies to know.  What 
gets done with this information if you get the risk score 
and it gets written down […]? 
  x 
SP19 Because I think it’s important for people to find out, you 
know, and just be aware that mouth cancer is an issue.  
And also if there is a risk, then it would be advisable or 
if…even if there was maybe a visible sign of mouth 
cancer, then I think it’s perfectly within the rights of the 
dentist to tell the patient to stop drinking or smoking or 
doing whatever.[…]  
 x  
SP20 I think I’d be happy, it would be fine. It won’t bother me 
in any way, no. 
 x  
SP21 […] Make you feel better, if you knew you were, you 
know, you were at low risk. 
 x  
SP22 I would be absolutely fine about receiving that.  […]  Yes, 
I think if you’re going to give someone a score, 
particularly if you tell them that they’re at high risk, you 
would want some kind of reassurance after that that you’re 
at high risk, so from now on during your check-ups we 
will check for that as well if we’ve got your permission, 
that kind of thing.  I think that would be really good.  But 
on its own it might just be, oh dear, this is something else I 
have to worry about. 
 x  
SP23 Oh well aye.  I wouldn’t say that I would be happy but I 
wouldn’t be like not happy.  I wouldn’t be over sure either 
because it is a good thing.  I would say in between not sure 
and happy […] Oh I'd be fine if they were doing that. 
 x  
SP24 Yeah, I’d be quite happy, I suppose, receiving a risk score, 
yes. 
 x  









Tables 5.9 and 5.10 show coded data indicating that the participants from both settings 
broadly welcomed the idea of having a risk score or a risk-level categorisation based on 
social history / modifiable risk factors. This could be an important driver for preventive 
care and a social facilitator towards conducting clinical oral examinations.  
Patients were finally asked whether they would be happy to visit the dentist for a mouth 
cancer check more often than normal (3-6 months) if deemed to be at high risk.  
 
Table 5.10 Perceptions on having a risk score from patients in Oman (B= barrier; 
F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient preference/motivation  
Social opportunity / influence for practitioners  
CODING SUMMARY 
Lack of patient acceptance indicates a potential barrier for dental professionals, as patients may be 
more collaborative re. their care if they know their risk level   
Question: How would you feel about dentist telling you a risk score as high, 
medium, or low for mouth cancer based on your personal information – e.g. 
smoking, alcohol, age, years of education, family history? 
ID Responses B F E 
OP1 Well, it is okay, he is the doctor and specialised 
so…..okay. 
 x  
OP2 I don’t mind to share my information, for my benefit.  x  
OP3 [It] means he will give me which category I belong… 
means if it’s low or high or medium. I think its ok to 
me…. I’m happy...  so happy 
 x  
OP4 Its good actually … Sure not. I don’t mind … they are 
only questions.  
 x  
OP5 No problem for me  x  
OP6 Well, since there is something in the favour of the patient 
and all this in order to come up invent or discover a cure 
for a better health, I would be happy in providing the 
right answers. 
 x  
OP7 No problem.. it is a research to help people, I don’t mind.   x  
OP8 No problem and I will not object, but again it depend on 
person  
 x  
OP9 Honestly, If he tell me that I belong to low risk group, I 
will be happy and I will take care and maintain my health 
 x  
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status. If someone at higher risk, I think he will try to 
prevent himself from that by trying to reduce smoking for 
example. 
OP10 Ya, no problem, I accept it  x  
OP11 I think its good thing, as it will help them and guide them 
to know what to do with the patient. 
 x  
OP12 They will be aware where they are from the cancer.  x  
OP13 Happy. Because I want to know the information and I feel 
they’re honest with me. If this affect, I like it or not, but 
the truth is should I know it. Yes. And I want to know the 
ways how I protect myself and protect my kids. I have 
three kids, so I should know all information. I like it. 
 x  
OP14 It’s good to inform me and to warn me. Warning in this 
kind of things is good. 
 x  
OP15 I’ll be happy if I don’t have…I will not get cancer.  I’ll be 
much happy. 
 x  
OP16 For me, I will be happy. Because now nobody care about 
the patient when they go to the hospital and mention with 
them these things.  So if the doctor say after the check-up 
and everything and tell me after asking about tobacco and 
this and tell me if you have risk to have this and this it is 
good for me, because I will feel his care and his - not like 
I'm going only for remove the teeth, I'm going and go out.  
So I feel it is very good, yes.  
 x  
OP17 Very happy, very happy. […]   x  
OP18 I would be happy, it’s okay. […]   x  
OP19 Yeah, sure.  I don’t mind….Yeah, I’d be very happy to 
know that I’m low risk….And if I get high I’d be upset.  I 
mean I’d be sad if they tell me I’m high score….That 
means I am sick and I’m at risk, a high risk…..Yeah, it is 
good.  It’s a good…  It gives me some indication, you 
know, somehow to know that what is my level or my 
chances of having cancer or having some sickness. 
 x  
OP20 Yeah, I’m very happy because, as I told you, that it’s 
going to be good too for precaution. 
 x  
OP21 Because I’m sorry maybe I’ll become happy. Because I 
know which is...if I have a medium or high or low group 
of cancer like that. Because it prevents...it prevents the 
cancer. 
 x  
OP22 Not sure.    x 
OP23 I will be happy, because it is better to know before the 
distance, so what the...will be...do about me, and for what 
will check. 
 x  
OP24 I think yes, and because it’s a type of knowledge which 
the patient should know and show, based on that thing he 
can feel what is the riskiness about his health, so I think 
it’s good to know this information. 
 x  









Table 5.11 Views on visiting the dentist every 3 to 6 months if high risk- Scotland 
(B= barrier; F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient preference/motivation  
Physical opportunity / resource issue for practitioners  
CODING SUMMARY 
Lack of patient attendance is an opportunity barrier  
Question: Would be happy to visit the dentist for a mouth cancer check more 
often (3-6 months) if dentist told you were at higher risk? 
ID Responses  B F E 
SP1 Oh aye.  Oh if I was at high risk I'd be back every day.  x  
SP2 Yeah, yeah.  x  
SP3 Yes, no problem.  x  
SP4 Yeah, I would do that, yeah.  x  
SP5 Oh probably more, yeah.  Aye. Every three months 
probably.  Aye.  Just to keep on top of it.   
 x  
SP6 [Patient not asked the question]   x 
SP7 Uh-huh.  x  
SP8 Yeah, I would do that if I was a high-risk, yes.  x  
SP9 Yeah.  x  
SP10 It would be difficult, I don't like visiting, it scares me a 
lot, yes, that is why I just this time with my teeth, it 
would be difficult I think. 
x   
SP11 Aye, maybe, aye.  x  
SP12 Yeah.  x  
SP13 Well they probably would recommend it.  If they 
recommended it, then I would just say that’s fine... 
 x  
SP14 Yes, aye.  x  
SP15 Yes.  x  
SP16 I suppose it depends on if you’re high risk, how long it 
takes to identify.  I mean, if I was at high risk of 
cancer…Yeah, come more often, yeah. Yeah, yes, I 
would think so, yes.  More often than the normal six 
months […] 
 x  
SP17 Aye, you would definitely be coming back more often, 
aye. 
 x  
SP18 If I was told I was at high risk, then yes.  x  
SP19 Oh yeah.  Increase…definitely increase the 
[appointments] to whatever’s…you know, affordable… 
 x  
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SP20 Yes, of course. I would, yes. I would, because I’d be 
worried… 
 x  
SP21 If that was absolutely...yeah, I would do that, no 
problem, if that was what was necessary. 
 x  
SP22 Well I try and make sure that I come every six months 
and I guess… 
 x  
SP23 Possibly, but I suppose that I would leave that up to the 
dentist to decide.  It’s not something I would know. 
Yeah, yeah, hmm. 
 x  
SP24 Yeah, yes.  x  







Table 5.12 Views on visiting the dentist every 3 to 6 months if high risk- Oman (B= 
barrier; F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient preference/motivation  
Physical opportunity / resource issue for practitioners  
CODING SUMMARY 
Lack of patient attendance is an opportunity barrier  
Question: Would be happy to visit the dentist for a mouth cancer check more 
often (3-6 months) if dentist told you were at higher risk? 
ID Responses B F E 
OP1 Yes I can come- as a doctor said every 3 to 6 month, or 
once yearly no problem as long as I don’t get the 
disease and it spread out.  
 x  
OP2 I will come, no problem   x  
OP3 Yes I agree  x  
OP4 I don’t mind, we need to follow up if we are in high risk 
and vies versa.  
 x  
OP5 I will come , I have it in my genes , the reasons is there , 
my percentage is 100% , I have to stop smoking and 
drinking this might reduce the percentage about 75 %,  
 x  
OP6 Yes I would visit, its for me  x  
OP7 That’s correct, as long as I am in low risk then its fine.   x  
OP8 If the person is honest with himself and have a proper 
lifestyle and I think he will come to clinic. As cancer is 
dangerous disease and treatment is expensive, so person 
must come. 
 x  
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OP9 Its excellent, I think it motivate us to take care of 
yourself.  
 x  
OP10 I …will accept that for sure.   x  
OP11 I think if the person in low category 12 month is too far. 
I see three to six months also too far for high risk 
patient it should be shorter duration for both categories.  
  x 
OP12 Every six months I will come, every three months I will 
not come. 
x   
OP13 Yes, I feel comfortable.  x  
OP14 Yeah. I’d prefer not to visit the doctor every six months.   x 
OP15 Definitely, everyone will come.  Yes, and the drinkers 
[18:04] they’ll come 
 x  
OP16 Yes, I feel it is very nice and because now in our 
country or in our primary health careit is crowded, they 
don't have appointments […] but if they know they will 
do this cancer check-up or like that, they will be happy 
[…]  
 x  
OP17 Yes, I'm happy because to checking every three or 
five/four months is, I'm very happy.  
 x  
OP18 Okay.  Yes, it’s good.  x  
OP19 Sure.  I should.  It’s not about being happy or not 
happy.  I should do it and it’s something I have to do 
until they make sure I am healthy. 
 x  
OP20 Yes, I do agree with that also, because as the risk 
becomes higher then you need to, what I mean, appear 
more frequently. 
 x  
OP21 Yeah, it’s okay also. Because I have and then must do 
check-up and then they know what we’ll do.  
 x  
OP22 Of course.  Because I would like to feel like...how can I 
say?  To feel that the progressive treatment is better and 
the condition is getting better, you know.  So I think, 
yeah. 
 x  
OP23 Yeah, of course, but I think it is long, long time.  Yeah, 
I think it is- it must be more short.  Maybe one to two 
month. I think it will be comfortable for the patient, 
yeah, to make sure about the cancer. 
 x  
OP24 Yeah, I’m fine, yeah, as long as it give me...give me 
like a report or something about my health, I’m fine, 
yeah.  I’m happy to...to get. 
 x  











It is clear from the tables above that patients from both settings have no objection in 
principle to attending the dental practice every 3 to 6 months if scored as high risk.  
Failure to attend can be problem for preventive appointments / check-ups in general, and 
evidence for frequency of recall is somewhat equivocal - so more research is needed to see 
if stratification of patients by risk is feasible and appropriate. A similar question was asked 
about less frequent check-up visits for low risk.  
 
Table 5.13  Patient views on visiting the oral health care setting every 12 months or 
2 years if low risk; Scotland (B= barrier; F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient preference/motivation  
Physical opportunity / resource issue for practitioners  
CODING SUMMARY 
Lack of patient willingness is an opportunity barrier as in places a burden on services so that 
high risk patients cannot be targeted  
Question: Would be happy to visit the dentist for a mouth cancer check 
less often (12 months or 2 years) if dentist told you were considered at low 
risk? 
ID Responses  B F E 
SP1 Still come in because you still need to look after 
your teeth. 
x   
SP2 Yeah.  x  
SP3 Yes, no problem, six months, a year, okay.  x  
SP4 Yeah, maybe less than that, once in a year.  x  
SP5 Less, I would say.  Once a year.  Aye.  x  
SP6 [Patient not asked the question]   x 
SP7 Once A year.  x  
SP8 I'd probably just come in as normal routine, 
because if there wasn’t really a higher chance then 
I'd just come on a basic routine, so I would. 
x   
SP9 Maybe once a year if it's low-risk.  x  
SP10 I may come once in a year, it depend, if I have to, I 
will come, if I don't I will not come, I will not. 
 x  
SP11 Aye, if I'm low, aye.  x  
SP12 I should actually visit the dentist more often   x 
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anyway in a year, but…I would go more often I 
think if I had any problems.   
SP13 Oh no, I think I coming every six months.  Well I 
only have hardly any teeth but my granddaughters, 
and my daughter, and my grandsons all come to 
this practice, and they’ve got perfect teeth, and I 
think if they come at least once a year, but I think if 
they’re maybe at a wee bit of risk, every six 
month’s a better time. 
x   
SP14 Yeah, I think it's six-monthly anyway, check-ups, 
so I think they could do it then, couldn’t they? 
  x 
SP15 I’d want to continue coming every six months. x   
SP16 Yeah, less often.  Yeah, once a year would be fine, 
yeah. 
 x  
SP17 I don’t think life works like that; I don’t think if 
somebody tells you that you’re low risk for 
something that you don’t need to keep getting 
checked – that’s not how it works. 
So I think most people know that if you’re at low 
risk it might mean you’re not at risk of getting it 
but it’s not a guarantee. 
x   
SP18 Then I still come for my check up every six 
months, theoretically. 
x   
SP19 Yeah.  I think that’s…I mean, I think that’s the 
same with most other cancers.  You know, 
it’s…like, if there’s a risk then…or there’s no risk 
[…]  
  x 
SP20 If I was low risk I would just do what I usually do, 
like the twice a year. 
x   
SP21 Yeah.  I mean, I would have to trust the dentist, 
there, them saying to me, you'd be better to have it 
done every whatever it is.  If it's a yearly, that's 
fine, I would trust the dentist to do that, you know, 
I wouldn't be able to maybe make that decision. 
 x  
SP22 Well normally you come for check-ups every six 
months to a year, so I think if they just did it as part 
of your normal check-up then that’s fine.  And I 
suppose they’re the experts, and if you’re at low 
risk then perhaps they don’t need to do it as often. 
 x  
SP23 I still prefer to come to the dentist twice a year at 
least, because…I don’t know, I just think it’s good 
to keep, for me, anyway, to keep coming, to keep 
familiar with being in the dentist’s chair, you 
know, because I get very nervous about it. 
x   
SP24 No, I prefer coming every six months to get the 
check-up. 
x   










Table 5.14 Patient views on visiting the oral health care setting every 12 months or 
2 years if low risk; Oman (B= barrier; F= facilitator; E= equivocal response) 
 
COM-B/ TDF CODING 
Patient preference/motivation  
Physical opportunity / resource issue for practitioners  
CODING SUMMARY 
Lack of patient willingness is an opportunity barrier as in places a burden on services so that 
high risk patients cannot be targeted  
Question: Would be happy to visit the dentist for a mouth cancer check 
less often (12 months or 2 years) if dentist told you were considered at low 
risk? 
ID Responses B F E 
OP1 Yes I can come. as a doctor said every 3 to 6 
month, or once yearly no problem as long as I 
don’t get the disease and it spread out.  
 x  
OP2 I would like to come, but I prefer every 6 months. x   
OP3 Yes- because I will detect the disease early and 
avoid any thing may happened and I can treat 
myself early by any easy way they will give me as 
treatment to protect myself from it.  
  x 
OP4 I don’t mind, we need to follow up if we are in 
high risk and vice versa.  
 x  
OP5 It is ok, I might not come. I will be relaxed cause I 
don’t have it, but if I have high percentage I will 
come. 
 x  
OP6 Yeah but it isn't just for cancer, it's for prevention. 
so if I don't have to visit the doctor for cancer it is 
understandable but that doesn’t mean that I have to 
stop visiting the doctor, additionally I have to visit 
the clinic every couple of months. 
x   
OP7 As long as I don’t have risk factors I can come 
every 24 months.  
 x  
OP8 It’s a good idea. I will come.   x  
OP9 Its excellent, I think it motivate us to take care of 
yourself. 
 x  
OP10 Yes I will come, …. I would be happy  x  
OP11 I think if the person in low category 12 month is 
too far. I see three to six months also too far for 
high risk patient it should be shorter duration for 
both categories.  
  x 
OP12 Check up...cancer check-up, no problem for me, I 
will come. Twice yearly I will not come, yearly... 
 x  
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OP13 I feel comfortable, it’s okay, because a long time 
between visit and visit. So we have another life 
outside clinic, it’s okay for me. It depend the point. 
 x  
OP14 Yes.  x  
OP15 Yes, sure.  x  
OP16 Yes.  x  
OP17 No, I'm not happy because it's too long. Well but I 
can't see another way, yes, because 12 months is 
too long.  
x   
OP18 Okay.  Yes, it’s good.  x  
OP19 Yeah, I think once a year is the least that each 
person should do it.  You know, I need a check-up 
just like anything…everything else like medical 
check-up.  If it’s not twice a year, it should be once 
a year, but not every two years as I think it’s a long 
period of time. 
  x 
OP20 Yes, that’s fine. I think if I am in low risk, 
annually, once, that’s fine. Yeah. 
 x  
OP21 It’s okay no problem, just to prevent.   x  
OP22 Yes, I would be happy.    x  
OP23 But easy to forget the appointment in 12 month, I 
think. It’s a good, great. 
 x  
OP24 Yeah, it’s okay as well, but maybe it’s better to...to 
do regular check, and less...lesser duration...less 
than 12 months.  Every six month will be better. 
x   







It is clear from Tables 13 and 14 above that patients from Scotland have more concern 
about waiting longer between appointments (professionals were similarly concerned). In 
Oman the view was more to trust the dentist and come less frequently which is an enabler 
to free up time and resources; again, more research is needed to see if stratification of 
patients by risk is feasible and appropriate.  
5.4.7 Barriers / Facilitators to being Checked by Opposite Gender OHCPs 
The social norm (social opportunity element) was also explored with respect to being 
examined by professionals of the opposite gender. As might be expected, Scottish dental 
patients had no objection to be treated and /or screened by any oral health professional of 
opposite gender as long as they were professionally competent: 
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“Oh yes, I’d understand that. For this country, fine, but everybody has their own cultures. 
So…” (SP7) 
“No, I wouldn’t bother. Male or female, it doesn’t bother me”(SP 11) 
“No problem.  Female, no problem, okay” (SP 19) 
“As long as they’re professional I don’t mind at all.  It’s…  Yeah, it doesn’t bother me” 
(SP24) 
Oman in contrast has a culturally oriented health care system, whereby patient and health 
care provider relationships are based on mutuality of predetermined social norms which are 
essential for overall quality patient care. Culturally and socially influenced norms affect all 
oral health care dental practitioners’ initiatives and behaviours including their performance 
of standards of screening practice. Thus, there was a mixed response; patients on the whole 
felt a same-gender examination would be preferable if possible. Below are some quoted 
responses from Omani patients:  
“Because relating to our culture I don’t like any male to touch my neck area” (SP 23) 
“We are as a conservative Islamic country. we are in touch with our religion, especially 
those villages in Aldakliah not in the coast “ (OP5) 
“If the dentist can palpate my head at the top my head cover its fine, but if he needs to 
expose my neck area and head, no, if my head is exposed its difficult.  “(OP5) 
“I think what is good for her health she has the right to do it. May be a female dentist will 
not be there but I prefer a female dentist” (OP10) 
“Well, in medication we should not bring our religions in a medical area, or our culture in 
with a doctor. Medication is something different than culture or religion; and it is a part of 
religion and a part of culture, and a part of morality as well” (OP 14) 
It is important to ask such questions. Whilst these interviews were with a population in an 
Islamic country, dental care worldwide employs a diverse workforce and serves patients 
from culturally diverse backgrounds. Such barriers as observed here are rarely addressed 







High oral health awareness and knowledge about oral cancer may facilitate early detection 
of lesions by practitioners in that patients will attend practice for checks and be amenable 
to checks being carried out, and discussions about social risk factors. This study 
highlighted a lack of awareness among the participants mainly in Oman, but generally 
showed a higher awareness among patients in Scotland. This is in agreement with findings 
in other studies which have investigated public awareness in different countries such as 
UK, India, Australia, Malaysia, and Turkey (Peker et al., 2010; Ghani et al., 2013; 
Formosa et al., 2015; Joseph et al., 2016; Conway and  Purkayastha, 2018). 
In Oman, lack of awareness about oral cancer may be partially explained by the low 
incidence of the disease (Chapter 1). Lack of awarenesss of oral cancer has previously 
been linked to low population incidence of the disease (Warnakulasuriya et al., 1999).  
The media profile of mouth cancer may also be a differential. In Oman, mass media focus 
on other types of cancer which have a higher level of incidence in the country, such as 
thyroid and breast cancer (MOH, 2019). In Scotland, patients reported that the main 
sources of their awareness and knowledge about oral cancer was the media (e.g. television, 
newspapers / magazines) which is similar to reports from other studies conducted in other 
countries such as UK and USA (Warnakulasuriya et al., 1999; West et al., 2006; Choi et 
al., 2008).  
It was interesting to find out that patients in both countries were generally unaware that 
screening can be part of their treatment or the OHCPs’ role. Other responses indicated that 
many patients are unaware if / whether oral cancer screening is taking place. While the 
COE might be adopted as a standard of care in dental settings in Scotland, like other 
countries (Gustavo et al, 2005), the practice is not communicated efficiently with the 
patients. Similar finding were also reported whereby dentists in the US were found not to 
be exchanging information with the patients while performing a COE (Choi et al., 2008).  
Professionals have a role to play in making sure patients consent to and are aware of the 
benefits of a COE (see Chapter 4). Many studies have assessed the screening practice for 
oral cavity cancer among oral health care professionals (Seoane-Lestón et al., 2010; 
Suresan and Vijay Kumar, 2012) and unfortunately reported lack of confidence and / or 




There were few barriers to being examined, but some Omani had issues with regard to 
gender. Data on cultural issues in the dental team-patient relationship have been slow to 
emerge (Butani et al., 2008). There are understandings of needs of Islamic patients in 
nursing (Blankinship, 2018) and some work in medicine speaks of ‘cultural competencies’ 
(Ezenkwele and Roodsari, 2013); various studies have described, for example, how 
patients prefer ethnically and dialectically matched dental providers (Wang, 2007). Attum 
and Shamoom cover a number of current issues affecting Muslim patients and conclude 
that “During a physical exam, it is desirable to have the health care professional of the 
same sex.” (Attum and Shamoom, 2020). 
In Scotland there was less of a barrier or ‘taboo’ in using the term cancer when conducting 
checks than in Oman. Previous work for example in Iran shows this is a ‘taboo’ subject, 
with important negative effects (Zamanzadeh et al., 2013). Professionals did, however, 
seem to thus overestimate the extent to which Scottish patients would see this as 
problematic. This could be a topic for intervention (see Chapter 6). 
Risk tools have been developed for many different types of cancer such as breast, lung, and 
prostate. Patients in this study were asked questions, based on a prototype risk prediction 
tool developed by the INHANCE network, to identify barriers and facilitators towards 
potential implementation in primary health care dental settings. Patients and oral health 
care professionals (Chapter 4) broadly reported positively toward such a tool. There was 
some question of whether using a tool electronically (i.e. as in an ‘app’ format) was less 
desirable than a face-to-face assessment. This raises resources / time issues for 
professionals (see Chapter 4). Future research is needed to take this further and assess 
feasibility and effectiveness of this tool.  
5.5.1 Strength and Limitations 
Strength of this study are various: 1) the first qualitative cross-cultural study conducted 
over two different systems to compare views and experiences of dental patients attending 
primary health care settings in relation to oral cavity cancer early detection / screening; 2) 
first empirical investigation guided by theoretical domain framework to identify factors 
(barriers / facilitators) associated with dentist behaviour in areas of oral cancer screening 
practice based on patients’ views; 3) use of a bilingual interview tool with dental patients 
focused on their clinical experiences with oral health care professionals practicing at 
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primary health care dental setting;  4) consistency of research interview methods both in 
Scotland and in Oman. 
This was a relatively novel use of these frameworks. In effect, patient wishes serve as 
social and / or resource enablers / barriers for the implementation of evidence-based 
behaviour by OHCPs. The main TDF domains emerging here, as designed, were thus to do 
with patient knowledge, their motivations towards the interactions in question, and social 
influences such as culture and gender. The environmental context and resources (physical 
opportunity in the COM-B model) for dental professionals are affected by patients’ 
willingness, for example, to attend practice more or less frequently. The COE and 
communication regarding cancer and risk are socially constrained (or otherwise) by patient 
preference and expectation. Patient beliefs about consequences (reflective motivation in 
the COM-B) is important in relation to their engagement in risk screening and subsequent 
targeted recall. In summary, the TDF / COM-B frameworks serve to ensure a range of 
questions are asked that cover potential influences on behaviour. Here this was limited to a 
smaller set of domains, as the behaviours in question are primarily specified for the 
professional teams to engage in. This study is adjunctive to that in Chapter 4. Thus, in 
Chapter 6 the synthesis takes place of the evidence-base review together with views from 
professionals and patients alike.  
As with any study’s methods, the mixed-data questionnaire utilized in this study has 
strengths and weaknesses. Examples of relative strengths include the use of open questions 
which facilitates the generation of subject viewpoints of greater depth, allows the 
researcher to gain deeper insights, and adds value and authentication to related themes in 
the analysis phase (Bryman, 2008; Creswell, 2009). Weaknesses (disadvantages) of open-
ended questions include: the risk of generation of unwanted data; the possibility of a 
diversion in interview focus; possible increased survey fatigue; being time and energy 
consuming; mandating equal attention for all participants; and, requiring bilingual 
translation, particularly for participants who speak English as a second language. Fixed 
response questions were utilised in part in responses to this, serving to: facilitate shorter 
interviews; ease broad comparisons between groups; check the ‘sense’ of open-ended 
responses against broad orientations. However,they do suffer from a general difficulty in 
interpreting the meaning of responses, and they limit reflection on experiences (Bryman, 




5.6 Conclusion  
In conclusion, patients are open to some aspects of comprehensive risk profiling and 
opportunistic screening in the dental primary care setting. They have little current 
awareness of what the dentist should and / or could do in this respect. Barriers include 
some culturally sensitive issues in Oman around gender-matched intra-and extra-oral 
examinations. In Scotland, the perceived unwillingness to talk openly about cancer appears 
overstated, based on this small set of patient interviews. Risk assessment was again 
received better in Scotland due to risk behaviours being culturally sensitive in Oman. 
Chapter 6 brings this together with the overview and the professional interviews to discuss 
recommendations and interventions. The models used here allow for targeting intervention 



















Chapter 6: Discussion and Conclusion 
6.1 Introduction  
This chapter discusses the findings of the thesis – synthesising the results across the systematic 
overview and qualitative studies chapters (6.2). A comparison of the findings between Oman and 
Scotland will then be drawn out (6.3), followed by a section on the strengths and limitations of the 
thesis approaches undertaken (6.4). The thesis findings will be interpreted in terms of 
recommendations for practice (including developing a potential intervention), for guidelines and 
policy, and for further research (6.5). Finally, the thesis will end with a conclusion section (6.6). 
6.2 Synthesis of Thesis Findings   
Evidence based dentistry and practice were at the centre of this thesis. The main research aims 
were to identify best practice in relation to early detection / screening of oral cavity cancer in 
primary care dental settings, and then to explore the barriers and facilitators to implementation 
from both oral health care professionals’ and patients’ perspectives.  
Oral cavity cancer survival is poor but there has been limited improvement in recent decades 
(Public Health Scotland, 2020). Advanced stage at presentation of these cancers is associated with 
greater morbidity and mortality (Seone et al., 2016). Development and implementation of clinical 
guidelines of best practice in the early detection / screening for oral cavity cancer in primary care 
dental practices has an important potential role in contributing to addressing these challenges. 
These clinical guidelines are developed statements and recommendations that guide the health care 
professionals to make the correct clinical decisions. Research indicates that clinical guidelines 
provide organisation, guidance, and support and can fill crucial gaps in the evidence base when the 
research evidence is sparse (Fischer et al., 2016). Despite the existence of a high number of clinical 
guidelines, their use is reported to be slow, unapplied, and neglected (Fischer et al., 2016). 
Therefore, it is seen as essential to develop implementation strategies by identifying and 
overcoming the barriers that affect the implementation of clinical guidelines and improve 
adherence and sustainability to them (Knops et al., 2010). A scoping review by Fischer and 
colleagues (2016) was conducted to categorize the barriers to implementation of clinical guidelines. 
It identified the barriers, interventions and strategies required for guidelines implementation. The 
review lists a number of barriers at different levels that hamper the implementation of clinical 
guidelines - for example, personal factors such as physician knowledge and attitudes; guidelines 
factors such as lack of evidence, poor method, lack of applicability; external factors such as lack of 
collaboration, lack of social and clinical norms, and lack of resources. The review also outlines a 
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number of strategies related to overcoming these barriers – for example, barriers related to personal 
factors could be solved by continuing professional development education programmes; barriers 
related to guideline dissemination and uptake could be solved using different platforms and making 
them easier to access and use; and barriers related to external factors could be overcome by 
improvements of organisation of care (Fischer et al., 2016). 
In this thesis it was essential to identify, understand and bridge any gaps between the evidence 
base, clinical guideline recommendations, and implementation barriers in primary dental care 
settings in relation to early detection / screening of OCC. This needed to include understanding of 
current knowledge, views, and practices both from an OHCP and patient perspective – and how 
these relate to best practice.   
The thesis research involved a systematic overview of the evidence-base for the early detection / 
screening of oral cavity cancer to identify best practice in the primary dental care setting; followed 
by qualitative research studies involving oral health care professionals and patients in Oman and 
Scotland to explore implementation factors for this best practice. 
The thesis developed a taxonomy of aspects of this best practice for early detection / screening of 
oral cavity cancer in primary dental care settings, which was used as a framework to assess the 
evidence-base: the effectiveness of the conventional oral examination (COE); whether the COE 
should differ based on risk or be targeted or delivered on a universal, all-patient basis; the 
frequency / recall interval for the COE; and the role and effectiveness of Adjunct Tools to the COE.  
The systematic overview (Chapter 3) found that there was limited evidence of the effectiveness of 
the COE for early detection / screening of oral cavity cancer. There was a tendency for high quality 
systematic reviews to suggest the COE was more effective in high prevalence populations and also 
when performed in high risk individuals (defined as those who use tobacco and consume alcohol). 
There was not enough evidence to support only doing COE or doing a more detailed and focused 
COE in high risk dental patients. While there was a lack of evidence per se on the effectiveness of 
opportunistic screening, this was the approach broadly concluded in the high quality systematic 
reviews and clinical guidelines. There was a limited evidence-base, but some clinical guideline 
support was identified for a risk-based recall interval for conducting a COE based on assessed oral 
cavity cancer risks (3-6 months for patients at high risk, and 1-2 years for those at low risk). There 
was no evidence for the effectiveness or role of adjunct technologies to the COE in the early 
detection / screening of oral cavity cancer.  
The qualitative study with oral health care professionals (OHCPs) found that COEs were generally 
routinely performed during dental check-ups, although there were some variations in clinical 
practice with regard to how COEs were performed in both Oman and Scotland (Chapter 4). This 
contrasted with a number of other studies in the literature where OHCPs often did not see COE for 
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early detection / screening of OCC as being part of their routine dental check-ups (Canto et al., 
2002; Horowitz et al., 2002; Choi et al., 2008). Adjunct methods were not used – although in Oman 
this was reported to be due to a lack of the availability of the technologies rather than knowledge of 
the lack of evidence for them. There was concordance in both countries about the role of COE 
opportunistically – rather than as a targeted approach or screening programme. However, while 
there was a reluctance by the OHCPs to label this as a specific COE for early detection of oral 
cavity cancer, they were prepared to consider the idea of using a risk prediction / assessment tool 
related to the delivery of the COE. 
OHCPs in both countries were more supportive of reducing the recall interval for COE for patients 
identified as high risk and less supportive of extending the recall interval for COE for patients 
identified at lower risk. Moreover the discussions on recall interval became more focused on 
recalling patients for review when a OPMD or suspicious lesion (such as an ulcer) was initially 
detected and ahead of referral. This is in-line with other sources of information on dentists’ views 
on recall interval in relation to oral cancer, such as the British Dental Association (BDA) Scotland 
branch who produced a report strongly advocating against any risk-based recall interval (BDA, 
2018). This position was based on their clinical opinion rather than scientific evidence or data. 
More understanding of the barriers and facilitators for risk-based recall intervals is required, 
especially as it is increasingly proposed in the redesign of dental services, including in the NHS in 
Scotland (BDA-Scotland, 2018) and England (PHE, 2017). 
Reading across to patients’ views and experiences in relation to early detection / screening of oral 
cancer (Chapter 5), there were differences in perspectives between patients and oral health care 
professionals. While the OHCPs were concerned about using the term “oral cancer” when 
performing a COE, patients, particularly those in Scotland, did not seem to have a problem with it. 
This finding goes along with patients not realising that a COE for early detection / screening of oral 
cancer was routinely performed when they attended for a dental check-up. Dental patients 
interviewed seemed to be happy to be assessed for their oral cancer risk, which agrees with recent 
trial research on communicating risk to dental patients (Harris et al., 2020). The patients indicated 
that they would be willing to consider attending more frequently (3-6 months) if they were 
identified as being in a high risk group, although they were more reluctant (and less forthcoming) 
on agreeing that they would attend less often if they were identified at low risk.  
6.3 Comparing Findings in Oman and Scotland  
Chapters 4 and 5 outlined various reported activities and viewpoints of OHCPs in Oman and 
Scotland with regards to the COE and associated practices. Examinations were broadly enacted by 
OHCPs. The interview with the OHCPs in Oman indicated challenges including: hierarchical 
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structure in the dental workforce where dental hygienists were not performing COE as it was 
considered the role of dentists; the absence of related clinical guidelines; lack of training 
programmes; lack of patients’ overall awareness that COE is expected as part of the professional 
duties of the OHCPs for early detection / screening for OCC. This suggests some capability issues 
(knowledge-based) that might be addressed through education / guidance or training (Welke et al., 
2003). Social influence from patients might facilitate COE, but only if patient awareness itself is 
addressed. We know that patients are less likely to receive intra- and extra-oral examinations if 
they are from less educated / low income groups (Gupta et al., 2019).  
In Scotland, there was a reported lack of awareness among patients that they were receiving a COE 
for early detection / screening of oral cavity cancer – despite OHCPs saying they were doing in. 
Barriers to implementing COE from the professional viewpoint were more often related to time / 
opportunity, which has been similarly reported in numerous health related studies (Gott et al., 
2004; Légaré et al., 2008; Harding et al., 2014). It is known that in dentistry in the UK, preventive 
care suffers implementation barriers due to the linking of remuneration to treatment items (Birch, 
1988) and also to the way dentists are trained (Glick et al., 2012).   
Building on the above, effective implementation requires consideration of factors beyond simple 
communication / guidance. Some form of enablement through the context of practice is needed and 
indeed has been documented before (Grytten, 2005). This is in line with the behaviour change 
theories applied in Chapters 4 and 5. There were no strong skill-based barriers in the capability of 
OHCPs in Oman or Scotland to perform oral cancer screening on their primary care patients, but 
efforts to get OHCPs to engage with COE linked to risk assessment are likely to be less than fully 
successful until a comprehensive process is clearly specified and remunerated.    
Optimising the role of the dental team is one way of potentially getting over the professional role 
barriers (Brocklehurst and Tickle, 2011) although further study is needed to determine public 
perceptions of the professional preventive role of dental team members in relation to oral diseases 
(Crigger et al., 2009). It is a finding of this study of COE that the long called-for shift to a culture 
of preventive practice including environmental restructuring according to research (Steele, 2009) 
would be the major enabler / facilitator, rather than training in techniques per se. It has been 
previously reported that OHCP uptake of attending to (reading) and undertaking training towards 
clinical guidelines is poor, but this can be inferred to be a symptom of lack of evidence-based 
environment / ethos rather than the ‘root cause’ (Witton and Moles, 2013).  
Patient willingness to accept checking for OCC was generally forthcoming in both settings. 
However, a differential appeared in terms of the use of the term cancer in conjunction with the 
examination (i.e. explaining to patients what is going on and why). Omani patients were far more 
equivocal as to whether this would be acceptable or would make them uneasy / fearful (Table 5.8). 
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This aversion to explicitly acknowledging that there is a risk of OCC has been referred to in 
generic terms before as the ‘ostrich strategy’ and observed across primary care prevention 
(Moreno-Peral et al., 2015). 
There is no easy way to reduce patient anxiety with regards to cancer, but a patient-centred 
approach based on shared decision-making is key (Calderón et al., 2011). Patients in both countries 
broadly welcomed the idea of having a risk score or a risk-level categorisation based on social 
history / modifiable risk factors. However, this was subject to some concerns about probing for 
alcohol in Oman - drinking alcohol is religiously forbidden and therefore it is a sensitive subject to 
be discussed. In Scotland, the barrier is more related to the socially normative acceptability of 
alcohol use. Some of the professionals highlighted the lack of awareness programmes or campaigns 
about the link between drinking alcohol and throat / mouth cancer in the same way that smoking is 
campaigned against. The different level of awareness of smoking versus alcohol risk is a 
worldwide problem (Yamsani et al., 2014).   
The combination of alcohol and smoking is a vital synergistic risk (Hashibe et al., 2009) and hence 
the management of patients must address lifestyles that contribute to an increased risk of oral 
cancer (Speight et al., 2010). However, alcohol drinking in the Eastern hemisphere is socially 
normative and drives much economic activity. Awareness campaigns that links mouth / throat 
cancer to drinking alcohol are much less well supported than those for smoking, which while still 
prevalent is socially less acceptable and, for example is banned in enclosed public spaces in the 
UK. Research into how best to raise awareness of alcohol risk, and combined risk, is needed.  
If deemed at risk, patients in both settings said they would attend for check-ups, which could be an 
important driver for conducting clinical oral examinations as well as receiving prevention 
interventions. The assessing of risk is embedded in social history taking but scoring / classifying in 
this way again needs more work on implementation (e.g. patients preferred a face-to-face history 
taking but this has time / resource implications in practice. The converse was not true - both 
professionals and patients were wary of less frequent checks for those deemed at low risk. 
There was a lack of evidence in the systematic reviews for the use of Adjunct Tools to support the 
COE in primary dental care (Patton, Epstein and Kerr, 2008; Rashid and Warnakulasuriya, 2015). 
In Scotland, whilst resource issues (training needs) were cited, there was some understanding of 
this evidence base, inhibiting use. This was less clear in Oman, where lack of use of Adjunct Tools 




6.4 Strengths and Limitations  
The strengths and limitations of the whole thesis will be discussed in turn here. Detailed 
methodological strengths and limitations are included at the end of each study chapter (Sections 
3.7, 3.8, 4.9.1, and 5.5.1). 
Strengths  
There was an initial intention to test the implementation of an intervention for early detection  / 
screening of oral cavity cancer in primary dental care. However, at the outset of the thesis, despite 
the seeming wealth of systematic reviews and clinical guidelines in the area, there was a lack of 
clarity on best practice for oral health care professionals. Therefore, a comprehensive systematic 
overview approach was taken to distil the evidence. A novel methodological approach was 
developed to bring together both systematic reviews and clinical guidelines. This overview 
included i) a systematic search of multiple databases including grey literatures sources to find 
relevant systematic reviews and clinical guidelines; ii) thorough quality appraisal of systematic 
reviews and clinical guidelines using critical appraisal tools and multiple assessors; and iii) a 
thematic narrative synthesis based on quality and recency of publications. The overview 
methodology followed and adapted best practice from systematic reviews (McKenzie, 2018). 
Assessing the thesis overview methods itself against the AMSTAR and ROBIS tools (Perry et al., 
2017; Banzi et al., 2018) shows a level of high quality and low risk of bias.  
Following the systematic overview, qualitative in-depth interviews with oral health care 
professionals were conducted following a semi-structured approach based on findings emerging 
from the ongoing overview synthesis. The data from these interviews were comprehensively 
analysed using psychological theory (COM-B and TDF) (Michie et al., 2014) to understand the 
barriers and facilitators from a OHCP perspective to implementing best practice interventions. This 
was then complemented by similar in-depth qualitative interviews with patients analysed again via 
psychological theory. Patients’ views are essential to roundly understand the challenge of 
implementing change in health care practice (Vahdat et al., 2014; Mohammed et al., 2016). 
Further, this thesis is the first qualitative cross-cultural study conducted over two different 
countries’ health care systems (Oman and Scotland) to compare views of OHCPs and dental 
patients in relation to early detection / screening. The qualitative approach was the best method to 
use for the studies because it helped to explore and to understand the behaviour of both OHCPS 
and the patients in relation to OCC early detection / screening (Creswell and Poth, 2016). Further, 
this approach enabled new understanding, revealing differences of views and behaviours between 
OHCPs and patients - including, for example, risk prediction and talking about oral cancer (Hulme, 
2007). In addition, this approach helped the researcher to have a deeper insight into understanding 
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the behaviour and the knowledge of the OHCPs and patients, using an up-to-date model of 
behaviour change – the Behaviour Change Wheel (BCW) (Michie et al., 2014). This approach 
helped the researcher to be creative in data analysis, for instance, thematic analysis was applied 
based on TDF /COM-B frameworks (Hulme, 2007). Moreover, the thesis is the first for its 
empirical investigation procedures guided by the theoretical domain framework to identify factors 
(barriers / facilitators) associated with dentist behaviour in areas of oral cancer screening practice 
based on patients’ views. Additionally, the thesis involved a bilingual interview tool (Arabic & 
English) with dental patients focused on their clinical experiences with oral health care 
professionals practicing at primary health care dental setting – enabling deep insights into cross-
country and culture comparisons between Oman and Scotland.   
Limitations  
The main limitation of the systematic overview was not necessarily in the methods employed, 
which followed standard guidelines for systematic reviews (Cochrane Collaboration, 2020), but 
was in the limited availability of high quality data within the systematic reviews or referred to 
within the clinical guidelines. On one hand, at the outset, it looked as though there were multiple 
sources of evidence, however, when they were reviewed thoroughly, the original source studies and 
trials which the systematic reviews had included were limited both in number and quality. An 
alternative approach would have been to have reviewed and updated these original systematic 
reviews. However, this would not have been feasible in the time-scales and would have limited the 
review to one dimension of the clinical practice of early detection/screening for oral cancer e.g. on 
adjunct methods. The overview approach enabled a broader perspective to be taken – but the 
limitation of the underlying evidence-base holds.   
With respect to the inherit limitations common with qualitative studies, this thesis was not 
exceptional. Purposive samples are limited by the thematic results being a reconstruction of the 
subjective experiences and perceptions of a small number of participants, working within the 
context of a specific situation and location. There were some limitations on questions on recall 
interval for undertaking COE and basing the recall frequency on a risk assessment were often 
responded to in relation to recalling OPMD lesions before referring for a specialist opinion.  
Moreover, the researcher’s subjective judgments as a OHCP and personal ideas relating to the need 
for OHCPs to implement improved methods of detecting, screening and preventing OCC might 
possibly bias some of the results and conclusions. However, this was mitigated as much as possible 




This section discusses recommendations that arise from the thesis findings. Firstly, these 
recommendations are described in relation to practice – in terms of developing clinical behaviour-
based interventions, then in relation to clinical guidelines and policy, and finally recommendations 
for further research are set out. 
6.5.1 Towards Recommendations for Clinical Behaviour-based Interventions   
Chapters 4 and 5 explored barriers that affect implementation as a first step to improve adherence 
to evidence-based early detection / screening of OCC (Knops et al., 2010) through the theoretical 
lens of the Behaviour Change Wheel and its antecedent frame of theoretical domains (Atkins et al., 
2017). This identified a number of barriers which might be addressed to improve care. Table (6.1) 
shows the generic intervention functions indicated guide based on the model.  
 
Table 6.1 General intervention guide based on behaviour change wheel domains 
(Michie et al., 2014).  
Type of 
intervention 
Capability Opportunity Motivation 
Physical Psychological Physical Social Automatic Reflective 
Education  √    √ 
Persuasion     √ √ 
Incentivisation     √ √ 
Coercion     √ √ 
Training √ √     
Restriction   √ √   
Environmental 
restructuring 
  √ √ √  
Modelling     √  
Enablement √ √ √ √ √  
The ticks indicate the type of intervention required to address the specific capability, opportunity, and 
motivation domain.  
 
Broadly speaking, as expected, education and training are indicated for knowledge and 
skill issues (and to help with judgement / reasoning i.e. reflective motivation), but 
opportunity barriers have to be targeted for enablement at the environmental level (such as 
providing resources or training).   
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In terms of the COE theme, there does not appear to be a technical issue. Basic skills 
(physical capability) of the OCHPs in Scotland and Oman when conducting COE appeared 
similar, though there was some variation in descriptions of COE (e.g. in examining aspects 
of the tongue; Uti and Fashina, 2006) which might provide a focus for refresher training 
and / or guidance (Fischer et al., 2016), though it is known that guidance itself has barriers 
to uptake (Kredo et al., 2018).  
In Scotland, physical opportunity barriers to COE (time / cost, and resources) were the 
limiting factors cited from the professional standpoint. The BCW model also refers to 
higher level policy functions (Michie et al., 2014) such as legislation or regulatory change, 
and service provision, and meaningful progress in opportunistic screening (incorporating 
risk / social history- see below) is likely to require some reconfiguration at this ‘macro’ 
level. This is reflected in wider studies on opportunistic behaviour change interventions 
showing workload and clinical environment issues have to be overcome to support uptake 
(Keyworth et al., 2019).  In Oman, professionals faced less resource barriers as the 
Ministry would provide these, but there was some sense that this was a ‘dentist only’ role, 
which could be targeted.  
Patients in Oman were especially unaware that screening could / should be part of dental 
care. Patients being unaware of why COE is being carried out might be a barrier and again 
wider level policy functions could help such as communication / awareness campaigns. 
There were more ‘taboos’ in terms of using the term cancer, (and social history taking with 
regards to alcohol) in Oman, but in general there are no major social influence / 
opportunity barriers for professionals in terms of patient factors (professionals somewhat 
overestimated the extent to which Scottish patients would see cancer discussions as 
problematic). Attempts to increase patient awareness / acceptance (education / training 
interventions) of course exist (more so in Scotland - in Oman the media focuses on higher 
incident diseases) and could be a driver for care through increased expectation (Paudyal et 
al., 2014).   
In terms of targeting, professionals in both countries largely carried out COE for all as 
indicated in Chapter 3 to be optimal. Evidence also suggests the use of risk assessment, 
and in both countries, professionals and patients reacted largely positively when asked 
about the prototype risk prediction tool developed by the INHANCE network (Lee et al., 
2020). This itself is an enabling intervention. An important issue to address is how / where 
the patient-tool interface would best be deployed, so that efficiency can be maintained, and 
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how best to communicate risk. Risk communication in relation to dental check-ups has 
begun to receive some recent research attention - albeit not specifically related to oral 
cancer risk (Harris et al., 2020).  
Whilst evidence is equivocal, current UK guidance (NICE, 2004a) is that the interval 
between oral health checks should be patient-specific, tailored to need and risk assessment. 
Interestingly, patients were happy to return for more frequent check-ups based on high 
risk, but less so to attend practice infrequently if deemed low risk. Getting patients to 
adhere to recommendations from health professionals is a known issue (WHO, 2003) and 
the small dataset in this study indicates ‘low risk’ patients may want to continue regular 
check-up appointments as usual rather than be ‘triaged’ to less frequent visits. 
Professionals were similarly wary of longer times between checks (inferring missed or late 
detection / diagnosis risk). Shorter intervals raised once again resource / capacity issues in 
Scotland.  
The use of Adjunct Tools in primary dental care lacked evidence (Messadi, 2013) and their 
use was limited in OHCPs in both Scotland and Oman. Omani reasons were more simply 
about opportunity / availability. There was some more reflection and reasoning in Scotland 
but also some citing of resource issues such as a need for training. This does suggest some 
educational intervention to bring knowledge of the evidence-base up-to-date could have 
utility (Seoane-Lestón et al., 2010; Suresan and Vijay Kumar, 2012).  
In summary, efforts in Oman could be more orientated towards dissemination of the 
evidence-base (education and training interventions on evidence-based COE, risk and 
recall) and in Scotland towards policy / practice-level efforts to enable redesign of practice 
towards implementing comprehensive risk based assessment and preventive practice, 
which could include integrating risk tools for target populations (Scottish Government, 
2018).  
Whilst sensitivities are likely to remain, patients themselves are generally open to 
comprehensive risk profiling and opportunistic screening in primary care, whilst having 
little current awareness of what the dentist should and / or could do in this respect.  
Religious / cultural inhibitors regarding the treatment of female patients by male dentists 
(Attum and Shamoon, 2020), and the psycho-social barrier of talking about oral cancer 
(Henderson and Weisman, 2001) might also suggest social-level (e.g. role modelling) 
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interventions in Oman. They also indicate that studies like this, which pay attention to 
cross-cultural / international differences, are important.  
6.5.2 Recommendations for Clinical Guidelines and Policy 
The systematic overview work of this thesis is contributing to the development of the 
updated (4th edition) of the Public Health England guidance for prevention in dental 
practices – the Delivering Better Oral Health evidence-based toolkit (PHE, 2017) which 
has an oral cancer group and section (chaired by supervisor DIC). The thesis contribution 
to this guidance has been in terms of informing the evidence review methods and in 
sharing sources (clinical guidelines, systematic reviews) and in identifying best practice. 
The thesis findings of asserting the importance of the COE as part of a dental assessment, 
and linking the recall interval for the COE to risk assessment have been brought into the 
consideration in the revised guidance due for publication in 2021.  
Despite opportunistic screening being called for and taking place in primary dental care for 
many years in Scotland and other countries, there seems to have been only limited 
improvement in survival from OCC - with limited data available to understand trends in 
stage of presentation  / diagnosis of head and neck cancer over time (Public Health 
Scotland, 2020). Additionally, studies have shown that during mouth cancer awareness 
campaigns there is an increase of referrals of patients with “non-suspicious” lesions 
(Rodgers et al., 2007). Therefore, most dentists in Scotland are likely to be carrying out 
some form of COE, but the quality of the COE and the decision making is not necessarily 
optimal.  Consequently, despite the raft of clinical guidelines identified in the thesis, there 
remains a need for a more practical clinical guideline, detailing the process of performing a 
conventional oral examination. This could involve a further systematic search and 
appraisal of the grey literature (along with further expert input) – including some of the 
guidelines identified in this thesis, but extending to include training manuals or continual 
professional development resources (including online resources), and referral guidelines, 
which were out with the scope of this thesis. As per the taxonomy developed in this thesis, 
this work should cover the details of extra- and intra-oral examination processes – 
including i) detailing the visual and tactile (palpation) approaches and the use of gauze and 
dental mirror; ii) clarifying the symptom and clinical sign checklist; iii) describing how to 
record and capture clinical examination information (e.g. on a “mouth map”, or grid, and / 
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or photographic images); iv) developing appropriate referral pathways for OPMD / 
suspected OCC; v) identifying longer-term monitoring and recall guidance of patients with 
these OPMD lesions. These more practical guides with aids and advice on how to carry out 
the COE would support OHCPs make decisions around detecting, reviewing and referring 
oral potentially malignant lesions and early OCCs.  
The other major challenge around the opportunistic screening model is that those from the 
most deprived groups, and indeed those subsequently diagnosed with oral cavity cancer, 
have been shown in a Scottish population data linkage analysis to be less likely to attend 
primary dental care in the two-year period preceding OCC diagnosis (Purkayastha et al., 
2018). Therefore alternative venues for opportunistic early detection / screening of OCC 
could be explored in primary and community services e.g. including general medical 
practice.  
In addition to developing further clinical guidelines, which pull together the evidence-base 
or best practice, it is even more important to implement already defined best practice. 
Implementation factors have been described in relation to taking forward a new 
intervention (Section 6.4.1). In relation to the policy development implications arising 
from this work, it could include introducing a risk-based assessment and recall interval in 
NHS Scotland and Oman. Such a system is already established in NHS England and in 
private dental insurance providers across the UK e.g. Denplan (2020). This approach is 
currently under review as part of the Oral Health Improvement Plan (Scottish Government, 
2018). Implementing such a policy faces some of the challenges of guidance 
implementation, but specifically here involves addressing the financial incentives or 
requirements to delivering in primary dental care services, which are largely run as 
independent contractor businesses.  
6.5.3 Recommendations for Future Research 
The James Lind Alliance – which is a priority setting partnership with a significant patient 
and public involvement alongside professional and academic input – produced a “Top 10 
Oral and Dental Health” research priorities in 2018 (James Lind Alliance Alliance). The 
number three priority is “What are the most effective ways of increasing early 
detection/diagnosis of oral cancer”. These have been adopted by the National Institute of 
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Health Research, which is a UK government agency which funds research into health and 
care. There is therefore an impetus for further research in the area of the thesis. 
There have been no randomised controlled trials (RCT) of early detection / screening of 
oral cavity cancer undertaken in Europe. Implementing a formal screening programme has 
all but been ruled out as RCTs demonstrating reduced mortality / improved survival from 
oral cavity cancer would need to be undertaken and the National Screening Programme 
criteria for the viability, effectiveness, cost-effectiveness, and appropriateness of a 
screening programme would need to be met (PHE, 2015). There is no doubt it would be 
very difficult to run such a RCT in a country with low incidence of oral cavity cancer. 
While the review of COE effectiveness in this thesis, which largely drew on the 
randomised community trial in Kerala, India (albeit with some risks of bias) did show a 
tendency for COE to be potentially effective in high risk individuals (defined as those who 
smoke and consume alcohol; Warnakulasuriya  et al. (2015) has set out a checklist for 
future studies on oral cancer screening in Europe. They proposed further research to 
improve opportunistic screening, including aspects of risk assessment, and future 
developed adjuncts. This fits in with the thesis findings which began to probe the potential 
for both a clearer defined “intervention” approach labelling the COE and “oral cancer 
screen or check-up”, linking to a risk assessment (possibly via a risk prediction tool) of the 
major risk factors – smoking and alcohol consumption, which would also determine the 
recall frequency interval for the COE. A future evaluation of an early detection / screening 
intervention could be further developed and piloted in primary dental (and possibly 
medical) practice settings, involving a risk assessment, an “oral cancer check” COE, with 
recall / repeat intervals tailored to risk, and possibly also incorporating prevention 
interventions related to the risk factors (as defined by the “sister” PhD to this thesis; 
Mathur, 2019).  
There was also modest evidence of cost-effectiveness of early detection / screening of 
OCC in high risk individuals in dental and medical practice settings based on modelling 
(Speight et al., 2006). Future clinical research needs to consider health economic 
evaluation. Further studies either via a simulation study or in a feasibility trial design could 
build on the implementation work of thesis.This could take a human factors / health care 
systems approach to further optimise implementation (Fischer et al., 2016).  
While the thesis did not identify any solid evidence-base for the effectiveness for the role 
of currently-evaluated Adjunct Tools or techniques, further research in this area, to 
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determine if newer approaches could provide a supportive solution, would also be 
warranted.  
6.6 Conclusions  
In conclusion, high mortality and low survival rates of oral cavity cancer associated with 
late stage presentation remain a public health challenge. Oral health care professionals 
working in primary care dental settings have an important role in reducing morbidity and 
mortality associated with oral cancer through early detection / screening. The thesis 
identified pragmatic best practice that the conventional oral examination undertaken 
opportunistically as part of the dental check-up, which has some evidence base. There is no 
evidence that the COE should be undertaken differently or more intensively for patients 
identified at high risk (i.e. those who smoke tobacco or consume alcohol). There are some 
pragmatic clinical guideline recommendations that the recall interval for COE should be 
more frequent for those at higher risk and less frequent for those at lower risk. There is no 
evidence for the current role of Adjunct Tools or techniques. The qualitative interviews 
highlighted some important differences between patients’ and OHCPs’ perspectives and 
between Oman and Scotland. Patients were generally and reassuringly more open to 
talking about mouth cancer than OHCPs, patients were also open to more frequent risk-
based recall intervals if identified as high risk for oral cancer, although were more reluctant 
to agree to a longer recall intervals if identified as having a lower risk. There were some 
commonalities and differences in the barriers / facilitators identified between Oman and 
Scotland and, should they be addressed, could support evidence implementation. In Oman 
there is a greater need for education and training related to oral cancer, while in Scotland 
there is a need for policy and health care system change to implement early detection  / 
screening linked to risk assessment and prevention interventions in dental practice. Further 
work is required in Oman to address cultural sensitivities which impact on full 
implementation of early detection / screening interventions.  
The thesis provides a good basis towards developing an intervention for early detection / 
screening of oral cavity cancer linked to a risk assessment and prevention interventions in 
primary dental care settings. Such a future intervention could have a potential to impact on 
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Appendix 3.1: List of Professional Organisations/Associations 
 
1. World Health Organization  
2. Central for Disease Control and Prevention (CDC) 
3. Head & Neck Cancers (Screening Guidelines) 
4. American Dental Association Council  
5. UK National Screening Committee 
6. HealthPartners Dental Group and Clinics 
7. US Preventive Services Task Force 
8. American Cancer Society 
9. Cancer Research UK 
10. British Dental Association 
11. New Zealand Guidelines Group, Ministry of Health 
12. Office of Oral Health, Maryland Department of Health & Mental Hygiene. 
13. Agency for Health care Research and Quality,  
14. U.S. Department of Health and Human Services 
15. The Royal College of Surgeons of England. 
16. National Institute of Dental and Craniofacial Research. 
17. Cancer care Ontario 
18. National Institute for Clinical Excellence Clinical 
19. British Association of Otorhinolaryngology, Head and Neck Surgery,  
20. College of Dental Surgeons of British Columbia 
21. Scottish Intercollegiate Guidelines Network 
22. National Institute for Health and Clinical Excellence, June 2005 
23. National Center for Chronic Disease Prevention and Health Promotion 
24. Oral Cancer Foundation 
25. National Cancer Institute 
26. Scottish Dental Clinical Effectiveness Programme (SDCEP) 
27. National Dental Advisory Committee (NDAC) 
28. NHS Education for Scotland (NES). 
29. Translation Research in a Dental Setting (TRiaDS) 











“Oral cancer screening guidelines”  
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 “Oral cancer detection guidance”  
“Detecting guidance for oral cancer”  
“Detecting for oral cancer guidance”  






 “Mouth cancer screening guidelines”  
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“Screening for mouth cancer guidelines”  







 “Mouth cancer detecting guidance”  
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Appendix 3.3: Sample search strategy in MEDLINE 
 
1. ((oral or mouth or head or neck or lip* or buccal or tongue) adj5 (cancer* or neoplasm*)).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique identifier] 
2. exp cancer screening/  
3. (assess* or exam* or inspect* or screen*).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier]  
4. exp "Head and Neck Neoplasms"/  
5. exp Mass Screening/  
6. Meta-Analysis as Topic/  
7. meta analy$.tw. 
8. metaanaly$.tw.  
9. Meta-Analysis/  
10. (systematic adj (review$1 or overview$1)).tw.  
11. exp Review Literature as Topic/  
12. 6 or 7 or 8 or 9 or 10 or 11  
13. cochrane.ab.  
14. embase.ab.  
15. (psychlit or psyclit).ab.  
16. (psychinfo or psycinfo).ab.  
17. (cinahl or cinhal).ab.  
18. science citation index.ab.  
19. bids.ab.  
20. cancerlit.ab.  
21. 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20  
22. reference list$.ab.  
23. bibliograph$.ab.  
24. hand-search$.ab.  
25. relevant journals.ab. 
26. manual search$.ab.  
27. 22 or 23 or 24 or 25 or 26  
28. selection criteria.ab.  
29. data extraction.ab.  
30. 28 or 29  
31. Review/  
32. 30 and 31  
33. Comment/  
34. Letter/  
35. Editorial/  
36. animal/  
37. human/  
38. 36 not (36 and 37)  
39. 33 or 34 or 35 or 38  
40. 12 or 21 or 27 or 32  
41. 40 not 39  
42. 2 or 3 or 5  
43. 1 or 4  
44. 41 and 42 and 43 
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Appendix 3.7: List of excluded systematic reviews (n=22)  
Excluded systematic reviews (n=22) Reason for exclusion 
Roseinberg D, Cretin S, (1989), Use of meta-
analysis to evaluate tolonium chloride in oral 
cancer screening. Oral Surg Med oral Pathol. 
67:621-7).  
Not strictly systematic review  
Jullien JA, Downer MC, Evaluation of a 
screening test for the early detection of oral 
cancer and precancer (1995). Community Dental 
Health, 12:3-7.  
Not a systematic review  
Jonathan J Deeks (2001). Systematic reviews of 
evaluation of diagnostic and screening tests. 
British Medical Journal.323:157-62. 
Systematic review related to diagnostic accuracy.  
Moles D, Downer M, Speight P (2002). Meta 
analysis of measures of performance reported in 
oral cancer and precancer screening 
studies.192:340-344. 
Not a systematic review  
Davenport CF, Elley KM, Fry-Smith A, Taylor-
Weet-man CL, Taylor RS. The effectiveness of 
routine dental checks: a systematic review of the 
evidencebase. BMJ 2003;195:87–98 
Duplicate to Davenport et al (HTA paper) – to be 
removed.   
Kujan  O, Glenny  AM, Duxbury  AJ, 
Thakker  N, Sloan  P, Duxbury  J. Screening 
programmes for the early detection and 
prevention of oral cancer. Cochrane Database of 
Systematic Reviews 2003, Issue 4. Art. No.: 
CD004150. DOI: 10.1002/14651858.CD004150. 
Outdated and modified to version 2005 
Kujan O, Glenny AM, Duxbury J, Thakker N, 
Sloan P. Evaluation of screening strategies for 
improving oral cancer mortality: a Cochrane 
systematic review. J Dent Educ. 2005;69:255-65. 
Outdated and modified to version 2006 
Beirne  PV, Forgie  A, Clarkson  JE, 
Worthington  HV. Recall intervals for oral health 
in primary care patients. Cochrane Database of 
Systematic Reviews 2005, Issue 2. Art. No.: 
CD004346. DOI: 
10.1002/14651858.CD004346.pub2. 
Outdated – updated 2008 is included in our SR 
list. 
Kujan  O, Glenny  AM, Oliver  R, Thakker  N, 
Sloan  P. Screening programmes for the early 
detection and prevention of oral cancer. Cochrane 
Database of Systematic Reviews 2006, Issue 3. 
Art. No.: CD004150. DOI: 
10.1002/14651858.CD004150.pub2. 
Outdated and modified to version 2010 
Speight PM, Palmer S, Moles DR, Downer MC, 
Smith DH, Henriksson M, et al. The cost-
effectiveness of screening for oral cancer in 
primary care. Health Technol Assess 2006;10(14). 
Executive summary: to be merged with review for  
Davenport et al,2003. 
Epstein JB, Sciubba J, Silverman S Jr, et al. 
Utility of toluidine blue in oral premalignant 
lesions and squamous cell carcinoma: continuing 
research and implication for clinical practice. 
Not a systematic review   
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Excluded systematic reviews (n=22) Reason for exclusion 
Head Neck 2007;29:948-58. 
Lingen MW, Kalmar JR, Karrison T, Speight PM 
(2008) Critical evaluation of diagnostic aids for 
the detection of oral cancer. Oral Oncol 44(1):10–
22 
Not a systematic review  
Mehanna HM, Rattay T, Smith J, McConkey CC. 
Treatment and follow up of dysplasia- a 
systematic review and meta-analysis. Head Neck. 
2009;31:1600–9. 
Not related to screening 
Cozens, N.J.A(2009). A systematic review that 
evaluates one-stop neck lump clinics. Clinical 
Otolaryngology, 34(1) 
Not related to screening 
Smith J, Rattay T, McConkey C, Helliwell T, 
Mehanna H (2009). Biomarkers in dysplasia of 
the oral cavity: asystematic review. Oral Oncol 
45:647–653 
Not related to oral cancer screening 
Brocklehurst  P, Kujan  O, Glenny  AM, 
Oliver  R, Sloan  P, Ogden  G, Shepherd  S. 
Screening programmes for the early detection and 
prevention of oral cancer. Cochrane Database of 
Systematic Reviews 2010, Issue 11. Art. No.: 
CD004150. DOI: 
10.1002/14651858.CD004150.pub3. 
Outdated and modified to version 2010, then 2010 
was modified to 2013 and it is included in our 
high quality systematic review.  
Rethman MP, Carpenter W, Cohen EE et al 
(2010). Evi-dence-based clinical 
recommendations regarding screeningfor oral 
squamous cell carcinomas.J Am Dent 
Assoc141:509–520. 
Outdated  
Almuammar A, Dryden C, Burr JA. 
Factorsassociated with late presentation of cancer: 
alimited literature review.J Radiother Pract 
2010;9(02):117–123 
Not related to screening 
Güneri P, Epstein JB, Kaya A, Veral A, Kazandı 
A, Boyacioglu H (2011) The utility of toluidine 
blue staining and brush cytology as adjuncts in 
clinical examination of suspicious oral mucosal 
lesions. Int J Oral Maxillofac Surg 40(2):155–161 
Not a systematic review 
Walter F, Webster A, Scott S, Emery J. The 
Andersen Model of Total Patient Delay: a 
systematic review of its application in cancer 
diagnosis. J Health Serv Res Policy 2012; 17( 2): 
110– 8.  
Not related to oral cancer screening 
Rethman MP, Carpenter W, Cohen EE, Epstein J, 
Evans CA, Flaitz CM, et al. Evidence-based 
clinical recommendations regarding screening for 
oral squamous cell carcinomas. Tex Dent J 
2012;129: 491-507. 
Add to clinical guideline list 
Macey, R., Walsh, T., Brocklehurst, P., Kerr, 
A.R., Liu, J.L., Lingen, M.W., Ogden, G.R., 
Warnakulasuriya, S. and Scully, C., 2015. 
Diagnostic tests for oral cancer and potentially 
malignant disorders in patients presenting with 
Systematic review related to diagnostic accuracy 
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Excluded systematic reviews (n=22) Reason for exclusion 
clinically evident lesions. Cochrane Database of 
























Appendix 3.8: List of included clinical guidelines (n=20) 
# Clinical Guidelines  
1 University of Glasgow Dental School.2003.Oral cancer Prevention and Detection for the primary 
Health Care Team.UK.2nd.Oral cancer awareness group, University of Glasgow Dental School. 
2 American Cancer Society. 2003. Guidelines for the early detection of cancer. US. A cancer journal 
for clinician. 
3 NHS. 2004. Guidance on cancer Services-Improving outcomes in head and neck cancers.UK. 
National Institute for Clinical Excellence. 
4 National Institute for Clinical Excellence. 2004. Dental recall, recall interval between routine dental 
examinations, UK. National Institute for Clinical Excellence. 
5 Cancer research UK. 2005. Mouth cancer referral guidelines for dentists. UK. NHS 
6 Scottish Intercollegiate Guidelines Net Work.2006. Diagnostic and management of head and neck 
cancer. UK. Scottish Intercollegiate Guidelines Network. 
7 Brouwers M, Crawford J, Elison P, Evans WK, Gagliardi A, Holmes D, et al. Organizational 
standards for diagnostic assessment programs. Toronto (ON): Cancer Care Ontario; 2007 Jun 15 [In 
review 2011 Sep]. Program in Evidence-based Care Evidence-based Series Organizational Standards 
for DAP IN REVIEW. 
8 Agency for Health care Research and Quality. 2007. Health Partners dental group and clinics oral 
cancer guideline.NGC-9498. Minneapolis. US department of Health and Human Services. 
9 College of Dental Surgeons of British Columbia. 2008. Guideline for the early detection of oral 
cancer in British Columbia. BC cancer Agency. 
10 Ministry of Health .2009. Suspected cancer in primary care guidelines for investigation, referral and 
reducing ethnic disparities. New Zealand. New Zealand guidelines group. 
11 British Dental Association.2010. Early detection and prevention of oral cancer: a management 
strategy for dental practice. UK.British Dental Association. 
12 ENTUK (2011). Head and Neck Cancer: Multidisciplinary Management Guidelines, 4th edition. 
British Association of Otorhinolaryngology, Head and Neck Surgery, The Royal College of Surgeons 
of England. 
13 Scottish Dental Clinic effectiveness Programme.2012. Oral health assessment and review dental 
clinic guidance. UK.1.0. Scottish Dental Clinic effectiveness Programme. 
14 Australian Government. 2013. South Australian Head and Neck cancer pathway. South Australia. 
Department of Health and Aging, Government of South Australia. 
15 National Institute of Dental and Craniofacial Research.2013.Detecting oral cancer A guide for Health 
Professionals.US. US department of Health and human services, National Institute of Health. 
16 Memorial Sloan Kettering Cancer Center.2014.Heas and Neck Cancers. US. Memorial Sloan 
Kettering Cancer Center 
17 U.S. Preventive Services Task Force. 2014. Screening for oral cancer: U.S. Preventive services Task 
Force Recommendation Statement.  US. Annals of Internal Medicine. 
18 Solution for Public Health.2015.Appraisal of Screening for oral cancer- a draft report for the UK 
National Screening Committee.UK. Solution for Public Health 
19 Maryland Comprehensive cancer control plan.2016-2020. oral cancer – chapter 12. Maryland. 
Maryland department of health and mental hygiene. 
20 American Dental Association. 2017. Evidence-based clinical practice guideline for the evaluation of 




Appendix 3.9: List of excluded clinical guidelines (n=8) 
 
N Clinical guidelines Reasons  
1 National Center for Chronic Disease Prevention and Health 
Promotion, Central for disease control and prevention.1996.Oral 
cancer background paper. Chapter IX: Health Promotion in oral 
cancer prevention and early detection. US.  
Not related to OCC, working draft 
for CDC report. 
2 British Dental Association.2000.Opportunistic oral cancer 
screening: A management strategy for dental practice.6.UK.  
British Dental Association 
Management not screening  
3 Centers for Disease Control and Prevention.2001.Promoting oral 
health: Interventions for preventing dental caries, oral and 
pharyngeal cancers, and sports-related craniofacial injuries.US. 
Epidemiology program office Centers for disease control and 
prevention. 
recommendation statement 
included in guideline #19 
 
4 National Institute for Health and Clinical 
Excellence.2005.Referral guidelines for suspected cancer. 27. 
UK. National Institute for Health and Clinical Excellence 
Deal with referral not screening  
 
5 Rethman MP, Carpenter W, Cohen EE, et al. Evidence‐based 
clinical recommendations regarding screening for oral squamous 
cell carcinomas. J Am Dent Assoc 2010; 141: 509– 520. 
Duplicate - published twice. 
2010:  Tex Dent J. 2012 
May;129(5):491-507. 
6 Speight, P.M. and Warnakulasuriya, S. (2010) Evaluation of 
Screening for Oral Cancer against National Screening Committee 
Criteria. UK National Screening Committee Publications. 
http://www.screening.nhs.uk/oralcancer 
Review paper, not actual 
guideline document. 
7 Maryland Comprehensive cancer control plan.2011-2015. oral 
cancer – chapter 12. Maryland. Maryland department of health 
and mental hygiene. 
Outdated replaced with new plan 
2016-2020 
8 Kaiser Permanente Research Affiliates EPC. 2013. Screening for 
oral cancer: A targeted evidence update for the US preventive 
services task force.102. Agency for Health care Research and 
Quality. 




Appendix 3.10: Moderate Quality Systematic Review- COE  
Study ID Results and / or Conclusions 
Downer et al (2004) Prevalence OCC or OPMD = 2% - 51% 
Pooled weighted Sensitivity = 0.85 (95%CI 0.73, 0.92) 
Specificity = 0.97 (95%CI 0.93, 0.98) 
“A generally high level of discriminatory ability and consistency in test 























Appendix 3.11: Low Quality Systematic Review- COE  
Study ID Results and / or Conclusions 
Warnakulasuriya et al (2015) Sensitivity (range) = 0.68 – 0.98 
Specificity (range) = 0.71 – 0.96  
“…the feasibility of screening for OPMDs by conventional oral examination 
has been demonstrated, supporting a strategy to adopt appropriate screening 
models, and further action from the European countries should be to demonstrate 
methods of halting their progression by tested interventions.” 
Carreras-Torras and Gay- 
Escoda (2015) 
Quotes Epstein et al (2012) sensitivity data  
“Therefore, COE cannot reliably differentiate between benign and dysplastic 
lesions, and this is probably due to the fact that a number of benign conditions 
mimic oral malignancies.” 
Patton (2003) Sensitivity (range) = 0.71 – 0.95 
Specificity (range) = 0.64 – 0.99  
“Routine oral visual examination can result in earlier detection of oral cancer, 
allowing interventions that contribute to reduced morbidity and/or improved 
survival. Mainly important is the identification and motivation of people in high-
risk groups (tobacco and alcohol users) who do not attend the health care 
regularly for targeted screening or clinical examination tobacco cessation 
interventions.”  
Walsh et al (2013)  “... even though the evidence of accuracy is not consistently strong, there is some 
evidence ... that implementing COE as a component of a population screening 
programme can reduce mortality and produce stage-shift in a high-risk 
population.”  
“General dental practitioners and dental care professionals should remain vigilant 
for signs of OPMD and oral cancer whilst performing routine oral examinations 
in practice.” 
Brocklehurst et al (2013)   “There is evidence that a visual examination as part of a population-based 
screening programme reduces the mortality rate of oral cancer in high-risk 
individuals.” 
“However, the evidence is limited to one study, which has a high risk of bias and 
did not account for the effect of cluster randomisation in the analysis.” 
“... good evidence that opportunistic screening of high-risk groups is cost-
effective” ... “However, these results also need to be read in context of the 
relative prevalence of the condition.” 
“The results suggest that there is insufficient evidence to recommend a whole 
population screening programme for oral cancer. However, the results from the 
Kerala study suggest that a targeted population approach could reduce the 
mortality rate and produce a stage shift, but the risk of bias in the included study 
means that further well-designed randomised controlled trials are necessary to 
establish the validity of this relationship.” 
“In the meantime, opportunistic visual screening by appropriately trained dentists 
and oral health practitioners is recommended for all patients and particularly for 
those who use tobacco, alcohol or both. Systematic examination of the oral 
cavity by front-line health workers should remain an integral part of their routine 




Appendix 3.12: Moderate Quality Clinical Guidelines - COE 







“Visual examination of the oral soft tissues, 
extraoral head and neck tissues and palpation of 
the head and neck lymph nodes is considered 
the standard of care as part of a complete dental 
examination.” 
“Major Recommendation”. 
Based on no quality of 
evidence rating, with no 










“Head and neck and oral soft tissue 
examination should be carried out …”  
“Key Point”  
Based on no quality of 
evidence rating, with no 














“Conduct a comprehensive extra-oral 
examination of the patient’s head and neck, 
including: 




Conduct comprehensive intra-oral examination 
oral mucosal tissue.” 
“Actions for the dental 
team”  Based on no quality 
of evidence rating, with no 









“… dental and medical examinations with 
appropriate health questionnaires (such as skin, 
voice, oral symptoms, swallowing and 
behavioural assessments for risk factors).” 
Based on no quality of 
evidence rating, with no 




















“…  We agree with the conclusion of the 
Cochrane review by Walsh et al (2013) that 
there is insufficient evidence to determine the 
screening test accuracy of conventional oral 
examination, vital rinsing, light-based 
detection, biomarkers or mouth self 
examination, used singly or in combination. 
The only relevant study (Ibrahim et al 2014) 
published after the Cochrane review claimed 
100% sensitivity for conventional oral 
examination with or without light-based 
detection and vital rinsing, but since the study 
design could not reliably ascertain cases of oral 
cancer that were missed by screening (i.e they 
only offered biopsy to people with suspicious 
lesions and did not report any follow-up”.  
Based on insufficient 
evidence  from Walsh et al 







“Increase the proportion of adults age 18 and 
older who have had an oral cancer exam in the 
past year.” 
Screening Target – Based 
on US guidelines. 
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“… examination of the oral mucosa is 
important in the early detection of oral 
cancer or potentially malignant lesions.” 
“… conduct a comprehensive examination 
for oral cancer.” 
Based on no quality of evidence 






“… dental check-up is an excellent 
opportunity for a head and neck 
examination.” 
Based on no quality of evidence 












“… primary care physicians … physical 
examination of the head and neck and 
oropharynx (the middle section of the 
throat that includes the soft palate, the base 
of the tongue, and the tonsils).” 
“… routine dental evaluation that includes 
examination of the neck and inspection of 
the oropharynx and the mouth.”  
“Our doctors recommend” 
Based on no quality of evidence 




Appendix 3.14: Low Quality Systematic Review- Target Population 
Study ID Results and / or Conclusions 
Warnakulasuriya et 
al, (2015) 
“It is interesting to note that several models of screening have been adapted in 
these European studies. Screening of high-risk groups rather than the whole 
population has been addressed by few authors.”  
“Target population: Constraints: There is no evidence of benefits from population-
based screening in Europe. Recommendation: On the basis of the balance of 
benefits and harms, opportunistic screening in dental practices or screening 
selected high-risk population groups may be considered for future studies.” 
“The feasibility of conducting screening studies in dental practices has however 
been criticised... in that the approach does not attract high-risk individuals, which 
the authors refer to as the ‘Inverse Screening Law.’” 
Patton (2004) “Oral cancer screening programmes in low-incidence areas of the world might be 
more cost effective if they target high-risk populations and obtain good compliance 
of the selected individuals with the screening process. 
“Low compliance with organized oral cancer community screening programmes 
and low general population prevalence of oral premalignant and malignant lesions 
suggest population-based oral cancer screening in many regions of the world may 
not result in reduced morbidity and mortality associated with oral cancer and hence 
may not be cost-effective.”  
“However, given the substantial morbidity and mortality that results when oral 
cancer is diagnosed in advanced stages, adults above the age of 40 years should 
undergo regular oral cancer examinations as part of medical and dental health 
check-ups. Routine oral visual examinations can result in earlier detection of oral 
cancer, allowing interventions that contribute to reduced morbidity and/or 
improved survival. Particularly important is the identification and motivation of 
people in high-risk groups, such as tobacco and alcohol users who do not regularly 
access health care, for targeted screening or clinical examination and tobacco 
cessation interventions.” 
Downer et al. (2006) “Overall, this review confirms that there are insufficient available data to make a 
determination as to the effectiveness of oral cancer screening programmes at the 
present time. However, since the review was completed evidence has emerged that 
screening high risk individuals, in developing countries at least, could be an 









Appendix 3.15: Moderate Quality Clinical Guidelines- Target 
Population 




“It is the expectation that a head, neck and oral soft 
tissue examination is completed on all patients at the 
time of the new patient examination and at general 
dental recall [appointment].” 
Based on no quality of evidence 









“ The UK Working Group on Screening for Oral Cancer 
and Precancer recommended “opportunistic screening” 
as the most suitable model for the UK population, based 
on the availability of dental manpower and the fact that 
most people return to a dentist annually for a mouth 
examination.” 
“NSC-UK does not recommend population screening for 
oral cancer, opportunistic case detection in routine 
practice is recommended by professional organizations”  
Based on the National Screening 
Committee (NSC- UK) 
recommendation (2003), but no 














“Incorporating routine oral cancer examinations ... into 
the daily practice of health care practitioners can 
increase the likelihood of earlier detection of oral  
cancer. However, there is no evidence that such early 
detection can decrease oral cancer mortality, 
nevertheless, routine examinations for early detection of 
oral cancer should still be recommended.” 
“For those at highest rIsk for oral cancer, access to the 
health care system is limited both in the US and in 
Maryland. Access is critical in order to receive timely 
and appropriate oral cancer examinations. It is well 
established that those populations with the highest oral 
cancer mortality rates experience the poorest access to 
the overall health care.” 
“Increase oral cancer screenings among adults by 
providing access to both primary care providers and oral 
health providers for low-income and underserved adult 
populations in Maryland by supporting community 
health centers, mobile screening services, seeking new 
funding sources (public and/or private), and advocating 
for policy changes and funding at the local, state, and 
federal levels.” 
Based on no quality of evidence 






“Carry our assessment of the head and neck of each 
patient” 
 
“Conduct an examination of each patient’s oral mucosal 
tissue in a systematic manner …”  
Based on no quality of evidence 





“The distribution of test values in the target population 
should be known and a suitable cut-off level defined and 
agreed: Criteria not met” 
Based on no quality of evidence 




Appendix 3.16: Low Quality Clinical Guidelines- Target Population 
 








“ On the occasion of a periodic health examination, the cancer-
related check-up should include examination for cancers of the 
... oral cavity ... as well as health counselling about tobacco, 
...risk factors” 
“…the ACS now recommends that the cancer- related check-up 
occur on the occasion of a general, periodic health examination, 
rather than as a stand-alone exam done at a specific interval 
based on an individual’s age”. 
“Recommendations for the early detection of cancer in Average- 
Risk, asymptomatic people is men and women age 20+.”. 
Based on no quality of 







“ Patients should be examined for potential malignancy at every 
dental examination.” 
 
“The level of suspicious should be higher if the patient is 
smoker or heavy alcohol drinker, chews betel nut (Areca nut) or 
tobacco, or is over 40 years.” 
Based on no quality of 







“A regular dental check-up is an excellent opportunity for a 
head and neck examination” 
“Clinicians should be particularly vigilant in checking those 
who use tobacco or excessive amounts of alcohol.” 
Based on no quality of 








“routine dental evaluation  
“Recommend ... physical examination of the head, neck, and 
oropharynx by your primary care physician.” 
“Recommend ... routine dental evaluation that includes 
examination of the neck and inspection of oropharynx and the 
mouth”.  
“Our doctors recommend” 
Based on no quality of 






Appendix 3.17: Moderate Quality Systematic Review- Frequency of 
COE 
Study ID Results and / or Conclusions 
Davenport et al (2003) “There is little existing evidence to support or refute the practice of encouraging 
6-monthly dental check-ups.” 
“Oral cancer Outcomes... 
... no association between dental check frequencies ≥ 12/12 and < 12/12 and a 
diagnosis of oral cancer and precancer” [one cross-sectional study].  
“... decreasing dental check-ups frequencies (>12/12 only and for intervals 
decreasing by ≥ 12/12) may results in a significantly increased tumor size and 





















Appendix 3.18: Moderate Quality Clinical Guidelines – Frequency of 
COE 
CG -ID Year  Recommendations Evidence Rating 
SAHNCP  2013 “.. Promotion of 6 -12 monthly dental and 
medical examinations with appropriate health 
questionnaires (such as skin, voice, oral 
symptoms, swallowing, and behavioural 
assessments for risk factors”. 
Based on no quality of 
evidence rating, with no 

























“… it is important that on registering with a 
dental practice, each patient receives a 
baseline comprehensive Oral Health 
Assessment (OHA). For adults, this is 
repeated after 24 months”.  
“In addition, during these time periods 
Focused Oral Health Review (FOHRs) can be 
carried out. Both the number of FOHRs and 
the intervals between them will vary 
depending on the patient’s risk of future oral 
disease.”  
“ NICE recommends the following shortest 
and longest intervals between one assessment 
and the next assessment:  
• The shortest interval for all patients is 3 
months. 
• The longest interval for patients younger 
than 18 years is 12 months. 
• The longest interval for patients aged 18 
years and older is 24 months. 
To operationalise this approach, it is 
recommended that after the first Oral Health 
Assessment, if it is considered necessary, the 
patient receives Focussed Oral Health 
Reviews (FOHRs) at variable risk-based 
intervals. At a FOHR, primarily those 
elements previously rated as high or medium 
risk are reassessed... Subsequently, it is 
recommended that patients receive a full Oral 
Health Assessment every 24 months after their 
last full OHA for adults and 12 months after 
their last full OHA for children. This ensures 
that each patient has a regular comprehensive 
assessment and reflects the maximum 
intervals recommended by NICE. 
Based on no quality of 
evidence rating, with no 
strength of recommendation 
assigned. 




“Since the objectives is opportunistic case 
finding rather than invitational screening, 
there is no precise answer to a question about 
the desirable intervals between mouth 
examinations.” 
Based on no quality of 
evidence rating, with no 








“Every patient needs tailored advice, however, 
and your practice routine should follow the 
NICE guidance on recall intervals. This takes 
into account all aspects of oral heath, 






“On the basis of present evidence and the 
potential for benefit, it is recommended that 
systematic oral cancer screening be offered... 
At present, our consensus recommendation is 
to offer this annually to all individuals from 
age 40”.  
Based on no quality of 
evidence rating, with no 









“A complete inspection of the oral and 
oropharyngeal soft tissue and head and neck 
lymph nodes should be conducted at each 
dental hygiene exam appointment. An 
individual determined to be at risk for oral 
cancer may require a more frequent recall 
intervals than caries and periodontal risks 
would dictate.” 
Based on no quality of 
evidence rating, with no 





Appendix 3.19: Low Quality Clinical Guidelines – Frequency of COE 
 
CG -ID Year  Recommendations Evidence Rating 






“... all individuals visit their primary care 
physician for a yearly physical 
examination of the head and neck and 
oropharynx” 
“... also recommend a yearly routine 
dental evaluation that includes 
examination of the neck and inspection 
of the oropharynx and the mouth”. 
Based on no quality of evidence 




Appendix 3.20: Moderate Quality Systematic Review- Adjunct Tools 
Study ID Results and / or Conclusions 
Patton et al 
(2008) 
“There is evidence that TB [Toluidine Blue] is effective as a diagnostic adjunct for use in high 
risk populations and suspicious mucosal lesions. OralCDx [cytopathology brush biopsy] is useful 
in assessment of dysplastic changes in clinically suspicious mucosal lesions; however, there are 
insufficient data meeting the inclusion criteria to assess 
usefulness in innocuous mucosal lesions. Overall, there is insufficient evidence to support or 
refute the use of visually based examination adjuncts.” 
“..the sensitivities of TB as a diagnostic adjunct varied from 38 to 98 percent (median, 85 percent) 
and specificities varied from 9 to 93 percent (median, 67 percent). The PPVs ranged from 33 to 93 
percent (median, 85 percent) and the NPVs from 22 to 92 percent (median, 83 percent).” 
“Most of the studies [with the better outcomes] either were conducted in referral specialty clinics 
[“oral mucosal disease clinics”] or involved surveillance or higher-risk populations … Therefore, 
the underlying population prevalence of OPML [oral potentially malignant lesions] in these 
studies was higher than that expected in a general dental practice with a low-risk population.” 
“…the results… of our systematic review support a recommendation for the use of TB as a 
surveillance or diagnostic adjunct in populations at higher risk.” 
“Given lack of data on the effectiveness of adjunctive cancer detection techniques in general 
dental practice settings…”  
Downer et al 
(2004) 
“…there were no known studies or clinical trials of this agent [toluidine blue] in progress as a 
screening test for oral cancer in a general practice setting.” 
“No reports were found of the use of toluidine blue dye as an aid in population screening of 
apparently healthy individuals for oral cancer and precancer…its use in screening in primary care 
would not be beneficial and could not be recommended.” 
Gray et al 
(2000) 
“No published studies have evaluated the use of toluidine blue dye in the general population. The 
one study in primary care had 140 patients and did not have the power to demonstrate any effect. 
There is no evidence that toluidine blue is effective in screening for oral cancer in primary care.” 
“Case series reports of the use of toluidine blue in secondary care show variable results in terms of 
the sensitivity and specificity of the test….the quality of these included studies is poor.” 
“[In the 14 included studies]…Reported sensitivity varies from 1.0 to 0.4. Since it is not proposed 
that toluidine blue screening be used to exclude the requirement to biopsy a visible lesion, the 
sensitivity of the test is not relevant (otherwise a negative result in a highly sensitive test could 
have been used exclude the need for biopsy). The reported specificity of toluidine blue varies 
from 0.31 to 0.92.” 
“The 14 studies in secondary care were all of people at high risk of oral cancer and all but one of 
the studies concerned people referred to secondary care with oral lesions. Thus, the results of the 
included studies relate to the test characteristics of toluidine blue as a screening test for oral 
cancer in people with detected oral lesions and are not generalisable to primary care.” 
“Economic Analysis: The cost per case detected would be £861,700…. it would cost 
£2,872,333/person cured. This is probably an underestimate of cost as most of the assumptions… 
are very optimistic and the calculation does not include treatment costs. Moreover there would be 
45,000 people who were made anxious per person cured.” 
“Currently there is no evidence to suggest that toluidine blue is a cost-effective method of picking 
up oral cancers in a primary care setting. Given the large number of people that will have false 
positive rates for a first positive test and even a double positive test, the harm of using it in terms 





Appendix 3.21: Low Quality Systematic Review- Adjunct Tools 
 
Study ID Results and / or Conclusions 
Carreras-Torras & Gay 
Escoda (2015) 
“The best diagnostic techniques is that which we have sufficient experience and 
training. Definitely tissue biopsy and histopathological examination should remain 
the gold standard for oral cancer diagnose. In this systematic review it has not 
been found sufficient [sic] scientific evidence on the majority of proposed 
techniques for early diagnosis of OSCC and OPMD.” 
The clinical application of toluidine blue has been shown to be selective staining 
of premalignant and malignant lesions… has a high sensitivity, but a low 
specificity 
due to the false positive that generates…. So, is recommended as an adjunct to the 
clinical examination of oral mucosal lesions, specifically in high-risk patients by 
expert providers,…” 
Patton (2003) “Toluidine blue has not been routinely used by physicians or dentists to screen 
either general or high-risk populations, and no community-based screening 
programmes could be identified that used this vital dye to aid visual exam.” 
“Toluidine blue …. sensitivities ranging from 97.8 to 93.5%, and specificities 
ranging from 92.9 to 73.3%, it was concluded that if toluidine blue is used to 
screen high-risk populations, the likelihood of a false negative finding is 
extremely low, whereas false positive results will be relatively numerous. 
However, given the high sensitivity of the test, the absolute number of false 
positive tests will be small… More recent studies…have demonstrated equally 
high sensitivities, but specificities as low as 45%, leading to a larger number of 
false positive results, generally caused by retention of stain in areas of 
inflammation or trauma. Tests with high false positive rates may be most 
beneficial when used in appropriately selected high-risk populations, thus making 
them less amenable to use as diagnostic aids in community-based screenings” 
“While the evidence is fair to support use of toluidine blue as an aid in diagnosis 
of oral cancer, there is insufficient evidence to determine whether the use of this 
or other adjunctive techniques will increase the detection or oral malignancies in 
community screening programmes.” 
“Adjunctive oral cancer screening aids, such as toluidine blue vital dye, may be 
effective in certain clinical settings. Additional studies are needed to evaluate the 
effectiveness of the oral cyto-brush and toluidine blue vital dye as aids to oral 




Appendix 3.22: Moderate Quality Clinical Guidelines – Adjunct tools 
CG -ID Recommendations Evidence Rating 
SPH (2015) “Has a reliable test suitable for use in 
primary care been identified? This may be 
an alternative or an adjunct to the visual 
examination.”  
“One of the questions for this current 
review is ‘has a reliable test suitable for use 
in primary care been identified? This may 
be an alternative or an adjunct to the visual 
examination.’ Potential adjunct tests 
include: 
• Vital rinsing or staining (Toluidine blue, 
Tolonium chloride)  
• Light-based detection (e.g. ViziLite and 
ViziLite Plus, Microlux/DL, VELscope, 
Orascoptic DK, Identafi 3000)  
• Mouth self-examination  
• Blood and saliva analysis.” 
“Criteria not met”.  
Based on no quality of 
evidence rating, with no 
strength of recommendation 
assigned. 
BDA (2010) “There is also the option, now, of using 
several chairside adjuncts to assist in oral 
mucosal screening, but the clinical decision 
(to refer or to monitor) should not be 
entirely based on these tools for the 
following reasons: 
1. They are not sufficiently tested in 
primary care, so the evidence for their 
effectiveness in primary care is lacking. 
2. Though the sensitivity is high (they can 
detect most lesions), the specificity 
remains low (they can also detect many 
benign lesions), leading to high false 
positive rates and unnecessary referrals. 
For most patients, a soft tissue examination 
without any use of adjuncts will be 
completely adequate. And you might, very 
occasionally, see a lesion that so obviously 
needs to be referred to a specialist that any 
additional investigation in practice would 
not be needed. But for high risk patients 
without obvious lesions, the accuracy of an 





also a possible benefit in the way the use of 
an adjunct raises patient awareness of a 
risk.” 
“Any diagnostic test for identifying a 
malignancy should not be used as a 
substitute for a thorough clinical 
examination.”  
“Adjunct tests can improve visibility and 
detection, but must not be used as a sole 
method for detecting lesions.”  
CDSBC (2008) “Adjunctive screening tools may be of 
added value and could be considered in 
conjunction with annual oral cancer 
screening examination or at the time of 
identification of any suspicious lesion”  
“Techniques currently used by the BC Oral 
Cancer Prevention Program affiliated 
clinics include toluidine blue staining and 
direct fluorescence visualization… 
Although these techniques are not 
diagnostic alone, they may enhance lesion 
characteristics, identify satellite lesion 
sites and assist in biopsy site selection. 
These techniques are complementary to and 
not a replacement for the 
comprehensive history and conventional 
visual and manual head, neck and oral 
examination. Good clinical 
judgment remains indicated in all 
circumstances.” 
“Toluidine blue Staining: The research was 
conducted at the BC Cancer Agency has 
shown that biopsy-proven oral malignant 
lesions that stain positively are six times 
more likely to become oral cancers than 
those that do not. The finding supports a 
role for this vital stain in identification of 
high-risk oral lesions.” 
Based on no quality of 
evidence rating, with no 
strength of recommendation 
assigned. 
 
AHRQ (2007) “Adjunctive toluidine blue dye to enhance 
the screening examination did not 
significantly improve detection of lesions 
nor reduce oral cancer incidence compared 
with a placebo-dye screening examination. 
No study evaluating other adjuncts 
(chemiluminescent lighting, auto 
fluorescent lighting, or brush 
cytopathology) met our inclusion criteria.” 
Based on no quality of 
evidence rating, with no 
































“Toluidine blue staining has gained 
support in some centres as a screening test 
for potentially malignant and malignant 
lesions of the oral mucosa. Whilst this 
technique may have some limited 
application in specialist centres, screening 
in the primary care setting should be 
focused upon detection of mucosal 
abnormalities by direct visualisation 
during a thorough examination of the oral 
tissues.”  
Based on no quality of evidence 




































From: Badriya Alrahbi <drbadriya.bsc.ihs@gmail.com> 
Date: Wed, Sep 28, 2016 at 6:44 AM 
Subject: Re: Ethical approval for the 2nd project 
To: Naeema Al Bulushi <nmalbulushi@gmail.com> 
 
Good morning  Ms Naima   
 
Thanks you for your email  
please note that this is a pre-pilot study therefore not required approval from central Research 
committee it only required approval from your university.once you get the full real proposal you can 
then send it to us for approval  





Dr. Badria Al-Rahbi 




















INFORMATION ABOUT THE RESEARCH 
 
“Oral cancer risk assessment and prevention: cross national pre-pilot 





You are being invited to take part in a research study. Before you decide whether to take part in the 
study, it is important that you understand why the research is being done and what it will involve for 
you. Please take some time to read the following information carefully. Feel free to discuss the 
study with others before you decide. Ask us if there is anything that is not clear or if you would like 
more information. Take time to decide whether or not you wish to take part. 
 
 
What is the purpose of the study? 
The study is a qualitative study, involving individual interview (one-to-one) to explore the views of 
dental teams in Scotland and Sultanate of Oman on oral cancer examination and prevention 
guidance. We want to find out the barriers and facilitators to oral cancer risk assessment, oral 
examination, preventive advice and referral in dental practice.  
 
 
Why have I been chosen? 
You are being asked to take part in the study because you are working in General Dental Practice 
and can inform us as to the feasibility of translation research evidence and guidelines to everyday 
working environments.  
 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you do decide to take part, please remember 





What will happen to me if I take part? 
We will invite you to participate in a 30-45 minute face-to-face interview. Questions will focus on the 
current barriers and facilitators to oral cancer risk assessment, examination, patient recall, advice-
giving and referral in dental practice. We would also like to explore which aspect of best practice for 
oral cancer risk assessment, examination and prevention are transferrable to dental practice to 
improve outcomes for patients. 
 
We will make sure that you are happy with being tape-recorded beforehand. 
 
 
What do I have to do? 
If you are happy to take part, we will contact you to arrange a mutually convenient time for the 
interview. If you do not want to take part, we will not contact you again. 
 
 
What are the possible disadvantages and risks of taking part? 
There are no identified risks and it is very unlikely that you will come to any harm as a result of 
taking part in the study. However, if you feel uncomfortable or do not wish to continue at any time, 
you can leave the discussion without giving any reason. 
 
 
What are the possible benefits of taking part? 
We hope the information that will be collected during this study will be useful to support 
implementation and sustained use of oral cancer guidance in risk assessment, examination, 
prevention and referral for the benefit of the public. 
 
Each face-to-face interview participant will receive CPD allowance (CPDA) from NES in direct 
return for participation in the study. (Scotland Only) 
 
 
Will my taking part in this study be kept confidential? 
Your information will be kept strictly confidential and anonymous. You will only be identified by an 
ID number, and any information about you will have your name removed so that you cannot be 
recognized from it. The anonymized interview notes and your records will be held securely for at 
least 10 years at the University of Glasgow (in accordance with Medical Research Council best 
research practice guidelines). We will then destroy them. 
 
 
What will happen to the results of the research study? 
The results will be used to write a PhD thesis, and will be made available as scientific papers in 
journals and presentations at seminars and/or conferences. We can also send you a short 





Who is organising and funding the research? 
The study is being conducted by the Glasgow Dental Hospital and School at the University of 
Glasgow. The study is funded by NHS Education for Scotland, Glasgow Dental Educational Trust, 
and Ministry of Health - Sultanate of Oman. 
 
 
Who has reviewed the study? 
The project has been reviewed by the College of Medicine, Veterinary and Life Sciences ethics 
committee, NHS West of Scotland Research Ethics Service (WoSRES) and NHS R&D 
Management committee. A study proposal has also been submitted to the Glasgow Dental Hospital 
and School Research Management Committee.  
 
 
Contact for Further Information: 
 
Please contact Dr Sweta Mathur at s.mathur.1@research.gla.ac.uk or +44 777 839 1940; 
 
Mrs Naeema Al Bulushi at n.al-bulushi.1@research.gla.ac.uk or +44 749 451 0033; 00968 
92303333 (Oman) 
  
If you have any concerns about any aspect of this study, please contact Dr Alastair Ross at 
alastair.ross@gla.ac.uk or +44 141 211 9811 
 
 





























Interview Topic Guide 
 
[For oral cancer feasibility interviews in Scotland and Sultanate of Oman; to 
be used in conjunction with slides/ display outlining the suggested stages of 
the pilot study] 
 
Title of Project: 
Oral cancer risk assessment, examination and prevention: cross national pre-pilot 





a) Introduce self and study background (i.e. systematic reviews/ 
evidence synthesis/ Scotland and Oman/ INHANCE/ pilot trial) 
b) Have you read the information sheet and consent form? Do you have 
any questions regarding this? 
c) I will audio-record the discussion, and the recordings will be kept for 
10 years after the project finishes, but everything you say will be in 
strictest confidence. 
d) Aim of these interviews: I would like to know about the current 
barriers and facilitators to oral cancer risk assessment, examination, 
recall interval, advice-giving and referral in dental practice. I would also 
like to explore which aspect of best practice for oral cancer risk 
assessment, examination and prevention are transferrable to dental 
practice to improve outcomes for patients. 
e) I would also like to know your views on current practice and any 
suggestions to help us guide our development of an oral cancer 





2. GENERAL INFO 
 
a) What is your current role/title? 
b) How long have you been practicing? 
c) What if any is your background relating to oral cancer? 
i. Any training? CPD? specialty etc.? 
 
 
3. CURRENT PRACTICE  
 
a) What risks of oral cancer do you know about? 
i. Smoking/ alcohol 
ii. Age/gender/socioeconomic status/education/family history 
iii. Do you ever discuss oral cancer risks with your patients? Is 
this as a norm if they have risk factors? Or if patients bring it 
up? 
iv. Do you target people based on risk? 
b) Examination, prevention and recall: Do you take these risks into 
account?  
i. How do you find out about these things? 
1. When / how do you take social history? 
ii. Do you use any assessment/screening tools? 
c) Do you carry out oral soft tissue examinations / and extra-oral 
examinations? 
i. How? Do you follow any guidelines? 
ii. Do you use any adjunct tools? 
iii. Why do you carry these out? on whom? When? How often? 
d) How many patients have you seen with oral cancer / suspicious 
lesions etc.? 
i. What happened next? 
ii. What about referral, follow up, recall? 
e) Do you ever give people advice on smoking? 
i. How? Who? When? 
f) Do you ever give people advice on drinking? 
i. How? Who? When? 
g) Have you ever referred anyone on to another service for their 
smoking/ drinking? 
i. How? What? [cessation /counselling service etc.] 
ii. What did that involve? or signpost – i.e. provide smoking quit 
line telephone number? 
iii. If not- why? 
h) Is there anything you think is missing/not working in your 
practice on oral cancer? 
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i. What?  
ii. What might improve things?  
 
 
4. RISK PROFILING/ASSESMENT: [INTRODUCE  THE INHANCE 
GRAPHIC] 
 
a) Are you aware of risk assessment tools for  breast cancer, 
cardiovascular diseases, etc.? 
  
b) What are your general views on this type of tool? 
 
c) Would it help to have a tool for oral cancer that profiled/ 
quantified risk using this type of information? (red, amber or 
green) 
 
d) How would it work best in practice?  
i. Where? When? Who?  
ii. 2 Ways of using this tool: 
1. Self-completion in waiting room- when patient come to 
you  
risk already calculated for your (save your time)?  
2. go over with dental professional- as part of oral health 
assessment (help to break ice and tailor advice)? 
iii. Online tool/ as an app/ paper questionnaire? 
 
e) Would you/ could you use this as a decision tool? 
i. To guide Oral exams?  Preventive strategies? Recall? 
Referral? 
ii. How would it help? Or What would the difficulties be? 
 
f) Would this tool help to introduce patient with term ‘oral cancer 
risk’? 
 
g) What about colleagues/ others that you know about/ work with?  
i. What would they think about this type of profiling? 
 
 





a) What are your general views on a comprehensive intra and 
extra oral examination? 
i. Who should get it, when, how often? 
ii. Including specifically pulling the tongue out with and 
examining posterior lateral border and under surface.. 
b) Should it be targeted to a risk profile e.g. charting/ recall 
interval etc.? 
c) How should it be explained/ introduced? 
i. Would it be good to tie it to a risk profile? or described as an 
“oral cancer check”? 
1. How would you feel about this? How do you think your 
patients would feel about this? 
ii. How does this soft tissue exam fit within a more general oral 
health assessment (including medical history/ dental charting/ 
BPE/ periodontal chart)? 
 
 
6. ADVICE/ BRIEF INTERVENTION [GIVE BRIEF EVIDENCE SUMMARY 
FROM SWETA’S REVIEW] 
 
a) Would you be comfortable giving brief (up to 5 min. at least) 
advice/counselling on Smoking, again tied to the risk profiling? 
i. Why? What would help? 
ii. When would this be possible/ useful, if at all? 
b) Would you be comfortable giving brief (up to 5 min. at least) 
advice/counselling on Alcohol, again tied to the risk profiling? 
i. Why? What would help? 
ii. When would this be possible/ useful, if at all? 
c) Would you attend training to learn how to counsel/ advise 
patients on their behaviours? 
i. Why/ why not? What about e-learning/ CPD type activity? 
ii. How much training would you think appropriate: 1 session 
(half a day) or 2 sessions (1 day)? 
d) Who is the best member of the dental team to give such advice? 
i. Dentist, Nurse, hygienist/therapist; why?  
e) What are the benefits/ drawbacks of advice/ counselling 
following from INHANCE risk profile? 
i. Having previously completed the risk tool – do you think the 
“ice will have been broken”? 
f) What should go alongside brief counselling? 





7. REFERRAL  
a) Would you be comfortable referring patients to services based 
on risk profiles?  
i. more intensive counselling, NRT/ pharmacological support, 
group activities 
b) Would you/ could you follow patients up to see if it worked? 
 
 
8. OTHER  
a) Is there anything about oral cancer early detection/ advice/ 
prevention we haven’t covered? 





















Appendix 5.1: Topic Guide 
             
 
“Oral (mouth) cancer risk assessment, examination and prevention: patients’ views and 
experiences to develop an intervention to implement best practice and clinical guidelines in 
general dental practices in Scotland and the Sultanate of Oman” 
9. INTRODUCTION (introduce self) 
▪ Have you read the information sheet and consent form? Do you have any 
questions regarding this? 
▪ I would like to know your views and experiences of previous and current 
dental practice visits in relation to oral/mouth examination, advice and 
referral for smoking, alcohol, etc. 
▪ There are no right answers; I just want to know your views. 
 
1) Thinking of the last 5 years, how often have you visited general dental 
practice? 
 


















2) Thinking of the last 5 years, what reasons have you had for visiting 
general dental practice? (tick all that apply) 
 
     
Check
-up 
      
Follow
-up 
      Pain / 
Emergenc
y 





    
Othe
r  




10. GENERAL AWARENESS AND RISKS 
 
1) Have you heard of mouth cancer? 
Yes       No 
 
Prompts: Where have you heard? What have you heard? e.g. from dental team, any 
history- you or in family, social media, or other. 
If mouth cancer patient- what their case is- how and when detected, referral and treatment? 
 
2) Do you know what causes mouth cancer? 
Overall how much do you know about causes for mouth cancer? 
Prompts: Smoking/ alcohol/ other form of tobacco/ age/ gender/ SES/ family 
history 






1) Has anyone from the dental team checked you for mouth cancer - 
inside the mouth (intra oral)? 
Prompts: retracting your cheek, pulling your lower lip to check the inner 
side of your lip, using gauze to grasp the tip of your tongue and look at 
the back and the side of the tongue 
Every visit or sometimes? 
























Do you know you could be checked for mouth cancer by dental team? 
 
2) Has anyone from the dental team checked you for mouth cancer - neck 
area (extra oral)? 
Prompts: did a member from a dental team palpate your face, ears, and neck area with their 
hands 
Every visit or sometimes? 
 
3) If no to 1) or 2), would you be happy to be examined during your 
appointment? 
If no, why not? 
 
4) If dental team checked, did they tell you it was a “mouth cancer check”? 
How would you feel about dental team using the term “mouth cancer check” while 
examining you? 
Prompts: why or why not? 
 
 
5) We’re conducting interviews in Oman as well: there are some cultural 
issues like- a male dentist checking a female patient, or vice-versa. 
What are your thoughts on this? 
Prompts: Would you be happy to be examined by female/male dentist? If not, why? 
 
12. PREVENTION (ADVICE/ REFERRAL) 
 
a. Smoking or other form of tobacco (views and experiences of current/previous visits) 
 
     
Not happy  
at all 1 
     
Not 
happy 2 
      
Not 
sure 3 









1) May I ask, are you a smoker? 
     Never       Current       Ex-
smoker 
 
2) Do you use any other tobacco products? 
Yes       No 
If yes, which ones? E.g. pipe tobacco, cigars, chewing tobacco, E-cigarettes or 
other? 
 
3) Has your dental team ever asked about your smoking status? 
     Yes       No 
 
4) If smoker, have you ever thought about quitting? 
     Yes       No 
Prompts: why or why not? 
 
5) If smoker (current or ex): has your dental team ever offered advice / 
counselling on smoking (or other form of tobacco)? 
     Yes       No 
 
Prompts: What did they say? Why you had that conversation? What context- mouth 
cancer, gum disease, staining, or other? 
What advice do you remember? 
▪ Harmful effects of smoking or benefits of quitting 
▪ Any leaflets or educational materials 
▪ Referral: cessation/counselling services or to pharmacist or provided 
smoking quit line number or medicines for quitting (NRT- gum, patches, 
and lozenges), etc. 
▪ Did it help? 
▪ Any follow-up (by phone calls or next appointment) 
 
6) How do you feel about receiving smoking advice from: 
□ Dental team within the practice (as part of consultation) 
□ Or dentist referring you to cessation services or GP 
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7) If current smoker, how would you feel about receiving brief advice up to 5 minutes 
from your dental team about quitting smoking? 
 
Prompts: why or why not? What would help? 
 
 
b. Alcohol (views and experiences of current/previous visits) 
 
1) May I ask, how often do you have a drink containing alcohol? 
 
     Never      Monthly 
or less 
     2–4 times per 
month 
     2–3 times per 
week 
      4+ times 
per week 
 
2) Has your dental team ever asked you about drinking? 
     Yes       No 
 
Prompts: If yes, did they use a tool or questionnaire to ask about alcohol? 
 
3) Has your dental team ever offered any advice / counselling on alcohol? 
     Yes       No 
 
     
Not happy  
at all 1 
     
Not 
happy 2 
      
Not 
sure 3 









Prompts: What did they say? Why you had that conversation? What context- mouth 
cancer, gum disease, trauma, or other? 
What advice do you remember? 
▪ Harmful effects of alcohol or benefits of moderating/ quitting 
▪ Talked about safe drinking levels 
▪ Any leaflets or educational materials 
▪ Referral: cessation/counselling services or to pharmacist or provided quit 
line number, etc. 
▪ Did it help? 
▪ Any follow-up (by phone calls or next appointment) 
 
4) How do you feel about receiving alcohol advice from: 
□ Dental team within the practice (as part of consultation) 
□ Or dentist referring you to cessation services or GP 
Prompts: why or why not? 
 
5) How would you feel about receiving brief advice up to 5 minutes from 
your dental team about alcohol? 






13. POTENTIAL INTERVENTION 
 
1) How would you feel about dentist telling you a risk score as 
high, medium or low for mouth cancer based on your personal 
information- e.g. smoking, alcohol, age, years of education, 
family history? 
 
     
Not happy  
at all 1 
     
Not 
happy 2 
      
Not 
sure 3 










Prompts: Which would then lead onto a mouth cancer check and then appropriate 
smoking/alcohol behavioural counselling? 
Do you think people will be happy to provide this information correctly to their dental 
team? 
 
2) How would you feel or how happy would you be about having a 
risk score/ categorisation? 
Prompts: why or why not? 
 
3) How would you feel if “mouth cancer check” was given 
following a discussion about mouth cancer risks? 
Prompts: why or why not? 
 
4) Would you be happy to enter this information onto a paper form 
or online form or an app at the practice or would you be happy 
for someone in the dental team to ask you these directly? 
Prompts: self-completion in waiting room? Or go over with dental team- as part of 
consultation? 
5) Which would you prefer to receive risk categorisation as: 
□ Traffic light - Red (for high), Amber (for medium), Green (for low) 
□ High, medium and low 
□ As a number or percentage score or in times  
e.g. chance of getting cancer in 5 or 10 or 20 years 
 
     
Not happy  
at all 1 
     
Not 
happy 2 
      
Not 
sure 3 




    
Very 
happy 5 
     
Not happy  
at all 1 
     
Not 
happy 2 
      
Not 
sure 3 









6) Would you be happy to visit the dentist for a mouth cancer check more 
often (3-6 months) if dentist told you were at higher risk? 
Prompts: people who smoke or drink alcohol should come every 3 to 6 months for check-
up than those who don’t smoke or drink- to make sure nothing is wrong. 
 
7) Would you be happy to visit the dentist less often (12months or 2 
yearly) if dentist told you were considered at low risk? 
Prompts: Note and you had no other dental problems and the dentist considered your teeth, 
gums and mouth healthy. 
 
14. OTHER  
 
1) Is there anything else re mouth cancer check, brief advice and referral you wish to 
say? 
 
15. GENERAL BACKGROUND INFORMATION (so we cover a range of patients, 
we’ll not disclose any information) 
 






3) What is your ethnic group? 
 
White 
Scottish Northern Irish 
Gypsy/ 
traveler  
English British Polish 






















Indian Scottish  






African Scottish  







Black Scottish  
or Black British 





4) For Oman:   Nationality:  
 
Omani        Non-Omani  
____________ 
 
5) Where do you live now: Governorate _________________ 
Province___________ 
 
6) Are you currently working? 
Yes       No 
 




7) What is your postcode? __________________ 
(It will not be used to look up your address or to identify you in any way. We are 
asking this so we get people from different parts of Scotland.) 
 



















































































































Appendix 5.7: Consent Form (Arabic and English)  
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Title of Project: 
Oral (mouth) cancer risk assessment, examination and prevention: patients’ views and experiences 
to develop an intervention to implement best practice and clinical guidelines in general dental 
practices in Scotland and Sultanate of Oman 
 
Name of Researcher(s): 
Ms Sweta Mathur; Mrs Naeema Al Bulushi; Dr Alastair Ross; Prof David Conway; Prof Lorna 
Macpherson; Prof John Gibson 
 
 
 Please initial box 
1. I confirm that I have read the information sheet dated 21 November 2016 
(Version 1.0) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason, without my medical care or legal rights 
being affected. 
 
3. I give my permission for the interview that I take part in to be tape-recorded. 
 
 
4. I agree to take part in the above study. 
 
 
5. I agree to be approached with opportunities to take part in further studies (if 
yes – please complete contact details below) 
 
 
           
Name of subject Date Signature 
 
    
Name of Person taking consent  Date Signature 
 
  
Contact details:  
 





Appendix 5.8: Information About the Research 
 
INFORMATION ABOUT THE RESEARCH 
“Oral cancer risk assessment, examination and 
prevention: patients’ views and experiences to 
develop an intervention to implement best practice 
and clinical guidelines in general dental practices in 
Scotland and the Sultanate of Oman” 
Introduction 
You are being invited to take part in a research 
study. Before you decide whether to take part in the 
study, it is important that you understand why the 
research is being done and what it will involve for 
you. Please take some time to read the following 
information carefully. Feel free to discuss the study 
with others before you decide. Ask us if there is 
anything that is not clear or if you would like more 
information. Take time to decide whether or not 
you wish to take part. 
What is the purpose of the study? 
The study is a qualitative study, involving 
individual interview (one-to-one) to explore the 
views and experiences of patients attending general 
dental practices in Scotland and Sultanate of Oman 
on oral cancer risk assessment, clinical examination 
and preventive interventions. We want to find out 
the barriers and facilitators associated with oral 
cancer early detection and prevention in dental 
practices, and gather your suggestions to inform the 
development of an oral cancer early detection and 
prevention intervention package. 
Why have I been chosen? 
You are being asked to take part in the study 
because you are attending general dental practice 
and can inform us as to the feasibility of translation 
research evidence and guidelines to everyday 
working environments.  
Do I have to take part? 
It is up to you to decide whether or not to take part. 
If you do decide to take part, please remember that 
you are free to withdraw at any time and without 
giving a reason. 
What will happen to me if I take part? 
We will invite you to participate in a 15-20 minute 
face-to-face interview. Questions will focus on the 
current barriers and facilitators to oral cancer risk 
assessment, examination, recall interval, advice-
giving and referral among patients attending general 
 لبحث معلومات عن ا
ظر وجهة ن سرطان الفم:من  صات و الوقايةوحتحديد المخاطر و الف "
رضى و تجاربهم لتطوير وسائل الوقاية لتطبيق أفضل السبل المتبعة و الم 
المبادئ التوجيهية السريرية في الممارسات العامة في مجال طب األسنان 




تشارك ما إذا كنت س ررفي دراسة بحثية. قبل أن تق اركةوون للمشأنتم مدع
من المهم أن تفهم لماذا يجري هذا البحث وما سينطوي ه الدراسة، في هذ
جى أخذ بعض الوقت لقراءة المعلومات التالية بعناية. ال عليه تجاهك. ير
ن هناك تتردد في مناقشة هذه الدراسة مع اآلخرين قبل أن تقرر. ابلغنا إذا كا
جى معلومات. يرفي مزيد من ال بء غير واضح، أو إذا كنت ترغأي شي
 ت الكافي لتقرر ما إذا كنت ترغب في المشاركة أو ال ترغب.   أخذ الوق
 
 ما هو غرض الدراسة؟ 
تعتبر هذه الدراسة نوعية حيث أنها تشمل على مقابلة فردية )واحد إلى 
ممارسات ين يحضرون الواحد( الستكشاف آراء وتجارب المرضى الذ
سرطان الفم قييم مخاطر ة عمان في تكتلندا، وسلطنسا األسنان العامة في 
ت والتسهيالت والفحص السريري والتدخالت الوقائية. نريد معرفة العقبا
المرتبطة بالكشف المبكر عن سرطان الفم والوقاية في ممارسات طب 
رطان الفم المبكر عن س األسنان، وجمع اقتراحاتكم ليسترشد بها في الكشف
 الوقائية.  ت ووضع حزمة التدخال
 
 
 لماذا تم اختياري أنا؟ 
لقد تم اختيارك للمشاركة في الدراسة ألنك تستخدم خدمات الممارسة العامة 
لطب األسنان، وبالتالي يمكن أن توضح لنا الجدوى من أدلة البحوث 
 والمبادئ التوجيهية لبيئات العمل اليومية.    
 
 شاركة في البحث؟ لزم بالمنا م هل أ
إذا كنت ترغب في مشاركة من عدمه. رار ال تخاذ قلكم ال كواألمر متر 
ي االنسحاب في أي وقت ودون إبداء المشاركة، الرجاء تذكر أنك حر ف
 األسباب. 
 
 ماذا سيحدث لي إذا كنت سأشارك في البحث؟ 
 20-15ين سوف ندعوكم للمشاركة في مقابلة وجها لوجه لمدة تتراوح ب
اطر ت لتقييم مخو التسهيال عقبات الحاليةلا قة. سوف تتركز األسئلة على دقي
سرطان الفم والفحص، والفاصل الزمني للتذكير، وإعطاء المشورة 
اإلحالة بين المرضى الذين يحضرون ممارسات األسنان العامة. كما نود و
ا يتعلق أن نعرف وجهات نظركم بشأن الممارسة السابقة والحالية فيم





dental practices. We would also like to know your 
views on previous and current practice in relation to 
oral examination and preventive advice. 
We will make sure that you are happy with being 
tape-recorded beforehand. 
What do I have to do? 
If you are happy to take part, we will arrange a 
mutually convenient time for the interview. If you 
do not want to take part, we will not contact you 
again. 
What are the possible disadvantages and risks of 
taking part? 
There are no identified risks and it is very unlikely 
that you will come to any harm as a result of taking 
part in the study. However, if you feel 
uncomfortable or do not wish to continue at any 
time, you can leave the discussion without giving 
any reason. 
What are the possible benefits of taking part? 
We hope the information that will be collected 
during this study will be useful to support 
implementation and sustained use of oral cancer 
guidance in risk assessment, examination, 
prevention and referral for the benefit of the public. 
Each face-to-face interview participant will receive 
_____ as an incentive? 
 
Will my taking part in this study be kept 
confidential? 
Your information will be kept strictly confidential 
and anonymous. You will only be identified by an 
ID number, and any information about you will 
have your name removed so that you cannot be 
recognized from it. The anonymized interview 
notes and your records will be held securely for at 
least 10 years at the University of Glasgow (in 
accordance with Medical Research Council best 
research practice guidelines). We will then destroy 
them. 
What will happen to the results of the research 
study? 
The results will be used to write a PhD thesis, and 
will be made available as scientific papers in 
journals and presentations at seminars and/or 
conferences. We can also send you a short summary 
of the findings if you wish. 
Who is organising and funding the research? 
The study is being conducted by the Glasgow 
Dental Hospital and School at the University of 
Glasgow. The study is funded by NHS Education 
for Scotland, Glasgow Dental Educational Trust, 
and Ministry of Health - Sultanate of Oman. 
 سجيل المقابلة مسبقاً.   تمانع من تن إن كنت ال وسوف نتأكد م
 ما يجب القيام به؟ 
إذا كنت سعيدًا المشاركة، سوف نرتب وقت مناسب للطرفين إلجراء 
 المقابلة. إذا كنت ال تريد المشاركة، سوف لن نتصل بك مرة أخرى. 
 
  ؟طر نتيجة المشاركة في البحث حتملة والمخاما هي العيوب الم
 وأنه من المستبعد جدًا أن تتعرض ألي م تحديدها مخاطر تذكر تال توجد أية 
ضرر نتيجة للمشاركة في الدراسة. ومع ذلك، إذا كنت تشعر بعدم 
االرتياح، أو ال ترغب في االستمرار في أي وقت، يمكنك ترك المناقشة 
 دون إبداء أي سبب.   
 
  ؟ المحتملة للمشاركة في البحثي الفوائد ه ما
خالل هذه الدراسة ستكون مفيدة لدعم يتم جمعها لومات التي سنأمل أن المع 
تنفيذ واالستخدام المستمر للتوجيهات المتعلق بتقييم وفحص مخاطر 
 سرطان الفم و اإلحالة من أجل خدمة الصالح العام. 
 
 
 كحافز؟ -------سوف يحصل كل مشارك في المقابلة وجها لوجه على 
 
 محاطة بالسرية؟ في هذه الدراسة  هل ستكون مشاركتي
 
معلومات الخاصة بك سرية ومجهولة تماما. سيتم التعرف عليك ى الستبق
فقط برقم معرف، وسيتم إزالة اسمك عن أي معلومات تتعلق بك بحيث ال 
ك من خاللها. سوف تبقي المالحظات من المقابلة يمكن أن يتم التعرف علي
 10ك محفوظة بشكل آمن لمدة ة المصدر والسجالت الخاصة بمجهول
ألقل في جامعة غالسكو )وفقا ألفضل الممارسات للمبادئ سنوات على ا
بحوث من قبل "مجلس البحوث الطبية"(. وبعد انقضاء تلك التوجيهية لل
 الفترة سوف يتم التخلص منها. 
 اذا سيحدث لنتائج الدراسة البحثية؟ م
 
ه، وستكون متاحة كورقة ستخدم لكتابة أطروحة دكتوراالنتائج سوف ت 
ت والعروض المقدمة في حلقات دراسية و/أو مؤتمرات. ة في المجالعلمي
 رسل لك ملخص مقتضب للنتائج إذا كنت ترغب في ذلك. ويمكن أيضا أن ن
 
 حث؟ ما هي الجهة المنظمة و الممولة للب
 
األسنان في جامعة يقوم بهذه الدراسة مستشفى ومدرسة غالسكو لطب 
خدمة الصحة الوطنية بل كال من  يتم تمويل هذه الدراسة من قغالسكو. و
ب األسنان و وزارة للتعليم ألجل اسكتلندا وصندوق غالسكو لتعليم ط
 الصحة في سلطنة عمان.   
 
 من الذي قام بمراجعة هذه الدراسة؟ 
 
الطب البيطري شروع تمت مراجعته من قبل كلية الطب ولجنة أخالقيات الم 
لوطنية لغرب دمة الصحة او خدمة أخالقيات البحوث لخ  وعلوم الحياة،
لصحي الوطني. كما تم اسكتلندا و اللجنة اإلدارية للبحث و التطوير للنظام ا 
 أيضا تقديم مسودة الدراسة إلى اللجنة اإلدارية للبحوث في مستشفى





Who has reviewed the study? 
The project has been reviewed by the College of 
Medicine, Veterinary and Life Sciences Ethics 
Committee, NHS West of Scotland Research Ethics 
Service (WoSRES) and NHS R&D Management 
committee. A study proposal has also been 
submitted to the Glasgow Dental Hospital and 
School Research Management Committee.  
Contact for Further Information: 
Please contact Dr Sweta Mathur at 
s.mathur.1@research.gla.ac.uk or  
+447778391940; 
Mrs Naeema Al Bulushi at  
n.al-bulushi.1@research.gla.ac.uk or  
+447494510033 (UK); 
 +96892303333 (Oman) 
 
If you have any concerns about any aspect of this 
study, please contact Dr Alastair Ross at 
alastair.ross@gla.ac.uk or  
+44 141 211 9811 
 
Thank you for taking the time to read this 
information. 
 المعلومات يمكن االتصال: للحصول على مزيد من 
 أو  s.mathur.1@research.gla.ac.ukمأثور  دكتوره/سويتالا
 ؛  447778391940+
 نعيمة البلوشي  الفاضلة/
 n.al-bulushi.1@research.gla.ac.uk  أو 
 ؛ )بريطانيا( 447494510033+
 )عمان( +96892303333
سة، يرجى ذا كان لديك أي قلق حول أي جانب من جوانب هذه الدراإ
 أليستر روس في اإلتصال بالدكتور 
alastair.ross@gla.ac.uk  أو 
+44 141 211 9811 
 
 شكرا لكم ألخذ الوقت لقراءة هذه المعلومات.
 
 
 
 
 
